Www.research.manchester.ac.uk



Cardiovascular Risk and its Modification in Patients with Connective Tissue DiseasesMiriam O’Sullivan PhD MRCPVisiting clinical research fellow*Ian N Bruce MD FRCPProfessor of RheumatologyDeborah PM Symmons MD FRCPProfessor of Rheumatology and Musculoskeletal EpidemiologyArthritis Research UK Centre for EpidemiologyCentre for Musculoskeletal ResearchUniversity of ManchesterStopford Building, Oxford RoadManchester M13 9PTNIHR Manchester Musculoskeletal Biomedical Research UnitCentral Manchester NHS Foundation TrustManchester Academic Health Science CentreManchesterDeborah.symmons@manchester.ac.ukTelephone: +44 161 275 5044 / FAX: +44 161 275 5043*Future address:Sligo University HospitalSligo, IrelandCorresponding author: Deborah Symmons Abstract It is well documented that patients with SLE are at an increased risk of atherosclerotic cardiovascular disease. There is evidence that traditional risk factors and disease-related factors are involved in this increased risk. Less is known about cardiovascular (CV) risk and outcomes in other connective tissue diseases (CTDs). Future longitudinal observational studies may help to answer these important questions, however, because CTDs are rare, collaboration between clinicians with similar research interests is needed to ensure large enough cohorts are available to address these issues.Here we review the evidence available for CV risk in CTDs and discuss the benefits of longitudinal observational studies in identifying CV outcomes. Structured care protocols for management of cardiovascular risk in CTDs are lacking. We propose a target-based approach to assessing and managing CV risk in CTDs. Key wordsConnective tissue diseasesSLESystemic sclerosisPrimary Sjogren’s syndromeIdiopathic Inflammatory MyopathiesCardiovascular diseaseCardiovascular risk managementIntroduction (Level A)Patients with inflammatory musculoskeletal diseases have an excess risk of atherosclerotic cardiovascular disease (ACVD) compared to the general population. A meta-analysis of 24 mortality studies in patients with rheumatoid arthritis (RA) reported a weighted combined all-cause standardized mortality ratio (meta-SMR) of 1.50 (95% 1.39-1.61) with similar increases for ischaemic heart disease (meta-SMR 1.59; 95%CI 1.46-1.73) and stroke (meta-SMR 1.52; 95% CI 1.40-1.67) ADDIN EN.CITE <EndNote><Cite><Author>Avina-Zubieta</Author><Year>2008</Year><RecNum>70</RecNum><DisplayText>(1)</DisplayText><record><rec-number>70</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">70</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Avina-Zubieta, J. A.</author><author>Choi, H. K.</author><author>Sadatsafavi, M.</author><author>Etminan, M.</author><author>Esdaile, J. M.</author><author>Lacaille, D.</author></authors></contributors><auth-address>University of British Columbia and Arthritis Research Centre of Canada, British Columbia, Canada. azubieta@arthritisresearch.ca</auth-address><titles><title>Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies</title><secondary-title>Arthritis Rheum</secondary-title><alt-title>Arthritis and rheumatism</alt-title></titles><periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></alt-periodical><pages>1690-7</pages><volume>59</volume><number>12</number><edition>2008/11/28</edition><keywords><keyword>Arthritis, Rheumatoid/*complications</keyword><keyword>Cardiovascular Diseases/*mortality</keyword><keyword>Confidence Intervals</keyword><keyword>Humans</keyword><keyword>Myocardial Ischemia/mortality</keyword><keyword>Stroke/mortality</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec 15</date></pub-dates></dates><isbn>0004-3591 (Print)&#xD;0004-3591 (Linking)</isbn><accession-num>19035419</accession-num><work-type>Comparative Study&#xD;Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls><related-urls><url>;(1). The bimodal pattern of death associated with systemic lupus erythematosus (SLE) was first described in 1976 ADDIN EN.CITE <EndNote><Cite><Author>Urowitz</Author><Year>1976</Year><RecNum>329</RecNum><DisplayText>(2)</DisplayText><record><rec-number>329</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">329</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Urowitz, M. B.</author><author>Bookman, A. A.</author><author>Koehler, B. E.</author><author>Gordon, D. A.</author><author>Smythe, H. A.</author><author>Ogryzlo, M. A.</author></authors></contributors><titles><title>The bimodal mortality pattern of systemic lupus erythematosus</title><secondary-title>The American journal of medicine</secondary-title><alt-title>Am J Med</alt-title></titles><periodical><full-title>The American journal of medicine</full-title><abbr-1>Am J Med</abbr-1></periodical><alt-periodical><full-title>The American journal of medicine</full-title><abbr-1>Am J Med</abbr-1></alt-periodical><pages>221-5</pages><volume>60</volume><number>2</number><dates><year>1976</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0002-9343 (Print)&#xD;0002-9343 (Linking)</isbn><accession-num>1251849</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(2), with the first mortality peak (within 1 year of diagnosis) being due mainly to active lupus and infection and the second peak (>5 years from diagnosis) being due mainly to cardiovascular events (CVEs). In 1997 Manzi et al reported that the risk of myocardial infarction (MI) was over 50 times higher in women aged 35-44 in the University of Pittsburgh lupus cohort than in age-matched women from the Framingham offspring cohort ADDIN EN.CITE <EndNote><Cite><Author>Manzi</Author><Year>1997</Year><RecNum>384</RecNum><DisplayText>(3)</DisplayText><record><rec-number>384</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">384</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Manzi, S.</author><author>Meilahn, E. N.</author><author>Rairie, J. E.</author><author>Conte, C. G.</author><author>Medsger, T. A., Jr.</author><author>Jansen-McWilliams, L.</author><author>D&apos;Agostino, R. B.</author><author>Kuller, L. H.</author></authors></contributors><auth-address>Department of Medicine, University of Pittsburgh, PA 15213, USA.</auth-address><titles><title>Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study</title><secondary-title>Am J Epidemiol</secondary-title><alt-title>Am J Epidemiol</alt-title></titles><periodical><full-title>Am J Epidemiol</full-title><abbr-1>American journal of epidemiology</abbr-1></periodical><alt-periodical><full-title>Am J Epidemiol</full-title><abbr-1>American journal of epidemiology</abbr-1></alt-periodical><pages>408-15</pages><volume>145</volume><number>5</number><dates><year>1997</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>0002-9262 (Print)&#xD;0002-9262 (Linking)</isbn><accession-num>9048514</accession-num><work-type>Comparative Study&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(3). In this chapter we summarise the most recent literature on the risk of ACVD and the risk factors for ACVD in patients with SLE, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease and primary Sjogren’s syndrome. We performed a Medline search up until 30th November 2015 searching for “ cardiovascular risk” and “cardiovascular mortality” and combined each with “ systemic lupus erythematosus”, “ systemic sclerosis”, “Sjogren’s syndrome”, “idiopathic inflammatory myopathy” and “mixed connective tissue disease”. We have focussed on reporting relevant systematic reviews and papers published in the last 5 years. We highlight the importance of longitudinal observational studies (LOS) in contributing to this knowledge and on the value of embedding research into routine clinical practice. Finally we review strategies for cardiovascular (CV) risk management in patients with connective tissue diseases (CTD). Cardiovascular disease in patients with SLE (Level A)SLE is a chronic inflammatory autoimmune condition with significant morbidity and mortality. Survival rates for SLE have improved dramatically in recent years ADDIN EN.CITE <EndNote><Cite><Author>Mak</Author><Year>2012</Year><RecNum>386</RecNum><DisplayText>(4)</DisplayText><record><rec-number>386</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">386</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mak, A.</author><author>Cheung, M. W.</author><author>Chiew, H. J.</author><author>Liu, Y.</author><author>Ho, R. C.</author></authors></contributors><auth-address>Division of Rheumatology, Department of Medicine, University Medicine Cluster, National University of Singapore, Singapore. mdcam@nus.edu.sg</auth-address><titles><title>Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s</title><secondary-title>Semin Arthritis Rheum</secondary-title><alt-title>Semin Arthritis Rheum</alt-title></titles><periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></alt-periodical><pages>830-9</pages><volume>41</volume><number>6</number><dates><year>2012</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1532-866X (Electronic)&#xD;0049-0172 (Linking)</isbn><accession-num>22257558</accession-num><work-type>Meta-Analysis</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(4). In an international study of 9547 patients from 23 centres the all-cause SMR estimates decreased significantly between the 1970s and 2001. However, the CV SMR increased slightly PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CZXJuYXRza3k8L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFy

PjxSZWNOdW0+MzM5PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig1KTwvRGlzcGxheVRleHQ+PHJlY29y

ZD48cmVjLW51bWJlcj4zMzk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjMzOTwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmVybmF0c2t5LCBTLjwvYXV0aG9yPjxh

dXRob3I+Qm9pdmluLCBKLiBGLjwvYXV0aG9yPjxhdXRob3I+Sm9zZXBoLCBMLjwvYXV0aG9yPjxh

dXRob3I+TWFuemksIFMuPC9hdXRob3I+PGF1dGhvcj5HaW56bGVyLCBFLjwvYXV0aG9yPjxhdXRo

b3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48YXV0aG9yPlVyb3dpdHosIE0uPC9hdXRob3I+PGF1

dGhvcj5Gb3J0aW4sIFAuIFIuPC9hdXRob3I+PGF1dGhvcj5QZXRyaSwgTS48L2F1dGhvcj48YXV0

aG9yPkJhcnIsIFMuPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+PGF1dGhvcj5C

YWUsIFMuIEMuPC9hdXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC48L2F1dGhvcj48YXV0aG9yPlpv

bWEsIEEuPC9hdXRob3I+PGF1dGhvcj5BcmFub3csIEMuPC9hdXRob3I+PGF1dGhvcj5Eb29sZXks

IE0uIEEuPC9hdXRob3I+PGF1dGhvcj5OaXZlZCwgTy48L2F1dGhvcj48YXV0aG9yPlN0dXJmZWx0

LCBHLjwvYXV0aG9yPjxhdXRob3I+U3RlaW5zc29uLCBLLjwvYXV0aG9yPjxhdXRob3I+QWxhcmNv

biwgRy48L2F1dGhvcj48YXV0aG9yPlNlbmVjYWwsIEouIEwuPC9hdXRob3I+PGF1dGhvcj5adW1t

ZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5IYW5seSwgSi48L2F1dGhvcj48YXV0aG9yPkVuc3dvcnRo

LCBTLjwvYXV0aG9yPjxhdXRob3I+UG9wZSwgSi48L2F1dGhvcj48YXV0aG9yPkVkd29ydGh5LCBT

LjwvYXV0aG9yPjxhdXRob3I+UmFobWFuLCBBLjwvYXV0aG9yPjxhdXRob3I+U2libGV5LCBKLjwv

YXV0aG9yPjxhdXRob3I+RWwtR2FiYWxhd3ksIEguPC9hdXRob3I+PGF1dGhvcj5NY0NhcnRoeSwg

VC48L2F1dGhvcj48YXV0aG9yPlN0IFBpZXJyZSwgWS48L2F1dGhvcj48YXV0aG9yPkNsYXJrZSwg

QS48L2F1dGhvcj48YXV0aG9yPlJhbXNleS1Hb2xkbWFuLCBSLjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPk1vbnRyZWFsIEdlbmVyYWwgSG9zcGl0YWwsIE1v

bnRyZWFsLCBRdWViZWMsIENhbmFkYS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Nb3J0

YWxpdHkgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10

aXRsZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRp

cyBSaGV1bTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhy

aXRpcyBSaGV1bTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBhbmQgcmhldW1hdGlzbTwv

YWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlz

IFJoZXVtPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGFuZCByaGV1bWF0aXNtPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjU1MC03PC9wYWdlcz48dm9sdW1lPjU0PC92b2x1

bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48

ZGF0ZT5BdWc8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDA0LTM1OTEgKFByaW50

KSYjeEQ7MDAwNC0zNTkxIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xNjg2ODk3Nzwv

YWNjZXNzaW9uLW51bT48d29yay10eXBlPk11bHRpY2VudGVyIFN0dWR5JiN4RDtSZXNlYXJjaCBT

dXBwb3J0LCBOb24tVS5TLiBHb3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CZXJuYXRza3k8L0F1dGhvcj48WWVhcj4yMDA2PC9ZZWFy

PjxSZWNOdW0+MzM5PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig1KTwvRGlzcGxheVRleHQ+PHJlY29y

ZD48cmVjLW51bWJlcj4zMzk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjMzOTwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmVybmF0c2t5LCBTLjwvYXV0aG9yPjxh

dXRob3I+Qm9pdmluLCBKLiBGLjwvYXV0aG9yPjxhdXRob3I+Sm9zZXBoLCBMLjwvYXV0aG9yPjxh

dXRob3I+TWFuemksIFMuPC9hdXRob3I+PGF1dGhvcj5HaW56bGVyLCBFLjwvYXV0aG9yPjxhdXRo

b3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48YXV0aG9yPlVyb3dpdHosIE0uPC9hdXRob3I+PGF1

dGhvcj5Gb3J0aW4sIFAuIFIuPC9hdXRob3I+PGF1dGhvcj5QZXRyaSwgTS48L2F1dGhvcj48YXV0

aG9yPkJhcnIsIFMuPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+PGF1dGhvcj5C

YWUsIFMuIEMuPC9hdXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC48L2F1dGhvcj48YXV0aG9yPlpv

bWEsIEEuPC9hdXRob3I+PGF1dGhvcj5BcmFub3csIEMuPC9hdXRob3I+PGF1dGhvcj5Eb29sZXks

IE0uIEEuPC9hdXRob3I+PGF1dGhvcj5OaXZlZCwgTy48L2F1dGhvcj48YXV0aG9yPlN0dXJmZWx0

LCBHLjwvYXV0aG9yPjxhdXRob3I+U3RlaW5zc29uLCBLLjwvYXV0aG9yPjxhdXRob3I+QWxhcmNv

biwgRy48L2F1dGhvcj48YXV0aG9yPlNlbmVjYWwsIEouIEwuPC9hdXRob3I+PGF1dGhvcj5adW1t

ZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5IYW5seSwgSi48L2F1dGhvcj48YXV0aG9yPkVuc3dvcnRo

LCBTLjwvYXV0aG9yPjxhdXRob3I+UG9wZSwgSi48L2F1dGhvcj48YXV0aG9yPkVkd29ydGh5LCBT

LjwvYXV0aG9yPjxhdXRob3I+UmFobWFuLCBBLjwvYXV0aG9yPjxhdXRob3I+U2libGV5LCBKLjwv

YXV0aG9yPjxhdXRob3I+RWwtR2FiYWxhd3ksIEguPC9hdXRob3I+PGF1dGhvcj5NY0NhcnRoeSwg

VC48L2F1dGhvcj48YXV0aG9yPlN0IFBpZXJyZSwgWS48L2F1dGhvcj48YXV0aG9yPkNsYXJrZSwg

QS48L2F1dGhvcj48YXV0aG9yPlJhbXNleS1Hb2xkbWFuLCBSLjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPk1vbnRyZWFsIEdlbmVyYWwgSG9zcGl0YWwsIE1v

bnRyZWFsLCBRdWViZWMsIENhbmFkYS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Nb3J0

YWxpdHkgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10

aXRsZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRp

cyBSaGV1bTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhy

aXRpcyBSaGV1bTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBhbmQgcmhldW1hdGlzbTwv

YWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlz

IFJoZXVtPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGFuZCByaGV1bWF0aXNtPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjU1MC03PC9wYWdlcz48dm9sdW1lPjU0PC92b2x1

bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48

ZGF0ZT5BdWc8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDA0LTM1OTEgKFByaW50

KSYjeEQ7MDAwNC0zNTkxIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xNjg2ODk3Nzwv

YWNjZXNzaW9uLW51bT48d29yay10eXBlPk11bHRpY2VudGVyIFN0dWR5JiN4RDtSZXNlYXJjaCBT

dXBwb3J0LCBOb24tVS5TLiBHb3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (5). CVEs remain one of the main causes of death in SLE. Cardiovascular mortality in patients with SLE (Level B)CV mortality is increased in SLE patients compared to the general population. In a meta-analysis of 27,123 SLE patients from 12 studies published prior to 2011, there was a 3-fold increased risk of all-cause mortality (meta-SMR 2.98, 95% CI 2.32–3.83) and an increased risk of death from cardiovascular disease (CVD) (meta-SMR 2.72, 95% CI 2.32- 3.83) ADDIN EN.CITE <EndNote><Cite><Author>Yurkovich</Author><Year>2014</Year><RecNum>325</RecNum><DisplayText>(6)</DisplayText><record><rec-number>325</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">325</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yurkovich, M.</author><author>Vostretsova, K.</author><author>Chen, W.</author><author>Avina-Zubieta, J. A.</author></authors></contributors><auth-address>University of British Columbia, Vancouver, British Columbia, Canada.</auth-address><titles><title>Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies</title><secondary-title>Arthritis Care Res (Hoboken)</secondary-title><alt-title>Arthritis Care Res (Hoboken)</alt-title></titles><periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></periodical><alt-periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></alt-periodical><pages>608-16</pages><volume>66</volume><number>4</number><dates><year>2014</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>2151-4658 (Electronic)&#xD;2151-464X (Linking)</isbn><accession-num>24106157</accession-num><work-type>Meta-Analysis&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(6). None of the studies of mortality published since 2011 has had sufficient numbers of deaths to be able to report a CV specific SMR PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5FbGZ2aW5nPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48

UmVjTnVtPjM0MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oNywgOCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzQyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkVsZnZpbmcsIFAuPC9hdXRob3I+PGF1

dGhvcj5QdW9sYWtrYSwgSy48L2F1dGhvcj48YXV0aG9yPkthdXRpYWluZW4sIEguPC9hdXRob3I+

PGF1dGhvcj5WaXJ0YSwgTC4gSi48L2F1dGhvcj48YXV0aG9yPlBvaGpvbGFpbmVuLCBULjwvYXV0

aG9yPjxhdXRob3I+S2FpcGlhaW5lbi1TZXBwYW5lbiwgTy48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE1lZGljaW5lLCBLdW9waW8g

VW5pdmVyc2l0eSBIb3NwaXRhbCwgS3VvcGlvLCBGaW5sYW5kIHBpYS5lbGZ2aW5nQGt1aC5maS4m

I3hEO0RlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFNvdXRoIEthcmVsaWEgQ2VudHJhbCBIb3NwaXRh

bCwgTGFwcGVlbnJhbnRhLCBGaW5sYW5kLiYjeEQ7VW5pdCBvZiBQcmltYXJ5IEhlYWx0aCBDYXJl

LCBIZWxzaW5raSBVbml2ZXJzaXR5IENlbnRyYWwgSG9zcGl0YWwsIEhlbHNpbmtpLCBGaW5sYW5k

IERlcGFydG1lbnQgb2YgR2VuZXJhbCBQcmFjdGljZSwgVW5pdmVyc2l0eSBvZiBIZWxzaW5raSwg

SGVsc2lua2ksIEZpbmxhbmQgVW5pdCBvZiBQcmltYXJ5IEhlYWx0aCBDYXJlLCBLdW9waW8gVW5p

dmVyc2l0eSBIb3NwaXRhbCwgS3VvcGlvLCBGaW5sYW5kLiYjeEQ7UmVzZWFyY2ggRGVwYXJ0bWVu

dCwgU29jaWFsIEluc3VyYW5jZSBJbnN0aXR1dGlvbiwgVHVya3UsIEZpbmxhbmQuJiN4RDtSZWhh

YmlsaXRhdGlvbiBVbml0LCBPcnRvbiBIb3NwaXRhbCwgSGVsc2lua2ksIEZpbmxhbmQuJiN4RDtE

ZXBhcnRtZW50IG9mIE1lZGljaW5lLCBLdW9waW8gVW5pdmVyc2l0eSBIb3NwaXRhbCwgS3VvcGlv

LCBGaW5sYW5kLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1vcnRhbGl0eSBhbmQgY2F1

c2VzIG9mIGRlYXRoIGFtb25nIGluY2lkZW50IGNhc2VzIG9mIHN5c3RlbWljIGx1cHVzIGVyeXRo

ZW1hdG9zdXMgaW4gRmlubGFuZCAyMDAwLTIwMDg8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+THVw

dXM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkx1cHVzPC9hbHQtdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+THVwdXM8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5MdXB1czwvZnVsbC10aXRsZT48L2FsdC1wZXJpb2Rp

Y2FsPjxwYWdlcz4xNDMwLTQ8L3BhZ2VzPjx2b2x1bWU+MjM8L3ZvbHVtZT48bnVtYmVyPjEzPC9u

dW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5Ob3Y8L2RhdGU+

PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDc3LTA5NjIgKEVsZWN0cm9uaWMpJiN4RDswOTYx

LTIwMzMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1MDU3MDM2PC9hY2Nlc3Npb24t

bnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTm9uLVUuUy4gR292JmFwb3M7dDwvd29y

ay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3Rl

LWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0

ZT48Q2l0ZT48QXV0aG9yPkxlcmFuZzwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+PFJlY051bT4z

NDM8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjM0MzwvcmVjLW51bWJlcj48Zm9yZWlnbi1r

ZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQw

cno1ZCI+MzQzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5MZXJhbmcs

IEsuPC9hdXRob3I+PGF1dGhvcj5HaWxib2UsIEkuIE0uPC9hdXRob3I+PGF1dGhvcj5TdGVpbmFy

IFRoZWxsZSwgRC48L2F1dGhvcj48YXV0aG9yPkdyYW4sIEouIFQuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBSaGV1bWF0b2xvZ3ks

IE9zbG8gVW5pdmVyc2l0eSBIb3NwaXRhbCwgUmlrc2hvc3BpdGFsZXQsIE9zbG8sIE5vcndheSBr

bGVyYW5nQG91cy1oZi5uby4mI3hEO0RlcGFydG1lbnQgb2YgUmhldW1hdG9sb2d5LCBPc2xvIFVu

aXZlcnNpdHkgSG9zcGl0YWwsIFJpa3Nob3NwaXRhbGV0LCBPc2xvLCBOb3J3YXkuJiN4RDtEZXBh

cnRtZW50IG9mIGJpb3N0YXRpc3RpY3MsIEluc3RpdHV0ZSBvZiBCYXNpYyBNZWRpY2FsIFNjaWVu

Y2VzLCBVbml2ZXJzaXR5IG9mIE9zbG8sIE9zbG8sIE5vcndheSBEZXBhcnRtZW50IG9mIFB1Ymxp

YyBIZWFsdGggYW5kIENvbW11bml0eSBNZWRpY2luZSwgR290aGVuYnVyZyBVbml2ZXJzaXR5LCBH

b3RoZW5idXJnLCBTd2VkZW4uJiN4RDtEZXBhcnRtZW50IG9mIFJoZXVtYXRvbG9neSwgT3NsbyBV

bml2ZXJzaXR5IEhvc3BpdGFsLCBSaWtzaG9zcGl0YWxldCwgT3NsbywgTm9yd2F5IEluc3RpdHV0

ZSBvZiBDbGluaWNhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBPc2xvLCBPc2xvLCBOb3J3YXku

PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+TW9ydGFsaXR5IGFuZCB5ZWFycyBvZiBwb3Rl

bnRpYWwgbGlmZSBsb3NzIGluIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM6IGEgcG9wdWxh

dGlvbi1iYXNlZCBjb2hvcnQgc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+THVwdXM8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkx1cHVzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+THVwdXM8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxhbHQtcGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5MdXB1czwvZnVsbC10aXRsZT48L2FsdC1wZXJpb2RpY2FsPjxw

YWdlcz4xNTQ2LTUyPC9wYWdlcz48dm9sdW1lPjIzPC92b2x1bWU+PG51bWJlcj4xNDwvbnVtYmVy

PjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RGVjPC9kYXRlPjwvcHVi

LWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3Ny0wOTYyIChFbGVjdHJvbmljKSYjeEQ7MDk2MS0yMDMz

IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNTIwOTA3MDwvYWNjZXNzaW9uLW51bT48

d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlw

ZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9F

bmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5FbGZ2aW5nPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48

UmVjTnVtPjM0MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oNywgOCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzQyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkVsZnZpbmcsIFAuPC9hdXRob3I+PGF1

dGhvcj5QdW9sYWtrYSwgSy48L2F1dGhvcj48YXV0aG9yPkthdXRpYWluZW4sIEguPC9hdXRob3I+

PGF1dGhvcj5WaXJ0YSwgTC4gSi48L2F1dGhvcj48YXV0aG9yPlBvaGpvbGFpbmVuLCBULjwvYXV0

aG9yPjxhdXRob3I+S2FpcGlhaW5lbi1TZXBwYW5lbiwgTy48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE1lZGljaW5lLCBLdW9waW8g

VW5pdmVyc2l0eSBIb3NwaXRhbCwgS3VvcGlvLCBGaW5sYW5kIHBpYS5lbGZ2aW5nQGt1aC5maS4m

I3hEO0RlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFNvdXRoIEthcmVsaWEgQ2VudHJhbCBIb3NwaXRh

bCwgTGFwcGVlbnJhbnRhLCBGaW5sYW5kLiYjeEQ7VW5pdCBvZiBQcmltYXJ5IEhlYWx0aCBDYXJl

LCBIZWxzaW5raSBVbml2ZXJzaXR5IENlbnRyYWwgSG9zcGl0YWwsIEhlbHNpbmtpLCBGaW5sYW5k

IERlcGFydG1lbnQgb2YgR2VuZXJhbCBQcmFjdGljZSwgVW5pdmVyc2l0eSBvZiBIZWxzaW5raSwg

SGVsc2lua2ksIEZpbmxhbmQgVW5pdCBvZiBQcmltYXJ5IEhlYWx0aCBDYXJlLCBLdW9waW8gVW5p

dmVyc2l0eSBIb3NwaXRhbCwgS3VvcGlvLCBGaW5sYW5kLiYjeEQ7UmVzZWFyY2ggRGVwYXJ0bWVu

dCwgU29jaWFsIEluc3VyYW5jZSBJbnN0aXR1dGlvbiwgVHVya3UsIEZpbmxhbmQuJiN4RDtSZWhh

YmlsaXRhdGlvbiBVbml0LCBPcnRvbiBIb3NwaXRhbCwgSGVsc2lua2ksIEZpbmxhbmQuJiN4RDtE

ZXBhcnRtZW50IG9mIE1lZGljaW5lLCBLdW9waW8gVW5pdmVyc2l0eSBIb3NwaXRhbCwgS3VvcGlv

LCBGaW5sYW5kLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1vcnRhbGl0eSBhbmQgY2F1

c2VzIG9mIGRlYXRoIGFtb25nIGluY2lkZW50IGNhc2VzIG9mIHN5c3RlbWljIGx1cHVzIGVyeXRo

ZW1hdG9zdXMgaW4gRmlubGFuZCAyMDAwLTIwMDg8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+THVw

dXM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkx1cHVzPC9hbHQtdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+THVwdXM8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5MdXB1czwvZnVsbC10aXRsZT48L2FsdC1wZXJpb2Rp

Y2FsPjxwYWdlcz4xNDMwLTQ8L3BhZ2VzPjx2b2x1bWU+MjM8L3ZvbHVtZT48bnVtYmVyPjEzPC9u

dW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5Ob3Y8L2RhdGU+

PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDc3LTA5NjIgKEVsZWN0cm9uaWMpJiN4RDswOTYx

LTIwMzMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1MDU3MDM2PC9hY2Nlc3Npb24t

bnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTm9uLVUuUy4gR292JmFwb3M7dDwvd29y

ay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3Rl

LWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0

ZT48Q2l0ZT48QXV0aG9yPkxlcmFuZzwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+PFJlY051bT4z

NDM8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjM0MzwvcmVjLW51bWJlcj48Zm9yZWlnbi1r

ZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQw

cno1ZCI+MzQzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5MZXJhbmcs

IEsuPC9hdXRob3I+PGF1dGhvcj5HaWxib2UsIEkuIE0uPC9hdXRob3I+PGF1dGhvcj5TdGVpbmFy

IFRoZWxsZSwgRC48L2F1dGhvcj48YXV0aG9yPkdyYW4sIEouIFQuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBSaGV1bWF0b2xvZ3ks

IE9zbG8gVW5pdmVyc2l0eSBIb3NwaXRhbCwgUmlrc2hvc3BpdGFsZXQsIE9zbG8sIE5vcndheSBr

bGVyYW5nQG91cy1oZi5uby4mI3hEO0RlcGFydG1lbnQgb2YgUmhldW1hdG9sb2d5LCBPc2xvIFVu

aXZlcnNpdHkgSG9zcGl0YWwsIFJpa3Nob3NwaXRhbGV0LCBPc2xvLCBOb3J3YXkuJiN4RDtEZXBh

cnRtZW50IG9mIGJpb3N0YXRpc3RpY3MsIEluc3RpdHV0ZSBvZiBCYXNpYyBNZWRpY2FsIFNjaWVu

Y2VzLCBVbml2ZXJzaXR5IG9mIE9zbG8sIE9zbG8sIE5vcndheSBEZXBhcnRtZW50IG9mIFB1Ymxp

YyBIZWFsdGggYW5kIENvbW11bml0eSBNZWRpY2luZSwgR290aGVuYnVyZyBVbml2ZXJzaXR5LCBH

b3RoZW5idXJnLCBTd2VkZW4uJiN4RDtEZXBhcnRtZW50IG9mIFJoZXVtYXRvbG9neSwgT3NsbyBV

bml2ZXJzaXR5IEhvc3BpdGFsLCBSaWtzaG9zcGl0YWxldCwgT3NsbywgTm9yd2F5IEluc3RpdHV0

ZSBvZiBDbGluaWNhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBPc2xvLCBPc2xvLCBOb3J3YXku

PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+TW9ydGFsaXR5IGFuZCB5ZWFycyBvZiBwb3Rl

bnRpYWwgbGlmZSBsb3NzIGluIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM6IGEgcG9wdWxh

dGlvbi1iYXNlZCBjb2hvcnQgc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+THVwdXM8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkx1cHVzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+THVwdXM8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxhbHQtcGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5MdXB1czwvZnVsbC10aXRsZT48L2FsdC1wZXJpb2RpY2FsPjxw

YWdlcz4xNTQ2LTUyPC9wYWdlcz48dm9sdW1lPjIzPC92b2x1bWU+PG51bWJlcj4xNDwvbnVtYmVy

PjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RGVjPC9kYXRlPjwvcHVi

LWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3Ny0wOTYyIChFbGVjdHJvbmljKSYjeEQ7MDk2MS0yMDMz

IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNTIwOTA3MDwvYWNjZXNzaW9uLW51bT48

d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlw

ZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9F

bmROb3RlPn==

ADDIN EN.CITE.DATA (7, 8). The most recent study followed 2740 incident cases of SLE identified using the UK primary-care based Clinical Practice Research Datalink and then linked to the national death register ADDIN EN.CITE <EndNote><Cite><Author>Rees</Author><Year>2016</Year><RecNum>338</RecNum><DisplayText>(9)</DisplayText><record><rec-number>338</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">338</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rees, F.</author><author>Doherty, M.</author><author>Grainge, M. J.</author><author>Lanyon, P.</author><author>Davenport, G.</author><author>Zhang, W.</author></authors></contributors><auth-address>Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Rheumatology Department, Nottingham University Hospitals NHS Trust, frees@.uk.&#xD;Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham.&#xD;Division of Epidemiology and Public Health, University of Nottingham, Nottingham and.&#xD;Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Rheumatology Department, Nottingham University Hospitals NHS Trust.&#xD;Arthritis Research UK Primary Care Centre, Keele University, Keele, UK.</auth-address><titles><title>Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012</title><secondary-title>Rheumatology (Oxford, England)</secondary-title><alt-title>Rheumatology (Oxford)</alt-title></titles><alt-periodical><full-title>Rheumatology (Oxford)</full-title><abbr-1>Rheumatology</abbr-1></alt-periodical><dates><year>2016</year><pub-dates><date>Jan 8</date></pub-dates></dates><isbn>1462-0332 (Electronic)&#xD;1462-0324 (Linking)</isbn><accession-num>26748350</accession-num><work-type>Journal article</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>Eng</language></record></Cite></EndNote>(9). The mortality rate ratio compared to age, sex and practice matched controls was 1.67 (95%CI 1.43, 1.94). Another UK-based study followed an inception cohort of 382 SLE patients recruited from 1989-2010. The all-cause SMR was 2.0 (95% CI 1.5, 2.8), with CVEs being one of the most common causes of death ( 27%) ADDIN EN.CITE <EndNote><Cite><Author>Yee</Author><Year>2015</Year><RecNum>335</RecNum><DisplayText>(10)</DisplayText><record><rec-number>335</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">335</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yee, C. S.</author><author>Su, L.</author><author>Toescu, V.</author><author>Hickman, R.</author><author>Situnayake, D.</author><author>Bowman, S.</author><author>Farewell, V.</author><author>Gordon, C.</author></authors></contributors><titles><title>Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years</title><secondary-title>Rheumatology (Oxford)</secondary-title></titles><periodical><full-title>Rheumatology (Oxford)</full-title><abbr-1>Rheumatology</abbr-1></periodical><pages>836-43</pages><volume>54</volume><number>5</number><dates><year>2015</year></dates><isbn>1462-0332 (Electronic)&#xD;1462-0324 (Linking)</isbn><work-type>Research Support, Non-U S Gov&apos;t</work-type><urls></urls></record></Cite></EndNote>(10). Ethnicity may play a role in risk of cardiovascular mortality in SLE. A systematic review of 5 observational studies involving 4469 Chinese patients with SLE found lower rates of death from CV causes than has been documented in other ethnic groups PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYW5nPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj

TnVtPjMzNzwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMTEpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjMzNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+MzM3PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5XYW5nLCBaLjwvYXV0aG9yPjxhdXRob3I+V2Fu

ZywgWS48L2F1dGhvcj48YXV0aG9yPlpodSwgUi48L2F1dGhvcj48YXV0aG9yPlRpYW4sIFguPC9h

dXRob3I+PGF1dGhvcj5YdSwgRC48L2F1dGhvcj48YXV0aG9yPldhbmcsIFEuPC9hdXRob3I+PGF1

dGhvcj5XdSwgQy48L2F1dGhvcj48YXV0aG9yPlpoYW5nLCBTLjwvYXV0aG9yPjxhdXRob3I+Wmhh

bywgSi48L2F1dGhvcj48YXV0aG9yPlpoYW8sIFkuPC9hdXRob3I+PGF1dGhvcj5MaSwgTS48L2F1

dGhvcj48YXV0aG9yPlplbmcsIFguPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgRGVwYXJ0bWVudCBvZiBSaGV1bWF0b2xvZ3kgKFpXLCBSWiwg

WFQsIERYLCBRVywgQ1csIFNaLCBKWiwgWVosIE1MLCBYWiksIFBla2luZyBVbmlvbiBNZWRpY2Fs

IENvbGxlZ2UgSG9zcGl0YWwsIFBla2luZyBVbmlvbiBNZWRpY2FsIENvbGxlZ2UgJmFtcDsgQ2hp

bmVzZSBBY2FkZW15IG9mIE1lZGljYWwgU2NpZW5jZSwgS2V5IExhYm9yYXRvcnkgb2YgUmhldW1h

dG9sb2d5IGFuZCBDbGluaWNhbCBJbW11bm9sb2d5LCBNaW5pc3RyeSBvZiBFZHVjYXRpb24sIDsg

YW5kIERlcGFydG1lbnQgb2YgRXBpZGVtaW9sb2d5IGFuZCBCaW8tc3RhdGlzdGljcyAoWVcpLCBJ

bnN0aXR1dGUgb2YgQmFzaWMgTWVkaWNhbCBTY2llbmNlcywgQ2hpbmEgQWNhZGVteSBvZiBNZWRp

Y2FsIFNjaWVuY2VzICZhbXA7IFBla2luZyBVbmlvbiBNZWRpY2FsIENvbGxlZ2UsIEJlaWppbmcs

IENoaW5hLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkxvbmctdGVybSBzdXJ2aXZhbCBh

bmQgZGVhdGggY2F1c2VzIG9mIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXMgaW4gQ2hpbmE6

IGEgc3lzdGVtaWMgcmV2aWV3IG9mIG9ic2VydmF0aW9uYWwgc3R1ZGllczwvdGl0bGU+PHNlY29u

ZGFyeS10aXRsZT5NZWRpY2luZSAoQmFsdGltb3JlKTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+TWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5N

ZWRpY2luZSAoQmFsdGltb3JlKTwvZnVsbC10aXRsZT48YWJici0xPk1lZGljaW5lPC9hYmJyLTE+

PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5NZWRpY2luZSAoQmFsdGlt

b3JlKTwvZnVsbC10aXRsZT48YWJici0xPk1lZGljaW5lPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNh

bD48cGFnZXM+ZTc5NDwvcGFnZXM+PHZvbHVtZT45NDwvdm9sdW1lPjxudW1iZXI+MTc8L251bWJl

cj48ZWRpdGlvbj4yMDE1LzA1LzAyPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DaGluYS9l

cGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx1

cHVzIEVyeXRoZW1hdG9zdXMsIFN5c3RlbWljLyBtb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+

UHJvZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29yZD48a2V5d29y

ZD5TdXJ2aXZhbCBBbmFseXNpczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE1

PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlz

Ym4+MTUzNi01OTY0IChFbGVjdHJvbmljKSYjeEQ7MDAyNS03OTc0IChMaW5raW5nKTwvaXNibj48

YWNjZXNzaW9uLW51bT4yNTkyOTkzMDwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGN1c3Rv

bTI+NDYwMzAzNDwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA5Ny9tZC4w

MDAwMDAwMDAwMDAwNzk0PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNl

LXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xh

bmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYW5nPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj

TnVtPjMzNzwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMTEpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjMzNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+MzM3PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5XYW5nLCBaLjwvYXV0aG9yPjxhdXRob3I+V2Fu

ZywgWS48L2F1dGhvcj48YXV0aG9yPlpodSwgUi48L2F1dGhvcj48YXV0aG9yPlRpYW4sIFguPC9h

dXRob3I+PGF1dGhvcj5YdSwgRC48L2F1dGhvcj48YXV0aG9yPldhbmcsIFEuPC9hdXRob3I+PGF1

dGhvcj5XdSwgQy48L2F1dGhvcj48YXV0aG9yPlpoYW5nLCBTLjwvYXV0aG9yPjxhdXRob3I+Wmhh

bywgSi48L2F1dGhvcj48YXV0aG9yPlpoYW8sIFkuPC9hdXRob3I+PGF1dGhvcj5MaSwgTS48L2F1

dGhvcj48YXV0aG9yPlplbmcsIFguPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgRGVwYXJ0bWVudCBvZiBSaGV1bWF0b2xvZ3kgKFpXLCBSWiwg

WFQsIERYLCBRVywgQ1csIFNaLCBKWiwgWVosIE1MLCBYWiksIFBla2luZyBVbmlvbiBNZWRpY2Fs

IENvbGxlZ2UgSG9zcGl0YWwsIFBla2luZyBVbmlvbiBNZWRpY2FsIENvbGxlZ2UgJmFtcDsgQ2hp

bmVzZSBBY2FkZW15IG9mIE1lZGljYWwgU2NpZW5jZSwgS2V5IExhYm9yYXRvcnkgb2YgUmhldW1h

dG9sb2d5IGFuZCBDbGluaWNhbCBJbW11bm9sb2d5LCBNaW5pc3RyeSBvZiBFZHVjYXRpb24sIDsg

YW5kIERlcGFydG1lbnQgb2YgRXBpZGVtaW9sb2d5IGFuZCBCaW8tc3RhdGlzdGljcyAoWVcpLCBJ

bnN0aXR1dGUgb2YgQmFzaWMgTWVkaWNhbCBTY2llbmNlcywgQ2hpbmEgQWNhZGVteSBvZiBNZWRp

Y2FsIFNjaWVuY2VzICZhbXA7IFBla2luZyBVbmlvbiBNZWRpY2FsIENvbGxlZ2UsIEJlaWppbmcs

IENoaW5hLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkxvbmctdGVybSBzdXJ2aXZhbCBh

bmQgZGVhdGggY2F1c2VzIG9mIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXMgaW4gQ2hpbmE6

IGEgc3lzdGVtaWMgcmV2aWV3IG9mIG9ic2VydmF0aW9uYWwgc3R1ZGllczwvdGl0bGU+PHNlY29u

ZGFyeS10aXRsZT5NZWRpY2luZSAoQmFsdGltb3JlKTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+TWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5N

ZWRpY2luZSAoQmFsdGltb3JlKTwvZnVsbC10aXRsZT48YWJici0xPk1lZGljaW5lPC9hYmJyLTE+

PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5NZWRpY2luZSAoQmFsdGlt

b3JlKTwvZnVsbC10aXRsZT48YWJici0xPk1lZGljaW5lPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNh

bD48cGFnZXM+ZTc5NDwvcGFnZXM+PHZvbHVtZT45NDwvdm9sdW1lPjxudW1iZXI+MTc8L251bWJl

cj48ZWRpdGlvbj4yMDE1LzA1LzAyPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DaGluYS9l

cGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx1

cHVzIEVyeXRoZW1hdG9zdXMsIFN5c3RlbWljLyBtb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+

UHJvZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29yZD48a2V5d29y

ZD5TdXJ2aXZhbCBBbmFseXNpczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE1

PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlz

Ym4+MTUzNi01OTY0IChFbGVjdHJvbmljKSYjeEQ7MDAyNS03OTc0IChMaW5raW5nKTwvaXNibj48

YWNjZXNzaW9uLW51bT4yNTkyOTkzMDwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PGN1c3Rv

bTI+NDYwMzAzNDwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA5Ny9tZC4w

MDAwMDAwMDAwMDAwNzk0PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48cmVtb3RlLWRhdGFiYXNl

LXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xh

bmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (11). CVEs accounted for 11.5% of all deaths whereas death from infection accounted for 33% of all deaths.Traditionally mortality studies have focussed on the underlying cause of death as recorded on the death certificate. A new methodology called multiple-cause-of-death analysis enables all the diagnoses recorded on the death certificate to be analysed. Two recently published studies have used this methodology in SLE. One study included 4815 death certificates from Sao Paulo, Brazil on which SLE was listed as a cause of death between 1985-2005 ADDIN EN.CITE <EndNote><Cite><Author>Souza</Author><Year>2012</Year><RecNum>387</RecNum><DisplayText>(12)</DisplayText><record><rec-number>387</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">387</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Souza, D. C.</author><author>Santo, A. H.</author><author>Sato, E. I.</author></authors></contributors><auth-address>Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.</auth-address><titles><title>Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis</title><secondary-title>J Rheumatol</secondary-title><alt-title>J Rheumatol</alt-title></titles><periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></periodical><alt-periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></alt-periodical><pages>496-503</pages><volume>39</volume><number>3</number><dates><year>2012</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0315-162X (Print)&#xD;0315-162X (Linking)</isbn><accession-num>22247362</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(12). The most common contributory causes of death were renal failure and sepsis. Only in 2003-7, and in individuals aged less than 50 years when they died, was CVD a more common cause of death than in the general population. The second study utilised the death certificates from all 1593 adults who died in France between 2000 and 2009 and in whom SLE was mentioned on the death certificate ADDIN EN.CITE <EndNote><Cite><Author>Thomas</Author><Year>2014</Year><RecNum>341</RecNum><DisplayText>(13)</DisplayText><record><rec-number>341</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">341</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, G.</author><author>Mancini, J.</author><author>Jourde-Chiche, N.</author><author>Sarlon, G.</author><author>Amoura, Z.</author><author>Harle, J. R.</author><author>Jougla, E.</author><author>Chiche, L.</author></authors></contributors><auth-address>Hopital de la Conception, AP-HM, and Universite Aix-Marseille, Marseille, France.</auth-address><titles><title>Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis</title><secondary-title>Arthritis &amp; rheumatology (Hoboken, N.J.)</secondary-title><alt-title>Arthritis Rheumatol</alt-title></titles><periodical><full-title>Arthritis &amp; rheumatology (Hoboken, N.J.)</full-title><abbr-1>Arthritis Rheumatol</abbr-1></periodical><alt-periodical><full-title>Arthritis &amp; rheumatology (Hoboken, N.J.)</full-title><abbr-1>Arthritis Rheumatol</abbr-1></alt-periodical><pages>2503-11</pages><volume>66</volume><number>9</number><dates><year>2014</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>2326-5205 (Electronic)</isbn><accession-num>24910304</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(13). The mean (SD) age at death of the SLE patients was 63.5 (18.4) years. The age-standardised mortality rate fell from 4.1 per million in 2000 to 3.0 per million in 2009. Amongst patients in whom SLE was listed as the underlying cause of death, 49.5% had CVD listed as another main cause. In patients in whom SLE was listed as a non-underlying cause of death, CVD was listed as the underlying cause of death more frequently than in the general population (relative risk (RR) 1.58; 95%CI 1.42-1.76). Myocardial infarction in patients with SLE (Level B)Patients with SLE have an increased risk of MI compared to the general population PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW56aTwvQXV0aG9yPjxZZWFyPjE5OTc8L1llYXI+PFJl

Y051bT4zODQ8L1JlY051bT48RGlzcGxheVRleHQ+KDMsIDE0KTwvRGlzcGxheVRleHQ+PHJlY29y

ZD48cmVjLW51bWJlcj4zODQ8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjM4NDwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TWFuemksIFMuPC9hdXRob3I+PGF1dGhv

cj5NZWlsYWhuLCBFLiBOLjwvYXV0aG9yPjxhdXRob3I+UmFpcmllLCBKLiBFLjwvYXV0aG9yPjxh

dXRob3I+Q29udGUsIEMuIEcuPC9hdXRob3I+PGF1dGhvcj5NZWRzZ2VyLCBULiBBLiwgSnIuPC9h

dXRob3I+PGF1dGhvcj5KYW5zZW4tTWNXaWxsaWFtcywgTC48L2F1dGhvcj48YXV0aG9yPkQmYXBv

cztBZ29zdGlubywgUi4gQi48L2F1dGhvcj48YXV0aG9yPkt1bGxlciwgTC4gSC48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE1lZGlj

aW5lLCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2gsIFBBIDE1MjEzLCBVU0EuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+QWdlLXNwZWNpZmljIGluY2lkZW5jZSByYXRlcyBvZiBteW9jYXJk

aWFsIGluZmFyY3Rpb24gYW5kIGFuZ2luYSBpbiB3b21lbiB3aXRoIHN5c3RlbWljIGx1cHVzIGVy

eXRoZW1hdG9zdXM6IGNvbXBhcmlzb24gd2l0aCB0aGUgRnJhbWluZ2hhbSBTdHVkeTwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5BbSBKIEVwaWRlbWlvbDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+QW0gSiBFcGlkZW1pb2w8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10aXRsZT48YWJici0xPkFtZXJpY2FuIGpvdXJuYWwg

b2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10aXRsZT48YWJici0xPkFtZXJpY2FuIGpvdXJu

YWwgb2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NDA4LTE1

PC9wYWdlcz48dm9sdW1lPjE0NTwvdm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxkYXRlcz48eWVh

cj4xOTk3PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyIDE8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4wMDAyLTkyNjIgKFByaW50KSYjeEQ7MDAwMi05MjYyIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT45MDQ4NTE0PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q29tcGFy

YXRpdmUgU3R1ZHkmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dv

cmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90

ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np

dGU+PENpdGU+PEF1dGhvcj5IYWs8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxSZWNOdW0+MzIz

PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zMjM8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5

cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6

NWQiPjMyMzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+SGFrLCBBLiBF

LjwvYXV0aG9yPjxhdXRob3I+S2FybHNvbiwgRS4gVy48L2F1dGhvcj48YXV0aG9yPkZlc2thbmlj

aCwgRC48L2F1dGhvcj48YXV0aG9yPlN0YW1wZmVyLCBNLiBKLjwvYXV0aG9yPjxhdXRob3I+Q29z

dGVuYmFkZXIsIEsuIEguPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+

PHRpdGxlPlN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXMgYW5kIHRoZSByaXNrIG9mIGNhcmRp

b3Zhc2N1bGFyIGRpc2Vhc2U6IHJlc3VsdHMgZnJvbSB0aGUgbnVyc2VzJmFwb3M7IGhlYWx0aCBz

dHVkeTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10

aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgUmhldW08L2Z1

bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgYW5kIHJoZXVtYXRpc208L2FiYnItMT48L3Blcmlv

ZGljYWw+PHBhZ2VzPjEzOTYtNDAyPC9wYWdlcz48dm9sdW1lPjYxPC92b2x1bWU+PG51bWJlcj4x

MDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAwNC0zNTkx

IChQcmludCkmI3hEOzAwMDQtMzU5MSAoTGlua2luZyk8L2lzYm4+PHdvcmstdHlwZT5SZXNlYXJj

aCBTdXBwb3J0LCBOIEkgSCAsIEV4dHJhbXVyYWwmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1V

IFMgR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PC9F

bmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW56aTwvQXV0aG9yPjxZZWFyPjE5OTc8L1llYXI+PFJl

Y051bT4zODQ8L1JlY051bT48RGlzcGxheVRleHQ+KDMsIDE0KTwvRGlzcGxheVRleHQ+PHJlY29y

ZD48cmVjLW51bWJlcj4zODQ8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjM4NDwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TWFuemksIFMuPC9hdXRob3I+PGF1dGhv

cj5NZWlsYWhuLCBFLiBOLjwvYXV0aG9yPjxhdXRob3I+UmFpcmllLCBKLiBFLjwvYXV0aG9yPjxh

dXRob3I+Q29udGUsIEMuIEcuPC9hdXRob3I+PGF1dGhvcj5NZWRzZ2VyLCBULiBBLiwgSnIuPC9h

dXRob3I+PGF1dGhvcj5KYW5zZW4tTWNXaWxsaWFtcywgTC48L2F1dGhvcj48YXV0aG9yPkQmYXBv

cztBZ29zdGlubywgUi4gQi48L2F1dGhvcj48YXV0aG9yPkt1bGxlciwgTC4gSC48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE1lZGlj

aW5lLCBVbml2ZXJzaXR5IG9mIFBpdHRzYnVyZ2gsIFBBIDE1MjEzLCBVU0EuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+QWdlLXNwZWNpZmljIGluY2lkZW5jZSByYXRlcyBvZiBteW9jYXJk

aWFsIGluZmFyY3Rpb24gYW5kIGFuZ2luYSBpbiB3b21lbiB3aXRoIHN5c3RlbWljIGx1cHVzIGVy

eXRoZW1hdG9zdXM6IGNvbXBhcmlzb24gd2l0aCB0aGUgRnJhbWluZ2hhbSBTdHVkeTwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5BbSBKIEVwaWRlbWlvbDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+QW0gSiBFcGlkZW1pb2w8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10aXRsZT48YWJici0xPkFtZXJpY2FuIGpvdXJuYWwg

b2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10aXRsZT48YWJici0xPkFtZXJpY2FuIGpvdXJu

YWwgb2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NDA4LTE1

PC9wYWdlcz48dm9sdW1lPjE0NTwvdm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxkYXRlcz48eWVh

cj4xOTk3PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyIDE8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4wMDAyLTkyNjIgKFByaW50KSYjeEQ7MDAwMi05MjYyIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT45MDQ4NTE0PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q29tcGFy

YXRpdmUgU3R1ZHkmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dv

cmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90

ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np

dGU+PENpdGU+PEF1dGhvcj5IYWs8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxSZWNOdW0+MzIz

PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zMjM8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5

cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6

NWQiPjMyMzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+SGFrLCBBLiBF

LjwvYXV0aG9yPjxhdXRob3I+S2FybHNvbiwgRS4gVy48L2F1dGhvcj48YXV0aG9yPkZlc2thbmlj

aCwgRC48L2F1dGhvcj48YXV0aG9yPlN0YW1wZmVyLCBNLiBKLjwvYXV0aG9yPjxhdXRob3I+Q29z

dGVuYmFkZXIsIEsuIEguPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+

PHRpdGxlPlN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXMgYW5kIHRoZSByaXNrIG9mIGNhcmRp

b3Zhc2N1bGFyIGRpc2Vhc2U6IHJlc3VsdHMgZnJvbSB0aGUgbnVyc2VzJmFwb3M7IGhlYWx0aCBz

dHVkeTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10

aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgUmhldW08L2Z1

bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgYW5kIHJoZXVtYXRpc208L2FiYnItMT48L3Blcmlv

ZGljYWw+PHBhZ2VzPjEzOTYtNDAyPC9wYWdlcz48dm9sdW1lPjYxPC92b2x1bWU+PG51bWJlcj4x

MDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAwNC0zNTkx

IChQcmludCkmI3hEOzAwMDQtMzU5MSAoTGlua2luZyk8L2lzYm4+PHdvcmstdHlwZT5SZXNlYXJj

aCBTdXBwb3J0LCBOIEkgSCAsIEV4dHJhbXVyYWwmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1V

IFMgR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PC9F

bmROb3RlPgB=

ADDIN EN.CITE.DATA (3, 14). Using health administrative databases from Canada between 1990-2007, Avina-Zubieta et al found that the overall multivariable RR for MI in patients with physician-diagnosed SLE, compared with age and sex matched controls, was 2.5 (95%CI 2.1, 3.1) ADDIN EN.CITE <EndNote><Cite><Year>2013</Year><RecNum>392</RecNum><DisplayText>(15)</DisplayText><record><rec-number>392</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">392</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title>Abstracts of the10th International Congress on SLE. April 18-21, 2013. Buenos Aires, Argentina</title><secondary-title>Lupus</secondary-title><alt-title>Lupus</alt-title></titles><periodical><full-title>Lupus</full-title></periodical><alt-periodical><full-title>Lupus</full-title></alt-periodical><pages>1-196</pages><volume>22 Suppl 1</volume><dates><year>2013</year></dates><isbn>1477-0962 (Electronic)&#xD;0961-2033 (Linking)</isbn><accession-num>23462274</accession-num><work-type>Congresses&#xD;Overall</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(15). The subsequent incidence of MI in 1207 patients with SLE from Taiwan, was 2.10 per 1000 person-years (pyrs) compared with 0.49 in age-and sex- matched controls, adjusted hazard ratio (HR) 5.11 (95% CI 2.63, 9.92) ADDIN EN.CITE <EndNote><Cite><Author>Lin</Author><Year>2014</Year><RecNum>336</RecNum><DisplayText>(16)</DisplayText><record><rec-number>336</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">336</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lin, C. Y.</author><author>Shih, C. C.</author><author>Yeh, C. C.</author><author>Chou, W. H.</author><author>Chen, T. L.</author><author>Liao, C. C.</author></authors></contributors><titles><title>Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies</title><secondary-title>Int J Cardiol</secondary-title></titles><periodical><full-title>Int J Cardiol</full-title><abbr-1>International journal of cardiology</abbr-1></periodical><pages>847-51</pages><volume>176</volume><number>3</number><dates><year>2014</year></dates><isbn>1874-1754 (Electronic)&#xD;0167-5273 (Linking)</isbn><work-type>Research Support, Non-U S Gov&apos;t</work-type><urls></urls></record></Cite></EndNote>(16). Patients with SLE have a higher prevalence of CVD even before diagnosis. The prior incidence of CVD was higher in 70 incident cases of SLE identified from The Marshfield Epidemiologic Study Area in Wisconsin, USA than in matched controls (23% vs 10%); OR 3.7 (1.8, 7.9) ADDIN EN.CITE <EndNote><Cite><Author>Bartels</Author><Year>2014</Year><RecNum>330</RecNum><DisplayText>(17)</DisplayText><record><rec-number>330</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">330</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bartels, C. M.</author><author>Buhr, K. A.</author><author>Goldberg, J. W.</author><author>Bell, C. L.</author><author>Visekruna, M.</author><author>Nekkanti, S.</author><author>Greenlee, R. T.</author></authors></contributors><titles><title>Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort</title><secondary-title>J Rheumatol</secondary-title></titles><periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></periodical><pages>680-7</pages><volume>41</volume><number>4</number><dates><year>2014</year></dates><isbn>0315-162X (Print)&#xD;0315-162X (Linking)</isbn><work-type>Comparative Study&#xD;Research Support, N I H , Extramural&#xD;Research Support, Non-U S Gov&apos;t</work-type><urls></urls></record></Cite></EndNote>(17). A study from the US National Heart, Lung and Blood Institute Dynamic Registry of patients undergoing percutaneous coronary interventions (PCI) found no significant differences in the mean percent of coronary artery stenosis and total occlusion in SLE vs non-SLE subjects ADDIN EN.CITE <EndNote><Cite><Author>Maksimowicz-McKinnon</Author><Year>2008</Year><RecNum>395</RecNum><DisplayText>(18)</DisplayText><record><rec-number>395</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">395</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Maksimowicz-McKinnon, K.</author><author>Selzer, F.</author><author>Manzi, S.</author><author>Kip, K. E.</author><author>Mulukutla, S. R.</author><author>Marroquin, O. C.</author><author>Smitherman, T. C.</author><author>Kuller, L. H.</author><author>Williams, D. O.</author><author>Wasko, M. C.</author></authors></contributors><titles><title>Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry</title><secondary-title>Circ Cardiovasc Interv</secondary-title></titles><periodical><full-title>Circ Cardiovasc Interv</full-title></periodical><pages>201-8</pages><volume>1</volume><number>3</number><dates><year>2008</year></dates><isbn>1941-7632 (Electronic)&#xD;1941-7640 (Linking)</isbn><work-type>Multicenter Study&#xD;Research Support, N I H , Extramural</work-type><urls></urls></record></Cite></EndNote>(18). However, SLE patients had significantly worse CV outcomes at one year following PCI including a higher risk of MI (15.6% vs. 4.8%, p=0.01), and repeat PCI (31.3% vs. 11.8%, p=0.009). A retrospective cohort study from Taiwan found that SLE was an independent predictor of inpatient mortality after PCI, OR 3.81 (95% CI 2.02, 7.16) ADDIN EN.CITE <EndNote><Cite><Author>Lai</Author><Year>2015</Year><RecNum>340</RecNum><DisplayText>(19)</DisplayText><record><rec-number>340</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">340</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lai, C. H.</author><author>Lai, W. W.</author><author>Chiou, M. J.</author><author>Lin, W. C.</author><author>Yang, Y. J.</author><author>Li, C. Y.</author><author>Tsai, L. M.</author></authors></contributors><auth-address>Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.&#xD;Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.&#xD;Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.&#xD;Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan.</auth-address><titles><title>Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study</title><secondary-title>Ann Rheum Dis</secondary-title><alt-title>Ann Rheum Dis</alt-title></titles><periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></periodical><alt-periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></alt-periodical><dates><year>2015</year><pub-dates><date>Aug 18</date></pub-dates></dates><isbn>1468-2060 (Electronic)&#xD;0003-4967 (Linking)</isbn><accession-num>26286017</accession-num><work-type>Journal article</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>Eng</language></record></Cite></EndNote>(19).Congestive Heart Failure in patients with SLE (Level B)The risk of hospitalization for congestive heart failure (CHF) in SLE appears to be substantially increased ADDIN REFMGR.CITE <Refman><Cite><Author>Ward</Author><Year>1999</Year><RecNum>63</RecNum><IDText>Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus</IDText><MDL Ref_Type="Journal"><Ref_Type>Journal</Ref_Type><Ref_ID>63</Ref_ID><Title_Primary>Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus</Title_Primary><Authors_Primary>Ward,M.M.</Authors_Primary><Date_Primary>1999</Date_Primary><Keywords>Adolescent Adult Aged California</Keywords><Keywords>epidemiology Cerebrovascular Disorders</Keywords><Keywords>complications</Keywords><Keywords>*epidemiology Female Heart Failure</Keywords><Keywords>complications</Keywords><Keywords>*epidemiology Hospitalization</Keywords><Keywords>statistics &amp; numerical data Humans Lupus Erythematosus,Systemic</Keywords><Keywords>complications</Keywords><Keywords>*epidemiolo</Keywords><Reprint>Not in File</Reprint><Start_Page>338</Start_Page><End_Page>346</End_Page><Periodical>Arthritis and Rheumatism</Periodical><Volume>42</Volume><Issue>2</Issue><ISSN_ISBN>0004-3591 (Print) 0004-3591 (Linking)</ISSN_ISBN><Address>Veterans Affairs Palo Alto Health Care System, California 94305, USA</Address><Web_URL> name="System">Arthritis Rheum</f></ZZ_JournalFull><ZZ_JournalStdAbbrev><f name="System">Arthritis and Rheumatism</f></ZZ_JournalStdAbbrev><ZZ_WorkformID>1</ZZ_WorkformID></MDL></Cite><Cite><Author>Ward</Author><Year>2004</Year><RecNum>75</RecNum><IDText>Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus</IDText><MDL Ref_Type="Journal"><Ref_Type>Journal</Ref_Type><Ref_ID>75</Ref_ID><Title_Primary>Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus</Title_Primary><Authors_Primary>Ward,M.M.</Authors_Primary><Date_Primary>2004</Date_Primary><Keywords>Aged Coronary Artery Bypass Female Heart Failure</Keywords><Keywords>etiology *Hospitalization Humans Length of Stay Lupus Erythematosus,Systemic</Keywords><Keywords>*complications Male Middle Aged Myocardial Infarction</Keywords><Keywords>complications</Keywords><Keywords>mortality</Keywords><Keywords>surgery</Keywords><Keywords>*therapy Outcome Assessment (Health Care)</Keywords><Reprint>Not in File</Reprint><Start_Page>3170</Start_Page><End_Page>3176</End_Page><Periodical>Arthritis and Rheumatism</Periodical><Volume>50</Volume><Issue>10</Issue><ISSN_ISBN>0004-3591 (Print) 0004-3591 (Linking)</ISSN_ISBN><Address>National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA20892-1828. wardm1@mail.</Address><Web_URL> name="System">Arthritis Rheum</f></ZZ_JournalFull><ZZ_JournalStdAbbrev><f name="System">Arthritis and Rheumatism</f></ZZ_JournalStdAbbrev><ZZ_WorkformID>1</ZZ_WorkformID></MDL></Cite><Cite><Author>Shah</Author><Year>2009</Year><RecNum>73</RecNum><IDText>Poor outcomes after acute myocardial infarction in systemic lupus erythematosus</IDText><MDL Ref_Type="Journal"><Ref_Type>Journal</Ref_Type><Ref_ID>73</Ref_ID><Title_Primary>Poor outcomes after acute myocardial infarction in systemic lupus erythematosus</Title_Primary><Authors_Primary>Shah,M.A.</Authors_Primary><Authors_Primary>Shah,A.M.</Authors_Primary><Authors_Primary>Krishnan,E.</Authors_Primary><Date_Primary>2009</Date_Primary><Keywords>Adult African Americans Aged Case-Control Studies Diabetes Mellitus</Keywords><Keywords>mortality European Continental Ancestry Group Female Hispanic Americans Hospital Mortality Humans Length of Stay Lupus Erythematosus,Systemic</Keywords><Keywords>*complications</Keywords><Keywords>ethnology</Keywords><Keywords>mortality Male Midd</Keywords><Reprint>Not in File</Reprint><Start_Page>570</Start_Page><End_Page>575</End_Page><Periodical>The Journal of rheumatology</Periodical><Volume>36</Volume><Issue>3</Issue><ISSN_ISBN>0315-162X (Print) 0315-162X (Linking)</ISSN_ISBN><Address>Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA</Address><Web_URL> name="System">J Rheumatol</f></ZZ_JournalFull><ZZ_JournalStdAbbrev><f name="System">The Journal of rheumatology</f></ZZ_JournalStdAbbrev><ZZ_WorkformID>1</ZZ_WorkformID></MDL></Cite></Refman>. Using the California Hospital Discharge Database, Ward found that the proportionate morbidity ratio for CHF in women with SLE compared to women without SLE was 3.22 (95%CI 2.55, 4.05) in those aged 18-44 years; 1.34 (95%CI 1.14, 1.56) in those aged 45-64 years; and 1.30 (95% 1.16, 1.45) in those aged 65 years and over ADDIN EN.CITE <EndNote><Cite><Author>Ward</Author><Year>1999</Year><RecNum>322</RecNum><DisplayText>(20)</DisplayText><record><rec-number>322</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">322</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ward, M. M.</author></authors></contributors><titles><title>Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus</title><secondary-title>Arthritis Rheum</secondary-title></titles><periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></periodical><pages>338-46</pages><volume>42</volume><number>2</number><dates><year>1999</year></dates><isbn>0004-3591 (Print)&#xD;0004-3591 (Linking)</isbn><urls></urls></record></Cite></EndNote>(20). The nature of CHF in SLE is likely to be multifactorial. Of 24 episodes of CHF in a large international inception cohort of SLE followed for up to 8 years, only 5 (21%) were attributed to atherosclerosis PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Vcm93aXR6PC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48

UmVjTnVtPjM5NzwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjEpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjM5NzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+Mzk3PC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Vcm93aXR6LCBNLiBCLjwvYXV0aG9yPjxh

dXRob3I+R2xhZG1hbiwgRC48L2F1dGhvcj48YXV0aG9yPkliYW5leiwgRC48L2F1dGhvcj48YXV0

aG9yPkJhZSwgUy4gQy48L2F1dGhvcj48YXV0aG9yPlNhbmNoZXotR3VlcnJlcm8sIEouPC9hdXRo

b3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+PGF1dGhvcj5DbGFya2UsIEEuPC9hdXRob3I+

PGF1dGhvcj5CZXJuYXRza3ksIFMuPC9hdXRob3I+PGF1dGhvcj5Gb3J0aW4sIFAuIFIuPC9hdXRo

b3I+PGF1dGhvcj5IYW5seSwgSi4gRy48L2F1dGhvcj48YXV0aG9yPldhbGxhY2UsIEQuIEouPC9h

dXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC48L2F1dGhvcj48YXV0aG9yPlJhaG1hbiwgQS48L2F1

dGhvcj48YXV0aG9yPkFsYXJjb24sIEcuIFMuPC9hdXRob3I+PGF1dGhvcj5NZXJyaWxsLCBKLiBU

LjwvYXV0aG9yPjxhdXRob3I+R2luemxlciwgRS48L2F1dGhvcj48YXV0aG9yPktoYW1hc2h0YSwg

TS48L2F1dGhvcj48YXV0aG9yPk5pdmVkLCBPLjwvYXV0aG9yPjxhdXRob3I+U3R1cmZlbHQsIEcu

PC9hdXRob3I+PGF1dGhvcj5CcnVjZSwgSS4gTi48L2F1dGhvcj48YXV0aG9yPlN0ZWluc3Nvbiwg

Sy48L2F1dGhvcj48YXV0aG9yPk1hbnppLCBTLjwvYXV0aG9yPjxhdXRob3I+UmFtc2V5LUdvbGRt

YW4sIFIuPC9hdXRob3I+PGF1dGhvcj5Eb29sZXksIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5ab21h

LCBBLjwvYXV0aG9yPjxhdXRob3I+S2FsdW5pYW4sIEsuPC9hdXRob3I+PGF1dGhvcj5SYW1vcywg

TS48L2F1dGhvcj48YXV0aG9yPlZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9y

PkFyYW5vdywgQy48L2F1dGhvcj48YXV0aG9yPlN0b2xsLCBULjwvYXV0aG9yPjxhdXRob3I+UGV0

cmksIE0uPC9hdXRob3I+PGF1dGhvcj5NYWRkaXNvbiwgUC48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Ub3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS4gbS51cm93aXR6QHV0b3JvbnRvLmNhPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+QXRoZXJvc2NsZXJvdGljIHZhc2N1bGFyIGV2ZW50cyBpbiBhIG11bHRp

bmF0aW9uYWwgaW5jZXB0aW9uIGNvaG9ydCBvZiBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3Vz

PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2Fs

dC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgQ2FyZSBS

ZXMgKEhvYm9rZW4pPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGNhcmUgJmFtcDsgcmVz

ZWFyY2g8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFy

dGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMg

Y2FyZSAmYW1wOyByZXNlYXJjaDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjg4MS03

PC9wYWdlcz48dm9sdW1lPjYyPC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4yMTUxLTQ2NTggKEVsZWN0cm9uaWMpJiN4RDsyMTUxLTQ2NFggKExpbmtpbmcpPC9p

c2JuPjxhY2Nlc3Npb24tbnVtPjIwNTM1Nzk5PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q29t

cGFyYXRpdmUgU3R1ZHkmI3hEO011bHRpY2VudGVyIFN0dWR5JiN4RDtSZXNlYXJjaCBTdXBwb3J0

LCBOLkkuSC4sIEV4dHJhbXVyYWwmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZh

cG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5O

TE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Vcm93aXR6PC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48

UmVjTnVtPjM5NzwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjEpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjM5NzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+Mzk3PC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Vcm93aXR6LCBNLiBCLjwvYXV0aG9yPjxh

dXRob3I+R2xhZG1hbiwgRC48L2F1dGhvcj48YXV0aG9yPkliYW5leiwgRC48L2F1dGhvcj48YXV0

aG9yPkJhZSwgUy4gQy48L2F1dGhvcj48YXV0aG9yPlNhbmNoZXotR3VlcnJlcm8sIEouPC9hdXRo

b3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+PGF1dGhvcj5DbGFya2UsIEEuPC9hdXRob3I+

PGF1dGhvcj5CZXJuYXRza3ksIFMuPC9hdXRob3I+PGF1dGhvcj5Gb3J0aW4sIFAuIFIuPC9hdXRo

b3I+PGF1dGhvcj5IYW5seSwgSi4gRy48L2F1dGhvcj48YXV0aG9yPldhbGxhY2UsIEQuIEouPC9h

dXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC48L2F1dGhvcj48YXV0aG9yPlJhaG1hbiwgQS48L2F1

dGhvcj48YXV0aG9yPkFsYXJjb24sIEcuIFMuPC9hdXRob3I+PGF1dGhvcj5NZXJyaWxsLCBKLiBU

LjwvYXV0aG9yPjxhdXRob3I+R2luemxlciwgRS48L2F1dGhvcj48YXV0aG9yPktoYW1hc2h0YSwg

TS48L2F1dGhvcj48YXV0aG9yPk5pdmVkLCBPLjwvYXV0aG9yPjxhdXRob3I+U3R1cmZlbHQsIEcu

PC9hdXRob3I+PGF1dGhvcj5CcnVjZSwgSS4gTi48L2F1dGhvcj48YXV0aG9yPlN0ZWluc3Nvbiwg

Sy48L2F1dGhvcj48YXV0aG9yPk1hbnppLCBTLjwvYXV0aG9yPjxhdXRob3I+UmFtc2V5LUdvbGRt

YW4sIFIuPC9hdXRob3I+PGF1dGhvcj5Eb29sZXksIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5ab21h

LCBBLjwvYXV0aG9yPjxhdXRob3I+S2FsdW5pYW4sIEsuPC9hdXRob3I+PGF1dGhvcj5SYW1vcywg

TS48L2F1dGhvcj48YXV0aG9yPlZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9y

PkFyYW5vdywgQy48L2F1dGhvcj48YXV0aG9yPlN0b2xsLCBULjwvYXV0aG9yPjxhdXRob3I+UGV0

cmksIE0uPC9hdXRob3I+PGF1dGhvcj5NYWRkaXNvbiwgUC48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Ub3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS4gbS51cm93aXR6QHV0b3JvbnRvLmNhPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+QXRoZXJvc2NsZXJvdGljIHZhc2N1bGFyIGV2ZW50cyBpbiBhIG11bHRp

bmF0aW9uYWwgaW5jZXB0aW9uIGNvaG9ydCBvZiBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3Vz

PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2Fs

dC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgQ2FyZSBS

ZXMgKEhvYm9rZW4pPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGNhcmUgJmFtcDsgcmVz

ZWFyY2g8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFy

dGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMg

Y2FyZSAmYW1wOyByZXNlYXJjaDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjg4MS03

PC9wYWdlcz48dm9sdW1lPjYyPC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4yMTUxLTQ2NTggKEVsZWN0cm9uaWMpJiN4RDsyMTUxLTQ2NFggKExpbmtpbmcpPC9p

c2JuPjxhY2Nlc3Npb24tbnVtPjIwNTM1Nzk5PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q29t

cGFyYXRpdmUgU3R1ZHkmI3hEO011bHRpY2VudGVyIFN0dWR5JiN4RDtSZXNlYXJjaCBTdXBwb3J0

LCBOLkkuSC4sIEV4dHJhbXVyYWwmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZh

cG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5O

TE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (21). CHF is more common in patients with SLE admitted with an MI compared to controls admitted with an MI (20% vs 15%) and the presence of CHF in SLE patients admitted with an MI is a risk factor for mortality (17.9% vs 5.8%) PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGFoPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj

TnVtPjM5OTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjIpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjM5OTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+Mzk5PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TaGFoLCBNLiBBLjwvYXV0aG9yPjxhdXRob3I+

U2hhaCwgQS4gTS48L2F1dGhvcj48YXV0aG9yPktyaXNobmFuLCBFLjwvYXV0aG9yPjwvYXV0aG9y

cz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVk

aWNpbmUsIFVuaXZlcnNpdHkgb2YgS2VudHVja3ksIExleGluZ3RvbiwgS2VudHVja3ksIFVTQS48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Qb29yIG91dGNvbWVzIGFmdGVyIGFjdXRlIG15

b2NhcmRpYWwgaW5mYXJjdGlvbiBpbiBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRs

ZT5UaGUgSm91cm5hbCBvZiByaGV1bWF0b2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9k

aWNhbD48ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3Vy

bmFsIG9mIHJoZXVtYXRvbG9neTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+SiBSaGV1bWF0b2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBv

ZiByaGV1bWF0b2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz41NzAtNTwvcGFn

ZXM+PHZvbHVtZT4zNjwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxlZGl0aW9uPjIwMDkvMDIv

MTI8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFm

cmljYW4gQW1lcmljYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+

Q2FzZS1Db250cm9sIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgTWVsbGl0dXMv

bW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkV1cm9wZWFuIENvbnRpbmVudGFsIEFuY2VzdHJ5

IEdyb3VwPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IaXNwYW5p

YyBBbWVyaWNhbnM8L2tleXdvcmQ+PGtleXdvcmQ+SG9zcGl0YWwgTW9ydGFsaXR5PC9rZXl3b3Jk

PjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5MZW5ndGggb2YgU3RheTwva2V5d29y

ZD48a2V5d29yZD5MdXB1cyBFcnl0aGVtYXRvc3VzLCBTeXN0ZW1pYy8gY29tcGxpY2F0aW9ucy9l

dGhub2xvZ3kvbW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdv

cmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY2FyZGlhbCBJbmZhcmN0aW9uLyBj

b21wbGljYXRpb25zL2V0aG5vbG9neS9tb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+T2RkcyBS

YXRpbzwva2V5d29yZD48a2V5d29yZD5Qcm9wb3J0aW9uYWwgSGF6YXJkcyBNb2RlbHM8L2tleXdv

cmQ+PGtleXdvcmQ+U2V4IERpc3RyaWJ1dGlvbjwva2V5d29yZD48a2V5d29yZD5Vbml0ZWQgU3Rh

dGVzL2VwaWRlbWlvbG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95

ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MDMxNS0xNjJYIChQcmludCkmI3hEOzAzMTUtMTYyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lv

bi1udW0+MTkyMDg1OTQ8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJl

c291cmNlLW51bT4xMC4zODk5L2pyaGV1bS4wODAzNzM8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+

PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGFoPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj

TnVtPjM5OTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjIpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjM5OTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+Mzk5PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TaGFoLCBNLiBBLjwvYXV0aG9yPjxhdXRob3I+

U2hhaCwgQS4gTS48L2F1dGhvcj48YXV0aG9yPktyaXNobmFuLCBFLjwvYXV0aG9yPjwvYXV0aG9y

cz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVk

aWNpbmUsIFVuaXZlcnNpdHkgb2YgS2VudHVja3ksIExleGluZ3RvbiwgS2VudHVja3ksIFVTQS48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Qb29yIG91dGNvbWVzIGFmdGVyIGFjdXRlIG15

b2NhcmRpYWwgaW5mYXJjdGlvbiBpbiBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRs

ZT5UaGUgSm91cm5hbCBvZiByaGV1bWF0b2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9k

aWNhbD48ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3Vy

bmFsIG9mIHJoZXVtYXRvbG9neTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+SiBSaGV1bWF0b2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBv

ZiByaGV1bWF0b2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz41NzAtNTwvcGFn

ZXM+PHZvbHVtZT4zNjwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxlZGl0aW9uPjIwMDkvMDIv

MTI8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFm

cmljYW4gQW1lcmljYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+

Q2FzZS1Db250cm9sIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhYmV0ZXMgTWVsbGl0dXMv

bW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkV1cm9wZWFuIENvbnRpbmVudGFsIEFuY2VzdHJ5

IEdyb3VwPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IaXNwYW5p

YyBBbWVyaWNhbnM8L2tleXdvcmQ+PGtleXdvcmQ+SG9zcGl0YWwgTW9ydGFsaXR5PC9rZXl3b3Jk

PjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5MZW5ndGggb2YgU3RheTwva2V5d29y

ZD48a2V5d29yZD5MdXB1cyBFcnl0aGVtYXRvc3VzLCBTeXN0ZW1pYy8gY29tcGxpY2F0aW9ucy9l

dGhub2xvZ3kvbW9ydGFsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdv

cmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY2FyZGlhbCBJbmZhcmN0aW9uLyBj

b21wbGljYXRpb25zL2V0aG5vbG9neS9tb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+T2RkcyBS

YXRpbzwva2V5d29yZD48a2V5d29yZD5Qcm9wb3J0aW9uYWwgSGF6YXJkcyBNb2RlbHM8L2tleXdv

cmQ+PGtleXdvcmQ+U2V4IERpc3RyaWJ1dGlvbjwva2V5d29yZD48a2V5d29yZD5Vbml0ZWQgU3Rh

dGVzL2VwaWRlbWlvbG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95

ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+

MDMxNS0xNjJYIChQcmludCkmI3hEOzAzMTUtMTYyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lv

bi1udW0+MTkyMDg1OTQ8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJl

c291cmNlLW51bT4xMC4zODk5L2pyaGV1bS4wODAzNzM8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+

PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (22).Stroke in patients with SLE (Level B) In a recent meta-analysis of 10 population-based cohort studies the pooled RR in patients with SLE for all types of stroke combined was 2.53 (95%CI 1.96, 3.26) ADDIN EN.CITE <EndNote><Cite><Author>Holmqvist</Author><Year>2015</Year><RecNum>400</RecNum><DisplayText>(23)</DisplayText><record><rec-number>400</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">400</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Holmqvist, M.</author><author>Simard, J. F.</author><author>Asplund, K.</author><author>Arkema, E. V.</author></authors></contributors><auth-address>Clinical Epidemiology Unit, Department of Medicine Solna , Karolinska Institute , Stockholm , Sweden.&#xD;Clinical Epidemiology Unit, Department of Medicine Solna , Karolinska Institute , Stockholm , Sweden ; Division of Epidemiology, Department of Health Research &amp; Policy , Stanford School of Medicine , Stanford, California , USA.&#xD;Department of Public Health and Clinical Medicine , Umea University , Umea , Sweden.</auth-address><titles><title>Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies</title><secondary-title>RMD open</secondary-title><alt-title>RMD Open</alt-title></titles><periodical><full-title>RMD open</full-title><abbr-1>RMD Open</abbr-1></periodical><alt-periodical><full-title>RMD open</full-title><abbr-1>RMD Open</abbr-1></alt-periodical><pages>e000168</pages><volume>1</volume><number>1</number><dates><year>2015</year></dates><isbn>2056-5933 (Electronic)&#xD;2056-5933 (Linking)</isbn><accession-num>26719816</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(23). The risks of ischaemic stroke (RR 2.10; 95%CI 1.68, 2.62), intracerebral haemorrhage (RR 2.72; 95%CI 2.15, 3.44) and subarachnoid haemorrhage (RR 3.85; 95%CI 3.20, 4.64) were all increased. The RR for stroke was highest in adults aged less than 50 years.Peripheral arterial disease in patients with SLE (Level B)Peripheral arterial disease (PAD) is more common in SLE than the general population PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CdXJnb3M8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+NDAyPC9SZWNOdW0+PERpc3BsYXlUZXh0PigyNCwgMjUpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjQwMjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDAyPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5CdXJnb3MsIFAuIEkuPC9hdXRob3I+

PGF1dGhvcj5WaWxhLCBMLiBNLjwvYXV0aG9yPjxhdXRob3I+UmV2ZWlsbGUsIEouIEQuPC9hdXRo

b3I+PGF1dGhvcj5BbGFyY29uLCBHLiBTLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnRzIG9mIE1lZGljaW5lLCBEaXZpc2lvbiBvZiBDbGlu

aWNhbCBJbW11bm9sb2d5IGFuZCBSaGV1bWF0b2xvZ3ksIFNjaG9vbCBvZiBNZWRpY2luZSwgVGhl

IFVuaXZlcnNpdHkgb2YgQWxhYmFtYSBhdCBCaXJtaW5naGFtLCBCaXJtaW5naGFtLCBBbGFiYW1h

LCBVU0EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UGVyaXBoZXJhbCB2YXNjdWxhciBk

YW1hZ2UgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czogZGF0YSBmcm9tIExVTUlOQSwg

YSBsYXJnZSBtdWx0aS1ldGhuaWMgVS5TLiBjb2hvcnQgKExYSVgpPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkx1cHVzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5MdXB1czwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkx1cHVzPC9mdWxsLXRpdGxlPjwvcGVy

aW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+THVwdXM8L2Z1bGwtdGl0bGU+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MTMwMy04PC9wYWdlcz48dm9sdW1lPjE4PC92b2x1bWU+PG51

bWJlcj4xNDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

RGVjPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3Ny0wOTYyIChFbGVjdHJvbmlj

KSYjeEQ7MDk2MS0yMDMzIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xOTg1MDY1ODwv

YWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE4uSS5ILiwgRXh0cmFt

dXJhbCYjeEQ7UmVzZWFyY2ggU3VwcG9ydCwgTm9uLVUuUy4gR292JmFwb3M7dDwvd29yay10eXBl

Pjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFi

YXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPkhhc3NhbjwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJlY051bT40MDQ8L1Jl

Y051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjQwNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxr

ZXkgYXBwPSJFTiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+

NDA0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+

MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXNzYW4sIEEuIEEu

PC9hdXRob3I+PGF1dGhvcj5IYWJpYiwgSC4gTS48L2F1dGhvcj48YXV0aG9yPkVpc3NhLCBBLiBB

LjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlZhc2N1bGFy

IFN1cmdlcnkgRGVwYXJ0bWVudCwgQWluIFNoYW1zIFVuaXZlcnNpdHksIENhaXJvLCBFZ3lwdC48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QZXJpcGhlcmFsIGFydGVyaWFsIGRpc2Vhc2Ug

aW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzOiBhIHByb3NwZWN0

aXZlIGNvbnRyb2xsZWQgc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SW50ZXJuYXRpb25h

bCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+SW50IEogUmhldW0gRGlzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvZnVsbC10

aXRsZT48YWJici0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBl

cmlvZGljYWw+PGZ1bGwtdGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBk

aXNlYXNlczwvZnVsbC10aXRsZT48YWJici0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvYWx0

LXBlcmlvZGljYWw+PHBhZ2VzPjMxOS0yNDwvcGFnZXM+PHZvbHVtZT4xNjwvdm9sdW1lPjxudW1i

ZXI+MzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVu

PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTc1Ni0xODVYIChFbGVjdHJvbmljKSYj

eEQ7MTc1Ni0xODQxIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMzk4MTc1NDwvYWNj

ZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48

L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CdXJnb3M8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+NDAyPC9SZWNOdW0+PERpc3BsYXlUZXh0PigyNCwgMjUpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjQwMjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDAyPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5CdXJnb3MsIFAuIEkuPC9hdXRob3I+

PGF1dGhvcj5WaWxhLCBMLiBNLjwvYXV0aG9yPjxhdXRob3I+UmV2ZWlsbGUsIEouIEQuPC9hdXRo

b3I+PGF1dGhvcj5BbGFyY29uLCBHLiBTLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnRzIG9mIE1lZGljaW5lLCBEaXZpc2lvbiBvZiBDbGlu

aWNhbCBJbW11bm9sb2d5IGFuZCBSaGV1bWF0b2xvZ3ksIFNjaG9vbCBvZiBNZWRpY2luZSwgVGhl

IFVuaXZlcnNpdHkgb2YgQWxhYmFtYSBhdCBCaXJtaW5naGFtLCBCaXJtaW5naGFtLCBBbGFiYW1h

LCBVU0EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UGVyaXBoZXJhbCB2YXNjdWxhciBk

YW1hZ2UgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czogZGF0YSBmcm9tIExVTUlOQSwg

YSBsYXJnZSBtdWx0aS1ldGhuaWMgVS5TLiBjb2hvcnQgKExYSVgpPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkx1cHVzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5MdXB1czwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkx1cHVzPC9mdWxsLXRpdGxlPjwvcGVy

aW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+THVwdXM8L2Z1bGwtdGl0bGU+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MTMwMy04PC9wYWdlcz48dm9sdW1lPjE4PC92b2x1bWU+PG51

bWJlcj4xNDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

RGVjPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3Ny0wOTYyIChFbGVjdHJvbmlj

KSYjeEQ7MDk2MS0yMDMzIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xOTg1MDY1ODwv

YWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE4uSS5ILiwgRXh0cmFt

dXJhbCYjeEQ7UmVzZWFyY2ggU3VwcG9ydCwgTm9uLVUuUy4gR292JmFwb3M7dDwvd29yay10eXBl

Pjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFi

YXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPkhhc3NhbjwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJlY051bT40MDQ8L1Jl

Y051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjQwNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxr

ZXkgYXBwPSJFTiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+

NDA0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+

MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXNzYW4sIEEuIEEu

PC9hdXRob3I+PGF1dGhvcj5IYWJpYiwgSC4gTS48L2F1dGhvcj48YXV0aG9yPkVpc3NhLCBBLiBB

LjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlZhc2N1bGFy

IFN1cmdlcnkgRGVwYXJ0bWVudCwgQWluIFNoYW1zIFVuaXZlcnNpdHksIENhaXJvLCBFZ3lwdC48

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QZXJpcGhlcmFsIGFydGVyaWFsIGRpc2Vhc2Ug

aW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzOiBhIHByb3NwZWN0

aXZlIGNvbnRyb2xsZWQgc3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SW50ZXJuYXRpb25h

bCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+SW50IEogUmhldW0gRGlzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvZnVsbC10

aXRsZT48YWJici0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBl

cmlvZGljYWw+PGZ1bGwtdGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBk

aXNlYXNlczwvZnVsbC10aXRsZT48YWJici0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvYWx0

LXBlcmlvZGljYWw+PHBhZ2VzPjMxOS0yNDwvcGFnZXM+PHZvbHVtZT4xNjwvdm9sdW1lPjxudW1i

ZXI+MzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVu

PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTc1Ni0xODVYIChFbGVjdHJvbmljKSYj

eEQ7MTc1Ni0xODQxIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMzk4MTc1NDwvYWNj

ZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48

L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (24, 25). A study from the National Health Insurance Research Database of Taiwan of over 10,000 SLE patients reported a 9-fold higher incidence of PAD compared with non-SLE patients ADDIN EN.CITE <EndNote><Cite><Author>Chuang</Author><Year>2015</Year><RecNum>405</RecNum><DisplayText>(26)</DisplayText><record><rec-number>405</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">405</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chuang, Y. W.</author><author>Yu, M. C.</author><author>Lin, C. L.</author><author>Yu, T. M.</author><author>Shu, K. H.</author><author>Kao, C. H.</author></authors></contributors><auth-address>From the Division of Nephrology, Taichung Veterans General Hospital, Taichung (Y-WC, T-MY, K-HS); Department of Pediatric Nephrology, Chang Gung Children&apos;s Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan (M-CY); Management Office for Health Data, China Medical University Hospital (C-LL); College of Medicine, China Medical University, Taichung (C-LL); Graduate Institute of Clinical Medicine Science, School of Medicine (T-MY); Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University (C-HK); and Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan (C-HK).</auth-address><titles><title>Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study</title><secondary-title>Medicine (Baltimore)</secondary-title><alt-title>Medicine (Baltimore)</alt-title></titles><periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></periodical><alt-periodical><full-title>Medicine (Baltimore)</full-title><abbr-1>Medicine</abbr-1></alt-periodical><pages>e2121</pages><volume>94</volume><number>46</number><dates><year>2015</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1536-5964 (Electronic)&#xD;0025-7974 (Linking)</isbn><accession-num>26579830</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(26).Subclinical atherosclerosis in patients with SLE (Level B)Subclinical atherosclerosis may manifest as endothelial dysfunction, arterial stiffness, a high carotid intima media thickness (cIMT), and plaque or coronary artery calcification (CAC). A recent meta-analysis showed that patients with SLE have a higher cIMT and an increased prevalence of carotid plaque compared with controls PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XdTwvQXV0aG9yPjxZZWFyPjIwMTY8L1llYXI+PFJlY051

bT4zMjE8L1JlY051bT48RGlzcGxheVRleHQ+KDI3KTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVj

LW51bWJlcj4zMjE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlk

PSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjMyMTwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V3UsIEcuIEMuPC9hdXRob3I+PGF1dGhvcj5MaXUs

IEguIFIuPC9hdXRob3I+PGF1dGhvcj5MZW5nLCBSLiBYLjwvYXV0aG9yPjxhdXRob3I+TGksIFgu

IFAuPC9hdXRob3I+PGF1dGhvcj5MaSwgWC4gTS48L2F1dGhvcj48YXV0aG9yPlBhbiwgSC4gRi48

L2F1dGhvcj48YXV0aG9yPlllLCBELiBRLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgRXBpZGVtaW9sb2d5IGFuZCBCaW9zdGF0aXN0

aWNzLCBTY2hvb2wgb2YgUHVibGljIEhlYWx0aCwgQW5odWkgTWVkaWNhbCBVbml2ZXJzaXR5LCA4

MSBNZWlzaGFuIFJvYWQsIEhlZmVpLCAyMzAwMzIgQW5odWksIENoaW5hOyBBbmh1aSBQcm92aW5j

aWFsIExhYm9yYXRvcnkgb2YgUG9wdWxhdGlvbiBIZWFsdGggJmFtcDsgTWFqb3IgRGlzZWFzZSBT

Y3JlZW5pbmcgYW5kIERpYWdub3NpcywgQW5odWkgTWVkaWNhbCBVbml2ZXJzaXR5LCA4MSBNZWlz

aGFuIFJvYWQsIEhlZmVpLCAyMzAwMzIgQW5odWksIENoaW5hLiYjeEQ7RGVwYXJ0bWVudCBvZiBF

cGlkZW1pb2xvZ3kgYW5kIEJpb3N0YXRpc3RpY3MsIFNjaG9vbCBvZiBQdWJsaWMgSGVhbHRoLCBB

bmh1aSBNZWRpY2FsIFVuaXZlcnNpdHksIDgxIE1laXNoYW4gUm9hZCwgSGVmZWksIDIzMDAzMiBB

bmh1aSwgQ2hpbmE7IEdyYWR1YXRlIFNjaG9vbCwgV2FubmFuIE1lZGljYWwgQ29sbGVnZSwgV2Vz

dCBvZiBXZW5jaGFuZyBSb2FkLCBVbml2ZXJzaXR5IFBhcmssIFd1aHUsIEFuaHVpIDI0MTAwMiwg

Q2hpbmEuJiN4RDtEZXBhcnRtZW50IG9mIFJoZXVtYXRvbG9neSwgQW5odWkgUHJvdmluY2lhbCBI

b3NwaXRhbCwgSGVmZWksIENoaW5hLiYjeEQ7RGVwYXJ0bWVudCBvZiBFcGlkZW1pb2xvZ3kgYW5k

IEJpb3N0YXRpc3RpY3MsIFNjaG9vbCBvZiBQdWJsaWMgSGVhbHRoLCBBbmh1aSBNZWRpY2FsIFVu

aXZlcnNpdHksIDgxIE1laXNoYW4gUm9hZCwgSGVmZWksIDIzMDAzMiBBbmh1aSwgQ2hpbmE7IEFu

aHVpIFByb3ZpbmNpYWwgTGFib3JhdG9yeSBvZiBQb3B1bGF0aW9uIEhlYWx0aCAmYW1wOyBNYWpv

ciBEaXNlYXNlIFNjcmVlbmluZyBhbmQgRGlhZ25vc2lzLCBBbmh1aSBNZWRpY2FsIFVuaXZlcnNp

dHksIDgxIE1laXNoYW4gUm9hZCwgSGVmZWksIDIzMDAzMiBBbmh1aSwgQ2hpbmEuIEVsZWN0cm9u

aWMgYWRkcmVzczogcGFuaGFpZmVuZzE5ODJAc2luYS5jb20uJiN4RDtEZXBhcnRtZW50IG9mIEVw

aWRlbWlvbG9neSBhbmQgQmlvc3RhdGlzdGljcywgU2Nob29sIG9mIFB1YmxpYyBIZWFsdGgsIEFu

aHVpIE1lZGljYWwgVW5pdmVyc2l0eSwgODEgTWVpc2hhbiBSb2FkLCBIZWZlaSwgMjMwMDMyIEFu

aHVpLCBDaGluYTsgQW5odWkgUHJvdmluY2lhbCBMYWJvcmF0b3J5IG9mIFBvcHVsYXRpb24gSGVh

bHRoICZhbXA7IE1ham9yIERpc2Vhc2UgU2NyZWVuaW5nIGFuZCBEaWFnbm9zaXMsIEFuaHVpIE1l

ZGljYWwgVW5pdmVyc2l0eSwgODEgTWVpc2hhbiBSb2FkLCBIZWZlaSwgMjMwMDMyIEFuaHVpLCBD

aGluYS4gRWxlY3Ryb25pYyBhZGRyZXNzOiB5ZHFhaG11QGdtYWlsLmNvbS48L2F1dGgtYWRkcmVz

cz48dGl0bGVzPjx0aXRsZT5TdWJjbGluaWNhbCBhdGhlcm9zY2xlcm9zaXMgaW4gcGF0aWVudHMg

d2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzOiBBIHN5c3RlbWljIHJldmlldyBhbmQg

bWV0YS1hbmFseXNpczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BdXRvaW1tdW5pdHkgcmV2aWV3

czwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QXV0b2ltbXVuIFJldjwvYWx0LXRpdGxlPjwv

dGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkF1dG9pbW11bml0eSByZXZpZXdzPC9mdWxs

LXRpdGxlPjxhYmJyLTE+QXV0b2ltbXVuIFJldjwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBl

cmlvZGljYWw+PGZ1bGwtdGl0bGU+QXV0b2ltbXVuaXR5IHJldmlld3M8L2Z1bGwtdGl0bGU+PGFi

YnItMT5BdXRvaW1tdW4gUmV2PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjItMzc8

L3BhZ2VzPjx2b2x1bWU+MTU8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48ZGF0ZXM+PHllYXI+

MjAxNjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkphbjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjE4NzMtMDE4MyAoRWxlY3Ryb25pYykmI3hEOzE1NjgtOTk3MiAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MjY0NTU1NjI8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5SZXZp

ZXc8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08

L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29y

ZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XdTwvQXV0aG9yPjxZZWFyPjIwMTY8L1llYXI+PFJlY051

bT4zMjE8L1JlY051bT48RGlzcGxheVRleHQ+KDI3KTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVj

LW51bWJlcj4zMjE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlk

PSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjMyMTwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V3UsIEcuIEMuPC9hdXRob3I+PGF1dGhvcj5MaXUs

IEguIFIuPC9hdXRob3I+PGF1dGhvcj5MZW5nLCBSLiBYLjwvYXV0aG9yPjxhdXRob3I+TGksIFgu

IFAuPC9hdXRob3I+PGF1dGhvcj5MaSwgWC4gTS48L2F1dGhvcj48YXV0aG9yPlBhbiwgSC4gRi48

L2F1dGhvcj48YXV0aG9yPlllLCBELiBRLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgRXBpZGVtaW9sb2d5IGFuZCBCaW9zdGF0aXN0

aWNzLCBTY2hvb2wgb2YgUHVibGljIEhlYWx0aCwgQW5odWkgTWVkaWNhbCBVbml2ZXJzaXR5LCA4

MSBNZWlzaGFuIFJvYWQsIEhlZmVpLCAyMzAwMzIgQW5odWksIENoaW5hOyBBbmh1aSBQcm92aW5j

aWFsIExhYm9yYXRvcnkgb2YgUG9wdWxhdGlvbiBIZWFsdGggJmFtcDsgTWFqb3IgRGlzZWFzZSBT

Y3JlZW5pbmcgYW5kIERpYWdub3NpcywgQW5odWkgTWVkaWNhbCBVbml2ZXJzaXR5LCA4MSBNZWlz

aGFuIFJvYWQsIEhlZmVpLCAyMzAwMzIgQW5odWksIENoaW5hLiYjeEQ7RGVwYXJ0bWVudCBvZiBF

cGlkZW1pb2xvZ3kgYW5kIEJpb3N0YXRpc3RpY3MsIFNjaG9vbCBvZiBQdWJsaWMgSGVhbHRoLCBB

bmh1aSBNZWRpY2FsIFVuaXZlcnNpdHksIDgxIE1laXNoYW4gUm9hZCwgSGVmZWksIDIzMDAzMiBB

bmh1aSwgQ2hpbmE7IEdyYWR1YXRlIFNjaG9vbCwgV2FubmFuIE1lZGljYWwgQ29sbGVnZSwgV2Vz

dCBvZiBXZW5jaGFuZyBSb2FkLCBVbml2ZXJzaXR5IFBhcmssIFd1aHUsIEFuaHVpIDI0MTAwMiwg

Q2hpbmEuJiN4RDtEZXBhcnRtZW50IG9mIFJoZXVtYXRvbG9neSwgQW5odWkgUHJvdmluY2lhbCBI

b3NwaXRhbCwgSGVmZWksIENoaW5hLiYjeEQ7RGVwYXJ0bWVudCBvZiBFcGlkZW1pb2xvZ3kgYW5k

IEJpb3N0YXRpc3RpY3MsIFNjaG9vbCBvZiBQdWJsaWMgSGVhbHRoLCBBbmh1aSBNZWRpY2FsIFVu

aXZlcnNpdHksIDgxIE1laXNoYW4gUm9hZCwgSGVmZWksIDIzMDAzMiBBbmh1aSwgQ2hpbmE7IEFu

aHVpIFByb3ZpbmNpYWwgTGFib3JhdG9yeSBvZiBQb3B1bGF0aW9uIEhlYWx0aCAmYW1wOyBNYWpv

ciBEaXNlYXNlIFNjcmVlbmluZyBhbmQgRGlhZ25vc2lzLCBBbmh1aSBNZWRpY2FsIFVuaXZlcnNp

dHksIDgxIE1laXNoYW4gUm9hZCwgSGVmZWksIDIzMDAzMiBBbmh1aSwgQ2hpbmEuIEVsZWN0cm9u

aWMgYWRkcmVzczogcGFuaGFpZmVuZzE5ODJAc2luYS5jb20uJiN4RDtEZXBhcnRtZW50IG9mIEVw

aWRlbWlvbG9neSBhbmQgQmlvc3RhdGlzdGljcywgU2Nob29sIG9mIFB1YmxpYyBIZWFsdGgsIEFu

aHVpIE1lZGljYWwgVW5pdmVyc2l0eSwgODEgTWVpc2hhbiBSb2FkLCBIZWZlaSwgMjMwMDMyIEFu

aHVpLCBDaGluYTsgQW5odWkgUHJvdmluY2lhbCBMYWJvcmF0b3J5IG9mIFBvcHVsYXRpb24gSGVh

bHRoICZhbXA7IE1ham9yIERpc2Vhc2UgU2NyZWVuaW5nIGFuZCBEaWFnbm9zaXMsIEFuaHVpIE1l

ZGljYWwgVW5pdmVyc2l0eSwgODEgTWVpc2hhbiBSb2FkLCBIZWZlaSwgMjMwMDMyIEFuaHVpLCBD

aGluYS4gRWxlY3Ryb25pYyBhZGRyZXNzOiB5ZHFhaG11QGdtYWlsLmNvbS48L2F1dGgtYWRkcmVz

cz48dGl0bGVzPjx0aXRsZT5TdWJjbGluaWNhbCBhdGhlcm9zY2xlcm9zaXMgaW4gcGF0aWVudHMg

d2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzOiBBIHN5c3RlbWljIHJldmlldyBhbmQg

bWV0YS1hbmFseXNpczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BdXRvaW1tdW5pdHkgcmV2aWV3

czwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QXV0b2ltbXVuIFJldjwvYWx0LXRpdGxlPjwv

dGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkF1dG9pbW11bml0eSByZXZpZXdzPC9mdWxs

LXRpdGxlPjxhYmJyLTE+QXV0b2ltbXVuIFJldjwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBl

cmlvZGljYWw+PGZ1bGwtdGl0bGU+QXV0b2ltbXVuaXR5IHJldmlld3M8L2Z1bGwtdGl0bGU+PGFi

YnItMT5BdXRvaW1tdW4gUmV2PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjItMzc8

L3BhZ2VzPjx2b2x1bWU+MTU8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48ZGF0ZXM+PHllYXI+

MjAxNjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkphbjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjE4NzMtMDE4MyAoRWxlY3Ryb25pYykmI3hEOzE1NjgtOTk3MiAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MjY0NTU1NjI8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5SZXZp

ZXc8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08

L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29y

ZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (27). Plaque and IMT measurement on carotid ultrasound in SLE can independently predict CVEs ADDIN EN.CITE <EndNote><Cite><Author>Kao</Author><Year>2013</Year><RecNum>423</RecNum><DisplayText>(28)</DisplayText><record><rec-number>423</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">423</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kao, A. H.</author><author>Lertratanakul, A.</author><author>Elliott, J. R.</author><author>Sattar, A.</author><author>Santelices, L.</author><author>Shaw, P.</author><author>Birru, M.</author><author>Avram, Z.</author><author>Thompson, T.</author><author>Sutton-Tyrrell, K.</author><author>Ramsey-Goldman, R.</author><author>Manzi, S.</author></authors></contributors><auth-address>Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania. Electronic address: akao@.</auth-address><titles><title>Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus</title><secondary-title>Am J Cardiol</secondary-title><alt-title>Am J Cardiol</alt-title></titles><periodical><full-title>Am J Cardiol</full-title><abbr-1>The American journal of cardiology</abbr-1></periodical><alt-periodical><full-title>Am J Cardiol</full-title><abbr-1>The American journal of cardiology</abbr-1></alt-periodical><pages>1025-32</pages><volume>112</volume><number>7</number><dates><year>2013</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>1879-1913 (Electronic)&#xD;0002-9149 (Linking)</isbn><accession-num>23827400</accession-num><work-type>Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(28). Risk factors for CVD in patients with SLE (Level B)The aetiology of the premature atherosclerosis seen in SLE is incompletely understood. Traditional cardiovascular risk factors (TRFs), disease-related factors and certain treatments all play a part. Tselios et al recently published a systematic review in which they identified 101 papers which explored risk factors for the development of atherosclerosis in SLE and which satisfied their inclusion criteria PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (29). The following section summarises the results of this systematic review.Traditional risk factors for CVD in patients with SLE (Level C)Classic TRFs include increasing age, male gender, smoking status, diabetes, hypertension and dyslipidaemia. A number of these factors are more common in patients with SLE including hypertension and diabetes, but not smoking or hypercholesterolaemia ADDIN EN.CITE <EndNote><Cite><Author>Bruce</Author><Year>2003</Year><RecNum>448</RecNum><DisplayText>(30)</DisplayText><record><rec-number>448</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">448</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bruce, I. N.</author><author>Urowitz, M. B.</author><author>Gladman, D. D.</author><author>Ibanez, D.</author><author>Steiner, G.</author></authors></contributors><auth-address>University of Toronto Lupus Clinic, and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.</auth-address><titles><title>Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study</title><secondary-title>Arthritis Rheum</secondary-title><alt-title>Arthritis Rheum</alt-title></titles><periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></alt-periodical><pages>3159-67</pages><volume>48</volume><number>11</number><dates><year>2003</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0004-3591 (Print)&#xD;0004-3591 (Linking)</isbn><accession-num>14613278</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(30). More recently described TRFs in the general population include a positive family history of CVD, high levels of high sensitivity C-reactive protein (hs-CRP), ethnicity, low levels of physical activity, obesity and the metabolic syndrome (MetS). MetS is a clustering of CV risk factors including abdominal (central) obesity, elevated blood pressure, elevated fasting plasma glucose, high serum triglycerides, and low high-density lipoprotein (HDL) levels. There is a higher prevalence of MetS in patients with SLE compared with matched controls ADDIN EN.CITE <EndNote><Cite><Author>Parker</Author><Year>2010</Year><RecNum>346</RecNum><DisplayText>(31)</DisplayText><record><rec-number>346</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">346</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Parker, B.</author><author>Bruce, I. N.</author></authors></contributors><auth-address>ARC Epidemiology Unit, Manchester Academic Health Sciences Centre, The University of Manchester Stopford Building, Oxford Road, Manchester M13 9PT, UK.</auth-address><titles><title>The metabolic syndrome in systemic lupus erythematosus</title><secondary-title>Rheum Dis Clin North Am</secondary-title><alt-title>Rheum Dis Clin North Am</alt-title></titles><periodical><full-title>Rheum Dis Clin North Am</full-title><abbr-1>Rheumatic diseases clinics of North America</abbr-1></periodical><alt-periodical><full-title>Rheum Dis Clin North Am</full-title><abbr-1>Rheumatic diseases clinics of North America</abbr-1></alt-periodical><pages>81-97, viii</pages><volume>36</volume><number>1</number><dates><year>2010</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1558-3163 (Electronic)&#xD;0889-857X (Linking)</isbn><accession-num>20202592</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(31). There is evidence that SLE-related factors including active disease, damage and renal involvement are independently associated with MetS and that MetS is prevalent early in the course of the disease PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJrZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS

ZWNOdW0+MzQ3PC9SZWNOdW0+PERpc3BsYXlUZXh0PigzMik8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MzQ3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDc8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBhcmtlciwgQi48L2F1dGhvcj48YXV0aG9y

PlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PGF1dGhvcj5HbGFkbWFuLCBELiBELjwvYXV0aG9yPjxh

dXRob3I+THVudCwgTS48L2F1dGhvcj48YXV0aG9yPkRvbm4sIFIuPC9hdXRob3I+PGF1dGhvcj5C

YWUsIFMuIEMuPC9hdXRob3I+PGF1dGhvcj5TYW5jaGV6LUd1ZXJyZXJvLCBKLjwvYXV0aG9yPjxh

dXRob3I+Um9tZXJvLURpYXosIEouPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+

PGF1dGhvcj5XYWxsYWNlLCBELiBKLjwvYXV0aG9yPjxhdXRob3I+Q2xhcmtlLCBBLiBFLjwvYXV0

aG9yPjxhdXRob3I+QmVybmF0c2t5LCBTLjwvYXV0aG9yPjxhdXRob3I+R2luemxlciwgRS4gTS48

L2F1dGhvcj48YXV0aG9yPklzZW5iZXJnLCBELiBBLjwvYXV0aG9yPjxhdXRob3I+UmFobWFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+TWVycmlsbCwgSi4gVC48L2F1dGhvcj48YXV0aG9yPkFsYXJjb24s

IEcuIFMuPC9hdXRob3I+PGF1dGhvcj5GZXNzbGVyLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+Rm9y

dGluLCBQLiBSLjwvYXV0aG9yPjxhdXRob3I+SGFubHksIEouIEcuPC9hdXRob3I+PGF1dGhvcj5Q

ZXRyaSwgTS48L2F1dGhvcj48YXV0aG9yPlN0ZWluc3NvbiwgSy48L2F1dGhvcj48YXV0aG9yPkRv

b2xleSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPk1hbnppLCBTLjwvYXV0aG9yPjxhdXRob3I+S2hh

bWFzaHRhLCBNLiBBLjwvYXV0aG9yPjxhdXRob3I+UmFtc2V5LUdvbGRtYW4sIFIuPC9hdXRob3I+

PGF1dGhvcj5ab21hLCBBLiBBLjwvYXV0aG9yPjxhdXRob3I+U3R1cmZlbHQsIEcuIEsuPC9hdXRo

b3I+PGF1dGhvcj5OaXZlZCwgTy48L2F1dGhvcj48YXV0aG9yPkFyYW5vdywgQy48L2F1dGhvcj48

YXV0aG9yPk1hY2theSwgTS48L2F1dGhvcj48YXV0aG9yPlJhbW9zLUNhc2FscywgTS48L2F1dGhv

cj48YXV0aG9yPnZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9yPkthbHVuaWFu

LCBLLiBDLjwvYXV0aG9yPjxhdXRob3I+UnVpei1JcmFzdG9yemEsIEcuPC9hdXRob3I+PGF1dGhv

cj5MaW0sIFMuIFMuPC9hdXRob3I+PGF1dGhvcj5LYW1lbiwgRC4gTC48L2F1dGhvcj48YXV0aG9y

PlBlc2Noa2VuLCBDLiBBLjwvYXV0aG9yPjxhdXRob3I+SW5hbmMsIE0uPC9hdXRob3I+PGF1dGhv

cj5CcnVjZSwgSS4gTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48

dGl0bGU+SW1wYWN0IG9mIGVhcmx5IGRpc2Vhc2UgZmFjdG9ycyBvbiBtZXRhYm9saWMgc3luZHJv

bWUgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czogZGF0YSBmcm9tIGFuIGludGVybmF0

aW9uYWwgaW5jZXB0aW9uIGNvaG9ydDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm4gUmhldW0g

RGlzPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5u

IFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRp

c2Vhc2VzPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTMwLTY8L3BhZ2VzPjx2b2x1bWU+

NzQ8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxNTwveWVhcj48L2Rh

dGVzPjxpc2JuPjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8

L2lzYm4+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOIEkgSCAsIEV4dHJhbXVyYWwmI3hE

O1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VIFMgR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwv

dXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJrZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS

ZWNOdW0+MzQ3PC9SZWNOdW0+PERpc3BsYXlUZXh0PigzMik8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MzQ3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDc8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBhcmtlciwgQi48L2F1dGhvcj48YXV0aG9y

PlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PGF1dGhvcj5HbGFkbWFuLCBELiBELjwvYXV0aG9yPjxh

dXRob3I+THVudCwgTS48L2F1dGhvcj48YXV0aG9yPkRvbm4sIFIuPC9hdXRob3I+PGF1dGhvcj5C

YWUsIFMuIEMuPC9hdXRob3I+PGF1dGhvcj5TYW5jaGV6LUd1ZXJyZXJvLCBKLjwvYXV0aG9yPjxh

dXRob3I+Um9tZXJvLURpYXosIEouPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+

PGF1dGhvcj5XYWxsYWNlLCBELiBKLjwvYXV0aG9yPjxhdXRob3I+Q2xhcmtlLCBBLiBFLjwvYXV0

aG9yPjxhdXRob3I+QmVybmF0c2t5LCBTLjwvYXV0aG9yPjxhdXRob3I+R2luemxlciwgRS4gTS48

L2F1dGhvcj48YXV0aG9yPklzZW5iZXJnLCBELiBBLjwvYXV0aG9yPjxhdXRob3I+UmFobWFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+TWVycmlsbCwgSi4gVC48L2F1dGhvcj48YXV0aG9yPkFsYXJjb24s

IEcuIFMuPC9hdXRob3I+PGF1dGhvcj5GZXNzbGVyLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+Rm9y

dGluLCBQLiBSLjwvYXV0aG9yPjxhdXRob3I+SGFubHksIEouIEcuPC9hdXRob3I+PGF1dGhvcj5Q

ZXRyaSwgTS48L2F1dGhvcj48YXV0aG9yPlN0ZWluc3NvbiwgSy48L2F1dGhvcj48YXV0aG9yPkRv

b2xleSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPk1hbnppLCBTLjwvYXV0aG9yPjxhdXRob3I+S2hh

bWFzaHRhLCBNLiBBLjwvYXV0aG9yPjxhdXRob3I+UmFtc2V5LUdvbGRtYW4sIFIuPC9hdXRob3I+

PGF1dGhvcj5ab21hLCBBLiBBLjwvYXV0aG9yPjxhdXRob3I+U3R1cmZlbHQsIEcuIEsuPC9hdXRo

b3I+PGF1dGhvcj5OaXZlZCwgTy48L2F1dGhvcj48YXV0aG9yPkFyYW5vdywgQy48L2F1dGhvcj48

YXV0aG9yPk1hY2theSwgTS48L2F1dGhvcj48YXV0aG9yPlJhbW9zLUNhc2FscywgTS48L2F1dGhv

cj48YXV0aG9yPnZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9yPkthbHVuaWFu

LCBLLiBDLjwvYXV0aG9yPjxhdXRob3I+UnVpei1JcmFzdG9yemEsIEcuPC9hdXRob3I+PGF1dGhv

cj5MaW0sIFMuIFMuPC9hdXRob3I+PGF1dGhvcj5LYW1lbiwgRC4gTC48L2F1dGhvcj48YXV0aG9y

PlBlc2Noa2VuLCBDLiBBLjwvYXV0aG9yPjxhdXRob3I+SW5hbmMsIE0uPC9hdXRob3I+PGF1dGhv

cj5CcnVjZSwgSS4gTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48

dGl0bGU+SW1wYWN0IG9mIGVhcmx5IGRpc2Vhc2UgZmFjdG9ycyBvbiBtZXRhYm9saWMgc3luZHJv

bWUgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czogZGF0YSBmcm9tIGFuIGludGVybmF0

aW9uYWwgaW5jZXB0aW9uIGNvaG9ydDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm4gUmhldW0g

RGlzPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5u

IFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRp

c2Vhc2VzPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTMwLTY8L3BhZ2VzPjx2b2x1bWU+

NzQ8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxNTwveWVhcj48L2Rh

dGVzPjxpc2JuPjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8

L2lzYm4+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOIEkgSCAsIEV4dHJhbXVyYWwmI3hE

O1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VIFMgR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwv

dXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (32).Among the non-modifiable TRFs, there is evidence that increasing age, postmenopausal status, male gender and a positive family history are independent risk factors for subclinical atherosclerosis and CVEs in patients with SLE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (29).Among the modifiable TRFs, obesity and arterial hypertension are independent risk factors for CVEs and subclinical atherosclerosis in patients with SLE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (29). Smoking has been shown to be associated with CVEs, carotid plaque and CAC in SLE. Total cholesterol has been shown to be an independent risk factor for CVEs and subclinical atherosclerosis. Although not an independent risk factor for CVE or CAC, high LDL levels were an independent predictor of increased cIMT and plaque formation ADDIN EN.CITE <EndNote><Cite><Author>Tselios</Author><Year>2014</Year><RecNum>442</RecNum><DisplayText>(33)</DisplayText><record><rec-number>442</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">442</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tselios, K.</author><author>Koumaras, C.</author><author>Urowitz, M. B.</author><author>Gladman, D. D.</author></authors></contributors><auth-address>Second Department of Internal Medicine, 424 General Military Hospital of Thessaloniki, Thessaloniki, Greece.&#xD;Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8. Electronic address: m.urowitz@utoronto.ca.&#xD;Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8.</auth-address><titles><title>Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal</title><secondary-title>Semin Arthritis Rheum</secondary-title><alt-title>Semin Arthritis Rheum</alt-title></titles><periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></alt-periodical><pages>521-5</pages><volume>43</volume><number>4</number><dates><year>2014</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1532-866X (Electronic)&#xD;0049-0172 (Linking)</isbn><accession-num>23953498</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(33). MetS is associated with increased cIMT, CAC and arterial stiffness.Disease specific risk factors for CVD in patients with SLE (level C)TRFs alone do not fully explain the increased risk of CVD seen in patients with SLE ADDIN EN.CITE <EndNote><Cite><Author>Esdaile</Author><Year>2001</Year><RecNum>345</RecNum><DisplayText>(34)</DisplayText><record><rec-number>345</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">345</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Esdaile, J. M.</author><author>Abrahamowicz, M.</author><author>Grodzicky, T.</author><author>Li, Y.</author><author>Panaritis, C.</author><author>du Berger, R.</author><author>Cote, R.</author><author>Grover, S. A.</author><author>Fortin, P. R.</author><author>Clarke, A. E.</author><author>Senecal, J. L.</author></authors></contributors><auth-address>University of British Columbia, Vancouver, Canada. jesdaile@bc.arthritis.ca</auth-address><titles><title>Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus</title><secondary-title>Arthritis Rheum</secondary-title><alt-title>Arthritis Rheum</alt-title></titles><periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></alt-periodical><pages>2331-7</pages><volume>44</volume><number>10</number><dates><year>2001</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0004-3591 (Print)&#xD;0004-3591 (Linking)</isbn><accession-num>11665973</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(34) either as a group or individually. What is more, in a study from the Toronto clinic, lupus patients with CVEs had more TRFs than those without events but they did not have a higher Framingham risk score ADDIN EN.CITE <EndNote><Cite><Author>Urowitz</Author><Year>2007</Year><RecNum>492</RecNum><DisplayText>(35)</DisplayText><record><rec-number>492</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">492</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Urowitz, M. B.</author><author>Ibanez, D.</author><author>Gladman, D. D.</author></authors></contributors><titles><title>Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors</title><secondary-title>J Rheumatol</secondary-title></titles><periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></periodical><pages>70-5</pages><volume>34</volume><number>1</number><dates><year>2007</year></dates><isbn>0315-162X (Print)&#xD;0315-162X (Linking)</isbn><work-type>Research Support, Non-U S Gov&apos;t</work-type><urls></urls></record></Cite></EndNote>(35). SLE disease activity has been shown to be an independent risk factor for CVEs and subclinical atherosclerosis PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (29). Cumulative damage; long disease duration; dsDNA antibodies, anti-cardiolipin antibodies and lupus anticoagulant have also been shown to be independent predictors of CVEs and subclinical atherosclerosis PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjksIDM2LTM4KTwvRGlzcGxheVRleHQ+

PHJlY29yZD48cmVjLW51bWJlcj40OTE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFw

cD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ5MTwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+VHNlbGlvcywgSy48L2F1dGhv

cj48YXV0aG9yPlNoZWFuZSwgQi4gSi48L2F1dGhvcj48YXV0aG9yPkdsYWRtYW4sIEQuIEQuPC9h

dXRob3I+PGF1dGhvcj5Vcm93aXR6LCBNLiBCLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkZyb20gdGhlIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBD

bGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNl

YXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFs

LCBUb3JvbnRvLCBPbnRhcmlvLCBDYW5hZGEuSy4gVHNlbGlvcywgTUQsIFBoRCwgQ2xpbmljYWwg

UmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50

cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZl

cnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgQi5KLiBTaGVh

bmUsIE1ELCBNQiwgQlNjLCBCQU8sIENsaW5pY2FsIFJlc2VhcmNoIEZlbGxvdywgVW5pdmVyc2l0

eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBp

biB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3Jv

bnRvIFdlc3Rlcm4gSG9zcGl0YWw7IEQuRC4gR2xhZG1hbiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Ig

b2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1

cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBE

aXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3Bp

dGFsOyBNLkIuIFVyb3dpdHosIE1ELCBGUkNQQywgUHJvZmVzc29yIG9mIE1lZGljaW5lLCBTZW5p

b3IgU2NpZW50aXN0LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbC4mI3hEO0Zyb20gdGhl

IFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lz

IFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0

d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLCBUb3JvbnRvLCBPbnRhcmlvLCBDYW5hZGEu

Sy4gVHNlbGlvcywgTUQsIFBoRCwgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5

IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGlu

IHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9u

dG8gV2VzdGVybiBIb3NwaXRhbDsgQi5KLiBTaGVhbmUsIE1ELCBNQiwgQlNjLCBCQU8sIENsaW5p

Y2FsIFJlc2VhcmNoIEZlbGxvdywgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IEQuRC4g

R2xhZG1hbiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRp

c3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25v

c2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGgg

TmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBNLkIuIFVyb3dpdHosIE1ELCBGUkNQ

QywgUHJvZmVzc29yIG9mIE1lZGljaW5lLCBTZW5pb3IgU2NpZW50aXN0LCBVbml2ZXJzaXR5IG9m

IFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRo

ZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8g

V2VzdGVybiBIb3NwaXRhbC4gbS51cm93aXR6QHV0b3JvbnRvLmNhLjwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPk9wdGltYWwgTW9uaXRvcmluZyBGb3IgQ29yb25hcnkgSGVhcnQgRGlzZWFz

ZSBSaXNrIGluIFBhdGllbnRzIHdpdGggU3lzdGVtaWMgTHVwdXMgRXJ5dGhlbWF0b3N1czogQSBT

eXN0ZW1hdGljIFJldmlldzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIFJoZXVtYXRvbDwvc2Vj

b25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBSaGV1bWF0b2w8L2FsdC10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRo

ZSBKb3VybmFsIG9mIHJoZXVtYXRvbG9neTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+SiBSaGV1bWF0b2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91

cm5hbCBvZiByaGV1bWF0b2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz41NC02

NTwvcGFnZXM+PHZvbHVtZT40Mzwvdm9sdW1lPjxudW1iZXI+MTwvbnVtYmVyPjxkYXRlcz48eWVh

cj4yMDE2PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MDMxNS0xNjJYIChQcmludCkmI3hEOzAzMTUtMTYyWCAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MjY1Njg1OTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QmFsbG9jY2E8

L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxSZWNOdW0+NTAxPC9SZWNOdW0+PHJlY29yZD48cmVj

LW51bWJlcj41MDE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlk

PSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjUwMTwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmFsbG9jY2EsIEYuPC9hdXRob3I+PGF1dGhvcj5E

JmFwb3M7QXNjZW56bywgRi48L2F1dGhvcj48YXV0aG9yPk1vcmV0dGksIEMuPC9hdXRob3I+PGF1

dGhvcj5PbWVkZSwgUC48L2F1dGhvcj48YXV0aG9yPkNlcnJhdG8sIEUuPC9hdXRob3I+PGF1dGhv

cj5CYXJiZXJvLCBVLjwvYXV0aG9yPjxhdXRob3I+QWJiYXRlLCBBLjwvYXV0aG9yPjxhdXRob3I+

QmVydGVybywgTS4gVC48L2F1dGhvcj48YXV0aG9yPlpvY2NhaSwgRy4gQi48L2F1dGhvcj48YXV0

aG9yPkdhaXRhLCBGLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy

ZXNzPkRpdmlzaW9uIG9mIENhcmRpb2xvZ3ksIENpdHRhIGRlbGxhIFNhbHV0ZSBlIGRlbGxhIFNj

aWVuemEsIFVuaXZlcnNpdHkgb2YgVHVyaW4sIEl0YWx5IGZsYXZpYWJsQGhvdG1haWwuaXQuJiN4

RDtEaXZpc2lvbiBvZiBDYXJkaW9sb2d5LCBDaXR0YSBkZWxsYSBTYWx1dGUgZSBkZWxsYSBTY2ll

bnphLCBVbml2ZXJzaXR5IG9mIFR1cmluLCBJdGFseS4mI3hEO1ZDVSBQYXVsZXkgSGVhcnQgQ2Vu

dGVyLCBWaXJnaW5pYSBDb21tb253ZWFsdGggVW5pdmVyc2l0eSwgUmljaG1vbmQsIFZBLCBVU0Eu

JiN4RDtEZXBhcnRtZW50IG9mIENsaW5pY2FsIEltbXVub2xvZ3ksIEFPIE9yZGluZSBNYXVyaXpp

YW5vLCBUb3Jpbm8sIEl0YWx5LiYjeEQ7RGVwYXJ0bWVudCBvZiBNZWRpY28tU3VyZ2ljYWwgU2Np

ZW5jZXMgYW5kIEJpb3RlY2hub2xvZ2llcywgU2FwaWVuemEgVW5pdmVyc2l0eSBvZiBSb21lLCBJ

dGFseS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QcmVkaWN0b3JzIG9mIGNhcmRpb3Zh

c2N1bGFyIGV2ZW50cyBpbiBwYXRpZW50cyB3aXRoIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9z

dXMgKFNMRSk6IGEgc3lzdGVtYXRpYyByZXZpZXcgYW5kIG1ldGEtYW5hbHlzaXM8L3RpdGxlPjxz

ZWNvbmRhcnktdGl0bGU+RXVyb3BlYW4gam91cm5hbCBvZiBwcmV2ZW50aXZlIGNhcmRpb2xvZ3k8

L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1ciBKIFByZXYgQ2FyZGlvbDwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1cm9wZWFuIGpvdXJuYWwgb2YgcHJl

dmVudGl2ZSBjYXJkaW9sb2d5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RXVyIEogUHJldiBDYXJkaW9s

PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXJvcGVh

biBqb3VybmFsIG9mIHByZXZlbnRpdmUgY2FyZGlvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkV1

ciBKIFByZXYgQ2FyZGlvbDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE0MzUtNDE8

L3BhZ2VzPjx2b2x1bWU+MjI8L3ZvbHVtZT48bnVtYmVyPjExPC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5Ob3Y8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4yMDQ3LTQ4ODEgKEVsZWN0cm9uaWMpJiN4RDsyMDQ3LTQ4NzMgKExpbmtpbmcpPC9p

c2JuPjxhY2Nlc3Npb24tbnVtPjI1MTM5NzcyPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48

cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxs

YW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkd1c3Rh

ZnNzb248L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxSZWNOdW0+NTAyPC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj41MDI8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjUwMjwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+R3VzdGFmc3NvbiwgSi4gVC48L2F1dGhv

cj48YXV0aG9yPlNpbWFyZCwgSi4gRi48L2F1dGhvcj48YXV0aG9yPkd1bm5hcnNzb24sIEkuPC9h

dXRob3I+PGF1dGhvcj5FbHZpbiwgSy48L2F1dGhvcj48YXV0aG9yPkx1bmRiZXJnLCBJLiBFLjwv

YXV0aG9yPjxhdXRob3I+SGFuc3NvbiwgTC4gTy48L2F1dGhvcj48YXV0aG9yPkxhcnNzb24sIEEu

PC9hdXRob3I+PGF1dGhvcj5TdmVudW5nc3NvbiwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5SaGV1bWF0b2xvZ3kgVW5pdCwgRGVwYXJ0bWVudCBvZiBN

ZWRpY2luZSwgS2Fyb2xpbnNrYSBVbml2ZXJzaXR5IEhvc3BpdGFsLCBTb2xuYSwgS2Fyb2xpbnNr

YSBJbnN0aXR1dGV0LCBTRS0xNzEgNzYgU3RvY2tob2xtLCBTd2VkZW4uIGpvaGFubmEuZ3VzdGFm

c3NvbkBrYXJvbGluc2thLnNlPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UmlzayBmYWN0

b3JzIGZvciBjYXJkaW92YXNjdWxhciBtb3J0YWxpdHkgaW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1p

YyBsdXB1cyBlcnl0aGVtYXRvc3VzLCBhIHByb3NwZWN0aXZlIGNvaG9ydCBzdHVkeTwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L3NlY29uZGFyeS10aXRsZT48YWx0

LXRpdGxlPkFydGhyaXRpcyBSZXMgVGhlcjwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2Fs

PjxmdWxsLXRpdGxlPkFydGhyaXRpcyBSZXMgVGhlcjwvZnVsbC10aXRsZT48YWJici0xPkFydGhy

aXRpcyByZXNlYXJjaCAmYW1wOyB0aGVyYXB5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5BcnRocml0aXMgcmVzZWFyY2ggJmFtcDsgdGhlcmFweTwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPlI0NjwvcGFnZXM+PHZvbHVtZT4xNDwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVy

PjxkYXRlcz48eWVhcj4yMDEyPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTQ3OC02MzYyIChFbGVjdHJv

bmljKSYjeEQ7MTQ3OC02MzU0IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjM5MDY4

MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdv

diZhcG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRl

cj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5NYWdkZXI8L0F1dGhvcj48WWVhcj4yMDEyPC9Z

ZWFyPjxSZWNOdW0+NDI2PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj40MjY8L3JlYy1udW1i

ZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0

djU1ZGVmcGZlOWRkMHJ6NWQiPjQyNjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+TWFnZGVyLCBMLiBTLjwvYXV0aG9yPjxhdXRob3I+UGV0cmksIE0uPC9hdXRob3I+PC9h

dXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBFcGlkZW1p

b2xvZ3kgYW5kIFB1YmxpYyBIZWFsdGgsIFVuaXZlcnNpdHkgb2YgTWFyeWxhbmQsIEJhbHRpbW9y

ZSwgTUQgMjEyMDEtMTU5NiwgVVNBLiBsbWFnZGVyQGVwaS51bWFyeWxhbmQuZWR1PC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+SW5jaWRlbmNlIG9mIGFuZCByaXNrIGZhY3RvcnMgZm9yIGFk

dmVyc2UgY2FyZGlvdmFzY3VsYXIgZXZlbnRzIGFtb25nIHBhdGllbnRzIHdpdGggc3lzdGVtaWMg

bHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIEVwaWRlbWlv

bDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QW0gSiBFcGlkZW1pb2w8L2FsdC10aXRsZT48

L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10aXRs

ZT48YWJici0xPkFtZXJpY2FuIGpvdXJuYWwgb2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9wZXJp

b2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10

aXRsZT48YWJici0xPkFtZXJpY2FuIGpvdXJuYWwgb2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+NzA4LTE5PC9wYWdlcz48dm9sdW1lPjE3Njwvdm9sdW1lPjxu

dW1iZXI+ODwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEyPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

T2N0IDE1PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3Ni02MjU2IChFbGVjdHJv

bmljKSYjeEQ7MDAwMi05MjYyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMzAyNDEz

NzwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE4uSS5ILiwgRXh0

cmFtdXJhbDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVy

Pk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwv

cmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjksIDM2LTM4KTwvRGlzcGxheVRleHQ+

PHJlY29yZD48cmVjLW51bWJlcj40OTE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFw

cD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ5MTwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+VHNlbGlvcywgSy48L2F1dGhv

cj48YXV0aG9yPlNoZWFuZSwgQi4gSi48L2F1dGhvcj48YXV0aG9yPkdsYWRtYW4sIEQuIEQuPC9h

dXRob3I+PGF1dGhvcj5Vcm93aXR6LCBNLiBCLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkZyb20gdGhlIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBD

bGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNl

YXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFs

LCBUb3JvbnRvLCBPbnRhcmlvLCBDYW5hZGEuSy4gVHNlbGlvcywgTUQsIFBoRCwgQ2xpbmljYWwg

UmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50

cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZl

cnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgQi5KLiBTaGVh

bmUsIE1ELCBNQiwgQlNjLCBCQU8sIENsaW5pY2FsIFJlc2VhcmNoIEZlbGxvdywgVW5pdmVyc2l0

eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBp

biB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3Jv

bnRvIFdlc3Rlcm4gSG9zcGl0YWw7IEQuRC4gR2xhZG1hbiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Ig

b2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1

cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBE

aXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3Bp

dGFsOyBNLkIuIFVyb3dpdHosIE1ELCBGUkNQQywgUHJvZmVzc29yIG9mIE1lZGljaW5lLCBTZW5p

b3IgU2NpZW50aXN0LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbC4mI3hEO0Zyb20gdGhl

IFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lz

IFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0

d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLCBUb3JvbnRvLCBPbnRhcmlvLCBDYW5hZGEu

Sy4gVHNlbGlvcywgTUQsIFBoRCwgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5

IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGlu

IHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9u

dG8gV2VzdGVybiBIb3NwaXRhbDsgQi5KLiBTaGVhbmUsIE1ELCBNQiwgQlNjLCBCQU8sIENsaW5p

Y2FsIFJlc2VhcmNoIEZlbGxvdywgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IEQuRC4g

R2xhZG1hbiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRp

c3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25v

c2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGgg

TmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBNLkIuIFVyb3dpdHosIE1ELCBGUkNQ

QywgUHJvZmVzc29yIG9mIE1lZGljaW5lLCBTZW5pb3IgU2NpZW50aXN0LCBVbml2ZXJzaXR5IG9m

IFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRo

ZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8g

V2VzdGVybiBIb3NwaXRhbC4gbS51cm93aXR6QHV0b3JvbnRvLmNhLjwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPk9wdGltYWwgTW9uaXRvcmluZyBGb3IgQ29yb25hcnkgSGVhcnQgRGlzZWFz

ZSBSaXNrIGluIFBhdGllbnRzIHdpdGggU3lzdGVtaWMgTHVwdXMgRXJ5dGhlbWF0b3N1czogQSBT

eXN0ZW1hdGljIFJldmlldzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIFJoZXVtYXRvbDwvc2Vj

b25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBSaGV1bWF0b2w8L2FsdC10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRo

ZSBKb3VybmFsIG9mIHJoZXVtYXRvbG9neTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+SiBSaGV1bWF0b2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91

cm5hbCBvZiByaGV1bWF0b2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz41NC02

NTwvcGFnZXM+PHZvbHVtZT40Mzwvdm9sdW1lPjxudW1iZXI+MTwvbnVtYmVyPjxkYXRlcz48eWVh

cj4yMDE2PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MDMxNS0xNjJYIChQcmludCkmI3hEOzAzMTUtMTYyWCAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MjY1Njg1OTE8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QmFsbG9jY2E8

L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxSZWNOdW0+NTAxPC9SZWNOdW0+PHJlY29yZD48cmVj

LW51bWJlcj41MDE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlk

PSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjUwMTwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmFsbG9jY2EsIEYuPC9hdXRob3I+PGF1dGhvcj5E

JmFwb3M7QXNjZW56bywgRi48L2F1dGhvcj48YXV0aG9yPk1vcmV0dGksIEMuPC9hdXRob3I+PGF1

dGhvcj5PbWVkZSwgUC48L2F1dGhvcj48YXV0aG9yPkNlcnJhdG8sIEUuPC9hdXRob3I+PGF1dGhv

cj5CYXJiZXJvLCBVLjwvYXV0aG9yPjxhdXRob3I+QWJiYXRlLCBBLjwvYXV0aG9yPjxhdXRob3I+

QmVydGVybywgTS4gVC48L2F1dGhvcj48YXV0aG9yPlpvY2NhaSwgRy4gQi48L2F1dGhvcj48YXV0

aG9yPkdhaXRhLCBGLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy

ZXNzPkRpdmlzaW9uIG9mIENhcmRpb2xvZ3ksIENpdHRhIGRlbGxhIFNhbHV0ZSBlIGRlbGxhIFNj

aWVuemEsIFVuaXZlcnNpdHkgb2YgVHVyaW4sIEl0YWx5IGZsYXZpYWJsQGhvdG1haWwuaXQuJiN4

RDtEaXZpc2lvbiBvZiBDYXJkaW9sb2d5LCBDaXR0YSBkZWxsYSBTYWx1dGUgZSBkZWxsYSBTY2ll

bnphLCBVbml2ZXJzaXR5IG9mIFR1cmluLCBJdGFseS4mI3hEO1ZDVSBQYXVsZXkgSGVhcnQgQ2Vu

dGVyLCBWaXJnaW5pYSBDb21tb253ZWFsdGggVW5pdmVyc2l0eSwgUmljaG1vbmQsIFZBLCBVU0Eu

JiN4RDtEZXBhcnRtZW50IG9mIENsaW5pY2FsIEltbXVub2xvZ3ksIEFPIE9yZGluZSBNYXVyaXpp

YW5vLCBUb3Jpbm8sIEl0YWx5LiYjeEQ7RGVwYXJ0bWVudCBvZiBNZWRpY28tU3VyZ2ljYWwgU2Np

ZW5jZXMgYW5kIEJpb3RlY2hub2xvZ2llcywgU2FwaWVuemEgVW5pdmVyc2l0eSBvZiBSb21lLCBJ

dGFseS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QcmVkaWN0b3JzIG9mIGNhcmRpb3Zh

c2N1bGFyIGV2ZW50cyBpbiBwYXRpZW50cyB3aXRoIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9z

dXMgKFNMRSk6IGEgc3lzdGVtYXRpYyByZXZpZXcgYW5kIG1ldGEtYW5hbHlzaXM8L3RpdGxlPjxz

ZWNvbmRhcnktdGl0bGU+RXVyb3BlYW4gam91cm5hbCBvZiBwcmV2ZW50aXZlIGNhcmRpb2xvZ3k8

L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1ciBKIFByZXYgQ2FyZGlvbDwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1cm9wZWFuIGpvdXJuYWwgb2YgcHJl

dmVudGl2ZSBjYXJkaW9sb2d5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RXVyIEogUHJldiBDYXJkaW9s

PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXJvcGVh

biBqb3VybmFsIG9mIHByZXZlbnRpdmUgY2FyZGlvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkV1

ciBKIFByZXYgQ2FyZGlvbDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE0MzUtNDE8

L3BhZ2VzPjx2b2x1bWU+MjI8L3ZvbHVtZT48bnVtYmVyPjExPC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5Ob3Y8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4yMDQ3LTQ4ODEgKEVsZWN0cm9uaWMpJiN4RDsyMDQ3LTQ4NzMgKExpbmtpbmcpPC9p

c2JuPjxhY2Nlc3Npb24tbnVtPjI1MTM5NzcyPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjwvdXJscz48

cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxs

YW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkd1c3Rh

ZnNzb248L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxSZWNOdW0+NTAyPC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj41MDI8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjUwMjwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+R3VzdGFmc3NvbiwgSi4gVC48L2F1dGhv

cj48YXV0aG9yPlNpbWFyZCwgSi4gRi48L2F1dGhvcj48YXV0aG9yPkd1bm5hcnNzb24sIEkuPC9h

dXRob3I+PGF1dGhvcj5FbHZpbiwgSy48L2F1dGhvcj48YXV0aG9yPkx1bmRiZXJnLCBJLiBFLjwv

YXV0aG9yPjxhdXRob3I+SGFuc3NvbiwgTC4gTy48L2F1dGhvcj48YXV0aG9yPkxhcnNzb24sIEEu

PC9hdXRob3I+PGF1dGhvcj5TdmVudW5nc3NvbiwgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5SaGV1bWF0b2xvZ3kgVW5pdCwgRGVwYXJ0bWVudCBvZiBN

ZWRpY2luZSwgS2Fyb2xpbnNrYSBVbml2ZXJzaXR5IEhvc3BpdGFsLCBTb2xuYSwgS2Fyb2xpbnNr

YSBJbnN0aXR1dGV0LCBTRS0xNzEgNzYgU3RvY2tob2xtLCBTd2VkZW4uIGpvaGFubmEuZ3VzdGFm

c3NvbkBrYXJvbGluc2thLnNlPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UmlzayBmYWN0

b3JzIGZvciBjYXJkaW92YXNjdWxhciBtb3J0YWxpdHkgaW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1p

YyBsdXB1cyBlcnl0aGVtYXRvc3VzLCBhIHByb3NwZWN0aXZlIGNvaG9ydCBzdHVkeTwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L3NlY29uZGFyeS10aXRsZT48YWx0

LXRpdGxlPkFydGhyaXRpcyBSZXMgVGhlcjwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2Fs

PjxmdWxsLXRpdGxlPkFydGhyaXRpcyBSZXMgVGhlcjwvZnVsbC10aXRsZT48YWJici0xPkFydGhy

aXRpcyByZXNlYXJjaCAmYW1wOyB0aGVyYXB5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5BcnRocml0aXMgcmVzZWFyY2ggJmFtcDsgdGhlcmFweTwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPlI0NjwvcGFnZXM+PHZvbHVtZT4xNDwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVy

PjxkYXRlcz48eWVhcj4yMDEyPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTQ3OC02MzYyIChFbGVjdHJv

bmljKSYjeEQ7MTQ3OC02MzU0IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjM5MDY4

MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdv

diZhcG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRl

cj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5NYWdkZXI8L0F1dGhvcj48WWVhcj4yMDEyPC9Z

ZWFyPjxSZWNOdW0+NDI2PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj40MjY8L3JlYy1udW1i

ZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0

djU1ZGVmcGZlOWRkMHJ6NWQiPjQyNjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+TWFnZGVyLCBMLiBTLjwvYXV0aG9yPjxhdXRob3I+UGV0cmksIE0uPC9hdXRob3I+PC9h

dXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBFcGlkZW1p

b2xvZ3kgYW5kIFB1YmxpYyBIZWFsdGgsIFVuaXZlcnNpdHkgb2YgTWFyeWxhbmQsIEJhbHRpbW9y

ZSwgTUQgMjEyMDEtMTU5NiwgVVNBLiBsbWFnZGVyQGVwaS51bWFyeWxhbmQuZWR1PC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+SW5jaWRlbmNlIG9mIGFuZCByaXNrIGZhY3RvcnMgZm9yIGFk

dmVyc2UgY2FyZGlvdmFzY3VsYXIgZXZlbnRzIGFtb25nIHBhdGllbnRzIHdpdGggc3lzdGVtaWMg

bHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIEVwaWRlbWlv

bDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QW0gSiBFcGlkZW1pb2w8L2FsdC10aXRsZT48

L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10aXRs

ZT48YWJici0xPkFtZXJpY2FuIGpvdXJuYWwgb2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9wZXJp

b2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIEVwaWRlbWlvbDwvZnVsbC10

aXRsZT48YWJici0xPkFtZXJpY2FuIGpvdXJuYWwgb2YgZXBpZGVtaW9sb2d5PC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+NzA4LTE5PC9wYWdlcz48dm9sdW1lPjE3Njwvdm9sdW1lPjxu

dW1iZXI+ODwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEyPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

T2N0IDE1PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3Ni02MjU2IChFbGVjdHJv

bmljKSYjeEQ7MDAwMi05MjYyIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMzAyNDEz

NzwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBvcnQsIE4uSS5ILiwgRXh0

cmFtdXJhbDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVy

Pk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwv

cmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA (29, 36-38). Antiphospholipid syndrome (APS) frequently co-exists with SLE ADDIN EN.CITE <EndNote><Cite><Author>Rojas-Villarraga</Author><Year>2010</Year><RecNum>504</RecNum><DisplayText>(39)</DisplayText><record><rec-number>504</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">504</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rojas-Villarraga, A.</author><author>Toro, C. E.</author><author>Espinosa, G.</author><author>Rodriguez-Velosa, Y.</author><author>Duarte-Rey, C.</author><author>Mantilla, R. D.</author><author>Iglesias-Gamarra, A.</author><author>Cervera, R.</author><author>Anaya, J. M.</author></authors></contributors><auth-address>Center for Autoimmune Diseases Research (CREA), School of Medicine, Rosario University, Bogota, Colombia.</auth-address><titles><title>Factors influencing polyautoimmunity in systemic lupus erythematosus</title><secondary-title>Autoimmunity reviews</secondary-title><alt-title>Autoimmun Rev</alt-title></titles><periodical><full-title>Autoimmunity reviews</full-title><abbr-1>Autoimmun Rev</abbr-1></periodical><alt-periodical><full-title>Autoimmunity reviews</full-title><abbr-1>Autoimmun Rev</abbr-1></alt-periodical><pages>229-32</pages><volume>9</volume><number>4</number><dates><year>2010</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1873-0183 (Electronic)&#xD;1568-9972 (Linking)</isbn><accession-num>19819350</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(39). Patients who have a diagnosis of both SLE and APS represent a more severe disease phenotype with higher risk of CVD ADDIN EN.CITE <EndNote><Cite><Author>Franco</Author><Year>2014</Year><RecNum>506</RecNum><DisplayText>(40)</DisplayText><record><rec-number>506</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">506</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Franco, J. S.</author><author>Molano-Gonzalez, N.</author><author>Rodriguez-Jimenez, M.</author><author>Acosta-Ampudia, Y.</author><author>Mantilla, R. D.</author><author>Amaya-Amaya, J.</author><author>Rojas-Villarraga, A.</author><author>Anaya, J. M.</author></authors></contributors><auth-address>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; Mederi, Hospital Universitario Mayor, Bogota, Colombia.&#xD;Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.</auth-address><titles><title>The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians</title><secondary-title>PLoS One</secondary-title><alt-title>PLoS One</alt-title></titles><periodical><full-title>PLoS One</full-title><abbr-1>PloS one</abbr-1></periodical><alt-periodical><full-title>PLoS One</full-title><abbr-1>PloS one</abbr-1></alt-periodical><pages>e110242</pages><volume>9</volume><number>10</number><dates><year>2014</year></dates><isbn>1932-6203 (Electronic)&#xD;1932-6203 (Linking)</isbn><accession-num>25343509</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(40). Both proteinuria and renal impairment are independent predictors of CVE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (29). Treatment related factors and the risk of CVD in patients with SLE (Level C)The negative effects of corticosteroids on CVE, hypertension, lipid profile and weight are well known. High cumulative steroid dose predicts plaque formation in patients with SLE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Eb3JpYTwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJl

Y051bT41MDg8L1JlY051bT48RGlzcGxheVRleHQ+KDQxKTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj41MDg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjUwODwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RG9yaWEsIEEuPC9hdXRob3I+PGF1dGhvcj5T

aG9lbmZlbGQsIFkuPC9hdXRob3I+PGF1dGhvcj5XdSwgUi48L2F1dGhvcj48YXV0aG9yPkdhbWJh

cmksIFAuIEYuPC9hdXRob3I+PGF1dGhvcj5QdWF0bywgTS48L2F1dGhvcj48YXV0aG9yPkdoaXJh

cmRlbGxvLCBBLjwvYXV0aG9yPjxhdXRob3I+R2lsYnVyZCwgQi48L2F1dGhvcj48YXV0aG9yPkNv

cmJhbmVzZSwgUy48L2F1dGhvcj48YXV0aG9yPlBhdG5haWssIE0uPC9hdXRob3I+PGF1dGhvcj5a

YW1waWVyaSwgUy48L2F1dGhvcj48YXV0aG9yPlBldGVyLCBKLiBCLjwvYXV0aG9yPjxhdXRob3I+

RmF2YXJldHRvLCBFLjwvYXV0aG9yPjxhdXRob3I+SWFjY2FyaW5vLCBMLjwvYXV0aG9yPjxhdXRo

b3I+U2hlcmVyLCBZLjwvYXV0aG9yPjxhdXRob3I+VG9kZXNjbywgUy48L2F1dGhvcj48YXV0aG9y

PlBhdWxldHRvLCBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy

ZXNzPkRpdmlzaW9uIG9mIFJoZXVtYXRvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2FsIGFuZCBT

dXJnaWNhbCBTY2llbmNlLCBVbml2ZXJzaXR5IG9mIFBhZG92YSwgSXRhbHkuIGFkb3JpYUB1bmlw

ZC5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJpc2sgZmFjdG9ycyBmb3Igc3ViY2xp

bmljYWwgYXRoZXJvc2NsZXJvc2lzIGluIGEgcHJvc3BlY3RpdmUgY29ob3J0IG9mIHBhdGllbnRz

IHdpdGggc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5Bbm4gUmhldW0gRGlzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5Bbm5hbHMgb2YgdGhl

IHJoZXVtYXRpYyBkaXNlYXNlczwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJo

ZXVtYXRpYyBkaXNlYXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+QW5uIFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUg

cmhldW1hdGljIGRpc2Vhc2VzPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTA3MS03

PC9wYWdlcz48dm9sdW1lPjYyPC92b2x1bWU+PG51bWJlcj4xMTwvbnVtYmVyPjxlZGl0aW9uPjIw

MDMvMTAvMzA8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3

b3JkPkFnZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPkFudGktSW5mbGFtbWF0b3J5IEFnZW50

cy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb3NjbGVyb3Npcy8gY29t

cGxpY2F0aW9ucy8gZGlhZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPkNhcm90aWQgQXJ0ZXJpZXMv

cGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNyb3NzLVNlY3Rpb25hbCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5Gb2xsb3ctVXAgU3R1ZGllczwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uL3Bh

dGhvbG9neTwva2V5d29yZD48a2V5d29yZD5MdXB1cyBFcnl0aGVtYXRvc3VzLCBTeXN0ZW1pYy8g

Y29tcGxpY2F0aW9ucy9kcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+THVwdXMgTmVwaHJp

dGlzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1p

ZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk11bHRpdmFyaWF0ZSBBbmFseXNpczwva2V5d29y

ZD48a2V5d29yZD5QcmVkbmlzb25lL3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5Q

cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29y

ZD48a2V5d29yZD5UdW5pY2EgSW50aW1hL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5VbHRy

YXNvbm9ncmFwaHksIERvcHBsZXIsIER1cGxleDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDAzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+Tm92PC9kYXRlPjwvcHViLWRhdGVzPjwv

ZGF0ZXM+PGlzYm4+MDAwMy00OTY3IChQcmludCkmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MTQ1ODM1NzA8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxj

dXN0b20yPjE3NTQzNzA8L2N1c3RvbTI+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48

L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Eb3JpYTwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJl

Y051bT41MDg8L1JlY051bT48RGlzcGxheVRleHQ+KDQxKTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj41MDg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjUwODwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RG9yaWEsIEEuPC9hdXRob3I+PGF1dGhvcj5T

aG9lbmZlbGQsIFkuPC9hdXRob3I+PGF1dGhvcj5XdSwgUi48L2F1dGhvcj48YXV0aG9yPkdhbWJh

cmksIFAuIEYuPC9hdXRob3I+PGF1dGhvcj5QdWF0bywgTS48L2F1dGhvcj48YXV0aG9yPkdoaXJh

cmRlbGxvLCBBLjwvYXV0aG9yPjxhdXRob3I+R2lsYnVyZCwgQi48L2F1dGhvcj48YXV0aG9yPkNv

cmJhbmVzZSwgUy48L2F1dGhvcj48YXV0aG9yPlBhdG5haWssIE0uPC9hdXRob3I+PGF1dGhvcj5a

YW1waWVyaSwgUy48L2F1dGhvcj48YXV0aG9yPlBldGVyLCBKLiBCLjwvYXV0aG9yPjxhdXRob3I+

RmF2YXJldHRvLCBFLjwvYXV0aG9yPjxhdXRob3I+SWFjY2FyaW5vLCBMLjwvYXV0aG9yPjxhdXRo

b3I+U2hlcmVyLCBZLjwvYXV0aG9yPjxhdXRob3I+VG9kZXNjbywgUy48L2F1dGhvcj48YXV0aG9y

PlBhdWxldHRvLCBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy

ZXNzPkRpdmlzaW9uIG9mIFJoZXVtYXRvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2FsIGFuZCBT

dXJnaWNhbCBTY2llbmNlLCBVbml2ZXJzaXR5IG9mIFBhZG92YSwgSXRhbHkuIGFkb3JpYUB1bmlw

ZC5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJpc2sgZmFjdG9ycyBmb3Igc3ViY2xp

bmljYWwgYXRoZXJvc2NsZXJvc2lzIGluIGEgcHJvc3BlY3RpdmUgY29ob3J0IG9mIHBhdGllbnRz

IHdpdGggc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5Bbm4gUmhldW0gRGlzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5Bbm5hbHMgb2YgdGhl

IHJoZXVtYXRpYyBkaXNlYXNlczwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJo

ZXVtYXRpYyBkaXNlYXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+QW5uIFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUg

cmhldW1hdGljIGRpc2Vhc2VzPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTA3MS03

PC9wYWdlcz48dm9sdW1lPjYyPC92b2x1bWU+PG51bWJlcj4xMTwvbnVtYmVyPjxlZGl0aW9uPjIw

MDMvMTAvMzA8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3

b3JkPkFnZSBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPkFudGktSW5mbGFtbWF0b3J5IEFnZW50

cy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QXJ0ZXJpb3NjbGVyb3Npcy8gY29t

cGxpY2F0aW9ucy8gZGlhZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPkNhcm90aWQgQXJ0ZXJpZXMv

cGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNyb3NzLVNlY3Rpb25hbCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5Gb2xsb3ctVXAgU3R1ZGllczwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJ0ZW5zaW9uL3Bh

dGhvbG9neTwva2V5d29yZD48a2V5d29yZD5MdXB1cyBFcnl0aGVtYXRvc3VzLCBTeXN0ZW1pYy8g

Y29tcGxpY2F0aW9ucy9kcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+THVwdXMgTmVwaHJp

dGlzL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1p

ZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk11bHRpdmFyaWF0ZSBBbmFseXNpczwva2V5d29y

ZD48a2V5d29yZD5QcmVkbmlzb25lL3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5Q

cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29y

ZD48a2V5d29yZD5UdW5pY2EgSW50aW1hL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5VbHRy

YXNvbm9ncmFwaHksIERvcHBsZXIsIER1cGxleDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDAzPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+Tm92PC9kYXRlPjwvcHViLWRhdGVzPjwv

ZGF0ZXM+PGlzYm4+MDAwMy00OTY3IChQcmludCkmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MTQ1ODM1NzA8L2FjY2Vzc2lvbi1udW0+PHVybHM+PC91cmxzPjxj

dXN0b20yPjE3NTQzNzA8L2N1c3RvbTI+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48

L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (41). Current steroid use, independent of disease activity, also predicts CVE ADDIN EN.CITE <EndNote><Cite><Author>Magder</Author><Year>2012</Year><RecNum>413</RecNum><DisplayText>(38)</DisplayText><record><rec-number>413</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">413</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Magder, L. S.</author><author>Petri, M.</author></authors></contributors><auth-address>Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD 21201-1596, USA. lmagder@epi.umaryland.edu</auth-address><titles><title>Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus</title><secondary-title>Am J Epidemiol</secondary-title><alt-title>Am J Epidemiol</alt-title></titles><periodical><full-title>Am J Epidemiol</full-title><abbr-1>American journal of epidemiology</abbr-1></periodical><alt-periodical><full-title>Am J Epidemiol</full-title><abbr-1>American journal of epidemiology</abbr-1></alt-periodical><pages>708-19</pages><volume>176</volume><number>8</number><dates><year>2012</year><pub-dates><date>Oct 15</date></pub-dates></dates><isbn>1476-6256 (Electronic)&#xD;0002-9262 (Linking)</isbn><accession-num>23024137</accession-num><work-type>Research Support, N.I.H., Extramural</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(38).The protective role of hydroxychloroquine has been demonstrated in a number of studies. In a Chinese SLE cohort, lack of use of hydroxychloroquine was an independent risk factor for CVD ADDIN EN.CITE <EndNote><Cite><Author>Yang</Author><Year>2012</Year><RecNum>509</RecNum><DisplayText>(42)</DisplayText><record><rec-number>509</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">509</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, L.</author><author>Tao, J.</author><author>Tang, X.</author><author>Wang, Y.</author><author>He, X.</author><author>Xu, G.</author><author>Ren, Y.</author><author>Tu, Y.</author></authors></contributors><auth-address>Department of Dermatology, Tongji Medical College, Affiliated Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.</auth-address><titles><title>Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients</title><secondary-title>Journal of the European Academy of Dermatology and Venereology : JEADV</secondary-title><alt-title>J Eur Acad Dermatol Venereol</alt-title></titles><periodical><full-title>Journal of the European Academy of Dermatology and Venereology : JEADV</full-title><abbr-1>J Eur Acad Dermatol Venereol</abbr-1></periodical><alt-periodical><full-title>Journal of the European Academy of Dermatology and Venereology : JEADV</full-title><abbr-1>J Eur Acad Dermatol Venereol</abbr-1></alt-periodical><pages>95-101</pages><volume>26</volume><number>1</number><dates><year>2012</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1468-3083 (Electronic)&#xD;0926-9959 (Linking)</isbn><accession-num>21851424</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(42). In a prospective study in the Toronto lupus cohort, patients who developed coronary artery disease (CAD) were significantly less likely to have been treated with hydroxychloroquine than those who did not develop CAD ADDIN EN.CITE <EndNote><Cite><Author>Nikpour</Author><Year>2011</Year><RecNum>428</RecNum><DisplayText>(43)</DisplayText><record><rec-number>428</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">428</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nikpour, M.</author><author>Urowitz, M. B.</author><author>Ibanez, D.</author><author>Harvey, P. J.</author><author>Gladman, D. D.</author></authors></contributors><auth-address>University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada.</auth-address><titles><title>Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study</title><secondary-title>Arthritis Res Ther</secondary-title><alt-title>Arthritis Res Ther</alt-title></titles><periodical><full-title>Arthritis Res Ther</full-title><abbr-1>Arthritis research &amp; therapy</abbr-1></periodical><alt-periodical><full-title>Arthritis Res Ther</full-title><abbr-1>Arthritis research &amp; therapy</abbr-1></alt-periodical><pages>R156</pages><volume>13</volume><number>5</number><dates><year>2011</year></dates><isbn>1478-6362 (Electronic)&#xD;1478-6354 (Linking)</isbn><accession-num>21955652</accession-num><work-type>Comparative Study&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(43).Cardiovascular disease in patients with systemic sclerosis (Level A)Systemic sclerosis (SSc) is an autoimmune CTD characterised by multiorgan fibrosis, vasculopathy triggered by endothelial injury, and autoantibody production. Inflammation plays a less prominent role in SSc than in SLE. SSc may directly affect the heart leading to myocardial fibrosis, conduction defects, left ventricular systolic and diastolic dysfunction and pericardial disease ADDIN EN.CITE <EndNote><Cite><Author>Meune</Author><Year>2010</Year><RecNum>366</RecNum><DisplayText>(44)</DisplayText><record><rec-number>366</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">366</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Meune, C.</author><author>Vignaux, O.</author><author>Kahan, A.</author><author>Allanore, Y.</author></authors></contributors><auth-address>Service de cardiologie, hopital Cochin, AP-HP, universite Paris Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. christophe.meune@cch.aphp.fr</auth-address><titles><title>Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies</title><secondary-title>Archives of cardiovascular diseases</secondary-title><alt-title>Arch Cardiovasc Dis</alt-title></titles><periodical><full-title>Archives of cardiovascular diseases</full-title><abbr-1>Arch Cardiovasc Dis</abbr-1></periodical><alt-periodical><full-title>Archives of cardiovascular diseases</full-title><abbr-1>Arch Cardiovasc Dis</abbr-1></alt-periodical><pages>46-52</pages><volume>103</volume><number>1</number><dates><year>2010</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1875-2128 (Electronic)&#xD;1875-2128 (Linking)</isbn><accession-num>20142120</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(44). Heart disease may also occur secondary to pulmonary hypertension in SSc. Although microvascular disease is the hallmark of SSc, there is growing evidence that macrovascular damage, resulting in ACVD is contributing to excess morbidity and mortality ADDIN EN.CITE <EndNote><Cite><Author>Cannarile</Author><Year>2015</Year><RecNum>368</RecNum><DisplayText>(45)</DisplayText><record><rec-number>368</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">368</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cannarile, F.</author><author>Valentini, V.</author><author>Mirabelli, G.</author><author>Alunno, A.</author><author>Terenzi, R.</author><author>Luccioli, F.</author><author>Gerli, R.</author><author>Bartoloni, E.</author></authors></contributors><auth-address>Department of Medicine, Rheumatology Unit, University of Perugia, Via dal Pozzo 06132, Perugia, Italy.</auth-address><titles><title>Cardiovascular disease in systemic sclerosis</title><secondary-title>Annals of translational medicine</secondary-title><alt-title>Ann Transl Med</alt-title></titles><periodical><full-title>Annals of translational medicine</full-title><abbr-1>Ann Transl Med</abbr-1></periodical><alt-periodical><full-title>Annals of translational medicine</full-title><abbr-1>Ann Transl Med</abbr-1></alt-periodical><pages>8</pages><volume>3</volume><number>1</number><dates><year>2015</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>2305-5839 (Print)&#xD;2305-5839 (Linking)</isbn><accession-num>25705640</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(45).Cardiovascular mortality in patients with SSc (Level B)A meta-analysis including 9239 SSc patients from 17 studies published prior to 2005 reported an all-cause meta-SMR of 2.72 (95%CI 1.93, 3.83) ADDIN EN.CITE <EndNote><Cite><Author>Rubio-Rivas</Author><Year>2014</Year><RecNum>407</RecNum><DisplayText>(46)</DisplayText><record><rec-number>407</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">407</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rubio-Rivas, M.</author><author>Royo, C.</author><author>Simeon, C. P.</author><author>Corbella, X.</author><author>Fonollosa, V.</author></authors></contributors><auth-address>Autoimmune Diseases Unit, Bellvitge University Hospital, Barcelona, Spain. Electronic address: mrubio@bellvitgehospital.cat.&#xD;Autoimmune Diseases Unit, Bellvitge University Hospital, Barcelona, Spain.&#xD;Vall d&apos;Hebron University Hospital, Barcelona, Spain.</auth-address><titles><title>Mortality and survival in systemic sclerosis: systematic review and meta-analysis</title><secondary-title>Semin Arthritis Rheum</secondary-title><alt-title>Semin Arthritis Rheum</alt-title></titles><periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></alt-periodical><pages>208-19</pages><volume>44</volume><number>2</number><dates><year>2014</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1532-866X (Electronic)&#xD;0049-0172 (Linking)</isbn><accession-num>24931517</accession-num><work-type>Meta-Analysis&#xD;Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(46). CVD specific SMR was not reported. In the EULAR Scleroderma Trials and Research (EUSTAR) database, 55% of 234 deaths in SSc were directly attributable to the disease and 41% due to non-SSc causes; 26% of the deaths directly attributed to SSc and 29% of the non-SSc causes of death were due to CVD PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5UeW5kYWxsPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48

UmVjTnVtPjM3OTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oNDcpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjM3OTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+Mzc5PC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5UeW5kYWxsLCBBLiBKLjwvYXV0aG9yPjxh

dXRob3I+QmFubmVydCwgQi48L2F1dGhvcj48YXV0aG9yPlZvbmssIE0uPC9hdXRob3I+PGF1dGhv

cj5BaXJvLCBQLjwvYXV0aG9yPjxhdXRob3I+Q296emksIEYuPC9hdXRob3I+PGF1dGhvcj5DYXJy

ZWlyYSwgUC4gRS48L2F1dGhvcj48YXV0aG9yPkJhbmNlbCwgRC4gRi48L2F1dGhvcj48YXV0aG9y

PkFsbGFub3JlLCBZLjwvYXV0aG9yPjxhdXRob3I+TXVsbGVyLUxhZG5lciwgVS48L2F1dGhvcj48

YXV0aG9yPkRpc3RsZXIsIE8uPC9hdXRob3I+PGF1dGhvcj5JYW5ub25lLCBGLjwvYXV0aG9yPjxh

dXRob3I+UGVsbGVyaXRvLCBSLjwvYXV0aG9yPjxhdXRob3I+UGlsZWNreXRlLCBNLjwvYXV0aG9y

PjxhdXRob3I+TWluaWF0aSwgSS48L2F1dGhvcj48YXV0aG9yPkFuYW5pZXZhLCBMLjwvYXV0aG9y

PjxhdXRob3I+R3VybWFuLCBBLiBCLjwvYXV0aG9yPjxhdXRob3I+RGFtamFub3YsIE4uPC9hdXRo

b3I+PGF1dGhvcj5NdWVsbGVyLCBBLjwvYXV0aG9yPjxhdXRob3I+VmFsZW50aW5pLCBHLjwvYXV0

aG9yPjxhdXRob3I+UmllbWVrYXN0ZW4sIEcuPC9hdXRob3I+PGF1dGhvcj5UaWtseSwgTS48L2F1

dGhvcj48YXV0aG9yPkh1bW1lcnMsIEwuPC9hdXRob3I+PGF1dGhvcj5IZW5yaXF1ZXMsIE0uIEou

PC9hdXRob3I+PGF1dGhvcj5DYXJhbWFzY2hpLCBQLjwvYXV0aG9yPjxhdXRob3I+U2NoZWphLCBB

LjwvYXV0aG9yPjxhdXRob3I+Um96bWFuLCBCLjwvYXV0aG9yPjxhdXRob3I+VG9uLCBFLjwvYXV0

aG9yPjxhdXRob3I+S3VtYW5vdmljcywgRy48L2F1dGhvcj48YXV0aG9yPkNvbGVpcm8sIEIuPC9h

dXRob3I+PGF1dGhvcj5GZWllcmwsIEUuPC9hdXRob3I+PGF1dGhvcj5TenVjcywgRy48L2F1dGhv

cj48YXV0aG9yPlZvbiBNdWhsZW4sIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5SaWNjaWVyaSwgVi48

L2F1dGhvcj48YXV0aG9yPk5vdmFrLCBTLjwvYXV0aG9yPjxhdXRob3I+Q2hpenpvbGluaSwgQy48

L2F1dGhvcj48YXV0aG9yPktvdHVsc2thLCBBLjwvYXV0aG9yPjxhdXRob3I+RGVudG9uLCBDLjwv

YXV0aG9yPjxhdXRob3I+Q29lbGhvLCBQLiBDLjwvYXV0aG9yPjxhdXRob3I+S290dGVyLCBJLjwv

YXV0aG9yPjxhdXRob3I+U2ltc2VrLCBJLjwvYXV0aG9yPjxhdXRob3I+ZGUgbGEgUGVuYSBMZWZl

YnZyZSwgUC4gRy48L2F1dGhvcj48YXV0aG9yPkhhY2h1bGxhLCBFLjwvYXV0aG9yPjxhdXRob3I+

U2VpYm9sZCwgSi4gUi48L2F1dGhvcj48YXV0aG9yPlJlZG5pYywgUy48L2F1dGhvcj48YXV0aG9y

PlN0b3JrLCBKLjwvYXV0aG9yPjxhdXRob3I+TW9yb3ZpYy1WZXJnbGVzLCBKLjwvYXV0aG9yPjxh

dXRob3I+V2Fsa2VyLCBVLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0

bGVzPjx0aXRsZT5DYXVzZXMgYW5kIHJpc2sgZmFjdG9ycyBmb3IgZGVhdGggaW4gc3lzdGVtaWMg

c2NsZXJvc2lzOiBhIHN0dWR5IGZyb20gdGhlIEVVTEFSIFNjbGVyb2Rlcm1hIFRyaWFscyBhbmQg

UmVzZWFyY2ggKEVVU1RBUikgZGF0YWJhc2U8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFJo

ZXVtIERpczwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRp

YyBkaXNlYXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTgwOS0xNTwvcGFnZXM+PHZv

bHVtZT42OTwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwveWVh

cj48L2RhdGVzPjxpc2JuPjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlu

a2luZyk8L2lzYm4+PHdvcmstdHlwZT5NdWx0aWNlbnRlciBTdHVkeSYjeEQ7UmVzZWFyY2ggU3Vw

cG9ydCwgTm9uLVUgUyBHb3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5UeW5kYWxsPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48

UmVjTnVtPjM3OTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oNDcpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjM3OTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+Mzc5PC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5UeW5kYWxsLCBBLiBKLjwvYXV0aG9yPjxh

dXRob3I+QmFubmVydCwgQi48L2F1dGhvcj48YXV0aG9yPlZvbmssIE0uPC9hdXRob3I+PGF1dGhv

cj5BaXJvLCBQLjwvYXV0aG9yPjxhdXRob3I+Q296emksIEYuPC9hdXRob3I+PGF1dGhvcj5DYXJy

ZWlyYSwgUC4gRS48L2F1dGhvcj48YXV0aG9yPkJhbmNlbCwgRC4gRi48L2F1dGhvcj48YXV0aG9y

PkFsbGFub3JlLCBZLjwvYXV0aG9yPjxhdXRob3I+TXVsbGVyLUxhZG5lciwgVS48L2F1dGhvcj48

YXV0aG9yPkRpc3RsZXIsIE8uPC9hdXRob3I+PGF1dGhvcj5JYW5ub25lLCBGLjwvYXV0aG9yPjxh

dXRob3I+UGVsbGVyaXRvLCBSLjwvYXV0aG9yPjxhdXRob3I+UGlsZWNreXRlLCBNLjwvYXV0aG9y

PjxhdXRob3I+TWluaWF0aSwgSS48L2F1dGhvcj48YXV0aG9yPkFuYW5pZXZhLCBMLjwvYXV0aG9y

PjxhdXRob3I+R3VybWFuLCBBLiBCLjwvYXV0aG9yPjxhdXRob3I+RGFtamFub3YsIE4uPC9hdXRo

b3I+PGF1dGhvcj5NdWVsbGVyLCBBLjwvYXV0aG9yPjxhdXRob3I+VmFsZW50aW5pLCBHLjwvYXV0

aG9yPjxhdXRob3I+UmllbWVrYXN0ZW4sIEcuPC9hdXRob3I+PGF1dGhvcj5UaWtseSwgTS48L2F1

dGhvcj48YXV0aG9yPkh1bW1lcnMsIEwuPC9hdXRob3I+PGF1dGhvcj5IZW5yaXF1ZXMsIE0uIEou

PC9hdXRob3I+PGF1dGhvcj5DYXJhbWFzY2hpLCBQLjwvYXV0aG9yPjxhdXRob3I+U2NoZWphLCBB

LjwvYXV0aG9yPjxhdXRob3I+Um96bWFuLCBCLjwvYXV0aG9yPjxhdXRob3I+VG9uLCBFLjwvYXV0

aG9yPjxhdXRob3I+S3VtYW5vdmljcywgRy48L2F1dGhvcj48YXV0aG9yPkNvbGVpcm8sIEIuPC9h

dXRob3I+PGF1dGhvcj5GZWllcmwsIEUuPC9hdXRob3I+PGF1dGhvcj5TenVjcywgRy48L2F1dGhv

cj48YXV0aG9yPlZvbiBNdWhsZW4sIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5SaWNjaWVyaSwgVi48

L2F1dGhvcj48YXV0aG9yPk5vdmFrLCBTLjwvYXV0aG9yPjxhdXRob3I+Q2hpenpvbGluaSwgQy48

L2F1dGhvcj48YXV0aG9yPktvdHVsc2thLCBBLjwvYXV0aG9yPjxhdXRob3I+RGVudG9uLCBDLjwv

YXV0aG9yPjxhdXRob3I+Q29lbGhvLCBQLiBDLjwvYXV0aG9yPjxhdXRob3I+S290dGVyLCBJLjwv

YXV0aG9yPjxhdXRob3I+U2ltc2VrLCBJLjwvYXV0aG9yPjxhdXRob3I+ZGUgbGEgUGVuYSBMZWZl

YnZyZSwgUC4gRy48L2F1dGhvcj48YXV0aG9yPkhhY2h1bGxhLCBFLjwvYXV0aG9yPjxhdXRob3I+

U2VpYm9sZCwgSi4gUi48L2F1dGhvcj48YXV0aG9yPlJlZG5pYywgUy48L2F1dGhvcj48YXV0aG9y

PlN0b3JrLCBKLjwvYXV0aG9yPjxhdXRob3I+TW9yb3ZpYy1WZXJnbGVzLCBKLjwvYXV0aG9yPjxh

dXRob3I+V2Fsa2VyLCBVLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0

bGVzPjx0aXRsZT5DYXVzZXMgYW5kIHJpc2sgZmFjdG9ycyBmb3IgZGVhdGggaW4gc3lzdGVtaWMg

c2NsZXJvc2lzOiBhIHN0dWR5IGZyb20gdGhlIEVVTEFSIFNjbGVyb2Rlcm1hIFRyaWFscyBhbmQg

UmVzZWFyY2ggKEVVU1RBUikgZGF0YWJhc2U8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFJo

ZXVtIERpczwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRp

YyBkaXNlYXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTgwOS0xNTwvcGFnZXM+PHZv

bHVtZT42OTwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwveWVh

cj48L2RhdGVzPjxpc2JuPjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlu

a2luZyk8L2lzYm4+PHdvcmstdHlwZT5NdWx0aWNlbnRlciBTdHVkeSYjeEQ7UmVzZWFyY2ggU3Vw

cG9ydCwgTm9uLVUgUyBHb3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (47).There is evidence of a higher case fatality for MI but not for stroke in patients with SSc compared with patients without CTD. Using the US Nationwide Inpatient Survey, Dave et al found that 5.5% of 61,734 admissions in patients with SSc were for a CVD diagnosis or procedure compared with 4.9% of SLE admissions, 7.1% of RA admissions and 6.7% of control admissions. Patients with SSc and MI were more likely to die during that admission than patients with SLE and MI, patients with RA and MI, or controls with MI ADDIN EN.CITE <EndNote><Cite><Author>Dave</Author><Year>2014</Year><RecNum>412</RecNum><DisplayText>(48)</DisplayText><record><rec-number>412</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">412</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dave, A. J.</author><author>Fiorentino, D.</author><author>Lingala, B.</author><author>Krishnan, E.</author><author>Chung, L.</author></authors></contributors><auth-address>Stanford University School of Medicine, Palo Alto, California.</auth-address><titles><title>Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis</title><secondary-title>Arthritis Care Res (Hoboken)</secondary-title><alt-title>Arthritis Care Res (Hoboken)</alt-title></titles><periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></periodical><alt-periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></alt-periodical><pages>323-7</pages><volume>66</volume><number>2</number><dates><year>2014</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>2151-4658 (Electronic)&#xD;2151-464X (Linking)</isbn><accession-num>24022876</accession-num><work-type>Comparative Study&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(48).Atherosclerotic CVD in patients with SSc (Level B)A number of large studies have reported an increased risk of ACVD in patients with SSc compared to the general population. A study of 850 patients with SSc from the Australian Scleroderma Cohort Study reported an odds ratio (OR) for self-reported coronary heart disease, after adjusting for TRFs, of 3.2 (95% CI: 2.3-4.5) compared with a control group from the Australian Diabetes, Obesity and Lifestyle Study and of 2.0 (95% CI: 2.3- 4.5) when compared with a cohort from the National Health Survey ADDIN EN.CITE <EndNote><Cite><Author>Ngian</Author><Year>2012</Year><RecNum>376</RecNum><DisplayText>(49)</DisplayText><record><rec-number>376</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">376</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ngian, G. S.</author><author>Sahhar, J.</author><author>Proudman, S. M.</author><author>Stevens, W.</author><author>Wicks, I. P.</author><author>Van Doornum, S.</author></authors></contributors><auth-address>Department of Medicine (RMH/WH)The University of Melbourne, Grattan StParkville 3050, Victoria, Australia. gngian@student.unimelb.edu.au</auth-address><titles><title>Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis</title><secondary-title>Ann Rheum Dis</secondary-title><alt-title>Ann Rheum Dis</alt-title></titles><periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></periodical><alt-periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></alt-periodical><pages>1980-3</pages><volume>71</volume><number>12</number><dates><year>2012</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1468-2060 (Electronic)&#xD;0003-4967 (Linking)</isbn><accession-num>22532628</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(49). In a study of 865 patients with SSc identified from a UK primary care database, the HR for MI, after adjusting for TRFs and steroid use, was 1.8 (95% CI: 1.07- 3.05), for stroke was 2.61 (95%CI: 1.54-4.44) and for PAD was 4.35 (95%CI: 2.74- 6.93) compared to age and sex matched controls ADDIN EN.CITE <EndNote><Cite><Author>Man</Author><Year>2013</Year><RecNum>377</RecNum><DisplayText>(50)</DisplayText><record><rec-number>377</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">377</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Man, A.</author><author>Zhu, Y.</author><author>Zhang, Y.</author><author>Dubreuil, M.</author><author>Rho, Y. H.</author><author>Peloquin, C.</author><author>Simms, R. W.</author><author>Choi, H. K.</author></authors></contributors><auth-address>Section of Rheumatology, Boston University School of Medicine, Boston, MA 02118, USA. adaman@bu.edu</auth-address><titles><title>The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study</title><secondary-title>Ann Rheum Dis</secondary-title><alt-title>Ann Rheum Dis</alt-title></titles><periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></periodical><alt-periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></alt-periodical><pages>1188-93</pages><volume>72</volume><number>7</number><dates><year>2013</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1468-2060 (Electronic)&#xD;0003-4967 (Linking)</isbn><accession-num>22904260</accession-num><work-type>Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(50). The adjusted HR for MI between 1344 incident cases of SSc and 13440 controls from Taiwan was 2.45 (95%CI 1.60, 3.75) ADDIN EN.CITE <EndNote><Cite><Author>Chu</Author><Year>2013</Year><RecNum>494</RecNum><DisplayText>(51)</DisplayText><record><rec-number>494</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">494</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, S. Y.</author><author>Chen, Y. J.</author><author>Liu, C. J.</author><author>Tseng, W. C.</author><author>Lin, M. W.</author><author>Hwang, C. Y.</author><author>Chen, C. C.</author><author>Lee, D. D.</author><author>Chen, T. J.</author><author>Chang, Y. T.</author><author>Wang, W. J.</author><author>Liu, H. N.</author></authors></contributors><auth-address>Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Dermatology, National Yang-Ming University, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.</auth-address><titles><title>Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study</title><secondary-title>The American journal of medicine</secondary-title><alt-title>Am J Med</alt-title></titles><periodical><full-title>The American journal of medicine</full-title><abbr-1>Am J Med</abbr-1></periodical><alt-periodical><full-title>The American journal of medicine</full-title><abbr-1>Am J Med</abbr-1></alt-periodical><pages>982-8</pages><volume>126</volume><number>11</number><dates><year>2013</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1555-7162 (Electronic)&#xD;0002-9343 (Linking)</isbn><accession-num>24157289</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(51). Subclinical atherosclerosis in patients with SSc (Level B)A recent systematic review and meta-analysis reported on 31 studies which had examined angiography, cIMT, carotid plaque, computed tomography or magnetic resonance imaging, flow mediated dilatation, ankle-brachial index or autopsy in patients with SSc and controls ADDIN EN.CITE <EndNote><Cite><Author>Au</Author><Year>2011</Year><RecNum>498</RecNum><DisplayText>(52)</DisplayText><record><rec-number>498</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">498</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Au, K.</author><author>Singh, M. K.</author><author>Bodukam, V.</author><author>Bae, S.</author><author>Maranian, P.</author><author>Ogawa, R.</author><author>Spiegel, B.</author><author>McMahon, M.</author><author>Hahn, B.</author><author>Khanna, D.</author></authors></contributors><auth-address>University of California, Los Angeles, CA, USA.</auth-address><titles><title>Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis</title><secondary-title>Arthritis Rheum</secondary-title><alt-title>Arthritis Rheum</alt-title></titles><periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></alt-periodical><pages>2078-90</pages><volume>63</volume><number>7</number><dates><year>2011</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1529-0131 (Electronic)&#xD;0004-3591 (Linking)</isbn><accession-num>21480189</accession-num><work-type>Meta-Analysis&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(52). Compared to controls, patients with SSc had a higher prevalence of coronary atherosclerosis, peripheral vascular disease and cerebrovascular calcification. Risk factors for CVD in patients with SSc (Level B)TRFs have been less studied in SSc than in SLE. Overall there appear to be fewer differences between SSc patients and general population controls than is the case for SLE. In the study from the UK database ADDIN EN.CITE <EndNote><Cite><Author>Man</Author><Year>2013</Year><RecNum>377</RecNum><DisplayText>(50)</DisplayText><record><rec-number>377</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">377</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Man, A.</author><author>Zhu, Y.</author><author>Zhang, Y.</author><author>Dubreuil, M.</author><author>Rho, Y. H.</author><author>Peloquin, C.</author><author>Simms, R. W.</author><author>Choi, H. K.</author></authors></contributors><auth-address>Section of Rheumatology, Boston University School of Medicine, Boston, MA 02118, USA. adaman@bu.edu</auth-address><titles><title>The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study</title><secondary-title>Ann Rheum Dis</secondary-title><alt-title>Ann Rheum Dis</alt-title></titles><periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></periodical><alt-periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></alt-periodical><pages>1188-93</pages><volume>72</volume><number>7</number><dates><year>2013</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1468-2060 (Electronic)&#xD;0003-4967 (Linking)</isbn><accession-num>22904260</accession-num><work-type>Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(50), the SSc cohort had a lower frequency of overweight and obesity than matched controls, but a higher frequency of past smoking and oral corticosteroid use. The frequency of hypertension, dyslipidaemia and diabetes were similar in the SSc group and matched controls. Hypercholesterolaemia, diabetes and obesity were less prevalent in the Australian Scleroderma Cohort than in community-based controls, while past smoking was more prevalent. The prevalence of hypertension was similar ADDIN EN.CITE <EndNote><Cite><Author>Ngian</Author><Year>2012</Year><RecNum>376</RecNum><DisplayText>(49)</DisplayText><record><rec-number>376</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">376</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ngian, G. S.</author><author>Sahhar, J.</author><author>Proudman, S. M.</author><author>Stevens, W.</author><author>Wicks, I. P.</author><author>Van Doornum, S.</author></authors></contributors><auth-address>Department of Medicine (RMH/WH)The University of Melbourne, Grattan StParkville 3050, Victoria, Australia. gngian@student.unimelb.edu.au</auth-address><titles><title>Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis</title><secondary-title>Ann Rheum Dis</secondary-title><alt-title>Ann Rheum Dis</alt-title></titles><periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></periodical><alt-periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></alt-periodical><pages>1980-3</pages><volume>71</volume><number>12</number><dates><year>2012</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1468-2060 (Electronic)&#xD;0003-4967 (Linking)</isbn><accession-num>22532628</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(49). Cardiovascular disease in patients with Idiopathic Inflammatory Myopathies (Level A)Idiopathic inflammatory myopathies (IIM) such as dermatomyositis and polymyositis are rare autoimmune diseases characterized by inflammation of skeletal muscle, proximal muscle weakness and elevated muscle enzymes. IIM can directly affect the heart causing myocarditis, myocardial fibrosis and arrhythmias ADDIN EN.CITE <EndNote><Cite><Author>Gupta</Author><Year>2011</Year><RecNum>350</RecNum><DisplayText>(53)</DisplayText><record><rec-number>350</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">350</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gupta, R.</author><author>Wayangankar, S. A.</author><author>Targoff, I. N.</author><author>Hennebry, T. A.</author></authors></contributors><titles><title>Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review</title><secondary-title>Int J Cardiol</secondary-title></titles><periodical><full-title>Int J Cardiol</full-title><abbr-1>International journal of cardiology</abbr-1></periodical><pages>261-70</pages><volume>148</volume><number>3</number><dates><year>2011</year></dates><isbn>1874-1754 (Electronic)&#xD;0167-5273 (Linking)</isbn><work-type>Review</work-type><urls></urls></record></Cite></EndNote>(53). Until recently evidence on the risk of ACVD in IIM has been scarce.The all-cause SMR was 1.75 (95%CI 1.41, 2.15) in 370 patients diagnosed with IIM since 1980 from the South Australian Myositis Database ADDIN EN.CITE <EndNote><Cite><Author>Limaye</Author><Year>2012</Year><RecNum>358</RecNum><DisplayText>(54)</DisplayText><record><rec-number>358</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">358</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Limaye, V.</author><author>Hakendorf, P.</author><author>Woodman, R. J.</author><author>Blumbergs, P.</author><author>Roberts-Thomson, P.</author></authors></contributors><titles><title>Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis</title><secondary-title>Intern Med J</secondary-title></titles><periodical><full-title>Intern Med J</full-title></periodical><pages>191-8</pages><volume>42</volume><number>2</number><dates><year>2012</year></dates><isbn>1445-5994 (Electronic)&#xD;1444-0903 (Linking)</isbn><work-type>Comparative Study&#xD;Research Support, Non-U S Gov&apos;t</work-type><urls></urls></record></Cite></EndNote>(54). CVD accounted for 30.5% of deaths. A meta-analysis, published in 2014, identified 4 LOS that had examined CAD as an outcome in 13,201 IIM patients ADDIN EN.CITE <EndNote><Cite><Author>Ungprasert</Author><Year>2014</Year><RecNum>351</RecNum><DisplayText>(55)</DisplayText><record><rec-number>351</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">351</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ungprasert, P.</author><author>Suksaranjit, P.</author><author>Spanuchart, I.</author><author>Leeaphorn, N.</author><author>Permpalung, N.</author></authors></contributors><auth-address>Department of Medicine, Faculty of medicine Siriraj hospital, Mahidol University, Bangkok 10700, Thailand. Electronic address: P.ungprasert@.&#xD;Department of Cardiology, University of Utah School of Medicine, Salt Lake City, UT.&#xD;Department of Internal Medicine, John A. Burns School of medicine, University of Hawaii, Honolulu, HI.&#xD;Department of Internal Medicine, Bassett Medical Center, Columbia University College of Physicians and Surgeons, Cooperstown, NY.</auth-address><titles><title>Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies</title><secondary-title>Semin Arthritis Rheum</secondary-title><alt-title>Semin Arthritis Rheum</alt-title></titles><periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></alt-periodical><pages>63-7</pages><volume>44</volume><number>1</number><dates><year>2014</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1532-866X (Electronic)&#xD;0049-0172 (Linking)</isbn><accession-num>24684974</accession-num><work-type>Meta-Analysis&#xD;Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(55). There was a significantly increased risk of CAD in patients with IIM compared with controls (pooled risk ratio 2.24 (95% CI: 1.02, 4.92)). In a more recent study from Taiwan the risk of acute coronary syndrome was significantly higher in patients with IIM than in controls, adjusted hazard ratio 1.98 (95% CI: 1.17 -3.35) ADDIN EN.CITE <EndNote><Cite><Author>Lin</Author><Year>2015</Year><RecNum>363</RecNum><DisplayText>(56)</DisplayText><record><rec-number>363</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">363</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lin, Y. N.</author><author>Lin, C. L.</author><author>Chang, K. C.</author><author>Kao, C. H.</author></authors></contributors><auth-address>Division of Cardiology, Department of Internal Medicine, China Medical University Hospital , Taichung , Taiwan.</auth-address><titles><title>Increased subsequent risk of acute coronary syndrome for patients with dermatomyositis/polymyositis: a nationwide population-based retrospective cohort study</title><secondary-title>Scandinavian journal of rheumatology</secondary-title><alt-title>Scand J Rheumatol</alt-title></titles><periodical><full-title>Scandinavian journal of rheumatology</full-title><abbr-1>Scand J Rheumatol</abbr-1></periodical><alt-periodical><full-title>Scandinavian journal of rheumatology</full-title><abbr-1>Scand J Rheumatol</abbr-1></alt-periodical><pages>42-7</pages><volume>44</volume><number>1</number><dates><year>2015</year></dates><isbn>1502-7732 (Electronic)&#xD;0300-9742 (Linking)</isbn><accession-num>25205256</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(56). There is evidence of an increased risk of ischaemic stroke in patients with dermatomyositis. In a study of 907 patients with dermatomyositis from Taiwan, the adjusted HR for ischaemic stroke over the first 2 years of disease was 1.67 (95% CI: 1.19, 2.34) compared to controls ADDIN EN.CITE <EndNote><Cite><Author>Lai</Author><Year>2013</Year><RecNum>361</RecNum><DisplayText>(57)</DisplayText><record><rec-number>361</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">361</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lai, Y. T.</author><author>Dai, Y. S.</author><author>Yen, M. F.</author><author>Chen, L. S.</author><author>Chen, H. H.</author><author>Cooper, R. G.</author><author>Pan, S. L.</author></authors></contributors><auth-address>Department of Physical Medicine and Rehabilitation, Sijhih Cathay General Hospital, New Taipei, Taiwan.</auth-address><titles><title>Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population-based longitudinal follow-up study</title><secondary-title>The British journal of dermatology</secondary-title><alt-title>Br J Dermatol</alt-title></titles><periodical><full-title>The British journal of dermatology</full-title><abbr-1>Br J Dermatol</abbr-1></periodical><alt-periodical><full-title>The British journal of dermatology</full-title><abbr-1>Br J Dermatol</abbr-1></alt-periodical><pages>1054-9</pages><volume>168</volume><number>5</number><dates><year>2013</year><pub-dates><date>May</date></pub-dates></dates><isbn>1365-2133 (Electronic)&#xD;0007-0963 (Linking)</isbn><accession-num>23330740</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(57). A study using a health administrative database from Quebec followed 607 patients with IIM for a mean of 4 years. The stroke rate (5.2/1000 pyrs) was similar to that reported in patients with RA ADDIN EN.CITE <EndNote><Cite><Author>Tisseverasinghe</Author><Year>2009</Year><RecNum>362</RecNum><DisplayText>(58)</DisplayText><record><rec-number>362</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">362</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tisseverasinghe, A.</author><author>Bernatsky, S.</author><author>Pineau, C. A.</author></authors></contributors><auth-address>Department of Medicine, Internal Medicine, McGill University Health Centre, Montreal, QC, Canada.</auth-address><titles><title>Arterial events in persons with dermatomyositis and polymyositis</title><secondary-title>J Rheumatol</secondary-title><alt-title>J Rheumatol</alt-title></titles><periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></periodical><alt-periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></alt-periodical><pages>1943-6</pages><volume>36</volume><number>9</number><dates><year>2009</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0315-162X (Print)&#xD;0315-162X (Linking)</isbn><accession-num>19648306</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(58). In this study, dyslipidaemia and hypertension were associated with arterial events, while immunosuppressive therapy was inversely associated. There is some evidence that TRFs are more prevalent in patients with IIM than in the general population. A cross-sectional study of 84 dermatomyositis patients identified 47% with MetS compared with 7% of healthy controls ADDIN EN.CITE <EndNote><Cite><Author>de Moraes</Author><Year>2013</Year><RecNum>354</RecNum><DisplayText>(59)</DisplayText><record><rec-number>354</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">354</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>de Moraes, M. T.</author><author>de Souza, F. H.</author><author>de Barros, T. B.</author><author>Shinjo, S. K.</author></authors></contributors><auth-address>Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.</auth-address><titles><title>Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease</title><secondary-title>Arthritis Care Res (Hoboken)</secondary-title><alt-title>Arthritis Care Res (Hoboken)</alt-title></titles><periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></periodical><alt-periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></alt-periodical><pages>793-9</pages><volume>65</volume><number>5</number><dates><year>2013</year><pub-dates><date>May</date></pub-dates></dates><isbn>2151-4658 (Electronic)&#xD;2151-464X (Linking)</isbn><accession-num>23139205</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(59). Diabetes was also more prevalent in the dermatomyositis group. Other cross-sectional studies have found higher rates of obesity, hypertension, diabetes and dyslipidaemia in patients with IIM compared with controls PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MaW1heWU8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+MzY0PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2MC02Mik8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzY0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNjQ8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkxpbWF5ZSwgVi4gUy48L2F1dGhvcj48

YXV0aG9yPkxlc3RlciwgUy48L2F1dGhvcj48YXV0aG9yPkJsdW1iZXJncywgUC48L2F1dGhvcj48

YXV0aG9yPlJvYmVydHMtVGhvbXNvbiwgUC4gSi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli

dXRvcnM+PGF1dGgtYWRkcmVzcz5SaGV1bWF0b2xvZ3kgRGVwYXJ0bWVudCwgUm95YWwgQWRlbGFp

ZGUgSG9zcGl0YWwsIFVuaXZlcnNpdHkgb2YgQWRlbGFpZGUsIEFkZWxhaWRlLCBTb3V0aCBBdXN0

cmFsaWEsIEF1c3RyYWxpYS4gVmlkeWEubGltYXllQGhlYWx0aC5zYS5nb3YuYTwvYXV0aC1hZGRy

ZXNzPjx0aXRsZXM+PHRpdGxlPklkaW9wYXRoaWMgaW5mbGFtbWF0b3J5IG15b3NpdGlzIGlzIGFz

c29jaWF0ZWQgd2l0aCBhIGhpZ2ggaW5jaWRlbmNlIG9mIGh5cGVydGVuc2lvbiBhbmQgZGlhYmV0

ZXMgbWVsbGl0dXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFs

IG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SW50IEog

UmhldW0gRGlzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SW50

ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvZnVsbC10aXRsZT48YWJi

ci0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwv

ZnVsbC10aXRsZT48YWJici0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjEzMi03PC9wYWdlcz48dm9sdW1lPjEzPC92b2x1bWU+PG51bWJlcj4yPC9udW1i

ZXI+PGRhdGVzPjx5ZWFyPjIwMTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXk8L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNzU2LTE4NVggKEVsZWN0cm9uaWMpJiN4RDsxNzU2LTE4

NDEgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIwNTM2NTk3PC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFi

YXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPldhbmc8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+MzY1PC9SZWNO

dW0+PHJlY29yZD48cmVjLW51bWJlcj4zNjU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjM2

NTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V2FuZywgSC48L2F1dGhv

cj48YXV0aG9yPkNhaSwgWS48L2F1dGhvcj48YXV0aG9yPkNhaSwgTC48L2F1dGhvcj48YXV0aG9y

Pkh1LCBZLjwvYXV0aG9yPjxhdXRob3I+Q2hlbiwgWC48L2F1dGhvcj48YXV0aG9yPkRlbmcsIEou

PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+Q2FyZGlvdmFz

Y3VsYXIgRGlzZWFzZSBSZXNlYXJjaCBJbnN0aXR1dGUsIFRoZSBUaGlyZCBQZW9wbGUmYXBvcztz

IEhvc3BpdGFsIG9mIENoZW5nZHUsIFRoZSBTZWNvbmQgQWZmaWxpYXRlZCBDaGVuZ2R1IENsaW5p

Y2FsIENvbGxlZ2Ugb2YgQ2hvbmdxaW5nIE1lZGljYWwgVW5pdmVyc2l0eSwgQ2hlbmdkdSwgU2lj

aHVhbiwgUGVvcGxlJmFwb3M7cyBSZXB1YmxpYyBvZiBDaGluYSA7IERlcGFydG1lbnQgb2YgU3Vy

Z2VyeSwgUmVubWluIEhvc3BpdGFsIG9mIEh1YmVpIFVuaXZlcnNpdHkgb2YgTWVkaWNpbmUsIFNo

aXlhbiwgSHViZWksIFBlb3BsZSZhcG9zO3MgUmVwdWJsaWMgb2YgQ2hpbmEuJiN4RDtEZXBhcnRt

ZW50IG9mIEdlcmlhdHJpY3MsIFdlc3QgQ2hpbmEgSG9zcGl0YWwsIFNpY2h1YW4gVW5pdmVyc2l0

eSwgQ2hlbmdkdSwgU2ljaHVhbiwgUGVvcGxlJmFwb3M7cyBSZXB1YmxpYyBvZiBDaGluYS4mI3hE

O0NhcmRpb3Zhc2N1bGFyIERpc2Vhc2UgUmVzZWFyY2ggSW5zdGl0dXRlLCBUaGUgVGhpcmQgUGVv

cGxlJmFwb3M7cyBIb3NwaXRhbCBvZiBDaGVuZ2R1LCBUaGUgU2Vjb25kIEFmZmlsaWF0ZWQgQ2hl

bmdkdSBDbGluaWNhbCBDb2xsZWdlIG9mIENob25ncWluZyBNZWRpY2FsIFVuaXZlcnNpdHksIENo

ZW5nZHUsIFNpY2h1YW4sIFBlb3BsZSZhcG9zO3MgUmVwdWJsaWMgb2YgQ2hpbmEuJiN4RDtEZXBh

cnRtZW50IG9mIFN1cmdlcnksIFJlbm1pbiBIb3NwaXRhbCBvZiBIdWJlaSBVbml2ZXJzaXR5IG9m

IE1lZGljaW5lLCBTaGl5YW4sIEh1YmVpLCBQZW9wbGUmYXBvcztzIFJlcHVibGljIG9mIENoaW5h

LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkFsdGVyZWQgbGlwaWQgbGV2ZWxzIGluIHVu

dHJlYXRlZCBwYXRpZW50cyB3aXRoIGVhcmx5IHBvbHlteW9zaXRpczwvdGl0bGU+PHNlY29uZGFy

eS10aXRsZT5QTG9TIE9uZTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+UGxvUyBvbmU8L2Fs

dC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5QTG9TIE9uZTwvZnVsbC10

aXRsZT48YWJici0xPlBsb1Mgb25lPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5QTG9TIE9uZTwvZnVsbC10aXRsZT48YWJici0xPlBsb1Mgb25lPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ZTg5ODI3PC9wYWdlcz48dm9sdW1lPjk8L3ZvbHVt

ZT48bnVtYmVyPjI8L251bWJlcj48ZWRpdGlvbj4yMDE0LzAzLzA0PC9lZGl0aW9uPjxrZXl3b3Jk

cz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2UgRmFjdG9yczwva2V5d29yZD48

a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFsY29ob2wgRHJpbmtpbmc8L2tleXdvcmQ+

PGtleXdvcmQ+QmlvbWFya2Vycy8gYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+Qm9keSBNYXNzIElu

ZGV4PC9rZXl3b3JkPjxrZXl3b3JkPkMtUmVhY3RpdmUgUHJvdGVpbi8gbWV0YWJvbGlzbTwva2V5

d29yZD48a2V5d29yZD5DYXNlLUNvbnRyb2wgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5DaGlu

YTwva2V5d29yZD48a2V5d29yZD5DaG9sZXN0ZXJvbC9ibG9vZDwva2V5d29yZD48a2V5d29yZD5E

eXNsaXBpZGVtaWFzL2Jsb29kLyBldGlvbG9neTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tl

eXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkxpbmVhciBNb2RlbHM8L2tl

eXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29y

ZD48a2V5d29yZD5Qb2x5bXlvc2l0aXMvIGJsb29kLyBjb21wbGljYXRpb25zPC9rZXl3b3JkPjxr

ZXl3b3JkPlNleCBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPlNtb2tpbmc8L2tleXdvcmQ+PGtl

eXdvcmQ+VHJpZ2x5Y2VyaWRlcy9ibG9vZDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDE0PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTkzMi02MjAzIChFbGVjdHJvbmljKSYjeEQ7MTkz

Mi02MjAzIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDU4NzA2NDwvYWNjZXNzaW9u

LW51bT48dXJscz48L3VybHM+PGN1c3RvbTI+MzkzMzY0ODwvY3VzdG9tMj48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTM3MS9qb3VybmFsLnBvbmUuMDA4OTgyNzwvZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1

dGhvcj5EaWVkZXJpY2hzZW48L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxSZWNOdW0+MzU1PC9S

ZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zNTU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQi

PjM1NTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUi

PjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGllZGVyaWNoc2Vu

LCBMLiBQLjwvYXV0aG9yPjxhdXRob3I+RGllZGVyaWNoc2VuLCBBLiBDLjwvYXV0aG9yPjxhdXRo

b3I+U2ltb25zZW4sIEouIEEuPC9hdXRob3I+PGF1dGhvcj5KdW5rZXIsIFAuPC9hdXRob3I+PGF1

dGhvcj5Tb25kZXJnYWFyZCwgSy48L2F1dGhvcj48YXV0aG9yPkx1bmRiZXJnLCBJLiBFLjwvYXV0

aG9yPjxhdXRob3I+VHZlZGUsIE4uPC9hdXRob3I+PGF1dGhvcj5HZXJrZSwgTy48L2F1dGhvcj48

YXV0aG9yPkNocmlzdGVuc2VuLCBBLiBGLjwvYXV0aG9yPjxhdXRob3I+RHJleWVyLCBMLjwvYXV0

aG9yPjxhdXRob3I+UGV0ZXJzZW4sIEguPC9hdXRob3I+PGF1dGhvcj5FanN0cnVwLCBMLjwvYXV0

aG9yPjxhdXRob3I+S2F5LCBTLiBELjwvYXV0aG9yPjxhdXRob3I+SmFjb2JzZW4sIFMuPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+T2RlbnNlIFVuaXZlcnNp

dHkgSG9zcGl0YWwsIE9kZW5zZSwgRGVubWFyay4mI3hEO0Fhcmh1cyBVbml2ZXJzaXR5IEhvc3Bp

dGFsLCBBYXJodXMsIERlbm1hcmsuJiN4RDtLYXJvbGluc2thIFVuaXZlcnNpdHkgSG9zcGl0YWws

IFN0b2NraG9sbSwgU3dlZGVuLiYjeEQ7Umlnc2hvc3BpdGFsZXQsIENvcGVuaGFnZW4gVW5pdmVy

c2l0eSBIb3NwaXRhbCwgQ29wZW5oYWdlbiwgRGVubWFyay4mI3hEO09kZW5zZSBVbml2ZXJzaXR5

IEhvc3BpdGFsLCBhbmQgVW5pdmVyc2l0eSBvZiBTb3V0aGVybiBEZW5tYXJrLCBPZGVuc2UsIERl

bm1hcmsuJiN4RDtHZW50b2Z0ZSBVbml2ZXJzaXR5IEhvc3BpdGFsLCBIZWxsZXJ1cCwgRGVubWFy

ay4mI3hEO0VzYmplcmcgSG9zcGl0YWwsIEVzYmplcmcsIERlbm1hcmsuPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+VHJhZGl0aW9uYWwgY2FyZGlvdmFzY3VsYXIgcmlzayBmYWN0b3JzIGFu

ZCBjb3JvbmFyeSBhcnRlcnkgY2FsY2lmaWNhdGlvbiBpbiBhZHVsdHMgd2l0aCBwb2x5bXlvc2l0

aXMgYW5kIGRlcm1hdG9teW9zaXRpczogYSBEYW5pc2ggbXVsdGljZW50ZXIgc3R1ZHk8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+QXJ0aHJpdGlzIENhcmUgUmVzIChIb2Jva2VuKTwvc2Vjb25kYXJ5

LXRpdGxlPjxhbHQtdGl0bGU+QXJ0aHJpdGlzIENhcmUgUmVzIChIb2Jva2VuKTwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9i

b2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgY2FyZSAmYW1wOyByZXNlYXJjaDwv

YWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlz

IENhcmUgUmVzIChIb2Jva2VuKTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBjYXJlICZh

bXA7IHJlc2VhcmNoPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ODQ4LTU0PC9wYWdl

cz48dm9sdW1lPjY3PC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTU8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4yMTUxLTQ2NTggKEVsZWN0cm9uaWMpJiN4RDsyMTUxLTQ2NFggKExpbmtpbmcpPC9pc2JuPjxh

Y2Nlc3Npb24tbnVtPjI1NDE4MzYwPC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+TXVsdGljZW50

ZXIgU3R1ZHkmI3hEO09ic2VydmF0aW9uYWwgU3R1ZHkmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5v

bi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFz

ZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9s

YW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MaW1heWU8L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+MzY0PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2MC02Mik8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzY0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNjQ8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkxpbWF5ZSwgVi4gUy48L2F1dGhvcj48

YXV0aG9yPkxlc3RlciwgUy48L2F1dGhvcj48YXV0aG9yPkJsdW1iZXJncywgUC48L2F1dGhvcj48

YXV0aG9yPlJvYmVydHMtVGhvbXNvbiwgUC4gSi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli

dXRvcnM+PGF1dGgtYWRkcmVzcz5SaGV1bWF0b2xvZ3kgRGVwYXJ0bWVudCwgUm95YWwgQWRlbGFp

ZGUgSG9zcGl0YWwsIFVuaXZlcnNpdHkgb2YgQWRlbGFpZGUsIEFkZWxhaWRlLCBTb3V0aCBBdXN0

cmFsaWEsIEF1c3RyYWxpYS4gVmlkeWEubGltYXllQGhlYWx0aC5zYS5nb3YuYTwvYXV0aC1hZGRy

ZXNzPjx0aXRsZXM+PHRpdGxlPklkaW9wYXRoaWMgaW5mbGFtbWF0b3J5IG15b3NpdGlzIGlzIGFz

c29jaWF0ZWQgd2l0aCBhIGhpZ2ggaW5jaWRlbmNlIG9mIGh5cGVydGVuc2lvbiBhbmQgZGlhYmV0

ZXMgbWVsbGl0dXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFs

IG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SW50IEog

UmhldW0gRGlzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SW50

ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwvZnVsbC10aXRsZT48YWJi

ci0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+SW50ZXJuYXRpb25hbCBqb3VybmFsIG9mIHJoZXVtYXRpYyBkaXNlYXNlczwv

ZnVsbC10aXRsZT48YWJici0xPkludCBKIFJoZXVtIERpczwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjEzMi03PC9wYWdlcz48dm9sdW1lPjEzPC92b2x1bWU+PG51bWJlcj4yPC9udW1i

ZXI+PGRhdGVzPjx5ZWFyPjIwMTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXk8L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNzU2LTE4NVggKEVsZWN0cm9uaWMpJiN4RDsxNzU2LTE4

NDEgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIwNTM2NTk3PC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFi

YXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPldhbmc8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+MzY1PC9SZWNO

dW0+PHJlY29yZD48cmVjLW51bWJlcj4zNjU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjM2

NTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V2FuZywgSC48L2F1dGhv

cj48YXV0aG9yPkNhaSwgWS48L2F1dGhvcj48YXV0aG9yPkNhaSwgTC48L2F1dGhvcj48YXV0aG9y

Pkh1LCBZLjwvYXV0aG9yPjxhdXRob3I+Q2hlbiwgWC48L2F1dGhvcj48YXV0aG9yPkRlbmcsIEou

PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+Q2FyZGlvdmFz

Y3VsYXIgRGlzZWFzZSBSZXNlYXJjaCBJbnN0aXR1dGUsIFRoZSBUaGlyZCBQZW9wbGUmYXBvcztz

IEhvc3BpdGFsIG9mIENoZW5nZHUsIFRoZSBTZWNvbmQgQWZmaWxpYXRlZCBDaGVuZ2R1IENsaW5p

Y2FsIENvbGxlZ2Ugb2YgQ2hvbmdxaW5nIE1lZGljYWwgVW5pdmVyc2l0eSwgQ2hlbmdkdSwgU2lj

aHVhbiwgUGVvcGxlJmFwb3M7cyBSZXB1YmxpYyBvZiBDaGluYSA7IERlcGFydG1lbnQgb2YgU3Vy

Z2VyeSwgUmVubWluIEhvc3BpdGFsIG9mIEh1YmVpIFVuaXZlcnNpdHkgb2YgTWVkaWNpbmUsIFNo

aXlhbiwgSHViZWksIFBlb3BsZSZhcG9zO3MgUmVwdWJsaWMgb2YgQ2hpbmEuJiN4RDtEZXBhcnRt

ZW50IG9mIEdlcmlhdHJpY3MsIFdlc3QgQ2hpbmEgSG9zcGl0YWwsIFNpY2h1YW4gVW5pdmVyc2l0

eSwgQ2hlbmdkdSwgU2ljaHVhbiwgUGVvcGxlJmFwb3M7cyBSZXB1YmxpYyBvZiBDaGluYS4mI3hE

O0NhcmRpb3Zhc2N1bGFyIERpc2Vhc2UgUmVzZWFyY2ggSW5zdGl0dXRlLCBUaGUgVGhpcmQgUGVv

cGxlJmFwb3M7cyBIb3NwaXRhbCBvZiBDaGVuZ2R1LCBUaGUgU2Vjb25kIEFmZmlsaWF0ZWQgQ2hl

bmdkdSBDbGluaWNhbCBDb2xsZWdlIG9mIENob25ncWluZyBNZWRpY2FsIFVuaXZlcnNpdHksIENo

ZW5nZHUsIFNpY2h1YW4sIFBlb3BsZSZhcG9zO3MgUmVwdWJsaWMgb2YgQ2hpbmEuJiN4RDtEZXBh

cnRtZW50IG9mIFN1cmdlcnksIFJlbm1pbiBIb3NwaXRhbCBvZiBIdWJlaSBVbml2ZXJzaXR5IG9m

IE1lZGljaW5lLCBTaGl5YW4sIEh1YmVpLCBQZW9wbGUmYXBvcztzIFJlcHVibGljIG9mIENoaW5h

LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkFsdGVyZWQgbGlwaWQgbGV2ZWxzIGluIHVu

dHJlYXRlZCBwYXRpZW50cyB3aXRoIGVhcmx5IHBvbHlteW9zaXRpczwvdGl0bGU+PHNlY29uZGFy

eS10aXRsZT5QTG9TIE9uZTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+UGxvUyBvbmU8L2Fs

dC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5QTG9TIE9uZTwvZnVsbC10

aXRsZT48YWJici0xPlBsb1Mgb25lPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5QTG9TIE9uZTwvZnVsbC10aXRsZT48YWJici0xPlBsb1Mgb25lPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ZTg5ODI3PC9wYWdlcz48dm9sdW1lPjk8L3ZvbHVt

ZT48bnVtYmVyPjI8L251bWJlcj48ZWRpdGlvbj4yMDE0LzAzLzA0PC9lZGl0aW9uPjxrZXl3b3Jk

cz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2UgRmFjdG9yczwva2V5d29yZD48

a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFsY29ob2wgRHJpbmtpbmc8L2tleXdvcmQ+

PGtleXdvcmQ+QmlvbWFya2Vycy8gYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+Qm9keSBNYXNzIElu

ZGV4PC9rZXl3b3JkPjxrZXl3b3JkPkMtUmVhY3RpdmUgUHJvdGVpbi8gbWV0YWJvbGlzbTwva2V5

d29yZD48a2V5d29yZD5DYXNlLUNvbnRyb2wgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5DaGlu

YTwva2V5d29yZD48a2V5d29yZD5DaG9sZXN0ZXJvbC9ibG9vZDwva2V5d29yZD48a2V5d29yZD5E

eXNsaXBpZGVtaWFzL2Jsb29kLyBldGlvbG9neTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tl

eXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkxpbmVhciBNb2RlbHM8L2tl

eXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29y

ZD48a2V5d29yZD5Qb2x5bXlvc2l0aXMvIGJsb29kLyBjb21wbGljYXRpb25zPC9rZXl3b3JkPjxr

ZXl3b3JkPlNleCBGYWN0b3JzPC9rZXl3b3JkPjxrZXl3b3JkPlNtb2tpbmc8L2tleXdvcmQ+PGtl

eXdvcmQ+VHJpZ2x5Y2VyaWRlcy9ibG9vZDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDE0PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTkzMi02MjAzIChFbGVjdHJvbmljKSYjeEQ7MTkz

Mi02MjAzIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNDU4NzA2NDwvYWNjZXNzaW9u

LW51bT48dXJscz48L3VybHM+PGN1c3RvbTI+MzkzMzY0ODwvY3VzdG9tMj48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTM3MS9qb3VybmFsLnBvbmUuMDA4OTgyNzwvZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1

dGhvcj5EaWVkZXJpY2hzZW48L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxSZWNOdW0+MzU1PC9S

ZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zNTU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQi

PjM1NTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUi

PjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+RGllZGVyaWNoc2Vu

LCBMLiBQLjwvYXV0aG9yPjxhdXRob3I+RGllZGVyaWNoc2VuLCBBLiBDLjwvYXV0aG9yPjxhdXRo

b3I+U2ltb25zZW4sIEouIEEuPC9hdXRob3I+PGF1dGhvcj5KdW5rZXIsIFAuPC9hdXRob3I+PGF1

dGhvcj5Tb25kZXJnYWFyZCwgSy48L2F1dGhvcj48YXV0aG9yPkx1bmRiZXJnLCBJLiBFLjwvYXV0

aG9yPjxhdXRob3I+VHZlZGUsIE4uPC9hdXRob3I+PGF1dGhvcj5HZXJrZSwgTy48L2F1dGhvcj48

YXV0aG9yPkNocmlzdGVuc2VuLCBBLiBGLjwvYXV0aG9yPjxhdXRob3I+RHJleWVyLCBMLjwvYXV0

aG9yPjxhdXRob3I+UGV0ZXJzZW4sIEguPC9hdXRob3I+PGF1dGhvcj5FanN0cnVwLCBMLjwvYXV0

aG9yPjxhdXRob3I+S2F5LCBTLiBELjwvYXV0aG9yPjxhdXRob3I+SmFjb2JzZW4sIFMuPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+T2RlbnNlIFVuaXZlcnNp

dHkgSG9zcGl0YWwsIE9kZW5zZSwgRGVubWFyay4mI3hEO0Fhcmh1cyBVbml2ZXJzaXR5IEhvc3Bp

dGFsLCBBYXJodXMsIERlbm1hcmsuJiN4RDtLYXJvbGluc2thIFVuaXZlcnNpdHkgSG9zcGl0YWws

IFN0b2NraG9sbSwgU3dlZGVuLiYjeEQ7Umlnc2hvc3BpdGFsZXQsIENvcGVuaGFnZW4gVW5pdmVy

c2l0eSBIb3NwaXRhbCwgQ29wZW5oYWdlbiwgRGVubWFyay4mI3hEO09kZW5zZSBVbml2ZXJzaXR5

IEhvc3BpdGFsLCBhbmQgVW5pdmVyc2l0eSBvZiBTb3V0aGVybiBEZW5tYXJrLCBPZGVuc2UsIERl

bm1hcmsuJiN4RDtHZW50b2Z0ZSBVbml2ZXJzaXR5IEhvc3BpdGFsLCBIZWxsZXJ1cCwgRGVubWFy

ay4mI3hEO0VzYmplcmcgSG9zcGl0YWwsIEVzYmplcmcsIERlbm1hcmsuPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+VHJhZGl0aW9uYWwgY2FyZGlvdmFzY3VsYXIgcmlzayBmYWN0b3JzIGFu

ZCBjb3JvbmFyeSBhcnRlcnkgY2FsY2lmaWNhdGlvbiBpbiBhZHVsdHMgd2l0aCBwb2x5bXlvc2l0

aXMgYW5kIGRlcm1hdG9teW9zaXRpczogYSBEYW5pc2ggbXVsdGljZW50ZXIgc3R1ZHk8L3RpdGxl

PjxzZWNvbmRhcnktdGl0bGU+QXJ0aHJpdGlzIENhcmUgUmVzIChIb2Jva2VuKTwvc2Vjb25kYXJ5

LXRpdGxlPjxhbHQtdGl0bGU+QXJ0aHJpdGlzIENhcmUgUmVzIChIb2Jva2VuKTwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9i

b2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgY2FyZSAmYW1wOyByZXNlYXJjaDwv

YWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlz

IENhcmUgUmVzIChIb2Jva2VuKTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBjYXJlICZh

bXA7IHJlc2VhcmNoPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+ODQ4LTU0PC9wYWdl

cz48dm9sdW1lPjY3PC92b2x1bWU+PG51bWJlcj42PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTU8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4yMTUxLTQ2NTggKEVsZWN0cm9uaWMpJiN4RDsyMTUxLTQ2NFggKExpbmtpbmcpPC9pc2JuPjxh

Y2Nlc3Npb24tbnVtPjI1NDE4MzYwPC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+TXVsdGljZW50

ZXIgU3R1ZHkmI3hEO09ic2VydmF0aW9uYWwgU3R1ZHkmI3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5v

bi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFz

ZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9s

YW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (60-62). High CAC scores on cardiac computed tomography were also more frequent in the IIM cohort PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EaWVkZXJpY2hzZW48L0F1dGhvcj48WWVhcj4yMDE1PC9Z

ZWFyPjxSZWNOdW0+MzU1PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2Mik8L0Rpc3BsYXlUZXh0Pjxy

ZWNvcmQ+PHJlYy1udW1iZXI+MzU1PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9

IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNTU8L2tl

eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm

LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkRpZWRlcmljaHNlbiwgTC4gUC48

L2F1dGhvcj48YXV0aG9yPkRpZWRlcmljaHNlbiwgQS4gQy48L2F1dGhvcj48YXV0aG9yPlNpbW9u

c2VuLCBKLiBBLjwvYXV0aG9yPjxhdXRob3I+SnVua2VyLCBQLjwvYXV0aG9yPjxhdXRob3I+U29u

ZGVyZ2FhcmQsIEsuPC9hdXRob3I+PGF1dGhvcj5MdW5kYmVyZywgSS4gRS48L2F1dGhvcj48YXV0

aG9yPlR2ZWRlLCBOLjwvYXV0aG9yPjxhdXRob3I+R2Vya2UsIE8uPC9hdXRob3I+PGF1dGhvcj5D

aHJpc3RlbnNlbiwgQS4gRi48L2F1dGhvcj48YXV0aG9yPkRyZXllciwgTC48L2F1dGhvcj48YXV0

aG9yPlBldGVyc2VuLCBILjwvYXV0aG9yPjxhdXRob3I+RWpzdHJ1cCwgTC48L2F1dGhvcj48YXV0

aG9yPktheSwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkphY29ic2VuLCBTLjwvYXV0aG9yPjwvYXV0

aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPk9kZW5zZSBVbml2ZXJzaXR5IEhvc3Bp

dGFsLCBPZGVuc2UsIERlbm1hcmsuJiN4RDtBYXJodXMgVW5pdmVyc2l0eSBIb3NwaXRhbCwgQWFy

aHVzLCBEZW5tYXJrLiYjeEQ7S2Fyb2xpbnNrYSBVbml2ZXJzaXR5IEhvc3BpdGFsLCBTdG9ja2hv

bG0sIFN3ZWRlbi4mI3hEO1JpZ3Nob3NwaXRhbGV0LCBDb3BlbmhhZ2VuIFVuaXZlcnNpdHkgSG9z

cGl0YWwsIENvcGVuaGFnZW4sIERlbm1hcmsuJiN4RDtPZGVuc2UgVW5pdmVyc2l0eSBIb3NwaXRh

bCwgYW5kIFVuaXZlcnNpdHkgb2YgU291dGhlcm4gRGVubWFyaywgT2RlbnNlLCBEZW5tYXJrLiYj

eEQ7R2VudG9mdGUgVW5pdmVyc2l0eSBIb3NwaXRhbCwgSGVsbGVydXAsIERlbm1hcmsuJiN4RDtF

c2JqZXJnIEhvc3BpdGFsLCBFc2JqZXJnLCBEZW5tYXJrLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+

PHRpdGxlPlRyYWRpdGlvbmFsIGNhcmRpb3Zhc2N1bGFyIHJpc2sgZmFjdG9ycyBhbmQgY29yb25h

cnkgYXJ0ZXJ5IGNhbGNpZmljYXRpb24gaW4gYWR1bHRzIHdpdGggcG9seW15b3NpdGlzIGFuZCBk

ZXJtYXRvbXlvc2l0aXM6IGEgRGFuaXNoIG11bHRpY2VudGVyIHN0dWR5PC90aXRsZT48c2Vjb25k

YXJ5LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L3NlY29uZGFyeS10aXRsZT48

YWx0LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2FsdC10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgQ2FyZSBSZXMgKEhvYm9rZW4pPC9m

dWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGNhcmUgJmFtcDsgcmVzZWFyY2g8L2FiYnItMT48

L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBDYXJlIFJl

cyAoSG9ib2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgY2FyZSAmYW1wOyByZXNl

YXJjaDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjg0OC01NDwvcGFnZXM+PHZvbHVt

ZT42Nzwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE1PC95ZWFyPjxw

dWItZGF0ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MjE1MS00

NjU4IChFbGVjdHJvbmljKSYjeEQ7MjE1MS00NjRYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9u

LW51bT4yNTQxODM2MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPk11bHRpY2VudGVyIFN0dWR5

JiN4RDtPYnNlcnZhdGlvbmFsIFN0dWR5JiN4RDtSZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBH

b3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlk

ZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+

PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5EaWVkZXJpY2hzZW48L0F1dGhvcj48WWVhcj4yMDE1PC9Z

ZWFyPjxSZWNOdW0+MzU1PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2Mik8L0Rpc3BsYXlUZXh0Pjxy

ZWNvcmQ+PHJlYy1udW1iZXI+MzU1PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9

IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNTU8L2tl

eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm

LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkRpZWRlcmljaHNlbiwgTC4gUC48

L2F1dGhvcj48YXV0aG9yPkRpZWRlcmljaHNlbiwgQS4gQy48L2F1dGhvcj48YXV0aG9yPlNpbW9u

c2VuLCBKLiBBLjwvYXV0aG9yPjxhdXRob3I+SnVua2VyLCBQLjwvYXV0aG9yPjxhdXRob3I+U29u

ZGVyZ2FhcmQsIEsuPC9hdXRob3I+PGF1dGhvcj5MdW5kYmVyZywgSS4gRS48L2F1dGhvcj48YXV0

aG9yPlR2ZWRlLCBOLjwvYXV0aG9yPjxhdXRob3I+R2Vya2UsIE8uPC9hdXRob3I+PGF1dGhvcj5D

aHJpc3RlbnNlbiwgQS4gRi48L2F1dGhvcj48YXV0aG9yPkRyZXllciwgTC48L2F1dGhvcj48YXV0

aG9yPlBldGVyc2VuLCBILjwvYXV0aG9yPjxhdXRob3I+RWpzdHJ1cCwgTC48L2F1dGhvcj48YXV0

aG9yPktheSwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkphY29ic2VuLCBTLjwvYXV0aG9yPjwvYXV0

aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPk9kZW5zZSBVbml2ZXJzaXR5IEhvc3Bp

dGFsLCBPZGVuc2UsIERlbm1hcmsuJiN4RDtBYXJodXMgVW5pdmVyc2l0eSBIb3NwaXRhbCwgQWFy

aHVzLCBEZW5tYXJrLiYjeEQ7S2Fyb2xpbnNrYSBVbml2ZXJzaXR5IEhvc3BpdGFsLCBTdG9ja2hv

bG0sIFN3ZWRlbi4mI3hEO1JpZ3Nob3NwaXRhbGV0LCBDb3BlbmhhZ2VuIFVuaXZlcnNpdHkgSG9z

cGl0YWwsIENvcGVuaGFnZW4sIERlbm1hcmsuJiN4RDtPZGVuc2UgVW5pdmVyc2l0eSBIb3NwaXRh

bCwgYW5kIFVuaXZlcnNpdHkgb2YgU291dGhlcm4gRGVubWFyaywgT2RlbnNlLCBEZW5tYXJrLiYj

eEQ7R2VudG9mdGUgVW5pdmVyc2l0eSBIb3NwaXRhbCwgSGVsbGVydXAsIERlbm1hcmsuJiN4RDtF

c2JqZXJnIEhvc3BpdGFsLCBFc2JqZXJnLCBEZW5tYXJrLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+

PHRpdGxlPlRyYWRpdGlvbmFsIGNhcmRpb3Zhc2N1bGFyIHJpc2sgZmFjdG9ycyBhbmQgY29yb25h

cnkgYXJ0ZXJ5IGNhbGNpZmljYXRpb24gaW4gYWR1bHRzIHdpdGggcG9seW15b3NpdGlzIGFuZCBk

ZXJtYXRvbXlvc2l0aXM6IGEgRGFuaXNoIG11bHRpY2VudGVyIHN0dWR5PC90aXRsZT48c2Vjb25k

YXJ5LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L3NlY29uZGFyeS10aXRsZT48

YWx0LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2FsdC10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgQ2FyZSBSZXMgKEhvYm9rZW4pPC9m

dWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGNhcmUgJmFtcDsgcmVzZWFyY2g8L2FiYnItMT48

L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBDYXJlIFJl

cyAoSG9ib2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgY2FyZSAmYW1wOyByZXNl

YXJjaDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjg0OC01NDwvcGFnZXM+PHZvbHVt

ZT42Nzwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE1PC95ZWFyPjxw

dWItZGF0ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MjE1MS00

NjU4IChFbGVjdHJvbmljKSYjeEQ7MjE1MS00NjRYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9u

LW51bT4yNTQxODM2MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPk11bHRpY2VudGVyIFN0dWR5

JiN4RDtPYnNlcnZhdGlvbmFsIFN0dWR5JiN4RDtSZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBH

b3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlk

ZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+

PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA (62).Cardiovascular disease in patients with mixed connective tissue disease (Level A)Mixed connective tissue disease (MCTD) has features of several CTDs including SLE, SSc, PM and RA in association with high titre antibody to U1 ribonucleoprotein (anti-RNP). A recent systematic review of 11 studies, including 616 patients with MCTD, found that the prevalence of cardiac involvement varied from 13% to 65% depending on the methodology used. Pericarditis was the most common cardiac manifestation ADDIN EN.CITE <EndNote><Cite><Author>Ungprasert</Author><Year>2014</Year><RecNum>373</RecNum><DisplayText>(63)</DisplayText><record><rec-number>373</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">373</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ungprasert, P.</author><author>Wannarong, T.</author><author>Panichsillapakit, T.</author><author>Cheungpasitporn, W.</author><author>Thongprayoon, C.</author><author>Ahmed, S.</author><author>Raddatz, D. A.</author></authors></contributors><auth-address>Department of Internal Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA. Electronic address: Patompong.Ungprasert@.&#xD;Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.&#xD;Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.&#xD;Department of Internal Medicine, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA.</auth-address><titles><title>Cardiac involvement in mixed connective tissue disease: a systematic review</title><secondary-title>Int J Cardiol</secondary-title><alt-title>Int J Cardiol</alt-title></titles><periodical><full-title>Int J Cardiol</full-title><abbr-1>International journal of cardiology</abbr-1></periodical><alt-periodical><full-title>Int J Cardiol</full-title><abbr-1>International journal of cardiology</abbr-1></alt-periodical><pages>326-30</pages><volume>171</volume><number>3</number><dates><year>2014</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>1874-1754 (Electronic)&#xD;0167-5273 (Linking)</isbn><accession-num>24433611</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(63). By far the largest included study followed 280 patients for a mean of 13 years; 7.8% of the cohort died with one third of deaths attributed to CVEs ADDIN EN.CITE <EndNote><Cite><Author>Hajas</Author><Year>2013</Year><RecNum>372</RecNum><DisplayText>(64)</DisplayText><record><rec-number>372</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">372</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hajas, A.</author><author>Szodoray, P.</author><author>Nakken, B.</author><author>Gaal, J.</author><author>Zold, E.</author><author>Laczik, R.</author><author>Demeter, N.</author><author>Nagy, G.</author><author>Szekanecz, Z.</author><author>Zeher, M.</author><author>Szegedi, G.</author><author>Bodolay, E.</author></authors></contributors><auth-address>Division of Clinical Immunology, Department of Medicine, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary.</auth-address><titles><title>Clinical course, prognosis, and causes of death in mixed connective tissue disease</title><secondary-title>J Rheumatol</secondary-title><alt-title>J Rheumatol</alt-title></titles><periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></periodical><alt-periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></alt-periodical><pages>1134-42</pages><volume>40</volume><number>7</number><dates><year>2013</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0315-162X (Print)&#xD;0315-162X (Linking)</isbn><accession-num>23637328</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(64). Bodolay et al reported more endothelial dysfunction and increased cIMT in patients with MCTD compared with healthy controls ADDIN EN.CITE <EndNote><Cite><Author>Soltesz</Author><Year>2010</Year><RecNum>516</RecNum><DisplayText>(65)</DisplayText><record><rec-number>516</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">516</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soltesz, P.</author><author>Bereczki, D.</author><author>Szodoray, P.</author><author>Magyar, M. T.</author><author>Der, H.</author><author>Csipo, I.</author><author>Hajas, A.</author><author>Paragh, G.</author><author>Szegedi, G.</author><author>Bodolay, E.</author></authors></contributors><auth-address>3rd Department of Medicine, Medical and Health Science Center, University of Debrecen, Moricz Zs, Str, 22, Debrecen 4032, Hungary. soltesz@</auth-address><titles><title>Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease</title><secondary-title>Arthritis Res Ther</secondary-title><alt-title>Arthritis Res Ther</alt-title></titles><periodical><full-title>Arthritis Res Ther</full-title><abbr-1>Arthritis research &amp; therapy</abbr-1></periodical><alt-periodical><full-title>Arthritis Res Ther</full-title><abbr-1>Arthritis research &amp; therapy</abbr-1></alt-periodical><pages>R78</pages><volume>12</volume><number>3</number><dates><year>2010</year></dates><isbn>1478-6362 (Electronic)&#xD;1478-6354 (Linking)</isbn><accession-num>20459625</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(65).Evidence on the prevalence of TRFs in MCTD is limited. One study reported significantly higher levels of total cholesterol and triglycerides in 37 patients with MCTD compared to 30 controls ADDIN EN.CITE <EndNote><Cite><Author>Bodolay</Author><Year>2008</Year><RecNum>515</RecNum><DisplayText>(66)</DisplayText><record><rec-number>515</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">515</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bodolay, E.</author><author>Seres, I.</author><author>Szodoray, P.</author><author>Csipo, I.</author><author>Jakab, Z.</author><author>Vegh, J.</author><author>Szilagyi, A.</author><author>Szegedi, G.</author><author>Paragh, G.</author></authors></contributors><auth-address>Division of Clinical Immunology, 3rd Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. bodolai@iiibel.dote.hu</auth-address><titles><title>Evaluation of paraoxonase activity in patients with mixed connective tissue disease</title><secondary-title>J Rheumatol</secondary-title><alt-title>J Rheumatol</alt-title></titles><periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></periodical><alt-periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></alt-periodical><pages>237-43</pages><volume>35</volume><number>2</number><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0315-162X (Print)&#xD;0315-162X (Linking)</isbn><accession-num>18085736</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(66). A large proportion of the MCTD group were taking corticosteroids. Cardiovascular disease in patients with primary Sjogren’s syndrome (Level A)Primary Sjogren’s syndrome (pSS) is an auto-immune disease characterised by lymphocytic infiltration of exocrine glands and associated with a wide range of auto-antibodies, in particular anti-SS-A/Ro and anti-SS-B/La antibodies. Mortality in pSS is increased compared to the general population. In 1045 Spanish patients with pSS followed for a mean of almost 10 years the SMR was 4.66 (95%CI 3.85, 5.60) PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Ccml0by1aZXJvbjwvQXV0aG9yPjxZZWFyPjIwMTQ8L1ll

YXI+PFJlY051bT40NDk8L1JlY051bT48RGlzcGxheVRleHQ+KDY3KTwvRGlzcGxheVRleHQ+PHJl

Y29yZD48cmVjLW51bWJlcj40NDk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0i

RU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0OTwva2V5

PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYt

dHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QnJpdG8tWmVyb24sIFAuPC9hdXRo

b3I+PGF1dGhvcj5Lb3N0b3YsIEIuPC9hdXRob3I+PGF1dGhvcj5Tb2xhbnMsIFIuPC9hdXRob3I+

PGF1dGhvcj5GcmFpbGUsIEcuPC9hdXRob3I+PGF1dGhvcj5TdWFyZXotQ3VlcnZvLCBDLjwvYXV0

aG9yPjxhdXRob3I+Q2FzYW5vdmFzLCBBLjwvYXV0aG9yPjxhdXRob3I+UmFzY29uLCBGLiBKLjwv

YXV0aG9yPjxhdXRob3I+UWFubmV0YSwgUi48L2F1dGhvcj48YXV0aG9yPlBlcmV6LUFsdmFyZXos

IFIuPC9hdXRob3I+PGF1dGhvcj5SaXBvbGwsIE0uPC9hdXRob3I+PGF1dGhvcj5Ba2FzYmksIE0u

PC9hdXRob3I+PGF1dGhvcj5QaW5pbGxhLCBCLjwvYXV0aG9yPjxhdXRob3I+Qm9zY2gsIEouIEEu

PC9hdXRob3I+PGF1dGhvcj5OYXZhLU1hdGVvcywgSi48L2F1dGhvcj48YXV0aG9yPkRpYXotTG9w

ZXosIEIuPC9hdXRob3I+PGF1dGhvcj5Nb3JlcmEtTW9yYWxlcywgTS4gTC48L2F1dGhvcj48YXV0

aG9yPkdoZWl0YXNpLCBILjwvYXV0aG9yPjxhdXRob3I+UmV0YW1vem8sIFMuPC9hdXRob3I+PGF1

dGhvcj5SYW1vcy1DYXNhbHMsIE0uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+U2pvZ3JlbiBTeW5kcm9tZSBSZXNlYXJjaCBHcm91cCAoQUdBVVIpLCBMYWJv

cmF0b3J5IG9mIEF1dG9pbW11bmUgRGlzZWFzZXMgSm9zZXAgRm9udCwgRGVwYXJ0bWVudCBvZiBB

dXRvaW1tdW5lIERpc2Vhc2VzLCBJbnN0aXR1dCBkJmFwb3M7SW52ZXN0aWdhY2lvbnMgQmlvbWVk

aXF1ZXMgQXVndXN0IFBpIGkgU3VueWVyIChJRElCQVBTKSwgSUNNaUQsIEhvc3BpdGFsIENsaW5p

YywgQmFyY2Vsb25hLCBTcGFpbi4mI3hEO1Nqb2dyZW4gU3luZHJvbWUgUmVzZWFyY2ggR3JvdXAg

KEFHQVVSKSwgTGFib3JhdG9yeSBvZiBBdXRvaW1tdW5lIERpc2Vhc2VzIEpvc2VwIEZvbnQsIERl

cGFydG1lbnQgb2YgQXV0b2ltbXVuZSBEaXNlYXNlcywgSW5zdGl0dXQgZCZhcG9zO0ludmVzdGln

YWNpb25zIEJpb21lZGlxdWVzIEF1Z3VzdCBQaSBpIFN1bnllciAoSURJQkFQUyksIElDTWlELCBI

b3NwaXRhbCBDbGluaWMsIEJhcmNlbG9uYSwgU3BhaW4gUHJpbWFyeSBDYXJlIFJlc2VhcmNoIEdy

b3VwLCBJbnN0aXR1dCBkJmFwb3M7SW52ZXN0aWdhY2lvbnMgQmlvbWVkaXF1ZXMgQXVndXN0IFBp

IGkgU3VueWVyIChJRElCQVBTKSwgUHJpbWFyeSBDYXJlIENlbnRyZSBMZXMgQ29ydHMsIENBUFNF

LCBCYXJjZWxvbmEsIFNwYWluLiYjeEQ7RGVwYXJ0bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSwg

SG9zcGl0YWwgVmFsbCBkJmFwb3M7SGVicm9uLCBCYXJjZWxvbmEsIFNwYWluLiYjeEQ7RGVwYXJ0

bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSwgSG9zcGl0YWwgUmFtb24geSBDYWphbCwgTWFkcmlk

LCBTcGFpbi4mI3hEO0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIFVu

aXZlcnNpdGFyaW8gQ2VudHJhbCBkZSBBc3R1cmlhcywgT3ZpZWRvLCBTcGFpbi4mI3hEO0RlcGFy

dG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIFBhcmMgVGF1bGksIFNhYmFkZWxs

LCBTcGFpbi4mI3hEO0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIFNv

biBFc3Bhc2VzLCBQYWxtYSBkZSBNYWxsb3JjYSwgU3BhaW4uJiN4RDtEZXBhcnRtZW50IG9mIElu

dGVybmFsIE1lZGljaW5lLCBIb3NwaXRhbCBKb2FuIFhYSUlJLCBUYXJyYWdvbmEsIFNwYWluLiYj

eEQ7RGVwYXJ0bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSwgSG9zcGl0YWwgZG8gTWVpeG9laXJv

LCBWaWdvLCBTcGFpbi4mI3hEO0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3Bp

dGFsIEluZmFudGEgU29maWEsIE1hZHJpZCwgU3BhaW4uJiN4RDtEZXBhcnRtZW50IG9mIEludGVy

bmFsIE1lZGljaW5lLCBIb3NwaXRhbCBJbmZhbnRhIExlb25vciwgTWFkcmlkLCBTcGFpbi4mI3hE

O0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIEdyZWdvcmlvIE1hcmFu

b24sIE1hZHJpZCwgU3BhaW4uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+U3lzdGVtaWMg

YWN0aXZpdHkgYW5kIG1vcnRhbGl0eSBpbiBwcmltYXJ5IFNqb2dyZW4gc3luZHJvbWU6IHByZWRp

Y3Rpbmcgc3Vydml2YWwgdXNpbmcgdGhlIEVVTEFSLVNTIERpc2Vhc2UgQWN0aXZpdHkgSW5kZXgg

KEVTU0RBSSkgaW4gMTA0NSBwYXRpZW50czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm4gUmhl

dW0gRGlzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5Bbm4gUmhldW0gRGlzPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5uIFJoZXVtIERpczwvZnVsbC10

aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRpc2Vhc2VzPC9hYmJyLTE+PC9w

ZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Bbm4gUmhldW0gRGlzPC9mdWxs

LXRpdGxlPjxhYmJyLTE+QW5uYWxzIG9mIHRoZSByaGV1bWF0aWMgZGlzZWFzZXM8L2FiYnItMT48

L2FsdC1wZXJpb2RpY2FsPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

Tm92IDI4PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ2OC0yMDYwIChFbGVjdHJv

bmljKSYjeEQ7MDAwMy00OTY3IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNTQzMzAy

MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPkpvdXJuYWwgYXJ0aWNsZTwvd29yay10eXBlPjx1

cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNl

LXByb3ZpZGVyPjxsYW5ndWFnZT5Fbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5v

dGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Ccml0by1aZXJvbjwvQXV0aG9yPjxZZWFyPjIwMTQ8L1ll

YXI+PFJlY051bT40NDk8L1JlY051bT48RGlzcGxheVRleHQ+KDY3KTwvRGlzcGxheVRleHQ+PHJl

Y29yZD48cmVjLW51bWJlcj40NDk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0i

RU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0OTwva2V5

PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYt

dHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QnJpdG8tWmVyb24sIFAuPC9hdXRo

b3I+PGF1dGhvcj5Lb3N0b3YsIEIuPC9hdXRob3I+PGF1dGhvcj5Tb2xhbnMsIFIuPC9hdXRob3I+

PGF1dGhvcj5GcmFpbGUsIEcuPC9hdXRob3I+PGF1dGhvcj5TdWFyZXotQ3VlcnZvLCBDLjwvYXV0

aG9yPjxhdXRob3I+Q2FzYW5vdmFzLCBBLjwvYXV0aG9yPjxhdXRob3I+UmFzY29uLCBGLiBKLjwv

YXV0aG9yPjxhdXRob3I+UWFubmV0YSwgUi48L2F1dGhvcj48YXV0aG9yPlBlcmV6LUFsdmFyZXos

IFIuPC9hdXRob3I+PGF1dGhvcj5SaXBvbGwsIE0uPC9hdXRob3I+PGF1dGhvcj5Ba2FzYmksIE0u

PC9hdXRob3I+PGF1dGhvcj5QaW5pbGxhLCBCLjwvYXV0aG9yPjxhdXRob3I+Qm9zY2gsIEouIEEu

PC9hdXRob3I+PGF1dGhvcj5OYXZhLU1hdGVvcywgSi48L2F1dGhvcj48YXV0aG9yPkRpYXotTG9w

ZXosIEIuPC9hdXRob3I+PGF1dGhvcj5Nb3JlcmEtTW9yYWxlcywgTS4gTC48L2F1dGhvcj48YXV0

aG9yPkdoZWl0YXNpLCBILjwvYXV0aG9yPjxhdXRob3I+UmV0YW1vem8sIFMuPC9hdXRob3I+PGF1

dGhvcj5SYW1vcy1DYXNhbHMsIE0uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+U2pvZ3JlbiBTeW5kcm9tZSBSZXNlYXJjaCBHcm91cCAoQUdBVVIpLCBMYWJv

cmF0b3J5IG9mIEF1dG9pbW11bmUgRGlzZWFzZXMgSm9zZXAgRm9udCwgRGVwYXJ0bWVudCBvZiBB

dXRvaW1tdW5lIERpc2Vhc2VzLCBJbnN0aXR1dCBkJmFwb3M7SW52ZXN0aWdhY2lvbnMgQmlvbWVk

aXF1ZXMgQXVndXN0IFBpIGkgU3VueWVyIChJRElCQVBTKSwgSUNNaUQsIEhvc3BpdGFsIENsaW5p

YywgQmFyY2Vsb25hLCBTcGFpbi4mI3hEO1Nqb2dyZW4gU3luZHJvbWUgUmVzZWFyY2ggR3JvdXAg

KEFHQVVSKSwgTGFib3JhdG9yeSBvZiBBdXRvaW1tdW5lIERpc2Vhc2VzIEpvc2VwIEZvbnQsIERl

cGFydG1lbnQgb2YgQXV0b2ltbXVuZSBEaXNlYXNlcywgSW5zdGl0dXQgZCZhcG9zO0ludmVzdGln

YWNpb25zIEJpb21lZGlxdWVzIEF1Z3VzdCBQaSBpIFN1bnllciAoSURJQkFQUyksIElDTWlELCBI

b3NwaXRhbCBDbGluaWMsIEJhcmNlbG9uYSwgU3BhaW4gUHJpbWFyeSBDYXJlIFJlc2VhcmNoIEdy

b3VwLCBJbnN0aXR1dCBkJmFwb3M7SW52ZXN0aWdhY2lvbnMgQmlvbWVkaXF1ZXMgQXVndXN0IFBp

IGkgU3VueWVyIChJRElCQVBTKSwgUHJpbWFyeSBDYXJlIENlbnRyZSBMZXMgQ29ydHMsIENBUFNF

LCBCYXJjZWxvbmEsIFNwYWluLiYjeEQ7RGVwYXJ0bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSwg

SG9zcGl0YWwgVmFsbCBkJmFwb3M7SGVicm9uLCBCYXJjZWxvbmEsIFNwYWluLiYjeEQ7RGVwYXJ0

bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSwgSG9zcGl0YWwgUmFtb24geSBDYWphbCwgTWFkcmlk

LCBTcGFpbi4mI3hEO0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIFVu

aXZlcnNpdGFyaW8gQ2VudHJhbCBkZSBBc3R1cmlhcywgT3ZpZWRvLCBTcGFpbi4mI3hEO0RlcGFy

dG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIFBhcmMgVGF1bGksIFNhYmFkZWxs

LCBTcGFpbi4mI3hEO0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIFNv

biBFc3Bhc2VzLCBQYWxtYSBkZSBNYWxsb3JjYSwgU3BhaW4uJiN4RDtEZXBhcnRtZW50IG9mIElu

dGVybmFsIE1lZGljaW5lLCBIb3NwaXRhbCBKb2FuIFhYSUlJLCBUYXJyYWdvbmEsIFNwYWluLiYj

eEQ7RGVwYXJ0bWVudCBvZiBJbnRlcm5hbCBNZWRpY2luZSwgSG9zcGl0YWwgZG8gTWVpeG9laXJv

LCBWaWdvLCBTcGFpbi4mI3hEO0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3Bp

dGFsIEluZmFudGEgU29maWEsIE1hZHJpZCwgU3BhaW4uJiN4RDtEZXBhcnRtZW50IG9mIEludGVy

bmFsIE1lZGljaW5lLCBIb3NwaXRhbCBJbmZhbnRhIExlb25vciwgTWFkcmlkLCBTcGFpbi4mI3hE

O0RlcGFydG1lbnQgb2YgSW50ZXJuYWwgTWVkaWNpbmUsIEhvc3BpdGFsIEdyZWdvcmlvIE1hcmFu

b24sIE1hZHJpZCwgU3BhaW4uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+U3lzdGVtaWMg

YWN0aXZpdHkgYW5kIG1vcnRhbGl0eSBpbiBwcmltYXJ5IFNqb2dyZW4gc3luZHJvbWU6IHByZWRp

Y3Rpbmcgc3Vydml2YWwgdXNpbmcgdGhlIEVVTEFSLVNTIERpc2Vhc2UgQWN0aXZpdHkgSW5kZXgg

KEVTU0RBSSkgaW4gMTA0NSBwYXRpZW50czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm4gUmhl

dW0gRGlzPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5Bbm4gUmhldW0gRGlzPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5uIFJoZXVtIERpczwvZnVsbC10

aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRpc2Vhc2VzPC9hYmJyLTE+PC9w

ZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Bbm4gUmhldW0gRGlzPC9mdWxs

LXRpdGxlPjxhYmJyLTE+QW5uYWxzIG9mIHRoZSByaGV1bWF0aWMgZGlzZWFzZXM8L2FiYnItMT48

L2FsdC1wZXJpb2RpY2FsPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

Tm92IDI4PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ2OC0yMDYwIChFbGVjdHJv

bmljKSYjeEQ7MDAwMy00OTY3IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yNTQzMzAy

MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPkpvdXJuYWwgYXJ0aWNsZTwvd29yay10eXBlPjx1

cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNl

LXByb3ZpZGVyPjxsYW5ndWFnZT5Fbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5v

dGU+AG==

ADDIN EN.CITE.DATA (67). CVD was the main cause of death. Reports on the occurrence of ACVD in patients with pSS have been inconsistent. A study of 5205 patients with a new diagnosis of pSS and no prior history of MI from Taiwan found similar numbers of acute MIs in the patients with pSS compared with age, gender and comorbidity matched controls: HR 0.86 (95%CI 0.55, 1.35) PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGlhbmc8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS

ZWNOdW0+NDU2PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2OCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+NDU2PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NTY8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoaWFuZywgQy4gSC48L2F1dGhvcj48YXV0

aG9yPkxpdSwgQy4gSi48L2F1dGhvcj48YXV0aG9yPkNoZW4sIFAuIEouPC9hdXRob3I+PGF1dGhv

cj5MZXUsIEguIEIuPC9hdXRob3I+PGF1dGhvcj5Ic3UsIEMuIFkuPC9hdXRob3I+PGF1dGhvcj5I

dWFuZywgUC4gSC48L2F1dGhvcj48YXV0aG9yPkNoZW4sIFQuIEouPC9hdXRob3I+PGF1dGhvcj5M

aW4sIFMuIEouPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBKLiBXLjwvYXV0aG9yPjxhdXRob3I+Q2hh

biwgVy4gTC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5D

aGFuLCBXTCYjeEQ7VGFpcGVpIFZldCBHZW4gSG9zcCwgSGVhbHRoY2FyZSAmYW1wOyBNYW5hZ2Vt

ZW50IEN0ciwgRGl2IENhcmRpb2wsIDIwMSxTZWMgMixTaGkgUGFpIFJkLCBUYWlwZWksIFRhaXdh

biYjeEQ7VGFpcGVpIFZldCBHZW4gSG9zcCwgSGVhbHRoY2FyZSAmYW1wOyBNYW5hZ2VtZW50IEN0

ciwgRGl2IENhcmRpb2wsIDIwMSxTZWMgMixTaGkgUGFpIFJkLCBUYWlwZWksIFRhaXdhbiYjeEQ7

Wmh1ZG9uZyBWZXQgSG9zcCwgRGl2IENhcmRpb2wsIERlcHQgTWVkLCBIc2luY2h1LCBUYWl3YW4m

I3hEO1RhaXBlaSBWZXQgR2VuIEhvc3AsIERpdiBDYXJkaW9sLCBEZXB0IE1lZCwgVGFpcGVpLCBU

YWl3YW4mI3hEO1RhaXBlaSBWZXQgR2VuIEhvc3AsIERpdiBIZW1hdG9sICZhbXA7IE9uY29sLCBE

ZXB0IE1lZCwgVGFpcGVpLCBUYWl3YW4mI3hEO1RhaXBlaSBWZXQgR2VuIEhvc3AsIERlcHQgTWVk

IFJlcyAmYW1wOyBFZHVjLCBUYWlwZWksIFRhaXdhbiYjeEQ7VGFpcGVpIFZldCBHZW4gSG9zcCwg

SGVhbHRoY2FyZSAmYW1wOyBNYW5hZ2VtZW50IEN0ciwgVGFpcGVpLCBUYWl3YW4mI3hEO1RhaXBl

aSBWZXQgR2VuIEhvc3AsIERlcHQgRmFtaWx5IE1lZCwgVGFpcGVpLCBUYWl3YW4mI3hEO05hdGwg

WWFuZyBNaW5nIFVuaXYgSG9zcCwgRGVwdCBJbnRlcm5hbCBNZWQsIFlpbGFuLCBUYWl3YW4mI3hE

O0NoaSBNZWkgTWVkIEN0ciwgRGVwdCBGYW1pbHkgTWVkLCBUYWluYW4sIFRhaXdhbiYjeEQ7Q2hp

IE1laSBNZWQgQ3RyLCBEZXB0IEdlcmlhdHIgTWVkLCBUYWluYW4sIFRhaXdhbiYjeEQ7TmF0bCBZ

YW5nIE1pbmcgVW5pdiwgQ2FyZGlvdmFzYyBSZXMgQ3RyLCBUYWlwZWkgMTEyLCBUYWl3YW4mI3hE

O05hdGwgWWFuZyBNaW5nIFVuaXYsIFNjaCBNZWQsIFRhaXBlaSAxMTIsIFRhaXdhbiYjeEQ7TmF0

bCBZYW5nIE1pbmcgVW5pdiwgSW5zdCBQaGFybWFjb2wsIFRhaXBlaSAxMTIsIFRhaXdhbiYjeEQ7

TmF0bCBZYW5nIE1pbmcgVW5pdiwgSW5zdCBDbGluIE1lZCwgVGFpcGVpIDExMiwgVGFpd2FuJiN4

RDtOYXRsIFlhbmcgTWluZyBVbml2LCBJbnN0IFB1YmwgSGx0aCwgVGFpcGVpIDExMiwgVGFpd2Fu

PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UHJpbWFyeSBTam9ncmVuJmFwb3M7cyBTeW5k

cm9tZSBhbmQgdGhlIFJpc2sgb2YgQWN1dGUgTXlvY2FyZGlhbCBJbmZhcmN0aW9uOiBBIE5hdGlv

bndpZGUgU3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QWN0YSBDYXJkaW9sb2dpY2EgU2lu

aWNhPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5BY3RhIENhcmRpb2wgU2luPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QWN0YSBDYXJkaW9sb2dpY2EgU2lu

aWNhPC9mdWxsLXRpdGxlPjxhYmJyLTE+QWN0YSBDYXJkaW9sIFNpbjwvYWJici0xPjwvcGVyaW9k

aWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QWN0YSBDYXJkaW9sb2dpY2EgU2luaWNh

PC9mdWxsLXRpdGxlPjxhYmJyLTE+QWN0YSBDYXJkaW9sIFNpbjwvYWJici0xPjwvYWx0LXBlcmlv

ZGljYWw+PHBhZ2VzPjEyNC0xMzE8L3BhZ2VzPjx2b2x1bWU+Mjk8L3ZvbHVtZT48bnVtYmVyPjI8

L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+YWN1dGUgbXlvY2FyZGlhbCBpbmZhcmN0aW9uPC9r

ZXl3b3JkPjxrZXl3b3JkPmF0aGVyb3NjbGVyb3Npczwva2V5d29yZD48a2V5d29yZD5wcmltYXJ5

IHNqb2dyZW4mYXBvcztzIHN5bmRyb21lPC9rZXl3b3JkPjxrZXl3b3JkPnN5c3RlbWljLWx1cHVz

LWVyeXRoZW1hdG9zdXM8L2tleXdvcmQ+PGtleXdvcmQ+ZW5kb3RoZWxpYWwgZHlzZnVuY3Rpb248

L2tleXdvcmQ+PGtleXdvcmQ+cmhldW1hdG9pZC1hcnRocml0aXM8L2tleXdvcmQ+PGtleXdvcmQ+

ZGlzZWFzZS1hY3Rpdml0eTwva2V5d29yZD48a2V5d29yZD5wcmV2YWxlbmNlPC9rZXl3b3JkPjxr

ZXl3b3JkPmRpYWdub3Npczwva2V5d29yZD48a2V5d29yZD50YWl3YW48L2tleXdvcmQ+PGtleXdv

cmQ+YXRoZXJvc2NsZXJvc2lzPC9rZXl3b3JkPjxrZXl3b3JkPmNvaG9ydDwva2V5d29yZD48a2V5

d29yZD5zdHJva2U8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMzwveWVhcj48

cHViLWRhdGVzPjxkYXRlPk1hcjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjEwMTEt

Njg0MjwvaXNibj48YWNjZXNzaW9uLW51bT5JU0k6MDAwMzE2MzA0MTAwMDAzPC9hY2Nlc3Npb24t

bnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD4mbHQ7R28gdG8gSVNJJmd0OzovLzAwMDMxNjMw

NDEwMDAwMzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFu

Z3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGlhbmc8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS

ZWNOdW0+NDU2PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2OCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+NDU2PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NTY8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoaWFuZywgQy4gSC48L2F1dGhvcj48YXV0

aG9yPkxpdSwgQy4gSi48L2F1dGhvcj48YXV0aG9yPkNoZW4sIFAuIEouPC9hdXRob3I+PGF1dGhv

cj5MZXUsIEguIEIuPC9hdXRob3I+PGF1dGhvcj5Ic3UsIEMuIFkuPC9hdXRob3I+PGF1dGhvcj5I

dWFuZywgUC4gSC48L2F1dGhvcj48YXV0aG9yPkNoZW4sIFQuIEouPC9hdXRob3I+PGF1dGhvcj5M

aW4sIFMuIEouPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBKLiBXLjwvYXV0aG9yPjxhdXRob3I+Q2hh

biwgVy4gTC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5D

aGFuLCBXTCYjeEQ7VGFpcGVpIFZldCBHZW4gSG9zcCwgSGVhbHRoY2FyZSAmYW1wOyBNYW5hZ2Vt

ZW50IEN0ciwgRGl2IENhcmRpb2wsIDIwMSxTZWMgMixTaGkgUGFpIFJkLCBUYWlwZWksIFRhaXdh

biYjeEQ7VGFpcGVpIFZldCBHZW4gSG9zcCwgSGVhbHRoY2FyZSAmYW1wOyBNYW5hZ2VtZW50IEN0

ciwgRGl2IENhcmRpb2wsIDIwMSxTZWMgMixTaGkgUGFpIFJkLCBUYWlwZWksIFRhaXdhbiYjeEQ7

Wmh1ZG9uZyBWZXQgSG9zcCwgRGl2IENhcmRpb2wsIERlcHQgTWVkLCBIc2luY2h1LCBUYWl3YW4m

I3hEO1RhaXBlaSBWZXQgR2VuIEhvc3AsIERpdiBDYXJkaW9sLCBEZXB0IE1lZCwgVGFpcGVpLCBU

YWl3YW4mI3hEO1RhaXBlaSBWZXQgR2VuIEhvc3AsIERpdiBIZW1hdG9sICZhbXA7IE9uY29sLCBE

ZXB0IE1lZCwgVGFpcGVpLCBUYWl3YW4mI3hEO1RhaXBlaSBWZXQgR2VuIEhvc3AsIERlcHQgTWVk

IFJlcyAmYW1wOyBFZHVjLCBUYWlwZWksIFRhaXdhbiYjeEQ7VGFpcGVpIFZldCBHZW4gSG9zcCwg

SGVhbHRoY2FyZSAmYW1wOyBNYW5hZ2VtZW50IEN0ciwgVGFpcGVpLCBUYWl3YW4mI3hEO1RhaXBl

aSBWZXQgR2VuIEhvc3AsIERlcHQgRmFtaWx5IE1lZCwgVGFpcGVpLCBUYWl3YW4mI3hEO05hdGwg

WWFuZyBNaW5nIFVuaXYgSG9zcCwgRGVwdCBJbnRlcm5hbCBNZWQsIFlpbGFuLCBUYWl3YW4mI3hE

O0NoaSBNZWkgTWVkIEN0ciwgRGVwdCBGYW1pbHkgTWVkLCBUYWluYW4sIFRhaXdhbiYjeEQ7Q2hp

IE1laSBNZWQgQ3RyLCBEZXB0IEdlcmlhdHIgTWVkLCBUYWluYW4sIFRhaXdhbiYjeEQ7TmF0bCBZ

YW5nIE1pbmcgVW5pdiwgQ2FyZGlvdmFzYyBSZXMgQ3RyLCBUYWlwZWkgMTEyLCBUYWl3YW4mI3hE

O05hdGwgWWFuZyBNaW5nIFVuaXYsIFNjaCBNZWQsIFRhaXBlaSAxMTIsIFRhaXdhbiYjeEQ7TmF0

bCBZYW5nIE1pbmcgVW5pdiwgSW5zdCBQaGFybWFjb2wsIFRhaXBlaSAxMTIsIFRhaXdhbiYjeEQ7

TmF0bCBZYW5nIE1pbmcgVW5pdiwgSW5zdCBDbGluIE1lZCwgVGFpcGVpIDExMiwgVGFpd2FuJiN4

RDtOYXRsIFlhbmcgTWluZyBVbml2LCBJbnN0IFB1YmwgSGx0aCwgVGFpcGVpIDExMiwgVGFpd2Fu

PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UHJpbWFyeSBTam9ncmVuJmFwb3M7cyBTeW5k

cm9tZSBhbmQgdGhlIFJpc2sgb2YgQWN1dGUgTXlvY2FyZGlhbCBJbmZhcmN0aW9uOiBBIE5hdGlv

bndpZGUgU3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QWN0YSBDYXJkaW9sb2dpY2EgU2lu

aWNhPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5BY3RhIENhcmRpb2wgU2luPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QWN0YSBDYXJkaW9sb2dpY2EgU2lu

aWNhPC9mdWxsLXRpdGxlPjxhYmJyLTE+QWN0YSBDYXJkaW9sIFNpbjwvYWJici0xPjwvcGVyaW9k

aWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QWN0YSBDYXJkaW9sb2dpY2EgU2luaWNh

PC9mdWxsLXRpdGxlPjxhYmJyLTE+QWN0YSBDYXJkaW9sIFNpbjwvYWJici0xPjwvYWx0LXBlcmlv

ZGljYWw+PHBhZ2VzPjEyNC0xMzE8L3BhZ2VzPjx2b2x1bWU+Mjk8L3ZvbHVtZT48bnVtYmVyPjI8

L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+YWN1dGUgbXlvY2FyZGlhbCBpbmZhcmN0aW9uPC9r

ZXl3b3JkPjxrZXl3b3JkPmF0aGVyb3NjbGVyb3Npczwva2V5d29yZD48a2V5d29yZD5wcmltYXJ5

IHNqb2dyZW4mYXBvcztzIHN5bmRyb21lPC9rZXl3b3JkPjxrZXl3b3JkPnN5c3RlbWljLWx1cHVz

LWVyeXRoZW1hdG9zdXM8L2tleXdvcmQ+PGtleXdvcmQ+ZW5kb3RoZWxpYWwgZHlzZnVuY3Rpb248

L2tleXdvcmQ+PGtleXdvcmQ+cmhldW1hdG9pZC1hcnRocml0aXM8L2tleXdvcmQ+PGtleXdvcmQ+

ZGlzZWFzZS1hY3Rpdml0eTwva2V5d29yZD48a2V5d29yZD5wcmV2YWxlbmNlPC9rZXl3b3JkPjxr

ZXl3b3JkPmRpYWdub3Npczwva2V5d29yZD48a2V5d29yZD50YWl3YW48L2tleXdvcmQ+PGtleXdv

cmQ+YXRoZXJvc2NsZXJvc2lzPC9rZXl3b3JkPjxrZXl3b3JkPmNvaG9ydDwva2V5d29yZD48a2V5

d29yZD5zdHJva2U8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMzwveWVhcj48

cHViLWRhdGVzPjxkYXRlPk1hcjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjEwMTEt

Njg0MjwvaXNibj48YWNjZXNzaW9uLW51bT5JU0k6MDAwMzE2MzA0MTAwMDAzPC9hY2Nlc3Npb24t

bnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD4mbHQ7R28gdG8gSVNJJmd0OzovLzAwMDMxNjMw

NDEwMDAwMzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFu

Z3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA (68). These researchers also found a similar incidence of ischaemic stroke in both groups: HR 0.84 (95% CI 0.63-1.12) PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGlhbmc8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxS

ZWNOdW0+MzMyPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2OSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MzMyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zMzI8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoaWFuZywgQ2hpYS1IdW5nPC9hdXRob3I+

PGF1dGhvcj5MaXUsIENoaWEtSmVuPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBQaW5nLUplbjwvYXV0

aG9yPjxhdXRob3I+SHVhbmcsIENoaW4tQ2hvdTwvYXV0aG9yPjxhdXRob3I+SHN1LCBDaGllbi1Z

aTwvYXV0aG9yPjxhdXRob3I+Q2hhbiwgV2FuLUxlb25nPC9hdXRob3I+PGF1dGhvcj5IdWFuZywg

UG8tSHN1bjwvYXV0aG9yPjxhdXRob3I+Q2hlbiwgVHplbmctSmk8L2F1dGhvcj48YXV0aG9yPkxp

biwgU2hpbmctSm9uZzwvYXV0aG9yPjxhdXRob3I+Q2hlbiwgSmF3LVdlbjwvYXV0aG9yPjxhdXRo

b3I+TGV1LCBIc2luLUJhbmc8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5DaGlhbmcsQ2hpYS1IdW5nLiBEaXZpc2lvbiBvZiBDYXJkaW9sb2d5LCBEZXBhcnRt

ZW50IG9mIE1lZGljaW5lLCBEYS1DaGllbiBHZW5lcmFsIEhvc3BpdGFsLCBNaWFvbGksIFRhaXdh

bi48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QcmltYXJ5IFNqb2dyZW4mYXBvcztzIHN5

bmRyb21lIGFuZCByaXNrIG9mIGlzY2hlbWljIHN0cm9rZTogYSBuYXRpb253aWRlIHN0dWR5PC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNsaW4gUmhldW1hdG9sPC9zZWNvbmRhcnktdGl0bGU+PGFs

dC10aXRsZT5DbGluIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxm

dWxsLXRpdGxlPkNsaW4gUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2xpbmljYWwgcmhl

dW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5DbGluIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPkNsaW5pY2FsIHJoZXVtYXRvbG9n

eTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjkzMS03PC9wYWdlcz48dm9sdW1lPjMz

PC92b2x1bWU+PG51bWJlcj43PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3

b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QXRoZXJvc2NsZXJvc2lzL2NvIFtD

b21wbGljYXRpb25zXTwva2V5d29yZD48a2V5d29yZD4qQnJhaW4gSXNjaGVtaWEvY28gW0NvbXBs

aWNhdGlvbnNdPC9rZXl3b3JkPjxrZXl3b3JkPkJyYWluIElzY2hlbWlhL21vIFtNb3J0YWxpdHld

PC9rZXl3b3JkPjxrZXl3b3JkPkNvbW9yYmlkaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW5jaWRlbmNlPC9rZXl3

b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+TXVsdGl2YXJpYXRlIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlByb3BvcnRp

b25hbCBIYXphcmRzIE1vZGVsczwva2V5d29yZD48a2V5d29yZD5SZWdpc3RyaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPlJldHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5SaXNrIEZh

Y3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+KlNqb2dyZW4mYXBvcztzIFN5bmRyb21lL2NvIFtDb21w

bGljYXRpb25zXTwva2V5d29yZD48a2V5d29yZD5Tam9ncmVuJmFwb3M7cyBTeW5kcm9tZS9tbyBb

TW9ydGFsaXR5XTwva2V5d29yZD48a2V5d29yZD4qU3Ryb2tlL2NvIFtDb21wbGljYXRpb25zXTwv

a2V5d29yZD48a2V5d29yZD5TdHJva2UvbW8gW01vcnRhbGl0eV08L2tleXdvcmQ+PGtleXdvcmQ+

VGFpd2FuL2VwIFtFcGlkZW1pb2xvZ3ldPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRj

b21lPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+PHB1Yi1kYXRl

cz48ZGF0ZT5KdWw8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDM0LTk5NDk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MjQ2NTE5MTU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQt

dXJscz48dXJsPmh0dHA6Ly9vdmlkc3Aub3ZpZC5jb20vb3ZpZHdlYi5jZ2k/VD1KUyZhbXA7Q1ND

PVkmYW1wO05FV1M9TiZhbXA7UEFHRT1mdWxsdGV4dCZhbXA7RD1tZWRsJmFtcDtBTj0yNDY1MTkx

NTwvdXJsPjx1cmw+aHR0cDovL21hbi1mZS5ob3N0ZWQuZXhsaWJyaXNncm91cC5jb20vb3BlbnVy

bC80NE1BTi80NE1BTl9zZXJ2aWNlc19wYWdlP3NpZD1PVklEOm1lZGxpbmUmYW1wO2lkPXBtaWQ6

MjQ2NTE5MTUmYW1wO2lkPWRvaToxMC4xMDA3JTJGczEwMDY3LTAxNC0yNTczLTcmYW1wO2lzc249

MDc3MC0zMTk4JmFtcDtpc2JuPSZhbXA7dm9sdW1lPTMzJmFtcDtpc3N1ZT03JmFtcDtzcGFnZT05

MzEmYW1wO3BhZ2VzPTkzMS03JmFtcDtkYXRlPTIwMTQmYW1wO3RpdGxlPUNsaW5pY2FsK1JoZXVt

YXRvbG9neTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1u

dW0+aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwNy9zMTAwNjctMDE0LTI1NzMtNzwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1uYW1lPk1FRExJTkU8L3JlbW90ZS1kYXRh

YmFzZS1uYW1lPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+T3ZpZCBUZWNobm9sb2dpZXM8L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFuZ3VhZ2U+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGlhbmc8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxS

ZWNOdW0+MzMyPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig2OSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MzMyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zMzI8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoaWFuZywgQ2hpYS1IdW5nPC9hdXRob3I+

PGF1dGhvcj5MaXUsIENoaWEtSmVuPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBQaW5nLUplbjwvYXV0

aG9yPjxhdXRob3I+SHVhbmcsIENoaW4tQ2hvdTwvYXV0aG9yPjxhdXRob3I+SHN1LCBDaGllbi1Z

aTwvYXV0aG9yPjxhdXRob3I+Q2hhbiwgV2FuLUxlb25nPC9hdXRob3I+PGF1dGhvcj5IdWFuZywg

UG8tSHN1bjwvYXV0aG9yPjxhdXRob3I+Q2hlbiwgVHplbmctSmk8L2F1dGhvcj48YXV0aG9yPkxp

biwgU2hpbmctSm9uZzwvYXV0aG9yPjxhdXRob3I+Q2hlbiwgSmF3LVdlbjwvYXV0aG9yPjxhdXRo

b3I+TGV1LCBIc2luLUJhbmc8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5DaGlhbmcsQ2hpYS1IdW5nLiBEaXZpc2lvbiBvZiBDYXJkaW9sb2d5LCBEZXBhcnRt

ZW50IG9mIE1lZGljaW5lLCBEYS1DaGllbiBHZW5lcmFsIEhvc3BpdGFsLCBNaWFvbGksIFRhaXdh

bi48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QcmltYXJ5IFNqb2dyZW4mYXBvcztzIHN5

bmRyb21lIGFuZCByaXNrIG9mIGlzY2hlbWljIHN0cm9rZTogYSBuYXRpb253aWRlIHN0dWR5PC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNsaW4gUmhldW1hdG9sPC9zZWNvbmRhcnktdGl0bGU+PGFs

dC10aXRsZT5DbGluIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxm

dWxsLXRpdGxlPkNsaW4gUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2xpbmljYWwgcmhl

dW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5DbGluIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPkNsaW5pY2FsIHJoZXVtYXRvbG9n

eTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjkzMS03PC9wYWdlcz48dm9sdW1lPjMz

PC92b2x1bWU+PG51bWJlcj43PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3

b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QXRoZXJvc2NsZXJvc2lzL2NvIFtD

b21wbGljYXRpb25zXTwva2V5d29yZD48a2V5d29yZD4qQnJhaW4gSXNjaGVtaWEvY28gW0NvbXBs

aWNhdGlvbnNdPC9rZXl3b3JkPjxrZXl3b3JkPkJyYWluIElzY2hlbWlhL21vIFtNb3J0YWxpdHld

PC9rZXl3b3JkPjxrZXl3b3JkPkNvbW9yYmlkaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW5jaWRlbmNlPC9rZXl3

b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+TXVsdGl2YXJpYXRlIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlByb3BvcnRp

b25hbCBIYXphcmRzIE1vZGVsczwva2V5d29yZD48a2V5d29yZD5SZWdpc3RyaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPlJldHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5SaXNrIEZh

Y3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+KlNqb2dyZW4mYXBvcztzIFN5bmRyb21lL2NvIFtDb21w

bGljYXRpb25zXTwva2V5d29yZD48a2V5d29yZD5Tam9ncmVuJmFwb3M7cyBTeW5kcm9tZS9tbyBb

TW9ydGFsaXR5XTwva2V5d29yZD48a2V5d29yZD4qU3Ryb2tlL2NvIFtDb21wbGljYXRpb25zXTwv

a2V5d29yZD48a2V5d29yZD5TdHJva2UvbW8gW01vcnRhbGl0eV08L2tleXdvcmQ+PGtleXdvcmQ+

VGFpd2FuL2VwIFtFcGlkZW1pb2xvZ3ldPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRj

b21lPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+PHB1Yi1kYXRl

cz48ZGF0ZT5KdWw8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDM0LTk5NDk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MjQ2NTE5MTU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQt

dXJscz48dXJsPmh0dHA6Ly9vdmlkc3Aub3ZpZC5jb20vb3ZpZHdlYi5jZ2k/VD1KUyZhbXA7Q1ND

PVkmYW1wO05FV1M9TiZhbXA7UEFHRT1mdWxsdGV4dCZhbXA7RD1tZWRsJmFtcDtBTj0yNDY1MTkx

NTwvdXJsPjx1cmw+aHR0cDovL21hbi1mZS5ob3N0ZWQuZXhsaWJyaXNncm91cC5jb20vb3BlbnVy

bC80NE1BTi80NE1BTl9zZXJ2aWNlc19wYWdlP3NpZD1PVklEOm1lZGxpbmUmYW1wO2lkPXBtaWQ6

MjQ2NTE5MTUmYW1wO2lkPWRvaToxMC4xMDA3JTJGczEwMDY3LTAxNC0yNTczLTcmYW1wO2lzc249

MDc3MC0zMTk4JmFtcDtpc2JuPSZhbXA7dm9sdW1lPTMzJmFtcDtpc3N1ZT03JmFtcDtzcGFnZT05

MzEmYW1wO3BhZ2VzPTkzMS03JmFtcDtkYXRlPTIwMTQmYW1wO3RpdGxlPUNsaW5pY2FsK1JoZXVt

YXRvbG9neTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1u

dW0+aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwNy9zMTAwNjctMDE0LTI1NzMtNzwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1uYW1lPk1FRExJTkU8L3JlbW90ZS1kYXRh

YmFzZS1uYW1lPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+T3ZpZCBUZWNobm9sb2dpZXM8L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFuZ3VhZ2U+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA (69). Contrary to these findings, Bartoloni et al reported a higher prevalence of self-reported cerebrovascular events (2.5% vs 1.4%) and MI (1.0% vs 0.4%) in 788 Italian women with pSS compared to 4774 age-matched female controls PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CYXJ0b2xvbmk8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+MzMzPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig3MCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzMzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zMzM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJhcnRvbG9uaSwgRS48L2F1dGhvcj48

YXV0aG9yPkJhbGRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5TY2hpbGxhY2ksIEcuPC9hdXRob3I+

PGF1dGhvcj5RdWFydHVjY2lvLCBMLjwvYXV0aG9yPjxhdXRob3I+UHJpb3JpLCBSLjwvYXV0aG9y

PjxhdXRob3I+Q2FydWJiaSwgRi48L2F1dGhvcj48YXV0aG9yPkJpbmksIFYuPC9hdXRob3I+PGF1

dGhvcj5BbHVubm8sIEEuPC9hdXRob3I+PGF1dGhvcj5Cb21iYXJkaWVyaSwgUy48L2F1dGhvcj48

YXV0aG9yPkRlIFZpdGEsIFMuPC9hdXRob3I+PGF1dGhvcj5WYWxlc2luaSwgRy48L2F1dGhvcj48

YXV0aG9yPkdpYWNvbWVsbGksIFIuPC9hdXRob3I+PGF1dGhvcj5HZXJsaSwgUi48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CYXJ0b2xvbmksRS4gUmhldW1h

dG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdp

YSwgUGVydWdpYSwgSXRhbHkuIEJhbGRpbmksQy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1l

bnQgb2YgQ2xpbmljYWwgYW5kIEV4cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQ

aXNhLCBQaXNhLCBJdGFseS4gU2NoaWxsYWNpLEcuIFVuaXQgb2YgSW50ZXJuYWwgTWVkaWNpbmUs

IERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFRlcm5pIFVuaXZlcnNpdHkgSG9zcGl0YWwsIFRlcm5p

LCBJdGFseS4gUXVhcnR1Y2NpbyxMLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2lj

YWwgU2NpZW5jZXMsIFJoZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVk

aW5lLCBJdGFseS4gUHJpb3JpLFIuIFJoZXVtYXRvbG9neSBVbml0LCBTYXBpZW56YSBVbml2ZXJz

aXR5IG9mIFJvbWUsIFJvbWUsIEl0YWx5LiBDYXJ1YmJpLEYuIFJoZXVtYXRvbG9neSBVbml0LCBE

ZXBhcnRtZW50IG9mIEJpb3RlY2hub2xvZ2ljYWwgYW5kIEFwcGxpZWQgQ2xpbmljYWwgU2NpZW5j

ZXMsIFVuaXZlcnNpdHkgb2YgTCZhcG9zO0FxdWlsYSwgTCZhcG9zO0FxdWlsYSwgSXRhbHkuIEJp

bmksVi4gSW50ZXJuYWwgTWVkaWNpbmUsIEVuZG9jcmluZSBhbmQgTWV0YWJvbGljIFNjaWVuY2Vz

IFNlY3Rpb24sIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdpYSwg

UGVydWdpYSwgSXRhbHkuIEFsdW5ubyxBLiBSaGV1bWF0b2xvZ3kgVW5pdCwgRGVwYXJ0bWVudCBv

ZiBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQZXJ1Z2lhLCBQZXJ1Z2lhLCBJdGFseS4gQm9tYmFy

ZGllcmksUy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEV4

cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4gRGUg

Vml0YSxTLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2ljYWwgU2NpZW5jZXMsIFJo

ZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVkaW5lLCBJdGFseS4gVmFs

ZXNpbmksRy4gUmhldW1hdG9sb2d5IFVuaXQsIFNhcGllbnphIFVuaXZlcnNpdHkgb2YgUm9tZSwg

Um9tZSwgSXRhbHkuIEdpYWNvbWVsbGksUi4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQg

b2YgQmlvdGVjaG5vbG9naWNhbCBhbmQgQXBwbGllZCBDbGluaWNhbCBTY2llbmNlcywgVW5pdmVy

c2l0eSBvZiBMJmFwb3M7QXF1aWxhLCBMJmFwb3M7QXF1aWxhLCBJdGFseS4gR2VybGksUi4gUmhl

dW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVy

dWdpYSwgUGVydWdpYSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2FyZGlv

dmFzY3VsYXIgZGlzZWFzZSByaXNrIGJ1cmRlbiBpbiBwcmltYXJ5IFNqb2dyZW4mYXBvcztzIHN5

bmRyb21lOiByZXN1bHRzIG9mIGEgcG9wdWxhdGlvbi1iYXNlZCBtdWx0aWNlbnRyZSBjb2hvcnQg

c3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBJbnRlcm4gTWVkPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvcGVyaW9kaWNhbD48

YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2luZTwv

ZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+

PHBhZ2VzPjE4NS05MjwvcGFnZXM+PHZvbHVtZT4yNzg8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwv

a2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVy

PC9rZXl3b3JkPjxrZXl3b3JkPkJpb2xvZ2ljYWwgTWFya2Vycy9ibCBbQmxvb2RdPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2JsIFtCbG9vZF08L2tleXdvcmQ+PGtl

eXdvcmQ+KkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2VwIFtFcGlkZW1pb2xvZ3ldPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2V0IFtFdGlvbG9neV08L2tleXdvcmQ+

PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JdGFseS9lcCBbRXBpZGVtaW9s

b2d5XTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2Vk

PC9rZXl3b3JkPjxrZXl3b3JkPlByZXZhbGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVj

dGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipSaXNrIEFzc2Vzc21lbnQvbXQgW01ldGhv

ZHNdPC9rZXl3b3JkPjxrZXl3b3JkPipTam9ncmVuJmFwb3M7cyBTeW5kcm9tZS9jbyBbQ29tcGxp

Y2F0aW9uc108L2tleXdvcmQ+PGtleXdvcmQ+U2pvZ3JlbiZhcG9zO3MgU3luZHJvbWUvZXAgW0Vw

aWRlbWlvbG9neV08L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1bHQ8L2tleXdvcmQ+PGtleXdv

cmQ+MCAoQmlvbG9naWNhbCBNYXJrZXJzKTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDE1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTM2NS0yNzk2PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1NTgyODgxPC9hY2Nlc3Np

b24tbnVtPjx3b3JrLXR5cGU+TXVsdGljZW50ZXIgU3R1ZHk8L3dvcmstdHlwZT48dXJscz48cmVs

YXRlZC11cmxzPjx1cmw+aHR0cDovL292aWRzcC5vdmlkLmNvbS9vdmlkd2ViLmNnaT9UPUpTJmFt

cDtDU0M9WSZhbXA7TkVXUz1OJmFtcDtQQUdFPWZ1bGx0ZXh0JmFtcDtEPW1lZGwmYW1wO0FOPTI1

NTgyODgxPC91cmw+PHVybD5odHRwOi8vbWFuLWZlLmhvc3RlZC5leGxpYnJpc2dyb3VwLmNvbS9v

cGVudXJsLzQ0TUFOLzQ0TUFOX3NlcnZpY2VzX3BhZ2U/c2lkPU9WSUQ6bWVkbGluZSZhbXA7aWQ9

cG1pZDoyNTU4Mjg4MSZhbXA7aWQ9ZG9pOjEwLjExMTElMkZqb2ltLjEyMzQ2JmFtcDtpc3NuPTA5

NTQtNjgyMCZhbXA7aXNibj0mYW1wO3ZvbHVtZT0yNzgmYW1wO2lzc3VlPTImYW1wO3NwYWdlPTE4

NSZhbXA7cGFnZXM9MTg1LTkyJmFtcDtkYXRlPTIwMTUmYW1wO3RpdGxlPUpvdXJuYWwrb2YrSW50

ZXJuYWwrTWVkaWNpbmU8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPmh0dHA6Ly9keC5kb2kub3JnLzEwLjExMTEvam9pbS4xMjM0NjwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1uYW1lPk1FRExJTkU8L3JlbW90ZS1kYXRh

YmFzZS1uYW1lPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+T3ZpZCBUZWNobm9sb2dpZXM8L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFuZ3VhZ2U+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CYXJ0b2xvbmk8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+MzMzPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig3MCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzMzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zMzM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJhcnRvbG9uaSwgRS48L2F1dGhvcj48

YXV0aG9yPkJhbGRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5TY2hpbGxhY2ksIEcuPC9hdXRob3I+

PGF1dGhvcj5RdWFydHVjY2lvLCBMLjwvYXV0aG9yPjxhdXRob3I+UHJpb3JpLCBSLjwvYXV0aG9y

PjxhdXRob3I+Q2FydWJiaSwgRi48L2F1dGhvcj48YXV0aG9yPkJpbmksIFYuPC9hdXRob3I+PGF1

dGhvcj5BbHVubm8sIEEuPC9hdXRob3I+PGF1dGhvcj5Cb21iYXJkaWVyaSwgUy48L2F1dGhvcj48

YXV0aG9yPkRlIFZpdGEsIFMuPC9hdXRob3I+PGF1dGhvcj5WYWxlc2luaSwgRy48L2F1dGhvcj48

YXV0aG9yPkdpYWNvbWVsbGksIFIuPC9hdXRob3I+PGF1dGhvcj5HZXJsaSwgUi48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CYXJ0b2xvbmksRS4gUmhldW1h

dG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdp

YSwgUGVydWdpYSwgSXRhbHkuIEJhbGRpbmksQy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1l

bnQgb2YgQ2xpbmljYWwgYW5kIEV4cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQ

aXNhLCBQaXNhLCBJdGFseS4gU2NoaWxsYWNpLEcuIFVuaXQgb2YgSW50ZXJuYWwgTWVkaWNpbmUs

IERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFRlcm5pIFVuaXZlcnNpdHkgSG9zcGl0YWwsIFRlcm5p

LCBJdGFseS4gUXVhcnR1Y2NpbyxMLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2lj

YWwgU2NpZW5jZXMsIFJoZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVk

aW5lLCBJdGFseS4gUHJpb3JpLFIuIFJoZXVtYXRvbG9neSBVbml0LCBTYXBpZW56YSBVbml2ZXJz

aXR5IG9mIFJvbWUsIFJvbWUsIEl0YWx5LiBDYXJ1YmJpLEYuIFJoZXVtYXRvbG9neSBVbml0LCBE

ZXBhcnRtZW50IG9mIEJpb3RlY2hub2xvZ2ljYWwgYW5kIEFwcGxpZWQgQ2xpbmljYWwgU2NpZW5j

ZXMsIFVuaXZlcnNpdHkgb2YgTCZhcG9zO0FxdWlsYSwgTCZhcG9zO0FxdWlsYSwgSXRhbHkuIEJp

bmksVi4gSW50ZXJuYWwgTWVkaWNpbmUsIEVuZG9jcmluZSBhbmQgTWV0YWJvbGljIFNjaWVuY2Vz

IFNlY3Rpb24sIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdpYSwg

UGVydWdpYSwgSXRhbHkuIEFsdW5ubyxBLiBSaGV1bWF0b2xvZ3kgVW5pdCwgRGVwYXJ0bWVudCBv

ZiBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQZXJ1Z2lhLCBQZXJ1Z2lhLCBJdGFseS4gQm9tYmFy

ZGllcmksUy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEV4

cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4gRGUg

Vml0YSxTLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2ljYWwgU2NpZW5jZXMsIFJo

ZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVkaW5lLCBJdGFseS4gVmFs

ZXNpbmksRy4gUmhldW1hdG9sb2d5IFVuaXQsIFNhcGllbnphIFVuaXZlcnNpdHkgb2YgUm9tZSwg

Um9tZSwgSXRhbHkuIEdpYWNvbWVsbGksUi4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQg

b2YgQmlvdGVjaG5vbG9naWNhbCBhbmQgQXBwbGllZCBDbGluaWNhbCBTY2llbmNlcywgVW5pdmVy

c2l0eSBvZiBMJmFwb3M7QXF1aWxhLCBMJmFwb3M7QXF1aWxhLCBJdGFseS4gR2VybGksUi4gUmhl

dW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVy

dWdpYSwgUGVydWdpYSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2FyZGlv

dmFzY3VsYXIgZGlzZWFzZSByaXNrIGJ1cmRlbiBpbiBwcmltYXJ5IFNqb2dyZW4mYXBvcztzIHN5

bmRyb21lOiByZXN1bHRzIG9mIGEgcG9wdWxhdGlvbi1iYXNlZCBtdWx0aWNlbnRyZSBjb2hvcnQg

c3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBJbnRlcm4gTWVkPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvcGVyaW9kaWNhbD48

YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2luZTwv

ZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+

PHBhZ2VzPjE4NS05MjwvcGFnZXM+PHZvbHVtZT4yNzg8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwv

a2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVy

PC9rZXl3b3JkPjxrZXl3b3JkPkJpb2xvZ2ljYWwgTWFya2Vycy9ibCBbQmxvb2RdPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2JsIFtCbG9vZF08L2tleXdvcmQ+PGtl

eXdvcmQ+KkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2VwIFtFcGlkZW1pb2xvZ3ldPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2V0IFtFdGlvbG9neV08L2tleXdvcmQ+

PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JdGFseS9lcCBbRXBpZGVtaW9s

b2d5XTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2Vk

PC9rZXl3b3JkPjxrZXl3b3JkPlByZXZhbGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVj

dGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipSaXNrIEFzc2Vzc21lbnQvbXQgW01ldGhv

ZHNdPC9rZXl3b3JkPjxrZXl3b3JkPipTam9ncmVuJmFwb3M7cyBTeW5kcm9tZS9jbyBbQ29tcGxp

Y2F0aW9uc108L2tleXdvcmQ+PGtleXdvcmQ+U2pvZ3JlbiZhcG9zO3MgU3luZHJvbWUvZXAgW0Vw

aWRlbWlvbG9neV08L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1bHQ8L2tleXdvcmQ+PGtleXdv

cmQ+MCAoQmlvbG9naWNhbCBNYXJrZXJzKTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDE1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTM2NS0yNzk2PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1NTgyODgxPC9hY2Nlc3Np

b24tbnVtPjx3b3JrLXR5cGU+TXVsdGljZW50ZXIgU3R1ZHk8L3dvcmstdHlwZT48dXJscz48cmVs

YXRlZC11cmxzPjx1cmw+aHR0cDovL292aWRzcC5vdmlkLmNvbS9vdmlkd2ViLmNnaT9UPUpTJmFt

cDtDU0M9WSZhbXA7TkVXUz1OJmFtcDtQQUdFPWZ1bGx0ZXh0JmFtcDtEPW1lZGwmYW1wO0FOPTI1

NTgyODgxPC91cmw+PHVybD5odHRwOi8vbWFuLWZlLmhvc3RlZC5leGxpYnJpc2dyb3VwLmNvbS9v

cGVudXJsLzQ0TUFOLzQ0TUFOX3NlcnZpY2VzX3BhZ2U/c2lkPU9WSUQ6bWVkbGluZSZhbXA7aWQ9

cG1pZDoyNTU4Mjg4MSZhbXA7aWQ9ZG9pOjEwLjExMTElMkZqb2ltLjEyMzQ2JmFtcDtpc3NuPTA5

NTQtNjgyMCZhbXA7aXNibj0mYW1wO3ZvbHVtZT0yNzgmYW1wO2lzc3VlPTImYW1wO3NwYWdlPTE4

NSZhbXA7cGFnZXM9MTg1LTkyJmFtcDtkYXRlPTIwMTUmYW1wO3RpdGxlPUpvdXJuYWwrb2YrSW50

ZXJuYWwrTWVkaWNpbmU8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPmh0dHA6Ly9keC5kb2kub3JnLzEwLjExMTEvam9pbS4xMjM0NjwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1uYW1lPk1FRExJTkU8L3JlbW90ZS1kYXRh

YmFzZS1uYW1lPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+T3ZpZCBUZWNobm9sb2dpZXM8L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFuZ3VhZ2U+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (70). There is some evidence of an increased prevalence of subclinical atherosclerosis in pSS. In a study of 200 women with pSS and 200 age matched female controls from the UK, hypertension (adjusted RR 2.02; 95%CI 1.19, 3.44) and hypertriglyceridaemia (adjusted RR 2.26; 1.26, 4.08) were more common in pSS ADDIN EN.CITE <EndNote><Cite><Author>Juarez</Author><Year>2014</Year><RecNum>462</RecNum><DisplayText>(71)</DisplayText><record><rec-number>462</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">462</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Juarez, M.</author><author>Toms, T. E.</author><author>de Pablo, P.</author><author>Mitchell, S.</author><author>Bowman, S.</author><author>Nightingale, P.</author><author>Price, E. J.</author><author>Griffiths, B.</author><author>Hunter, J.</author><author>Gupta, M.</author><author>Bombardieri, M.</author><author>Sutdliffe, N.</author><author>Pitzalis, C.</author><author>Pease, C.</author><author>Andrews, J.</author><author>Emery, P.</author><author>Regan, M.</author><author>Giles, I.</author><author>Isenberg, D.</author><author>Moots, R.</author><author>Collins, K. S.</author><author>Ng, W. F.</author><author>Kitas, G. D.</author></authors></contributors><titles><title>Cardiovascular risk factors in women with primary Sjogren&apos;s syndrome: United Kingdom primary Sjogren&apos;s syndrome registry results</title><secondary-title>Arthritis Care Res (Hoboken)</secondary-title><alt-title>Arthritis Care Res (Hoboken)</alt-title></titles><periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></periodical><alt-periodical><full-title>Arthritis Care Res (Hoboken)</full-title><abbr-1>Arthritis care &amp; research</abbr-1></alt-periodical><pages>757-64</pages><volume>66</volume><number>5</number><dates><year>2014</year><pub-dates><date>May</date></pub-dates></dates><isbn>2151-4658 (Electronic)&#xD;2151-464X (Linking)</isbn><accession-num>24877201</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(71) whereas smoking was less common (3.8% vs 10.1%; p= 0.026). Bartoloni et al also found that smoking was less common in women with pSS PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CYXJ0b2xvbmk8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+MzMzPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig3MCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzMzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zMzM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJhcnRvbG9uaSwgRS48L2F1dGhvcj48

YXV0aG9yPkJhbGRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5TY2hpbGxhY2ksIEcuPC9hdXRob3I+

PGF1dGhvcj5RdWFydHVjY2lvLCBMLjwvYXV0aG9yPjxhdXRob3I+UHJpb3JpLCBSLjwvYXV0aG9y

PjxhdXRob3I+Q2FydWJiaSwgRi48L2F1dGhvcj48YXV0aG9yPkJpbmksIFYuPC9hdXRob3I+PGF1

dGhvcj5BbHVubm8sIEEuPC9hdXRob3I+PGF1dGhvcj5Cb21iYXJkaWVyaSwgUy48L2F1dGhvcj48

YXV0aG9yPkRlIFZpdGEsIFMuPC9hdXRob3I+PGF1dGhvcj5WYWxlc2luaSwgRy48L2F1dGhvcj48

YXV0aG9yPkdpYWNvbWVsbGksIFIuPC9hdXRob3I+PGF1dGhvcj5HZXJsaSwgUi48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CYXJ0b2xvbmksRS4gUmhldW1h

dG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdp

YSwgUGVydWdpYSwgSXRhbHkuIEJhbGRpbmksQy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1l

bnQgb2YgQ2xpbmljYWwgYW5kIEV4cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQ

aXNhLCBQaXNhLCBJdGFseS4gU2NoaWxsYWNpLEcuIFVuaXQgb2YgSW50ZXJuYWwgTWVkaWNpbmUs

IERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFRlcm5pIFVuaXZlcnNpdHkgSG9zcGl0YWwsIFRlcm5p

LCBJdGFseS4gUXVhcnR1Y2NpbyxMLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2lj

YWwgU2NpZW5jZXMsIFJoZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVk

aW5lLCBJdGFseS4gUHJpb3JpLFIuIFJoZXVtYXRvbG9neSBVbml0LCBTYXBpZW56YSBVbml2ZXJz

aXR5IG9mIFJvbWUsIFJvbWUsIEl0YWx5LiBDYXJ1YmJpLEYuIFJoZXVtYXRvbG9neSBVbml0LCBE

ZXBhcnRtZW50IG9mIEJpb3RlY2hub2xvZ2ljYWwgYW5kIEFwcGxpZWQgQ2xpbmljYWwgU2NpZW5j

ZXMsIFVuaXZlcnNpdHkgb2YgTCZhcG9zO0FxdWlsYSwgTCZhcG9zO0FxdWlsYSwgSXRhbHkuIEJp

bmksVi4gSW50ZXJuYWwgTWVkaWNpbmUsIEVuZG9jcmluZSBhbmQgTWV0YWJvbGljIFNjaWVuY2Vz

IFNlY3Rpb24sIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdpYSwg

UGVydWdpYSwgSXRhbHkuIEFsdW5ubyxBLiBSaGV1bWF0b2xvZ3kgVW5pdCwgRGVwYXJ0bWVudCBv

ZiBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQZXJ1Z2lhLCBQZXJ1Z2lhLCBJdGFseS4gQm9tYmFy

ZGllcmksUy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEV4

cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4gRGUg

Vml0YSxTLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2ljYWwgU2NpZW5jZXMsIFJo

ZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVkaW5lLCBJdGFseS4gVmFs

ZXNpbmksRy4gUmhldW1hdG9sb2d5IFVuaXQsIFNhcGllbnphIFVuaXZlcnNpdHkgb2YgUm9tZSwg

Um9tZSwgSXRhbHkuIEdpYWNvbWVsbGksUi4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQg

b2YgQmlvdGVjaG5vbG9naWNhbCBhbmQgQXBwbGllZCBDbGluaWNhbCBTY2llbmNlcywgVW5pdmVy

c2l0eSBvZiBMJmFwb3M7QXF1aWxhLCBMJmFwb3M7QXF1aWxhLCBJdGFseS4gR2VybGksUi4gUmhl

dW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVy

dWdpYSwgUGVydWdpYSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2FyZGlv

dmFzY3VsYXIgZGlzZWFzZSByaXNrIGJ1cmRlbiBpbiBwcmltYXJ5IFNqb2dyZW4mYXBvcztzIHN5

bmRyb21lOiByZXN1bHRzIG9mIGEgcG9wdWxhdGlvbi1iYXNlZCBtdWx0aWNlbnRyZSBjb2hvcnQg

c3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBJbnRlcm4gTWVkPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvcGVyaW9kaWNhbD48

YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2luZTwv

ZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+

PHBhZ2VzPjE4NS05MjwvcGFnZXM+PHZvbHVtZT4yNzg8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwv

a2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVy

PC9rZXl3b3JkPjxrZXl3b3JkPkJpb2xvZ2ljYWwgTWFya2Vycy9ibCBbQmxvb2RdPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2JsIFtCbG9vZF08L2tleXdvcmQ+PGtl

eXdvcmQ+KkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2VwIFtFcGlkZW1pb2xvZ3ldPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2V0IFtFdGlvbG9neV08L2tleXdvcmQ+

PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JdGFseS9lcCBbRXBpZGVtaW9s

b2d5XTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2Vk

PC9rZXl3b3JkPjxrZXl3b3JkPlByZXZhbGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVj

dGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipSaXNrIEFzc2Vzc21lbnQvbXQgW01ldGhv

ZHNdPC9rZXl3b3JkPjxrZXl3b3JkPipTam9ncmVuJmFwb3M7cyBTeW5kcm9tZS9jbyBbQ29tcGxp

Y2F0aW9uc108L2tleXdvcmQ+PGtleXdvcmQ+U2pvZ3JlbiZhcG9zO3MgU3luZHJvbWUvZXAgW0Vw

aWRlbWlvbG9neV08L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1bHQ8L2tleXdvcmQ+PGtleXdv

cmQ+MCAoQmlvbG9naWNhbCBNYXJrZXJzKTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDE1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTM2NS0yNzk2PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1NTgyODgxPC9hY2Nlc3Np

b24tbnVtPjx3b3JrLXR5cGU+TXVsdGljZW50ZXIgU3R1ZHk8L3dvcmstdHlwZT48dXJscz48cmVs

YXRlZC11cmxzPjx1cmw+aHR0cDovL292aWRzcC5vdmlkLmNvbS9vdmlkd2ViLmNnaT9UPUpTJmFt

cDtDU0M9WSZhbXA7TkVXUz1OJmFtcDtQQUdFPWZ1bGx0ZXh0JmFtcDtEPW1lZGwmYW1wO0FOPTI1

NTgyODgxPC91cmw+PHVybD5odHRwOi8vbWFuLWZlLmhvc3RlZC5leGxpYnJpc2dyb3VwLmNvbS9v

cGVudXJsLzQ0TUFOLzQ0TUFOX3NlcnZpY2VzX3BhZ2U/c2lkPU9WSUQ6bWVkbGluZSZhbXA7aWQ9

cG1pZDoyNTU4Mjg4MSZhbXA7aWQ9ZG9pOjEwLjExMTElMkZqb2ltLjEyMzQ2JmFtcDtpc3NuPTA5

NTQtNjgyMCZhbXA7aXNibj0mYW1wO3ZvbHVtZT0yNzgmYW1wO2lzc3VlPTImYW1wO3NwYWdlPTE4

NSZhbXA7cGFnZXM9MTg1LTkyJmFtcDtkYXRlPTIwMTUmYW1wO3RpdGxlPUpvdXJuYWwrb2YrSW50

ZXJuYWwrTWVkaWNpbmU8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPmh0dHA6Ly9keC5kb2kub3JnLzEwLjExMTEvam9pbS4xMjM0NjwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1uYW1lPk1FRExJTkU8L3JlbW90ZS1kYXRh

YmFzZS1uYW1lPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+T3ZpZCBUZWNobm9sb2dpZXM8L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFuZ3VhZ2U+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CYXJ0b2xvbmk8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+MzMzPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig3MCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzMzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zMzM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJhcnRvbG9uaSwgRS48L2F1dGhvcj48

YXV0aG9yPkJhbGRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5TY2hpbGxhY2ksIEcuPC9hdXRob3I+

PGF1dGhvcj5RdWFydHVjY2lvLCBMLjwvYXV0aG9yPjxhdXRob3I+UHJpb3JpLCBSLjwvYXV0aG9y

PjxhdXRob3I+Q2FydWJiaSwgRi48L2F1dGhvcj48YXV0aG9yPkJpbmksIFYuPC9hdXRob3I+PGF1

dGhvcj5BbHVubm8sIEEuPC9hdXRob3I+PGF1dGhvcj5Cb21iYXJkaWVyaSwgUy48L2F1dGhvcj48

YXV0aG9yPkRlIFZpdGEsIFMuPC9hdXRob3I+PGF1dGhvcj5WYWxlc2luaSwgRy48L2F1dGhvcj48

YXV0aG9yPkdpYWNvbWVsbGksIFIuPC9hdXRob3I+PGF1dGhvcj5HZXJsaSwgUi48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5CYXJ0b2xvbmksRS4gUmhldW1h

dG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdp

YSwgUGVydWdpYSwgSXRhbHkuIEJhbGRpbmksQy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1l

bnQgb2YgQ2xpbmljYWwgYW5kIEV4cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQ

aXNhLCBQaXNhLCBJdGFseS4gU2NoaWxsYWNpLEcuIFVuaXQgb2YgSW50ZXJuYWwgTWVkaWNpbmUs

IERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFRlcm5pIFVuaXZlcnNpdHkgSG9zcGl0YWwsIFRlcm5p

LCBJdGFseS4gUXVhcnR1Y2NpbyxMLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2lj

YWwgU2NpZW5jZXMsIFJoZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVk

aW5lLCBJdGFseS4gUHJpb3JpLFIuIFJoZXVtYXRvbG9neSBVbml0LCBTYXBpZW56YSBVbml2ZXJz

aXR5IG9mIFJvbWUsIFJvbWUsIEl0YWx5LiBDYXJ1YmJpLEYuIFJoZXVtYXRvbG9neSBVbml0LCBE

ZXBhcnRtZW50IG9mIEJpb3RlY2hub2xvZ2ljYWwgYW5kIEFwcGxpZWQgQ2xpbmljYWwgU2NpZW5j

ZXMsIFVuaXZlcnNpdHkgb2YgTCZhcG9zO0FxdWlsYSwgTCZhcG9zO0FxdWlsYSwgSXRhbHkuIEJp

bmksVi4gSW50ZXJuYWwgTWVkaWNpbmUsIEVuZG9jcmluZSBhbmQgTWV0YWJvbGljIFNjaWVuY2Vz

IFNlY3Rpb24sIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVydWdpYSwg

UGVydWdpYSwgSXRhbHkuIEFsdW5ubyxBLiBSaGV1bWF0b2xvZ3kgVW5pdCwgRGVwYXJ0bWVudCBv

ZiBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQZXJ1Z2lhLCBQZXJ1Z2lhLCBJdGFseS4gQm9tYmFy

ZGllcmksUy4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEV4

cGVyaW1lbnRhbCBNZWRpY2luZSwgVW5pdmVyc2l0eSBvZiBQaXNhLCBQaXNhLCBJdGFseS4gRGUg

Vml0YSxTLiBEZXBhcnRtZW50IG9mIE1lZGljYWwgYW5kIEJpb2xvZ2ljYWwgU2NpZW5jZXMsIFJo

ZXVtYXRvbG9neSBDbGluaWMsIFVuaXZlcnNpdHkgb2YgVWRpbmUsIFVkaW5lLCBJdGFseS4gVmFs

ZXNpbmksRy4gUmhldW1hdG9sb2d5IFVuaXQsIFNhcGllbnphIFVuaXZlcnNpdHkgb2YgUm9tZSwg

Um9tZSwgSXRhbHkuIEdpYWNvbWVsbGksUi4gUmhldW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQg

b2YgQmlvdGVjaG5vbG9naWNhbCBhbmQgQXBwbGllZCBDbGluaWNhbCBTY2llbmNlcywgVW5pdmVy

c2l0eSBvZiBMJmFwb3M7QXF1aWxhLCBMJmFwb3M7QXF1aWxhLCBJdGFseS4gR2VybGksUi4gUmhl

dW1hdG9sb2d5IFVuaXQsIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIFVuaXZlcnNpdHkgb2YgUGVy

dWdpYSwgUGVydWdpYSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2FyZGlv

dmFzY3VsYXIgZGlzZWFzZSByaXNrIGJ1cmRlbiBpbiBwcmltYXJ5IFNqb2dyZW4mYXBvcztzIHN5

bmRyb21lOiByZXN1bHRzIG9mIGEgcG9wdWxhdGlvbi1iYXNlZCBtdWx0aWNlbnRyZSBjb2hvcnQg

c3R1ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBJbnRlcm4gTWVkPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2lu

ZTwvZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvcGVyaW9kaWNhbD48

YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiBJbnRlcm5hbCBNZWRpY2luZTwv

ZnVsbC10aXRsZT48YWJici0xPkogSW50ZXJuIE1lZDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+

PHBhZ2VzPjE4NS05MjwvcGFnZXM+PHZvbHVtZT4yNzg8L3ZvbHVtZT48bnVtYmVyPjI8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwv

a2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVy

PC9rZXl3b3JkPjxrZXl3b3JkPkJpb2xvZ2ljYWwgTWFya2Vycy9ibCBbQmxvb2RdPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2JsIFtCbG9vZF08L2tleXdvcmQ+PGtl

eXdvcmQ+KkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2VwIFtFcGlkZW1pb2xvZ3ldPC9rZXl3b3Jk

PjxrZXl3b3JkPkNhcmRpb3Zhc2N1bGFyIERpc2Vhc2VzL2V0IFtFdGlvbG9neV08L2tleXdvcmQ+

PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JdGFseS9lcCBbRXBpZGVtaW9s

b2d5XTwva2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2Vk

PC9rZXl3b3JkPjxrZXl3b3JkPlByZXZhbGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVj

dGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipSaXNrIEFzc2Vzc21lbnQvbXQgW01ldGhv

ZHNdPC9rZXl3b3JkPjxrZXl3b3JkPipTam9ncmVuJmFwb3M7cyBTeW5kcm9tZS9jbyBbQ29tcGxp

Y2F0aW9uc108L2tleXdvcmQ+PGtleXdvcmQ+U2pvZ3JlbiZhcG9zO3MgU3luZHJvbWUvZXAgW0Vw

aWRlbWlvbG9neV08L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1bHQ8L2tleXdvcmQ+PGtleXdv

cmQ+MCAoQmlvbG9naWNhbCBNYXJrZXJzKTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDE1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTM2NS0yNzk2PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1NTgyODgxPC9hY2Nlc3Np

b24tbnVtPjx3b3JrLXR5cGU+TXVsdGljZW50ZXIgU3R1ZHk8L3dvcmstdHlwZT48dXJscz48cmVs

YXRlZC11cmxzPjx1cmw+aHR0cDovL292aWRzcC5vdmlkLmNvbS9vdmlkd2ViLmNnaT9UPUpTJmFt

cDtDU0M9WSZhbXA7TkVXUz1OJmFtcDtQQUdFPWZ1bGx0ZXh0JmFtcDtEPW1lZGwmYW1wO0FOPTI1

NTgyODgxPC91cmw+PHVybD5odHRwOi8vbWFuLWZlLmhvc3RlZC5leGxpYnJpc2dyb3VwLmNvbS9v

cGVudXJsLzQ0TUFOLzQ0TUFOX3NlcnZpY2VzX3BhZ2U/c2lkPU9WSUQ6bWVkbGluZSZhbXA7aWQ9

cG1pZDoyNTU4Mjg4MSZhbXA7aWQ9ZG9pOjEwLjExMTElMkZqb2ltLjEyMzQ2JmFtcDtpc3NuPTA5

NTQtNjgyMCZhbXA7aXNibj0mYW1wO3ZvbHVtZT0yNzgmYW1wO2lzc3VlPTImYW1wO3NwYWdlPTE4

NSZhbXA7cGFnZXM9MTg1LTkyJmFtcDtkYXRlPTIwMTUmYW1wO3RpdGxlPUpvdXJuYWwrb2YrSW50

ZXJuYWwrTWVkaWNpbmU8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPmh0dHA6Ly9keC5kb2kub3JnLzEwLjExMTEvam9pbS4xMjM0NjwvZWxlY3Ryb25p

Yy1yZXNvdXJjZS1udW0+PHJlbW90ZS1kYXRhYmFzZS1uYW1lPk1FRExJTkU8L3JlbW90ZS1kYXRh

YmFzZS1uYW1lPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+T3ZpZCBUZWNobm9sb2dpZXM8L3Jl

bW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+RW5nbGlzaDwvbGFuZ3VhZ2U+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (70). This may be because smoking exacerbates the symptoms of xerostomia. Much of the excess hypertension found in the UK study was previously undiagnosed, suggesting that patients with pSS should have their blood pressure monitored regularly. Mechanisms for the accelerated development of atherosclerosis in patients with CTDIn addition to TRFs, there are other important mechanisms related to CTDs that contribute to the increased CV risk. Chronic inflammation is a cornerstone of the pathogenesis of many CTDs and is also central to the development of atherosclerosis ADDIN EN.CITE <EndNote><Cite><Author>Mankad</Author><Year>2015</Year><RecNum>518</RecNum><DisplayText>(72)</DisplayText><record><rec-number>518</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">518</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mankad, R.</author></authors></contributors><auth-address>Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA, mankad.rekha@mayo.edu.</auth-address><titles><title>Atherosclerotic vascular disease in the autoimmune rheumatologic patient</title><secondary-title>Current atherosclerosis reports</secondary-title><alt-title>Curr Atheroscler Rep</alt-title></titles><periodical><full-title>Current atherosclerosis reports</full-title><abbr-1>Curr Atheroscler Rep</abbr-1></periodical><alt-periodical><full-title>Current atherosclerosis reports</full-title><abbr-1>Curr Atheroscler Rep</abbr-1></alt-periodical><pages>497</pages><volume>17</volume><number>4</number><dates><year>2015</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1534-6242 (Electronic)&#xD;1523-3804 (Linking)</isbn><accession-num>25721102</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(72). Immune-mediated changes play a role in the pathogenesis of both CTD and atherosclerosis. Autoantibody formation, which is a hallmark of CTD, contributes to vascular damage and risk of thrombosis ADDIN EN.CITE <EndNote><Cite><Author>Mankad</Author><Year>2015</Year><RecNum>518</RecNum><DisplayText>(72)</DisplayText><record><rec-number>518</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">518</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mankad, R.</author></authors></contributors><auth-address>Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA, mankad.rekha@mayo.edu.</auth-address><titles><title>Atherosclerotic vascular disease in the autoimmune rheumatologic patient</title><secondary-title>Current atherosclerosis reports</secondary-title><alt-title>Curr Atheroscler Rep</alt-title></titles><periodical><full-title>Current atherosclerosis reports</full-title><abbr-1>Curr Atheroscler Rep</abbr-1></periodical><alt-periodical><full-title>Current atherosclerosis reports</full-title><abbr-1>Curr Atheroscler Rep</abbr-1></alt-periodical><pages>497</pages><volume>17</volume><number>4</number><dates><year>2015</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1534-6242 (Electronic)&#xD;1523-3804 (Linking)</isbn><accession-num>25721102</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(72).The mechanisms at play in the development of ACVD in SSc have not being fully elucidated and microvascular disease may also contribute. Endothelial cell injury induced by anti-endothelial antibodies, ischaemia/reperfusion damage, and immune-mediated cytotoxicity represent the main causes of vascular injury together with an impaired vascular repair mechanism ADDIN EN.CITE <EndNote><Cite><Author>Cannarile</Author><Year>2015</Year><RecNum>368</RecNum><DisplayText>(45)</DisplayText><record><rec-number>368</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">368</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cannarile, F.</author><author>Valentini, V.</author><author>Mirabelli, G.</author><author>Alunno, A.</author><author>Terenzi, R.</author><author>Luccioli, F.</author><author>Gerli, R.</author><author>Bartoloni, E.</author></authors></contributors><auth-address>Department of Medicine, Rheumatology Unit, University of Perugia, Via dal Pozzo 06132, Perugia, Italy.</auth-address><titles><title>Cardiovascular disease in systemic sclerosis</title><secondary-title>Annals of translational medicine</secondary-title><alt-title>Ann Transl Med</alt-title></titles><periodical><full-title>Annals of translational medicine</full-title><abbr-1>Ann Transl Med</abbr-1></periodical><alt-periodical><full-title>Annals of translational medicine</full-title><abbr-1>Ann Transl Med</abbr-1></alt-periodical><pages>8</pages><volume>3</volume><number>1</number><dates><year>2015</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>2305-5839 (Print)&#xD;2305-5839 (Linking)</isbn><accession-num>25705640</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(45).Contribution of LOS to understanding the development of CVD in the clinical course of CTD (level A)The clinical course of treated CTD can be studied in a number of contexts including randomised controlled trials (RCTs) and longitudinal observational studies (LOS). LOS comprise cohorts of patients with the CTD of interest, with few exclusion criteria, followed prospectively. Investigation and treatment will be according to local practice and may or may not be protocol driven. The cohort may either be assembled as close as possible to disease onset (inception cohorts) or assembled from prevalent cases, or both. The quality of a LOS is determined by (i) the representativeness of the cohort (and thus the generalisability of the results); (ii) the breadth, quality and completeness of the data; and (iii) the comprehensiveness of the capture and validation of outcome data. LOS may recruit specifically for research purposes or may be derived from disease registers compiled within clinical practice. Some studies are a hybrid. Alternatively CTD cohorts may be assembled from within large administrative health databases or from national disease registers. Each of these sources has its own strengths and weaknesses. As illustrated earlier in this Chapter, most of the information on the incidence and prevalence of fatal and non-fatal CVEs in CTD is derived from LOS and administrative datasets. Modifying cardiovascular risk in clinical practice (Level A)Evidence-based protocols for the screening and management of CV risk factors in CTD do not currently exist. However, the elevated risk of CVD in SLE and the need to address this risk has been acknowledged by experts in two consensus documents PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3NjYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl

Y051bT40NDM8L1JlY051bT48RGlzcGxheVRleHQ+KDczLCA3NCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDQzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NDM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1vc2NhLCBNLjwvYXV0aG9yPjxhdXRo

b3I+VGFuaSwgQy48L2F1dGhvcj48YXV0aG9yPkFyaW5nZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5C

b21iYXJkaWVyaSwgUy48L2F1dGhvcj48YXV0aG9yPkJvdW1wYXMsIEQuPC9hdXRob3I+PGF1dGhv

cj5CcmV5LCBSLjwvYXV0aG9yPjxhdXRob3I+Q2VydmVyYSwgUi48L2F1dGhvcj48YXV0aG9yPkRv

cmlhLCBBLjwvYXV0aG9yPjxhdXRob3I+SmF5bmUsIEQuPC9hdXRob3I+PGF1dGhvcj5LaGFtYXNo

dGEsIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5LdWhuLCBBLjwvYXV0aG9yPjxhdXRob3I+R29yZG9u

LCBDLjwvYXV0aG9yPjxhdXRob3I+UGV0cmksIE0uPC9hdXRob3I+PGF1dGhvcj5SZWt2aWcsIE8u

IFAuPC9hdXRob3I+PGF1dGhvcj5TY2huZWlkZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5TaGVyZXIs

IFkuPC9hdXRob3I+PGF1dGhvcj5TaG9lbmZlbGQsIFkuPC9hdXRob3I+PGF1dGhvcj5TbW9sZW4s

IEouIFMuPC9hdXRob3I+PGF1dGhvcj5UYWxhcmljbywgUi48L2F1dGhvcj48YXV0aG9yPlRpbmNh

bmksIEEuPC9hdXRob3I+PGF1dGhvcj52YW4gVm9sbGVuaG92ZW4sIFIuIEYuPC9hdXRob3I+PGF1

dGhvcj5XYXJkLCBNLiBNLjwvYXV0aG9yPjxhdXRob3I+V2VydGgsIFYuIFAuPC9hdXRob3I+PGF1

dGhvcj5DYXJtb25hLCBMLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1h

ZGRyZXNzPkNvcnJlc3BvbmRlbmNlIHRvIERyIE1hcnRhIE1vc2NhLCBVbml2ZXJzaXR5IG9mIFBp

c2EsIHZpYSBSb21hIDY3LCBPc3BlZGFsZSBTLiBDaGlhcmEsIFBpc2EsIDU2MTI2LCBJdGFseS4g

bWFydGEubW9zY2FAaW50Lm1lZC51bmlwaS5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxl

PkV1cm9wZWFuIExlYWd1ZSBBZ2FpbnN0IFJoZXVtYXRpc20gcmVjb21tZW5kYXRpb25zIGZvciBt

b25pdG9yaW5nIHBhdGllbnRzIHdpdGggc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1cyBpbiBj

bGluaWNhbCBwcmFjdGljZSBhbmQgaW4gb2JzZXJ2YXRpb25hbCBzdHVkaWVzPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkFubiBSaGV1bSBEaXM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFu

biBSaGV1bSBEaXM8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5B

bm4gUmhldW0gRGlzPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW5uYWxzIG9mIHRoZSByaGV1bWF0aWMg

ZGlzZWFzZXM8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRp

YyBkaXNlYXNlczwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjEyNjktNzQ8L3BhZ2Vz

Pjx2b2x1bWU+Njk8L3ZvbHVtZT48bnVtYmVyPjc8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+MTk4OTI3NTA8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5Db25zZW5zdXMg

RGV2ZWxvcG1lbnQgQ29uZmVyZW5jZSYjeEQ7UHJhY3RpY2UgR3VpZGVsaW5lPC93b3JrLXR5cGU+

PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJh

c2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRl

PjxBdXRob3I+TW9zY2E8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxSZWNOdW0+NDQ1PC9SZWNO

dW0+PHJlY29yZD48cmVjLW51bWJlcj40NDU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0

NTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9zY2EsIEwuPC9hdXRo

b3I+PGF1dGhvcj5CZW5qYW1pbiwgRS4gSi48L2F1dGhvcj48YXV0aG9yPkJlcnJhLCBLLjwvYXV0

aG9yPjxhdXRob3I+QmV6YW5zb24sIEouIEwuPC9hdXRob3I+PGF1dGhvcj5Eb2xvciwgUi4gSi48

L2F1dGhvcj48YXV0aG9yPkxsb3lkLUpvbmVzLCBELiBNLjwvYXV0aG9yPjxhdXRob3I+TmV3Ynks

IEwuIEsuPC9hdXRob3I+PGF1dGhvcj5QaW5hLCBJLiBMLjwvYXV0aG9yPjxhdXRob3I+Um9nZXIs

IFYuIEwuPC9hdXRob3I+PGF1dGhvcj5TaGF3LCBMLiBKLjwvYXV0aG9yPjxhdXRob3I+Wmhhbywg

RC48L2F1dGhvcj48YXV0aG9yPkJlY2tpZSwgVC4gTS48L2F1dGhvcj48YXV0aG9yPkJ1c2huZWxs

LCBDLjwvYXV0aG9yPjxhdXRob3I+RCZhcG9zO0FybWllbnRvLCBKLjwvYXV0aG9yPjxhdXRob3I+

S3Jpcy1FdGhlcnRvbiwgUC4gTS48L2F1dGhvcj48YXV0aG9yPkZhbmcsIEouPC9hdXRob3I+PGF1

dGhvcj5HYW5pYXRzLCBULiBHLjwvYXV0aG9yPjxhdXRob3I+R29tZXMsIEEuIFMuPC9hdXRob3I+

PGF1dGhvcj5HcmFjaWEsIEMuIFIuPC9hdXRob3I+PGF1dGhvcj5IYWFuLCBDLiBLLjwvYXV0aG9y

PjxhdXRob3I+SmFja3NvbiwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkp1ZGVsc29uLCBELiBSLjwv

YXV0aG9yPjxhdXRob3I+S2VsZXBvdXJpcywgRS48L2F1dGhvcj48YXV0aG9yPkxhdmllLCBDLiBK

LjwvYXV0aG9yPjxhdXRob3I+TW9vcmUsIEEuPC9hdXRob3I+PGF1dGhvcj5OdXNzbWVpZXIsIE4u

IEEuPC9hdXRob3I+PGF1dGhvcj5PZmlsaSwgRS48L2F1dGhvcj48YXV0aG9yPk9wYXJpbCwgUy48

L2F1dGhvcj48YXV0aG9yPk91eWFuZywgUC48L2F1dGhvcj48YXV0aG9yPlBpbm4sIFYuIFcuPC9h

dXRob3I+PGF1dGhvcj5TaGVyaWYsIEsuPC9hdXRob3I+PGF1dGhvcj5TbWl0aCwgUy4gQy4sIEpy

LjwvYXV0aG9yPjxhdXRob3I+U29wa28sIEcuPC9hdXRob3I+PGF1dGhvcj5DaGFuZHJhLVN0cm9i

b3MsIE4uPC9hdXRob3I+PGF1dGhvcj5VcmJpbmEsIEUuIE0uPC9hdXRob3I+PGF1dGhvcj5WYWNj

YXJpbm8sIFYuPC9hdXRob3I+PGF1dGhvcj5XZW5nZXIsIE4uIEsuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkVmZmVjdGl2ZW5lc3MtYmFzZWQgZ3VpZGVs

aW5lcyBmb3IgdGhlIHByZXZlbnRpb24gb2YgY2FyZGlvdmFzY3VsYXIgZGlzZWFzZSBpbiB3b21l

bi0tMjAxMSB1cGRhdGU6IGEgZ3VpZGVsaW5lIGZyb20gdGhlIGFtZXJpY2FuIGhlYXJ0IGFzc29j

aWF0aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5DaXJjdWxhdGlvbjwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2Fs

PjxmdWxsLXRpdGxlPkNpcmN1bGF0aW9uPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248

L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNpcmN1bGF0

aW9uPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248L2FiYnItMT48L2FsdC1wZXJpb2Rp

Y2FsPjxwYWdlcz4xMjQzLTYyPC9wYWdlcz48dm9sdW1lPjEyMzwvdm9sdW1lPjxudW1iZXI+MTE8

L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1hciAyMjwv

ZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hE

OzAwMDktNzMyMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjEzMjUwODc8L2FjY2Vz

c2lvbi1udW0+PHdvcmstdHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48

L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92

aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3NjYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl

Y051bT40NDM8L1JlY051bT48RGlzcGxheVRleHQ+KDczLCA3NCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDQzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NDM8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1vc2NhLCBNLjwvYXV0aG9yPjxhdXRo

b3I+VGFuaSwgQy48L2F1dGhvcj48YXV0aG9yPkFyaW5nZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5C

b21iYXJkaWVyaSwgUy48L2F1dGhvcj48YXV0aG9yPkJvdW1wYXMsIEQuPC9hdXRob3I+PGF1dGhv

cj5CcmV5LCBSLjwvYXV0aG9yPjxhdXRob3I+Q2VydmVyYSwgUi48L2F1dGhvcj48YXV0aG9yPkRv

cmlhLCBBLjwvYXV0aG9yPjxhdXRob3I+SmF5bmUsIEQuPC9hdXRob3I+PGF1dGhvcj5LaGFtYXNo

dGEsIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5LdWhuLCBBLjwvYXV0aG9yPjxhdXRob3I+R29yZG9u

LCBDLjwvYXV0aG9yPjxhdXRob3I+UGV0cmksIE0uPC9hdXRob3I+PGF1dGhvcj5SZWt2aWcsIE8u

IFAuPC9hdXRob3I+PGF1dGhvcj5TY2huZWlkZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5TaGVyZXIs

IFkuPC9hdXRob3I+PGF1dGhvcj5TaG9lbmZlbGQsIFkuPC9hdXRob3I+PGF1dGhvcj5TbW9sZW4s

IEouIFMuPC9hdXRob3I+PGF1dGhvcj5UYWxhcmljbywgUi48L2F1dGhvcj48YXV0aG9yPlRpbmNh

bmksIEEuPC9hdXRob3I+PGF1dGhvcj52YW4gVm9sbGVuaG92ZW4sIFIuIEYuPC9hdXRob3I+PGF1

dGhvcj5XYXJkLCBNLiBNLjwvYXV0aG9yPjxhdXRob3I+V2VydGgsIFYuIFAuPC9hdXRob3I+PGF1

dGhvcj5DYXJtb25hLCBMLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1h

ZGRyZXNzPkNvcnJlc3BvbmRlbmNlIHRvIERyIE1hcnRhIE1vc2NhLCBVbml2ZXJzaXR5IG9mIFBp

c2EsIHZpYSBSb21hIDY3LCBPc3BlZGFsZSBTLiBDaGlhcmEsIFBpc2EsIDU2MTI2LCBJdGFseS4g

bWFydGEubW9zY2FAaW50Lm1lZC51bmlwaS5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxl

PkV1cm9wZWFuIExlYWd1ZSBBZ2FpbnN0IFJoZXVtYXRpc20gcmVjb21tZW5kYXRpb25zIGZvciBt

b25pdG9yaW5nIHBhdGllbnRzIHdpdGggc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1cyBpbiBj

bGluaWNhbCBwcmFjdGljZSBhbmQgaW4gb2JzZXJ2YXRpb25hbCBzdHVkaWVzPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkFubiBSaGV1bSBEaXM8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFu

biBSaGV1bSBEaXM8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5B

bm4gUmhldW0gRGlzPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW5uYWxzIG9mIHRoZSByaGV1bWF0aWMg

ZGlzZWFzZXM8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRp

YyBkaXNlYXNlczwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjEyNjktNzQ8L3BhZ2Vz

Pjx2b2x1bWU+Njk8L3ZvbHVtZT48bnVtYmVyPjc8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMDwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2Ju

PjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8L2lzYm4+PGFj

Y2Vzc2lvbi1udW0+MTk4OTI3NTA8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5Db25zZW5zdXMg

RGV2ZWxvcG1lbnQgQ29uZmVyZW5jZSYjeEQ7UHJhY3RpY2UgR3VpZGVsaW5lPC93b3JrLXR5cGU+

PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJh

c2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRl

PjxBdXRob3I+TW9zY2E8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxSZWNOdW0+NDQ1PC9SZWNO

dW0+PHJlY29yZD48cmVjLW51bWJlcj40NDU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0

NTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9zY2EsIEwuPC9hdXRo

b3I+PGF1dGhvcj5CZW5qYW1pbiwgRS4gSi48L2F1dGhvcj48YXV0aG9yPkJlcnJhLCBLLjwvYXV0

aG9yPjxhdXRob3I+QmV6YW5zb24sIEouIEwuPC9hdXRob3I+PGF1dGhvcj5Eb2xvciwgUi4gSi48

L2F1dGhvcj48YXV0aG9yPkxsb3lkLUpvbmVzLCBELiBNLjwvYXV0aG9yPjxhdXRob3I+TmV3Ynks

IEwuIEsuPC9hdXRob3I+PGF1dGhvcj5QaW5hLCBJLiBMLjwvYXV0aG9yPjxhdXRob3I+Um9nZXIs

IFYuIEwuPC9hdXRob3I+PGF1dGhvcj5TaGF3LCBMLiBKLjwvYXV0aG9yPjxhdXRob3I+Wmhhbywg

RC48L2F1dGhvcj48YXV0aG9yPkJlY2tpZSwgVC4gTS48L2F1dGhvcj48YXV0aG9yPkJ1c2huZWxs

LCBDLjwvYXV0aG9yPjxhdXRob3I+RCZhcG9zO0FybWllbnRvLCBKLjwvYXV0aG9yPjxhdXRob3I+

S3Jpcy1FdGhlcnRvbiwgUC4gTS48L2F1dGhvcj48YXV0aG9yPkZhbmcsIEouPC9hdXRob3I+PGF1

dGhvcj5HYW5pYXRzLCBULiBHLjwvYXV0aG9yPjxhdXRob3I+R29tZXMsIEEuIFMuPC9hdXRob3I+

PGF1dGhvcj5HcmFjaWEsIEMuIFIuPC9hdXRob3I+PGF1dGhvcj5IYWFuLCBDLiBLLjwvYXV0aG9y

PjxhdXRob3I+SmFja3NvbiwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkp1ZGVsc29uLCBELiBSLjwv

YXV0aG9yPjxhdXRob3I+S2VsZXBvdXJpcywgRS48L2F1dGhvcj48YXV0aG9yPkxhdmllLCBDLiBK

LjwvYXV0aG9yPjxhdXRob3I+TW9vcmUsIEEuPC9hdXRob3I+PGF1dGhvcj5OdXNzbWVpZXIsIE4u

IEEuPC9hdXRob3I+PGF1dGhvcj5PZmlsaSwgRS48L2F1dGhvcj48YXV0aG9yPk9wYXJpbCwgUy48

L2F1dGhvcj48YXV0aG9yPk91eWFuZywgUC48L2F1dGhvcj48YXV0aG9yPlBpbm4sIFYuIFcuPC9h

dXRob3I+PGF1dGhvcj5TaGVyaWYsIEsuPC9hdXRob3I+PGF1dGhvcj5TbWl0aCwgUy4gQy4sIEpy

LjwvYXV0aG9yPjxhdXRob3I+U29wa28sIEcuPC9hdXRob3I+PGF1dGhvcj5DaGFuZHJhLVN0cm9i

b3MsIE4uPC9hdXRob3I+PGF1dGhvcj5VcmJpbmEsIEUuIE0uPC9hdXRob3I+PGF1dGhvcj5WYWNj

YXJpbm8sIFYuPC9hdXRob3I+PGF1dGhvcj5XZW5nZXIsIE4uIEsuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkVmZmVjdGl2ZW5lc3MtYmFzZWQgZ3VpZGVs

aW5lcyBmb3IgdGhlIHByZXZlbnRpb24gb2YgY2FyZGlvdmFzY3VsYXIgZGlzZWFzZSBpbiB3b21l

bi0tMjAxMSB1cGRhdGU6IGEgZ3VpZGVsaW5lIGZyb20gdGhlIGFtZXJpY2FuIGhlYXJ0IGFzc29j

aWF0aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5DaXJjdWxhdGlvbjwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2Fs

PjxmdWxsLXRpdGxlPkNpcmN1bGF0aW9uPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248

L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNpcmN1bGF0

aW9uPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248L2FiYnItMT48L2FsdC1wZXJpb2Rp

Y2FsPjxwYWdlcz4xMjQzLTYyPC9wYWdlcz48dm9sdW1lPjEyMzwvdm9sdW1lPjxudW1iZXI+MTE8

L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1hciAyMjwv

ZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hE

OzAwMDktNzMyMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjEzMjUwODc8L2FjY2Vz

c2lvbi1udW0+PHdvcmstdHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48

L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92

aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (73, 74). The EULAR recommendation for monitoring patients with SLE advises screening for TRFs at baseline and at least annually thereafter PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3NjYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl

Y051bT40NDM8L1JlY051bT48RGlzcGxheVRleHQ+KDczKTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj40NDM8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0Mzwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9zY2EsIE0uPC9hdXRob3I+PGF1dGhvcj5U

YW5pLCBDLjwvYXV0aG9yPjxhdXRob3I+QXJpbmdlciwgTS48L2F1dGhvcj48YXV0aG9yPkJvbWJh

cmRpZXJpLCBTLjwvYXV0aG9yPjxhdXRob3I+Qm91bXBhcywgRC48L2F1dGhvcj48YXV0aG9yPkJy

ZXksIFIuPC9hdXRob3I+PGF1dGhvcj5DZXJ2ZXJhLCBSLjwvYXV0aG9yPjxhdXRob3I+RG9yaWEs

IEEuPC9hdXRob3I+PGF1dGhvcj5KYXluZSwgRC48L2F1dGhvcj48YXV0aG9yPktoYW1hc2h0YSwg

TS4gQS48L2F1dGhvcj48YXV0aG9yPkt1aG4sIEEuPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMu

PC9hdXRob3I+PGF1dGhvcj5QZXRyaSwgTS48L2F1dGhvcj48YXV0aG9yPlJla3ZpZywgTy4gUC48

L2F1dGhvcj48YXV0aG9yPlNjaG5laWRlciwgTS48L2F1dGhvcj48YXV0aG9yPlNoZXJlciwgWS48

L2F1dGhvcj48YXV0aG9yPlNob2VuZmVsZCwgWS48L2F1dGhvcj48YXV0aG9yPlNtb2xlbiwgSi4g

Uy48L2F1dGhvcj48YXV0aG9yPlRhbGFyaWNvLCBSLjwvYXV0aG9yPjxhdXRob3I+VGluY2FuaSwg

QS48L2F1dGhvcj48YXV0aG9yPnZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9y

PldhcmQsIE0uIE0uPC9hdXRob3I+PGF1dGhvcj5XZXJ0aCwgVi4gUC48L2F1dGhvcj48YXV0aG9y

PkNhcm1vbmEsIEwuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJl

c3M+Q29ycmVzcG9uZGVuY2UgdG8gRHIgTWFydGEgTW9zY2EsIFVuaXZlcnNpdHkgb2YgUGlzYSwg

dmlhIFJvbWEgNjcsIE9zcGVkYWxlIFMuIENoaWFyYSwgUGlzYSwgNTYxMjYsIEl0YWx5LiBtYXJ0

YS5tb3NjYUBpbnQubWVkLnVuaXBpLml0PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RXVy

b3BlYW4gTGVhZ3VlIEFnYWluc3QgUmhldW1hdGlzbSByZWNvbW1lbmRhdGlvbnMgZm9yIG1vbml0

b3JpbmcgcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzIGluIGNsaW5p

Y2FsIHByYWN0aWNlIGFuZCBpbiBvYnNlcnZhdGlvbmFsIHN0dWRpZXM8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+QW5uIFJoZXVtIERpczwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QW5uIFJo

ZXVtIERpczwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFubiBS

aGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRpYyBkaXNl

YXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5u

IFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRp

c2Vhc2VzPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTI2OS03NDwvcGFnZXM+PHZv

bHVtZT42OTwvdm9sdW1lPjxudW1iZXI+NzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEwPC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+SnVsPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ2

OC0yMDYwIChFbGVjdHJvbmljKSYjeEQ7MDAwMy00OTY3IChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4xOTg5Mjc1MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPkNvbnNlbnN1cyBEZXZl

bG9wbWVudCBDb25mZXJlbmNlJiN4RDtQcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJs

cz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3NjYTwvQXV0aG9yPjxZZWFyPjIwMTA8L1llYXI+PFJl

Y051bT40NDM8L1JlY051bT48RGlzcGxheVRleHQ+KDczKTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj40NDM8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0Mzwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9zY2EsIE0uPC9hdXRob3I+PGF1dGhvcj5U

YW5pLCBDLjwvYXV0aG9yPjxhdXRob3I+QXJpbmdlciwgTS48L2F1dGhvcj48YXV0aG9yPkJvbWJh

cmRpZXJpLCBTLjwvYXV0aG9yPjxhdXRob3I+Qm91bXBhcywgRC48L2F1dGhvcj48YXV0aG9yPkJy

ZXksIFIuPC9hdXRob3I+PGF1dGhvcj5DZXJ2ZXJhLCBSLjwvYXV0aG9yPjxhdXRob3I+RG9yaWEs

IEEuPC9hdXRob3I+PGF1dGhvcj5KYXluZSwgRC48L2F1dGhvcj48YXV0aG9yPktoYW1hc2h0YSwg

TS4gQS48L2F1dGhvcj48YXV0aG9yPkt1aG4sIEEuPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMu

PC9hdXRob3I+PGF1dGhvcj5QZXRyaSwgTS48L2F1dGhvcj48YXV0aG9yPlJla3ZpZywgTy4gUC48

L2F1dGhvcj48YXV0aG9yPlNjaG5laWRlciwgTS48L2F1dGhvcj48YXV0aG9yPlNoZXJlciwgWS48

L2F1dGhvcj48YXV0aG9yPlNob2VuZmVsZCwgWS48L2F1dGhvcj48YXV0aG9yPlNtb2xlbiwgSi4g

Uy48L2F1dGhvcj48YXV0aG9yPlRhbGFyaWNvLCBSLjwvYXV0aG9yPjxhdXRob3I+VGluY2FuaSwg

QS48L2F1dGhvcj48YXV0aG9yPnZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9y

PldhcmQsIE0uIE0uPC9hdXRob3I+PGF1dGhvcj5XZXJ0aCwgVi4gUC48L2F1dGhvcj48YXV0aG9y

PkNhcm1vbmEsIEwuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJl

c3M+Q29ycmVzcG9uZGVuY2UgdG8gRHIgTWFydGEgTW9zY2EsIFVuaXZlcnNpdHkgb2YgUGlzYSwg

dmlhIFJvbWEgNjcsIE9zcGVkYWxlIFMuIENoaWFyYSwgUGlzYSwgNTYxMjYsIEl0YWx5LiBtYXJ0

YS5tb3NjYUBpbnQubWVkLnVuaXBpLml0PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RXVy

b3BlYW4gTGVhZ3VlIEFnYWluc3QgUmhldW1hdGlzbSByZWNvbW1lbmRhdGlvbnMgZm9yIG1vbml0

b3JpbmcgcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzIGluIGNsaW5p

Y2FsIHByYWN0aWNlIGFuZCBpbiBvYnNlcnZhdGlvbmFsIHN0dWRpZXM8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+QW5uIFJoZXVtIERpczwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QW5uIFJo

ZXVtIERpczwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFubiBS

aGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRpYyBkaXNl

YXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5u

IFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRp

c2Vhc2VzPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTI2OS03NDwvcGFnZXM+PHZv

bHVtZT42OTwvdm9sdW1lPjxudW1iZXI+NzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEwPC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+SnVsPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ2

OC0yMDYwIChFbGVjdHJvbmljKSYjeEQ7MDAwMy00OTY3IChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4xOTg5Mjc1MDwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPkNvbnNlbnN1cyBEZXZl

bG9wbWVudCBDb25mZXJlbmNlJiN4RDtQcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJs

cz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE.DATA (73). The American Heart Association Guidelines for the prevention of CVD in women have included SLE as a group at increased CVD risk PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3NjYTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+PFJl

Y051bT40NDU8L1JlY051bT48RGlzcGxheVRleHQ+KDc0KTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj40NDU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0NTwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9zY2EsIEwuPC9hdXRob3I+PGF1dGhvcj5C

ZW5qYW1pbiwgRS4gSi48L2F1dGhvcj48YXV0aG9yPkJlcnJhLCBLLjwvYXV0aG9yPjxhdXRob3I+

QmV6YW5zb24sIEouIEwuPC9hdXRob3I+PGF1dGhvcj5Eb2xvciwgUi4gSi48L2F1dGhvcj48YXV0

aG9yPkxsb3lkLUpvbmVzLCBELiBNLjwvYXV0aG9yPjxhdXRob3I+TmV3YnksIEwuIEsuPC9hdXRo

b3I+PGF1dGhvcj5QaW5hLCBJLiBMLjwvYXV0aG9yPjxhdXRob3I+Um9nZXIsIFYuIEwuPC9hdXRo

b3I+PGF1dGhvcj5TaGF3LCBMLiBKLjwvYXV0aG9yPjxhdXRob3I+WmhhbywgRC48L2F1dGhvcj48

YXV0aG9yPkJlY2tpZSwgVC4gTS48L2F1dGhvcj48YXV0aG9yPkJ1c2huZWxsLCBDLjwvYXV0aG9y

PjxhdXRob3I+RCZhcG9zO0FybWllbnRvLCBKLjwvYXV0aG9yPjxhdXRob3I+S3Jpcy1FdGhlcnRv

biwgUC4gTS48L2F1dGhvcj48YXV0aG9yPkZhbmcsIEouPC9hdXRob3I+PGF1dGhvcj5HYW5pYXRz

LCBULiBHLjwvYXV0aG9yPjxhdXRob3I+R29tZXMsIEEuIFMuPC9hdXRob3I+PGF1dGhvcj5HcmFj

aWEsIEMuIFIuPC9hdXRob3I+PGF1dGhvcj5IYWFuLCBDLiBLLjwvYXV0aG9yPjxhdXRob3I+SmFj

a3NvbiwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkp1ZGVsc29uLCBELiBSLjwvYXV0aG9yPjxhdXRo

b3I+S2VsZXBvdXJpcywgRS48L2F1dGhvcj48YXV0aG9yPkxhdmllLCBDLiBKLjwvYXV0aG9yPjxh

dXRob3I+TW9vcmUsIEEuPC9hdXRob3I+PGF1dGhvcj5OdXNzbWVpZXIsIE4uIEEuPC9hdXRob3I+

PGF1dGhvcj5PZmlsaSwgRS48L2F1dGhvcj48YXV0aG9yPk9wYXJpbCwgUy48L2F1dGhvcj48YXV0

aG9yPk91eWFuZywgUC48L2F1dGhvcj48YXV0aG9yPlBpbm4sIFYuIFcuPC9hdXRob3I+PGF1dGhv

cj5TaGVyaWYsIEsuPC9hdXRob3I+PGF1dGhvcj5TbWl0aCwgUy4gQy4sIEpyLjwvYXV0aG9yPjxh

dXRob3I+U29wa28sIEcuPC9hdXRob3I+PGF1dGhvcj5DaGFuZHJhLVN0cm9ib3MsIE4uPC9hdXRo

b3I+PGF1dGhvcj5VcmJpbmEsIEUuIE0uPC9hdXRob3I+PGF1dGhvcj5WYWNjYXJpbm8sIFYuPC9h

dXRob3I+PGF1dGhvcj5XZW5nZXIsIE4uIEsuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0

b3JzPjx0aXRsZXM+PHRpdGxlPkVmZmVjdGl2ZW5lc3MtYmFzZWQgZ3VpZGVsaW5lcyBmb3IgdGhl

IHByZXZlbnRpb24gb2YgY2FyZGlvdmFzY3VsYXIgZGlzZWFzZSBpbiB3b21lbi0tMjAxMSB1cGRh

dGU6IGEgZ3VpZGVsaW5lIGZyb20gdGhlIGFtZXJpY2FuIGhlYXJ0IGFzc29jaWF0aW9uPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRs

ZT5DaXJjdWxhdGlvbjwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkNpcmN1bGF0aW9uPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248L2FiYnItMT48L3Bl

cmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNpcmN1bGF0aW9uPC9mdWxsLXRp

dGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4x

MjQzLTYyPC9wYWdlcz48dm9sdW1lPjEyMzwvdm9sdW1lPjxudW1iZXI+MTE8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1hciAyMjwvZGF0ZT48L3B1Yi1k

YXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjEzMjUwODc8L2FjY2Vzc2lvbi1udW0+PHdv

cmstdHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90

ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3Vh

Z2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3NjYTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+PFJl

Y051bT40NDU8L1JlY051bT48RGlzcGxheVRleHQ+KDc0KTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj40NDU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ0NTwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW9zY2EsIEwuPC9hdXRob3I+PGF1dGhvcj5C

ZW5qYW1pbiwgRS4gSi48L2F1dGhvcj48YXV0aG9yPkJlcnJhLCBLLjwvYXV0aG9yPjxhdXRob3I+

QmV6YW5zb24sIEouIEwuPC9hdXRob3I+PGF1dGhvcj5Eb2xvciwgUi4gSi48L2F1dGhvcj48YXV0

aG9yPkxsb3lkLUpvbmVzLCBELiBNLjwvYXV0aG9yPjxhdXRob3I+TmV3YnksIEwuIEsuPC9hdXRo

b3I+PGF1dGhvcj5QaW5hLCBJLiBMLjwvYXV0aG9yPjxhdXRob3I+Um9nZXIsIFYuIEwuPC9hdXRo

b3I+PGF1dGhvcj5TaGF3LCBMLiBKLjwvYXV0aG9yPjxhdXRob3I+WmhhbywgRC48L2F1dGhvcj48

YXV0aG9yPkJlY2tpZSwgVC4gTS48L2F1dGhvcj48YXV0aG9yPkJ1c2huZWxsLCBDLjwvYXV0aG9y

PjxhdXRob3I+RCZhcG9zO0FybWllbnRvLCBKLjwvYXV0aG9yPjxhdXRob3I+S3Jpcy1FdGhlcnRv

biwgUC4gTS48L2F1dGhvcj48YXV0aG9yPkZhbmcsIEouPC9hdXRob3I+PGF1dGhvcj5HYW5pYXRz

LCBULiBHLjwvYXV0aG9yPjxhdXRob3I+R29tZXMsIEEuIFMuPC9hdXRob3I+PGF1dGhvcj5HcmFj

aWEsIEMuIFIuPC9hdXRob3I+PGF1dGhvcj5IYWFuLCBDLiBLLjwvYXV0aG9yPjxhdXRob3I+SmFj

a3NvbiwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkp1ZGVsc29uLCBELiBSLjwvYXV0aG9yPjxhdXRo

b3I+S2VsZXBvdXJpcywgRS48L2F1dGhvcj48YXV0aG9yPkxhdmllLCBDLiBKLjwvYXV0aG9yPjxh

dXRob3I+TW9vcmUsIEEuPC9hdXRob3I+PGF1dGhvcj5OdXNzbWVpZXIsIE4uIEEuPC9hdXRob3I+

PGF1dGhvcj5PZmlsaSwgRS48L2F1dGhvcj48YXV0aG9yPk9wYXJpbCwgUy48L2F1dGhvcj48YXV0

aG9yPk91eWFuZywgUC48L2F1dGhvcj48YXV0aG9yPlBpbm4sIFYuIFcuPC9hdXRob3I+PGF1dGhv

cj5TaGVyaWYsIEsuPC9hdXRob3I+PGF1dGhvcj5TbWl0aCwgUy4gQy4sIEpyLjwvYXV0aG9yPjxh

dXRob3I+U29wa28sIEcuPC9hdXRob3I+PGF1dGhvcj5DaGFuZHJhLVN0cm9ib3MsIE4uPC9hdXRo

b3I+PGF1dGhvcj5VcmJpbmEsIEUuIE0uPC9hdXRob3I+PGF1dGhvcj5WYWNjYXJpbm8sIFYuPC9h

dXRob3I+PGF1dGhvcj5XZW5nZXIsIE4uIEsuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0

b3JzPjx0aXRsZXM+PHRpdGxlPkVmZmVjdGl2ZW5lc3MtYmFzZWQgZ3VpZGVsaW5lcyBmb3IgdGhl

IHByZXZlbnRpb24gb2YgY2FyZGlvdmFzY3VsYXIgZGlzZWFzZSBpbiB3b21lbi0tMjAxMSB1cGRh

dGU6IGEgZ3VpZGVsaW5lIGZyb20gdGhlIGFtZXJpY2FuIGhlYXJ0IGFzc29jaWF0aW9uPC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRs

ZT5DaXJjdWxhdGlvbjwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkNpcmN1bGF0aW9uPC9mdWxsLXRpdGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248L2FiYnItMT48L3Bl

cmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkNpcmN1bGF0aW9uPC9mdWxsLXRp

dGxlPjxhYmJyLTE+Q2lyY3VsYXRpb248L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4x

MjQzLTYyPC9wYWdlcz48dm9sdW1lPjEyMzwvdm9sdW1lPjxudW1iZXI+MTE8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1hciAyMjwvZGF0ZT48L3B1Yi1k

YXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjEzMjUwODc8L2FjY2Vzc2lvbi1udW0+PHdv

cmstdHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90

ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3Vh

Z2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (74). There is evidence that composite risk scores such as the Framingham risk score underestimate risk in SLE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CcnVjZTwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJl

Y051bT40NDg8L1JlY051bT48RGlzcGxheVRleHQ+KDMwLCAzNCwgNzUpPC9EaXNwbGF5VGV4dD48

cmVjb3JkPjxyZWMtbnVtYmVyPjQ0ODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBw

PSJFTiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDQ4PC9r

ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl

Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5CcnVjZSwgSS4gTi48L2F1dGhv

cj48YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PGF1dGhvcj5HbGFkbWFuLCBELiBELjwv

YXV0aG9yPjxhdXRob3I+SWJhbmV6LCBELjwvYXV0aG9yPjxhdXRob3I+U3RlaW5lciwgRy48L2F1

dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Vbml2ZXJzaXR5IG9m

IFRvcm9udG8gTHVwdXMgQ2xpbmljLCBhbmQgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBp

biB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5SaXNrIGZh

Y3RvcnMgZm9yIGNvcm9uYXJ5IGhlYXJ0IGRpc2Vhc2UgaW4gd29tZW4gd2l0aCBzeXN0ZW1pYyBs

dXB1cyBlcnl0aGVtYXRvc3VzOiB0aGUgVG9yb250byBSaXNrIEZhY3RvciBTdHVkeTwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRp

dGxlPkFydGhyaXRpcyBSaGV1bTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkFydGhyaXRpcyBSaGV1bTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBhbmQg

cmhldW1hdGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0

bGU+QXJ0aHJpdGlzIFJoZXVtPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGFuZCByaGV1

bWF0aXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzE1OS02NzwvcGFnZXM+PHZv

bHVtZT40ODwvdm9sdW1lPjxudW1iZXI+MTE8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwMzwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk5vdjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAw

MDQtMzU5MSAoUHJpbnQpJiN4RDswMDA0LTM1OTEgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24t

bnVtPjE0NjEzMjc4PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwg

Tm9uLVUuUy4gR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFi

YXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8

L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkVzZGFpbGU8L0F1dGhvcj48

WWVhcj4yMDAxPC9ZZWFyPjxSZWNOdW0+NDY0PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj40

NjQ8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5

ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ2NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxy

ZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3Jz

PjxhdXRob3JzPjxhdXRob3I+RXNkYWlsZSwgSi4gTS48L2F1dGhvcj48YXV0aG9yPkFicmFoYW1v

d2ljeiwgTS48L2F1dGhvcj48YXV0aG9yPkdyb2R6aWNreSwgVC48L2F1dGhvcj48YXV0aG9yPkxp

LCBZLjwvYXV0aG9yPjxhdXRob3I+UGFuYXJpdGlzLCBDLjwvYXV0aG9yPjxhdXRob3I+ZHUgQmVy

Z2VyLCBSLjwvYXV0aG9yPjxhdXRob3I+Q290ZSwgUi48L2F1dGhvcj48YXV0aG9yPkdyb3Zlciwg

Uy4gQS48L2F1dGhvcj48YXV0aG9yPkZvcnRpbiwgUC4gUi48L2F1dGhvcj48YXV0aG9yPkNsYXJr

ZSwgQS4gRS48L2F1dGhvcj48YXV0aG9yPlNlbmVjYWwsIEouIEwuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+VW5pdmVyc2l0eSBvZiBCcml0aXNoIENvbHVt

YmlhLCBWYW5jb3V2ZXIsIENhbmFkYS4gamVzZGFpbGVAYmMuYXJ0aHJpdGlzLmNhPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+VHJhZGl0aW9uYWwgRnJhbWluZ2hhbSByaXNrIGZhY3RvcnMg

ZmFpbCB0byBmdWxseSBhY2NvdW50IGZvciBhY2NlbGVyYXRlZCBhdGhlcm9zY2xlcm9zaXMgaW4g

c3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcnRo

cml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRpcyBSaGV1bTwv

YWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBSaGV1

bTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBhbmQgcmhldW1hdGlzbTwvYWJici0xPjwv

cGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlzIFJoZXVtPC9m

dWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGFuZCByaGV1bWF0aXNtPC9hYmJyLTE+PC9hbHQt

cGVyaW9kaWNhbD48cGFnZXM+MjMzMS03PC9wYWdlcz48dm9sdW1lPjQ0PC92b2x1bWU+PG51bWJl

cj4xMDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAxPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0

PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwNC0zNTkxIChQcmludCkmI3hEOzAw

MDQtMzU5MSAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTE2NjU5NzM8L2FjY2Vzc2lv

bi1udW0+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBHb3YmYXBvczt0PC93

b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9D

aXRlPjxDaXRlPjxBdXRob3I+TyZhcG9zO05laWxsPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48

UmVjTnVtPjUxOTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NTE5PC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRl

ZnBmZTlkZDByejVkIj41MTk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91

cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

Pk8mYXBvcztOZWlsbCwgUy4gRy48L2F1dGhvcj48YXV0aG9yPlBlZ28tUmVpZ29zYSwgSi4gTS48

L2F1dGhvcj48YXV0aG9yPkhpbmdvcmFuaSwgQS4gRC48L2F1dGhvcj48YXV0aG9yPkJlc3NhbnQs

IFIuPC9hdXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC4gQS48L2F1dGhvcj48YXV0aG9yPlJhaG1h

biwgQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5DZW50

cmUgZm9yIFJoZXVtYXRvbG9neSBSZXNlYXJjaCwgRGl2aXNpb24gb2YgTWVkaWNpbmUsIFVuaXZl

cnNpdHkgQ29sbGVnZSBMb25kb24sIExvbmRvbiwgVUsuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+VXNlIG9mIGEgc3RyYXRlZ3kgYmFzZWQgb24gY2FsY3VsYXRlZCByaXNrIHNjb3JlcyBp

biBtYW5hZ2luZyBjYXJkaW92YXNjdWxhciByaXNrIGZhY3RvcnMgaW4gYSBsYXJnZSBCcml0aXNo

IGNvaG9ydCBvZiBwYXRpZW50cyB3aXRoIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM8L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+UmhldW1hdG9sb2d5IChPeGZvcmQsIEVuZ2xhbmQpPC9zZWNv

bmRhcnktdGl0bGU+PGFsdC10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2FsdC10aXRsZT48

L3RpdGxlcz48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UmhldW1hdG9sb2d5IChPeGZvcmQp

PC9mdWxsLXRpdGxlPjxhYmJyLTE+UmhldW1hdG9sb2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNh

bD48cGFnZXM+NTczLTU8L3BhZ2VzPjx2b2x1bWU+NDg8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJl

cj48ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1

Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NjItMDMzMiAoRWxlY3Ryb25pYykmI3hEOzE0NjItMDMy

NCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTkyNzM1NDA8L2FjY2Vzc2lvbi1udW0+

PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBHb3YmYXBvczt0PC93b3JrLXR5

cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0

YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CcnVjZTwvQXV0aG9yPjxZZWFyPjIwMDM8L1llYXI+PFJl

Y051bT40NDg8L1JlY051bT48RGlzcGxheVRleHQ+KDMwLCAzNCwgNzUpPC9EaXNwbGF5VGV4dD48

cmVjb3JkPjxyZWMtbnVtYmVyPjQ0ODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBw

PSJFTiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDQ4PC9r

ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl

Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5CcnVjZSwgSS4gTi48L2F1dGhv

cj48YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PGF1dGhvcj5HbGFkbWFuLCBELiBELjwv

YXV0aG9yPjxhdXRob3I+SWJhbmV6LCBELjwvYXV0aG9yPjxhdXRob3I+U3RlaW5lciwgRy48L2F1

dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Vbml2ZXJzaXR5IG9m

IFRvcm9udG8gTHVwdXMgQ2xpbmljLCBhbmQgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBp

biB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5SaXNrIGZh

Y3RvcnMgZm9yIGNvcm9uYXJ5IGhlYXJ0IGRpc2Vhc2UgaW4gd29tZW4gd2l0aCBzeXN0ZW1pYyBs

dXB1cyBlcnl0aGVtYXRvc3VzOiB0aGUgVG9yb250byBSaXNrIEZhY3RvciBTdHVkeTwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRp

dGxlPkFydGhyaXRpcyBSaGV1bTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkFydGhyaXRpcyBSaGV1bTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBhbmQg

cmhldW1hdGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0

bGU+QXJ0aHJpdGlzIFJoZXVtPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGFuZCByaGV1

bWF0aXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzE1OS02NzwvcGFnZXM+PHZv

bHVtZT40ODwvdm9sdW1lPjxudW1iZXI+MTE8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwMzwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk5vdjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAw

MDQtMzU5MSAoUHJpbnQpJiN4RDswMDA0LTM1OTEgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24t

bnVtPjE0NjEzMjc4PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwg

Tm9uLVUuUy4gR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFi

YXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8

L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkVzZGFpbGU8L0F1dGhvcj48

WWVhcj4yMDAxPC9ZZWFyPjxSZWNOdW0+NDY0PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj40

NjQ8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5

ZWI5dDJhcGVydDk0djU1ZGVmcGZlOWRkMHJ6NWQiPjQ2NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxy

ZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3Jz

PjxhdXRob3JzPjxhdXRob3I+RXNkYWlsZSwgSi4gTS48L2F1dGhvcj48YXV0aG9yPkFicmFoYW1v

d2ljeiwgTS48L2F1dGhvcj48YXV0aG9yPkdyb2R6aWNreSwgVC48L2F1dGhvcj48YXV0aG9yPkxp

LCBZLjwvYXV0aG9yPjxhdXRob3I+UGFuYXJpdGlzLCBDLjwvYXV0aG9yPjxhdXRob3I+ZHUgQmVy

Z2VyLCBSLjwvYXV0aG9yPjxhdXRob3I+Q290ZSwgUi48L2F1dGhvcj48YXV0aG9yPkdyb3Zlciwg

Uy4gQS48L2F1dGhvcj48YXV0aG9yPkZvcnRpbiwgUC4gUi48L2F1dGhvcj48YXV0aG9yPkNsYXJr

ZSwgQS4gRS48L2F1dGhvcj48YXV0aG9yPlNlbmVjYWwsIEouIEwuPC9hdXRob3I+PC9hdXRob3Jz

PjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+VW5pdmVyc2l0eSBvZiBCcml0aXNoIENvbHVt

YmlhLCBWYW5jb3V2ZXIsIENhbmFkYS4gamVzZGFpbGVAYmMuYXJ0aHJpdGlzLmNhPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+VHJhZGl0aW9uYWwgRnJhbWluZ2hhbSByaXNrIGZhY3RvcnMg

ZmFpbCB0byBmdWxseSBhY2NvdW50IGZvciBhY2NlbGVyYXRlZCBhdGhlcm9zY2xlcm9zaXMgaW4g

c3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcnRo

cml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRpcyBSaGV1bTwv

YWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBSaGV1

bTwvZnVsbC10aXRsZT48YWJici0xPkFydGhyaXRpcyBhbmQgcmhldW1hdGlzbTwvYWJici0xPjwv

cGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlzIFJoZXVtPC9m

dWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGFuZCByaGV1bWF0aXNtPC9hYmJyLTE+PC9hbHQt

cGVyaW9kaWNhbD48cGFnZXM+MjMzMS03PC9wYWdlcz48dm9sdW1lPjQ0PC92b2x1bWU+PG51bWJl

cj4xMDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAxPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+T2N0

PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwNC0zNTkxIChQcmludCkmI3hEOzAw

MDQtMzU5MSAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTE2NjU5NzM8L2FjY2Vzc2lv

bi1udW0+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBHb3YmYXBvczt0PC93

b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9D

aXRlPjxDaXRlPjxBdXRob3I+TyZhcG9zO05laWxsPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48

UmVjTnVtPjUxOTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NTE5PC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRl

ZnBmZTlkZDByejVkIj41MTk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91

cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

Pk8mYXBvcztOZWlsbCwgUy4gRy48L2F1dGhvcj48YXV0aG9yPlBlZ28tUmVpZ29zYSwgSi4gTS48

L2F1dGhvcj48YXV0aG9yPkhpbmdvcmFuaSwgQS4gRC48L2F1dGhvcj48YXV0aG9yPkJlc3NhbnQs

IFIuPC9hdXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC4gQS48L2F1dGhvcj48YXV0aG9yPlJhaG1h

biwgQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5DZW50

cmUgZm9yIFJoZXVtYXRvbG9neSBSZXNlYXJjaCwgRGl2aXNpb24gb2YgTWVkaWNpbmUsIFVuaXZl

cnNpdHkgQ29sbGVnZSBMb25kb24sIExvbmRvbiwgVUsuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+VXNlIG9mIGEgc3RyYXRlZ3kgYmFzZWQgb24gY2FsY3VsYXRlZCByaXNrIHNjb3JlcyBp

biBtYW5hZ2luZyBjYXJkaW92YXNjdWxhciByaXNrIGZhY3RvcnMgaW4gYSBsYXJnZSBCcml0aXNo

IGNvaG9ydCBvZiBwYXRpZW50cyB3aXRoIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM8L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+UmhldW1hdG9sb2d5IChPeGZvcmQsIEVuZ2xhbmQpPC9zZWNv

bmRhcnktdGl0bGU+PGFsdC10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2FsdC10aXRsZT48

L3RpdGxlcz48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UmhldW1hdG9sb2d5IChPeGZvcmQp

PC9mdWxsLXRpdGxlPjxhYmJyLTE+UmhldW1hdG9sb2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNh

bD48cGFnZXM+NTczLTU8L3BhZ2VzPjx2b2x1bWU+NDg8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJl

cj48ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1

Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NjItMDMzMiAoRWxlY3Ryb25pYykmI3hEOzE0NjItMDMy

NCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTkyNzM1NDA8L2FjY2Vzc2lvbi1udW0+

PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBHb3YmYXBvczt0PC93b3JrLXR5

cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0

YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwv

RW5kTm90ZT4A

ADDIN EN.CITE.DATA (30, 34, 75). In one study, a multiplication of the Framingham risk score components by 2 was shown to improve accuracy ADDIN EN.CITE <EndNote><Cite><Author>Urowitz</Author><Year>2011</Year><RecNum>465</RecNum><DisplayText>(76)</DisplayText><record><rec-number>465</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">465</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Urowitz, M. B.</author><author>Ibanez, D.</author><author>Gladman, D. D.</author></authors></contributors><auth-address>Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada</auth-address><titles><title>Adjusted Framingham Risk Factor Scoring for Systemic Lupus Erythematosus</title><secondary-title>Arthritis Rheum</secondary-title><alt-title>Arthritis Rheum-Us</alt-title></titles><periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></periodical><pages>S884-S885</pages><volume>63</volume><number>10</number><dates><year>2011</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0004-3591</isbn><accession-num>ISI:000297621502648</accession-num><urls><related-urls><url>&lt;Go to ISI&gt;://000297621502648</url></related-urls></urls><language>English</language></record></Cite></EndNote>(76). In the absence of evidence-based guidelines for CV risk assessment in CTDs in general, we propose using previously published recommendations for CV risk management in SLE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYWplZDwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJl

Y051bT40MTU8L1JlY051bT48RGlzcGxheVRleHQ+KDc3LCA3OCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDE1PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40MTU8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPldhamVkLCBKLjwvYXV0aG9yPjxhdXRo

b3I+QWhtYWQsIFkuPC9hdXRob3I+PGF1dGhvcj5EdXJyaW5ndG9uLCBQLiBOLjwvYXV0aG9yPjxh

dXRob3I+QnJ1Y2UsIEkuIE4uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRo

LWFkZHJlc3M+VGhlIFVuaXZlcnNpdHkgb2YgTWFuY2hlc3RlciwgUmhldW1hdGlzbSBSZXNlYXJj

aCBDZW50cmUsIENlbnRyYWwgTWFuY2hlc3RlciBhbmQgTWFuY2hlc3RlciBDaGlsZHJlbiZhcG9z

O3MgVW5pdmVyc2l0eSBIb3NwaXRhbHMgTkhTIFRydXN0LCBPeGZvcmQgUm9hZCwgTWFuY2hlc3Rl

ciBNMTMgOVdMLCBVSy48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QcmV2ZW50aW9uIG9m

IGNhcmRpb3Zhc2N1bGFyIGRpc2Vhc2UgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1cy0t

cHJvcG9zZWQgZ3VpZGVsaW5lcyBmb3IgcmlzayBmYWN0b3IgbWFuYWdlbWVudDwvdGl0bGU+PHNl

Y29uZGFyeS10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCwgRW5nbGFuZCk8L3NlY29uZGFyeS10

aXRsZT48YWx0LXRpdGxlPlJoZXVtYXRvbG9neSAoT3hmb3JkKTwvYWx0LXRpdGxlPjwvdGl0bGVz

PjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2Z1bGwt

dGl0bGU+PGFiYnItMT5SaGV1bWF0b2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdl

cz43LTEyPC9wYWdlcz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVz

Pjx5ZWFyPjIwMDQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+

PC9kYXRlcz48aXNibj4xNDYyLTAzMjQgKFByaW50KSYjeEQ7MTQ2Mi0wMzI0IChMaW5raW5nKTwv

aXNibj48YWNjZXNzaW9uLW51bT4xMjg2NzU3ODwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJl

dmlldzwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5M

TTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVj

b3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkJpY2hpbGU8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFy

PjxSZWNOdW0+NDkwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj40OTA8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1

ZGVmcGZlOWRkMHJ6NWQiPjQ5MDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJK

b3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRo

b3I+QmljaGlsZSwgVC48L2F1dGhvcj48YXV0aG9yPlBldHJpLCBNLjwvYXV0aG9yPjwvYXV0aG9y

cz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkpvaG5zIEhvcGtpbnMgVW5pdmVyc2l0eSBT

Y2hvb2wgb2YgTWVkaWNpbmUsIERpdmlzaW9uIG9mIFJoZXVtYXRvbG9neSwgQmFsdGltb3JlLCBN

YXJ5bGFuZCAyMTIwNSwgVW5pdGVkIFN0YXRlcy4mI3hEO0pvaG5zIEhvcGtpbnMgVW5pdmVyc2l0

eSBTY2hvb2wgb2YgTWVkaWNpbmUsIERpdmlzaW9uIG9mIFJoZXVtYXRvbG9neSwgQmFsdGltb3Jl

LCBNYXJ5bGFuZCAyMTIwNSwgVW5pdGVkIFN0YXRlcy4gRWxlY3Ryb25pYyBhZGRyZXNzOiBtcGV0

cmlAamhtaS5lZHUuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UHJldmVudGlvbiBhbmQg

bWFuYWdlbWVudCBvZiBjby1tb3JiaWRpdGllcyBpbiBTTEU8L3RpdGxlPjxzZWNvbmRhcnktdGl0

bGU+UHJlc3NlIG1lZGljYWxlIChQYXJpcywgRnJhbmNlIDogMTk4Myk8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPlByZXNzZSBNZWQ8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5QcmVzc2UgbWVkaWNhbGUgKFBhcmlzLCBGcmFuY2UgOiAxOTgzKTwvZnVsbC10

aXRsZT48YWJici0xPlByZXNzZSBNZWQ8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPlByZXNzZSBtZWRpY2FsZSAoUGFyaXMsIEZyYW5jZSA6IDE5ODMpPC9m

dWxsLXRpdGxlPjxhYmJyLTE+UHJlc3NlIE1lZDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBh

Z2VzPmUxODctOTU8L3BhZ2VzPjx2b2x1bWU+NDM8L3ZvbHVtZT48bnVtYmVyPjYgUHQgMjwvbnVt

YmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVuPC9kYXRlPjwv

cHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDc1NS00OTgyIChQcmludCkmI3hEOzA3NTUtNDk4MiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjQ4NTUwNDc8L2FjY2Vzc2lvbi1udW0+PHdv

cmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOLkkuSC4sIEV4dHJhbXVyYWwmI3hEO1Jldmlldzwv

d29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVt

b3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwv

Q2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYWplZDwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJl

Y051bT40MTU8L1JlY051bT48RGlzcGxheVRleHQ+KDc3LCA3OCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDE1PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40MTU8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPldhamVkLCBKLjwvYXV0aG9yPjxhdXRo

b3I+QWhtYWQsIFkuPC9hdXRob3I+PGF1dGhvcj5EdXJyaW5ndG9uLCBQLiBOLjwvYXV0aG9yPjxh

dXRob3I+QnJ1Y2UsIEkuIE4uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRo

LWFkZHJlc3M+VGhlIFVuaXZlcnNpdHkgb2YgTWFuY2hlc3RlciwgUmhldW1hdGlzbSBSZXNlYXJj

aCBDZW50cmUsIENlbnRyYWwgTWFuY2hlc3RlciBhbmQgTWFuY2hlc3RlciBDaGlsZHJlbiZhcG9z

O3MgVW5pdmVyc2l0eSBIb3NwaXRhbHMgTkhTIFRydXN0LCBPeGZvcmQgUm9hZCwgTWFuY2hlc3Rl

ciBNMTMgOVdMLCBVSy48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QcmV2ZW50aW9uIG9m

IGNhcmRpb3Zhc2N1bGFyIGRpc2Vhc2UgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1cy0t

cHJvcG9zZWQgZ3VpZGVsaW5lcyBmb3IgcmlzayBmYWN0b3IgbWFuYWdlbWVudDwvdGl0bGU+PHNl

Y29uZGFyeS10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCwgRW5nbGFuZCk8L3NlY29uZGFyeS10

aXRsZT48YWx0LXRpdGxlPlJoZXVtYXRvbG9neSAoT3hmb3JkKTwvYWx0LXRpdGxlPjwvdGl0bGVz

PjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2Z1bGwt

dGl0bGU+PGFiYnItMT5SaGV1bWF0b2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdl

cz43LTEyPC9wYWdlcz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVz

Pjx5ZWFyPjIwMDQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+

PC9kYXRlcz48aXNibj4xNDYyLTAzMjQgKFByaW50KSYjeEQ7MTQ2Mi0wMzI0IChMaW5raW5nKTwv

aXNibj48YWNjZXNzaW9uLW51bT4xMjg2NzU3ODwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJl

dmlldzwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5M

TTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVj

b3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkJpY2hpbGU8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFy

PjxSZWNOdW0+NDkwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj40OTA8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSIwZXo1c2U5ZWI5dDJhcGVydDk0djU1

ZGVmcGZlOWRkMHJ6NWQiPjQ5MDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJK

b3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRo

b3I+QmljaGlsZSwgVC48L2F1dGhvcj48YXV0aG9yPlBldHJpLCBNLjwvYXV0aG9yPjwvYXV0aG9y

cz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkpvaG5zIEhvcGtpbnMgVW5pdmVyc2l0eSBT

Y2hvb2wgb2YgTWVkaWNpbmUsIERpdmlzaW9uIG9mIFJoZXVtYXRvbG9neSwgQmFsdGltb3JlLCBN

YXJ5bGFuZCAyMTIwNSwgVW5pdGVkIFN0YXRlcy4mI3hEO0pvaG5zIEhvcGtpbnMgVW5pdmVyc2l0

eSBTY2hvb2wgb2YgTWVkaWNpbmUsIERpdmlzaW9uIG9mIFJoZXVtYXRvbG9neSwgQmFsdGltb3Jl

LCBNYXJ5bGFuZCAyMTIwNSwgVW5pdGVkIFN0YXRlcy4gRWxlY3Ryb25pYyBhZGRyZXNzOiBtcGV0

cmlAamhtaS5lZHUuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UHJldmVudGlvbiBhbmQg

bWFuYWdlbWVudCBvZiBjby1tb3JiaWRpdGllcyBpbiBTTEU8L3RpdGxlPjxzZWNvbmRhcnktdGl0

bGU+UHJlc3NlIG1lZGljYWxlIChQYXJpcywgRnJhbmNlIDogMTk4Myk8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPlByZXNzZSBNZWQ8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5QcmVzc2UgbWVkaWNhbGUgKFBhcmlzLCBGcmFuY2UgOiAxOTgzKTwvZnVsbC10

aXRsZT48YWJici0xPlByZXNzZSBNZWQ8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPlByZXNzZSBtZWRpY2FsZSAoUGFyaXMsIEZyYW5jZSA6IDE5ODMpPC9m

dWxsLXRpdGxlPjxhYmJyLTE+UHJlc3NlIE1lZDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBh

Z2VzPmUxODctOTU8L3BhZ2VzPjx2b2x1bWU+NDM8L3ZvbHVtZT48bnVtYmVyPjYgUHQgMjwvbnVt

YmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVuPC9kYXRlPjwv

cHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDc1NS00OTgyIChQcmludCkmI3hEOzA3NTUtNDk4MiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjQ4NTUwNDc8L2FjY2Vzc2lvbi1udW0+PHdv

cmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOLkkuSC4sIEV4dHJhbXVyYWwmI3hEO1Jldmlldzwv

d29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVt

b3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwv

Q2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA (77, 78) and more recent recommendations for coronary heart disease risk assessment also in SLE by Tselios et alPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Uc2VsaW9zPC9BdXRob3I+PFllYXI+MjAxNjwvWWVhcj48

UmVjTnVtPjQ5MTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMjkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjQ5MTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDkxPC9rZXk+PC9m

b3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBl

Pjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Uc2VsaW9zLCBLLjwvYXV0aG9yPjxhdXRo

b3I+U2hlYW5lLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhvcj48

YXV0aG9yPlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RnJvbSB0aGUgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywg

Q2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBV

bml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9u

dG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2VsaW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJj

aCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3Ig

UHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBI

ZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQs

IE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVzZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRv

cm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUgZm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBS

aGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNpdHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2Vz

dGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFuLCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRp

Y2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5pdmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5p

YywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2Vz

LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0u

Qi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9mZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2ll

bnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJv

Z25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFs

dGggTmV0d29yaywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLiYjeEQ7RnJvbSB0aGUgVW5pdmVy

c2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1ZGll

cyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrLCBU

b3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWwsIFRvcm9udG8sIE9udGFyaW8sIENhbmFkYS5LLiBUc2Vs

aW9zLCBNRCwgUGhELCBDbGluaWNhbCBSZXNlYXJjaCBGZWxsb3csIFVuaXZlcnNpdHkgb2YgVG9y

b250byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJo

ZXVtYXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0

ZXJuIEhvc3BpdGFsOyBCLkouIFNoZWFuZSwgTUQsIE1CLCBCU2MsIEJBTywgQ2xpbmljYWwgUmVz

ZWFyY2ggRmVsbG93LCBVbml2ZXJzaXR5IG9mIFRvcm9udG8gTHVwdXMgQ2xpbmljLCBDZW50cmUg

Zm9yIFByb2dub3NpcyBTdHVkaWVzIGluIHRoZSBSaGV1bWF0aWMgRGlzZWFzZXMsIFVuaXZlcnNp

dHkgSGVhbHRoIE5ldHdvcmssIFRvcm9udG8gV2VzdGVybiBIb3NwaXRhbDsgRC5ELiBHbGFkbWFu

LCBNRCwgRlJDUEMsIFByb2Zlc3NvciBvZiBNZWRpY2luZSwgU2VuaW9yIFNjaWVudGlzdCwgVW5p

dmVyc2l0eSBvZiBUb3JvbnRvIEx1cHVzIENsaW5pYywgQ2VudHJlIGZvciBQcm9nbm9zaXMgU3R1

ZGllcyBpbiB0aGUgUmhldW1hdGljIERpc2Vhc2VzLCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3Jr

LCBUb3JvbnRvIFdlc3Rlcm4gSG9zcGl0YWw7IE0uQi4gVXJvd2l0eiwgTUQsIEZSQ1BDLCBQcm9m

ZXNzb3Igb2YgTWVkaWNpbmUsIFNlbmlvciBTY2llbnRpc3QsIFVuaXZlcnNpdHkgb2YgVG9yb250

byBMdXB1cyBDbGluaWMsIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMgaW4gdGhlIFJoZXVt

YXRpYyBEaXNlYXNlcywgVW5pdmVyc2l0eSBIZWFsdGggTmV0d29yaywgVG9yb250byBXZXN0ZXJu

IEhvc3BpdGFsLiBtLnVyb3dpdHpAdXRvcm9udG8uY2EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+T3B0aW1hbCBNb25pdG9yaW5nIEZvciBDb3JvbmFyeSBIZWFydCBEaXNlYXNlIFJpc2sg

aW4gUGF0aWVudHMgd2l0aCBTeXN0ZW1pYyBMdXB1cyBFcnl0aGVtYXRvc3VzOiBBIFN5c3RlbWF0

aWMgUmV2aWV3PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogUmhldW1hdG9sPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5KIFJoZXVtYXRvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPkogUmhldW1hdG9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJu

YWwgb2YgcmhldW1hdG9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIFJoZXVtYXRvbDwvZnVsbC10aXRsZT48YWJici0xPlRoZSBKb3VybmFsIG9m

IHJoZXVtYXRvbG9neTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjU0LTY1PC9wYWdl

cz48dm9sdW1lPjQzPC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTY8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMzE1LTE2MlggKFByaW50KSYjeEQ7MDMxNS0xNjJYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNjU2ODU5MTwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (29) as a framework to guide CV risk evaluation in CTDs.We suggest that a target-based approach is appropriate to assess and manage CV risk for these patients (Table 1). Such an approach will pay attention to TRFs and disease specific factors. Prompt screening for TRFs early in the course of the CTD is advisable. Thereafter, assessment of TRFs should be performed annually in all patients and more frequently (6-12 monthly) in those with already identified CV risk factors. A high index of suspicion for clinical CV disease is also recommended. Hypertension (Level C)There is an increased prevalence of hypertension in most CTDs PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CcnVjZTwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl

Y051bT40Mzk8L1JlY051bT48RGlzcGxheVRleHQ+KDcxLCA3OSk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDM5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40Mzk8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJydWNlLCBJLiBOLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlRoZSBVbml2ZXJzaXR5IG9mIE1h

bmNoZXN0ZXIsIFJoZXVtYXRpc20gUmVzZWFyY2ggQ2VudHJlLCBDZW50cmFsIE1hbmNoZXN0ZXIg

YW5kIE1hbmNoZXN0ZXIgQ2hpbGRyZW4mYXBvcztzIFVuaXZlcnNpdHkgSG9zcGl0YWwgVHJ1c3Qs

IE94Zm9yZCBSb2FkLCBNYW5jaGVzdGVyIE0xMyA5V0wsIFVLLiBpYW4uYnJ1Y2VAbWFuY2hlc3Rl

ci5hYy51azwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPiZhcG9zO05vdCBvbmx5Li4uYnV0

IGFsc28mYXBvczs6IGZhY3RvcnMgdGhhdCBjb250cmlidXRlIHRvIGFjY2VsZXJhdGVkIGF0aGVy

b3NjbGVyb3NpcyBhbmQgcHJlbWF0dXJlIGNvcm9uYXJ5IGhlYXJ0IGRpc2Vhc2UgaW4gc3lzdGVt

aWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5SaGV1bWF0b2xv

Z3kgKE94Zm9yZCwgRW5nbGFuZCk8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPlJoZXVtYXRv

bG9neSAoT3hmb3JkKTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2Z1bGwtdGl0bGU+PGFiYnItMT5SaGV1bWF0b2xv

Z3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNDkyLTUwMjwvcGFnZXM+PHZvbHVt

ZT40NDwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNTwveWVhcj48

cHViLWRhdGVzPjxkYXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NjIt

MDMyNCAoUHJpbnQpJiN4RDsxNDYyLTAzMjQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjE2MjM0Mjc3PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTm9u

LVUuUy4gR292JmFwb3M7dCYjeEQ7UmV2aWV3PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+SnVhcmV6PC9B

dXRob3I+PFllYXI+MjAxNDwvWWVhcj48UmVjTnVtPjQ2MjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1u

dW1iZXI+NDYyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

MGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NjI8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkp1YXJleiwgTS48L2F1dGhvcj48YXV0aG9yPlRvbXMs

IFQuIEUuPC9hdXRob3I+PGF1dGhvcj5kZSBQYWJsbywgUC48L2F1dGhvcj48YXV0aG9yPk1pdGNo

ZWxsLCBTLjwvYXV0aG9yPjxhdXRob3I+Qm93bWFuLCBTLjwvYXV0aG9yPjxhdXRob3I+TmlnaHRp

bmdhbGUsIFAuPC9hdXRob3I+PGF1dGhvcj5QcmljZSwgRS4gSi48L2F1dGhvcj48YXV0aG9yPkdy

aWZmaXRocywgQi48L2F1dGhvcj48YXV0aG9yPkh1bnRlciwgSi48L2F1dGhvcj48YXV0aG9yPkd1

cHRhLCBNLjwvYXV0aG9yPjxhdXRob3I+Qm9tYmFyZGllcmksIE0uPC9hdXRob3I+PGF1dGhvcj5T

dXRkbGlmZmUsIE4uPC9hdXRob3I+PGF1dGhvcj5QaXR6YWxpcywgQy48L2F1dGhvcj48YXV0aG9y

PlBlYXNlLCBDLjwvYXV0aG9yPjxhdXRob3I+QW5kcmV3cywgSi48L2F1dGhvcj48YXV0aG9yPkVt

ZXJ5LCBQLjwvYXV0aG9yPjxhdXRob3I+UmVnYW4sIE0uPC9hdXRob3I+PGF1dGhvcj5HaWxlcywg

SS48L2F1dGhvcj48YXV0aG9yPklzZW5iZXJnLCBELjwvYXV0aG9yPjxhdXRob3I+TW9vdHMsIFIu

PC9hdXRob3I+PGF1dGhvcj5Db2xsaW5zLCBLLiBTLjwvYXV0aG9yPjxhdXRob3I+TmcsIFcuIEYu

PC9hdXRob3I+PGF1dGhvcj5LaXRhcywgRy4gRC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli

dXRvcnM+PHRpdGxlcz48dGl0bGU+Q2FyZGlvdmFzY3VsYXIgcmlzayBmYWN0b3JzIGluIHdvbWVu

IHdpdGggcHJpbWFyeSBTam9ncmVuJmFwb3M7cyBzeW5kcm9tZTogVW5pdGVkIEtpbmdkb20gcHJp

bWFyeSBTam9ncmVuJmFwb3M7cyBzeW5kcm9tZSByZWdpc3RyeSByZXN1bHRzPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2FsdC10aXRsZT48L3Rp

dGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgQ2FyZSBSZXMgKEhvYm9rZW4p

PC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGNhcmUgJmFtcDsgcmVzZWFyY2g8L2FiYnIt

MT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBDYXJl

IFJlcyAoSG9ib2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgY2FyZSAmYW1wOyBy

ZXNlYXJjaDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjc1Ny02NDwvcGFnZXM+PHZv

bHVtZT42Njwvdm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MjE1

MS00NjU4IChFbGVjdHJvbmljKSYjeEQ7MjE1MS00NjRYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNDg3NzIwMTwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBv

cnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1k

YXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+

ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CcnVjZTwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl

Y051bT40Mzk8L1JlY051bT48RGlzcGxheVRleHQ+KDcxLCA3OSk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDM5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40Mzk8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJydWNlLCBJLiBOLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlRoZSBVbml2ZXJzaXR5IG9mIE1h

bmNoZXN0ZXIsIFJoZXVtYXRpc20gUmVzZWFyY2ggQ2VudHJlLCBDZW50cmFsIE1hbmNoZXN0ZXIg

YW5kIE1hbmNoZXN0ZXIgQ2hpbGRyZW4mYXBvcztzIFVuaXZlcnNpdHkgSG9zcGl0YWwgVHJ1c3Qs

IE94Zm9yZCBSb2FkLCBNYW5jaGVzdGVyIE0xMyA5V0wsIFVLLiBpYW4uYnJ1Y2VAbWFuY2hlc3Rl

ci5hYy51azwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPiZhcG9zO05vdCBvbmx5Li4uYnV0

IGFsc28mYXBvczs6IGZhY3RvcnMgdGhhdCBjb250cmlidXRlIHRvIGFjY2VsZXJhdGVkIGF0aGVy

b3NjbGVyb3NpcyBhbmQgcHJlbWF0dXJlIGNvcm9uYXJ5IGhlYXJ0IGRpc2Vhc2UgaW4gc3lzdGVt

aWMgbHVwdXMgZXJ5dGhlbWF0b3N1czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5SaGV1bWF0b2xv

Z3kgKE94Zm9yZCwgRW5nbGFuZCk8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPlJoZXVtYXRv

bG9neSAoT3hmb3JkKTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2Z1bGwtdGl0bGU+PGFiYnItMT5SaGV1bWF0b2xv

Z3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNDkyLTUwMjwvcGFnZXM+PHZvbHVt

ZT40NDwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNTwveWVhcj48

cHViLWRhdGVzPjxkYXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NjIt

MDMyNCAoUHJpbnQpJiN4RDsxNDYyLTAzMjQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjE2MjM0Mjc3PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTm9u

LVUuUy4gR292JmFwb3M7dCYjeEQ7UmV2aWV3PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+SnVhcmV6PC9B

dXRob3I+PFllYXI+MjAxNDwvWWVhcj48UmVjTnVtPjQ2MjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1u

dW1iZXI+NDYyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

MGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NjI8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkp1YXJleiwgTS48L2F1dGhvcj48YXV0aG9yPlRvbXMs

IFQuIEUuPC9hdXRob3I+PGF1dGhvcj5kZSBQYWJsbywgUC48L2F1dGhvcj48YXV0aG9yPk1pdGNo

ZWxsLCBTLjwvYXV0aG9yPjxhdXRob3I+Qm93bWFuLCBTLjwvYXV0aG9yPjxhdXRob3I+TmlnaHRp

bmdhbGUsIFAuPC9hdXRob3I+PGF1dGhvcj5QcmljZSwgRS4gSi48L2F1dGhvcj48YXV0aG9yPkdy

aWZmaXRocywgQi48L2F1dGhvcj48YXV0aG9yPkh1bnRlciwgSi48L2F1dGhvcj48YXV0aG9yPkd1

cHRhLCBNLjwvYXV0aG9yPjxhdXRob3I+Qm9tYmFyZGllcmksIE0uPC9hdXRob3I+PGF1dGhvcj5T

dXRkbGlmZmUsIE4uPC9hdXRob3I+PGF1dGhvcj5QaXR6YWxpcywgQy48L2F1dGhvcj48YXV0aG9y

PlBlYXNlLCBDLjwvYXV0aG9yPjxhdXRob3I+QW5kcmV3cywgSi48L2F1dGhvcj48YXV0aG9yPkVt

ZXJ5LCBQLjwvYXV0aG9yPjxhdXRob3I+UmVnYW4sIE0uPC9hdXRob3I+PGF1dGhvcj5HaWxlcywg

SS48L2F1dGhvcj48YXV0aG9yPklzZW5iZXJnLCBELjwvYXV0aG9yPjxhdXRob3I+TW9vdHMsIFIu

PC9hdXRob3I+PGF1dGhvcj5Db2xsaW5zLCBLLiBTLjwvYXV0aG9yPjxhdXRob3I+TmcsIFcuIEYu

PC9hdXRob3I+PGF1dGhvcj5LaXRhcywgRy4gRC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmli

dXRvcnM+PHRpdGxlcz48dGl0bGU+Q2FyZGlvdmFzY3VsYXIgcmlzayBmYWN0b3JzIGluIHdvbWVu

IHdpdGggcHJpbWFyeSBTam9ncmVuJmFwb3M7cyBzeW5kcm9tZTogVW5pdGVkIEtpbmdkb20gcHJp

bWFyeSBTam9ncmVuJmFwb3M7cyBzeW5kcm9tZSByZWdpc3RyeSByZXN1bHRzPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPkFydGhyaXRpcyBDYXJlIFJlcyAoSG9ib2tlbik8L2FsdC10aXRsZT48L3Rp

dGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgQ2FyZSBSZXMgKEhvYm9rZW4p

PC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlzIGNhcmUgJmFtcDsgcmVzZWFyY2g8L2FiYnIt

MT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFydGhyaXRpcyBDYXJl

IFJlcyAoSG9ib2tlbik8L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgY2FyZSAmYW1wOyBy

ZXNlYXJjaDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjc1Ny02NDwvcGFnZXM+PHZv

bHVtZT42Njwvdm9sdW1lPjxudW1iZXI+NTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+TWF5PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MjE1

MS00NjU4IChFbGVjdHJvbmljKSYjeEQ7MjE1MS00NjRYIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yNDg3NzIwMTwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPlJlc2VhcmNoIFN1cHBv

cnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1k

YXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+

ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (71, 79). Hypertension is defined as values >140mmHg systolic and/or >90mmHg diastolic blood pressure. Tselios et al point out that current hypertension guidelines may not apply to patients with SLE ADDIN EN.CITE <EndNote><Cite><Author>Tselios</Author><Year>2014</Year><RecNum>442</RecNum><DisplayText>(33)</DisplayText><record><rec-number>442</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">442</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tselios, K.</author><author>Koumaras, C.</author><author>Urowitz, M. B.</author><author>Gladman, D. D.</author></authors></contributors><auth-address>Second Department of Internal Medicine, 424 General Military Hospital of Thessaloniki, Thessaloniki, Greece.&#xD;Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8. Electronic address: m.urowitz@utoronto.ca.&#xD;Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8.</auth-address><titles><title>Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal</title><secondary-title>Semin Arthritis Rheum</secondary-title><alt-title>Semin Arthritis Rheum</alt-title></titles><periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Semin Arthritis Rheum</full-title><abbr-1>Seminars in arthritis and rheumatism</abbr-1></alt-periodical><pages>521-5</pages><volume>43</volume><number>4</number><dates><year>2014</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1532-866X (Electronic)&#xD;0049-0172 (Linking)</isbn><accession-num>23953498</accession-num><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(33). Patients with CTDs have not, however, been previously included in treatment recommendations. We recommend that blood pressure should be measured at each clinic visit. When elevated, it should be monitored closely and an assessment of steroid use and renal function should be made ADDIN EN.CITE <EndNote><Cite><Author>Wajed</Author><Year>2004</Year><RecNum>415</RecNum><DisplayText>(77)</DisplayText><record><rec-number>415</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">415</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wajed, J.</author><author>Ahmad, Y.</author><author>Durrington, P. N.</author><author>Bruce, I. N.</author></authors></contributors><auth-address>The University of Manchester, Rheumatism Research Centre, Central Manchester and Manchester Children&apos;s University Hospitals NHS Trust, Oxford Road, Manchester M13 9WL, UK.</auth-address><titles><title>Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management</title><secondary-title>Rheumatology (Oxford, England)</secondary-title><alt-title>Rheumatology (Oxford)</alt-title></titles><alt-periodical><full-title>Rheumatology (Oxford)</full-title><abbr-1>Rheumatology</abbr-1></alt-periodical><pages>7-12</pages><volume>43</volume><number>1</number><dates><year>2004</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1462-0324 (Print)&#xD;1462-0324 (Linking)</isbn><accession-num>12867578</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(77). Advice should be given on non-pharmacological interventions such as exercise, weight loss and dietary salt restriction. Pharmacological treatment should be initiated if blood pressure remains consistently elevated above 140/90mmHg PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW5jaWE8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS

ZWNOdW0+NDQxPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig4MCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+NDQxPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NDE8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1hbmNpYSwgRy48L2F1dGhvcj48YXV0aG9y

PkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhv

cj5SZWRvbiwgSi48L2F1dGhvcj48YXV0aG9yPlphbmNoZXR0aSwgQS48L2F1dGhvcj48YXV0aG9y

PkJvaG0sIE0uPC9hdXRob3I+PGF1dGhvcj5DaHJpc3RpYWVucywgVC48L2F1dGhvcj48YXV0aG9y

PkNpZmtvdmEsIFIuPC9hdXRob3I+PGF1dGhvcj5EZSBCYWNrZXIsIEcuPC9hdXRob3I+PGF1dGhv

cj5Eb21pbmljemFrLCBBLjwvYXV0aG9yPjxhdXRob3I+R2FsZGVyaXNpLCBNLjwvYXV0aG9yPjxh

dXRob3I+R3JvYmJlZSwgRC4gRS48L2F1dGhvcj48YXV0aG9yPkphYXJzbWEsIFQuPC9hdXRob3I+

PGF1dGhvcj5LaXJjaGhvZiwgUC48L2F1dGhvcj48YXV0aG9yPktqZWxkc2VuLCBTLiBFLjwvYXV0

aG9yPjxhdXRob3I+TGF1cmVudCwgUy48L2F1dGhvcj48YXV0aG9yPk1hbm9saXMsIEEuIEouPC9h

dXRob3I+PGF1dGhvcj5OaWxzc29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+UnVpbG9wZSwgTC4g

TS48L2F1dGhvcj48YXV0aG9yPlNjaG1pZWRlciwgUi4gRS48L2F1dGhvcj48YXV0aG9yPlNpcm5l

cywgUC4gQS48L2F1dGhvcj48YXV0aG9yPlNsZWlnaHQsIFAuPC9hdXRob3I+PGF1dGhvcj5WaWln

aW1hYSwgTS48L2F1dGhvcj48YXV0aG9yPldhZWJlciwgQi48L2F1dGhvcj48YXV0aG9yPlphbm5h

ZCwgRi48L2F1dGhvcj48YXV0aG9yPlJlZG9uLCBKLjwvYXV0aG9yPjxhdXRob3I+RG9taW5pY3ph

aywgQS48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhvcj5OaWxz

c29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+QnVybmllciwgTS48L2F1dGhvcj48YXV0aG9yPlZp

aWdpbWFhLCBNLjwvYXV0aG9yPjxhdXRob3I+QW1icm9zaW9uaSwgRS48L2F1dGhvcj48YXV0aG9y

PkNhdWZpZWxkLCBNLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1dGhvcj48YXV0aG9yPk9s

c2VuLCBNLiBILjwvYXV0aG9yPjxhdXRob3I+U2NobWllZGVyLCBSLiBFLjwvYXV0aG9yPjxhdXRo

b3I+VHNpb3VmaXMsIEMuPC9hdXRob3I+PGF1dGhvcj52YW4gZGUgQm9ybmUsIFAuPC9hdXRob3I+

PGF1dGhvcj5aYW1vcmFubywgSi4gTC48L2F1dGhvcj48YXV0aG9yPkFjaGVuYmFjaCwgUy48L2F1

dGhvcj48YXV0aG9yPkJhdW1nYXJ0bmVyLCBILjwvYXV0aG9yPjxhdXRob3I+QmF4LCBKLiBKLjwv

YXV0aG9yPjxhdXRob3I+QnVlbm8sIEguPC9hdXRob3I+PGF1dGhvcj5EZWFuLCBWLjwvYXV0aG9y

PjxhdXRob3I+RGVhdG9uLCBDLjwvYXV0aG9yPjxhdXRob3I+RXJvbCwgQy48L2F1dGhvcj48YXV0

aG9yPkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPkZlcnJhcmksIFIuPC9hdXRob3I+PGF1dGhv

cj5IYXNkYWksIEQuPC9hdXRob3I+PGF1dGhvcj5Ib2VzLCBBLiBXLjwvYXV0aG9yPjxhdXRob3I+

S2lyY2hob2YsIFAuPC9hdXRob3I+PGF1dGhvcj5LbnV1dGksIEouPC9hdXRob3I+PGF1dGhvcj5L

b2xoLCBQLjwvYXV0aG9yPjxhdXRob3I+TGFuY2VsbG90dGksIFAuPC9hdXRob3I+PGF1dGhvcj5M

aW5oYXJ0LCBBLjwvYXV0aG9yPjxhdXRob3I+Tmlob3lhbm5vcG91bG9zLCBQLjwvYXV0aG9yPjxh

dXRob3I+UGllcG9saSwgTS4gRi48L2F1dGhvcj48YXV0aG9yPlBvbmlrb3dza2ksIFAuPC9hdXRo

b3I+PGF1dGhvcj5TaXJuZXMsIFAuIEEuPC9hdXRob3I+PGF1dGhvcj5UYW1hcmdvLCBKLiBMLjwv

YXV0aG9yPjxhdXRob3I+VGVuZGVyYSwgTS48L2F1dGhvcj48YXV0aG9yPlRvcmJpY2tpLCBBLjwv

YXV0aG9yPjxhdXRob3I+V2lqbnMsIFcuPC9hdXRob3I+PGF1dGhvcj5XaW5kZWNrZXIsIFMuPC9h

dXRob3I+PGF1dGhvcj5DbGVtZW50LCBELiBMLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1

dGhvcj48YXV0aG9yPkdpbGxlYmVydCwgVC4gQy48L2F1dGhvcj48YXV0aG9yPlRlbmRlcmEsIE0u

PC9hdXRob3I+PGF1dGhvcj5Sb3NlaSwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkFtYnJvc2lvbmks

IEUuPC9hdXRob3I+PGF1dGhvcj5BbmtlciwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkJhdWVyc2Fj

aHMsIEouPC9hdXRob3I+PGF1dGhvcj5IaXRpaiwgSi4gQi48L2F1dGhvcj48YXV0aG9yPkNhdWxm

aWVsZCwgTS48L2F1dGhvcj48YXV0aG9yPkRlIEJ1eXplcmUsIE0uPC9hdXRob3I+PGF1dGhvcj5E

ZSBHZWVzdCwgUy48L2F1dGhvcj48YXV0aG9yPkRlcnVtZWF1eCwgRy4gQS48L2F1dGhvcj48YXV0

aG9yPkVyZGluZSwgUy48L2F1dGhvcj48YXV0aG9yPkZhcnNhbmcsIEMuPC9hdXRob3I+PGF1dGhv

cj5GdW5jay1CcmVudGFubywgQy48L2F1dGhvcj48YXV0aG9yPkdlcmMsIFYuPC9hdXRob3I+PGF1

dGhvcj5HZXJtYW5vLCBHLjwvYXV0aG9yPjxhdXRob3I+R2llbGVuLCBTLjwvYXV0aG9yPjxhdXRo

b3I+SGFsbGVyLCBILjwvYXV0aG9yPjxhdXRob3I+SG9lcywgQS4gVy48L2F1dGhvcj48YXV0aG9y

PkpvcmRhbiwgSi48L2F1dGhvcj48YXV0aG9yPkthaGFuLCBULjwvYXV0aG9yPjxhdXRob3I+S29t

YWpkYSwgTS48L2F1dGhvcj48YXV0aG9yPkxvdmljLCBELjwvYXV0aG9yPjxhdXRob3I+TWFocmhv

bGR0LCBILjwvYXV0aG9yPjxhdXRob3I+T2xzZW4sIE0uIEguPC9hdXRob3I+PGF1dGhvcj5Pc3Rl

cmdyZW4sIEouPC9hdXRob3I+PGF1dGhvcj5QYXJhdGksIEcuPC9hdXRob3I+PGF1dGhvcj5QZXJr

LCBKLjwvYXV0aG9yPjxhdXRob3I+UG9sb25pYSwgSi48L2F1dGhvcj48YXV0aG9yPlBvcGVzY3Us

IEIuIEEuPC9hdXRob3I+PGF1dGhvcj5SZWluZXIsIFouPC9hdXRob3I+PGF1dGhvcj5SeWRlbiwg

TC48L2F1dGhvcj48YXV0aG9yPlNpcmVua28sIFkuPC9hdXRob3I+PGF1dGhvcj5TdGFudG9uLCBB

LjwvYXV0aG9yPjxhdXRob3I+U3RydWlqa2VyLUJvdWRpZXIsIEguPC9hdXRob3I+PGF1dGhvcj5U

c2lvdWZpcywgQy48L2F1dGhvcj48YXV0aG9yPnZhbiBkZSBCb3JuZSwgUC48L2F1dGhvcj48YXV0

aG9yPlZsYWNob3BvdWxvcywgQy48L2F1dGhvcj48YXV0aG9yPlZvbHBlLCBNLjwvYXV0aG9yPjxh

dXRob3I+V29vZCwgRC4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5DZW50cm8gZGkgRmlzaW9sb2dpYSBDbGluaWNhIGUgSXBlcnRlbnNpb25lLCBVbml2

ZXJzaXRhIE1pbGFuby1CaWNvY2NhLCBNaWxhbm8sIEl0YWx5LiBnaXVzZXBwZS5tYW5jaWFAdW5p

bWliLml0PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+MjAxMyBFU0gvRVNDIGd1aWRlbGlu

ZXMgZm9yIHRoZSBtYW5hZ2VtZW50IG9mIGFydGVyaWFsIGh5cGVydGVuc2lvbjogdGhlIFRhc2sg

Rm9yY2UgZm9yIHRoZSBNYW5hZ2VtZW50IG9mIEFydGVyaWFsIEh5cGVydGVuc2lvbiBvZiB0aGUg

RXVyb3BlYW4gU29jaWV0eSBvZiBIeXBlcnRlbnNpb24gKEVTSCkgYW5kIG9mIHRoZSBFdXJvcGVh

biBTb2NpZXR5IG9mIENhcmRpb2xvZ3kgKEVTQyk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RXVy

IEhlYXJ0IEo8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1ciBIZWFydCBKPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RXVyIEhlYXJ0IEo8L2Z1bGwtdGl0

bGU+PGFiYnItMT5FdXJvcGVhbiBoZWFydCBqb3VybmFsPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXIgSGVhcnQgSjwvZnVsbC10aXRsZT48YWJici0x

PkV1cm9wZWFuIGhlYXJ0IGpvdXJuYWw8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4y

MTU5LTIxOTwvcGFnZXM+PHZvbHVtZT4zNDwvdm9sdW1lPjxudW1iZXI+Mjg8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAxMzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxpc2JuPjE1MjItOTY0NSAoRWxlY3Ryb25pYykmI3hEOzAxOTUtNjY4WCAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjM3NzE4NDQ8L2FjY2Vzc2lvbi1udW0+PHdvcmst

dHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1k

YXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+

ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW5jaWE8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS

ZWNOdW0+NDQxPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig4MCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+NDQxPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NDE8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1hbmNpYSwgRy48L2F1dGhvcj48YXV0aG9y

PkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhv

cj5SZWRvbiwgSi48L2F1dGhvcj48YXV0aG9yPlphbmNoZXR0aSwgQS48L2F1dGhvcj48YXV0aG9y

PkJvaG0sIE0uPC9hdXRob3I+PGF1dGhvcj5DaHJpc3RpYWVucywgVC48L2F1dGhvcj48YXV0aG9y

PkNpZmtvdmEsIFIuPC9hdXRob3I+PGF1dGhvcj5EZSBCYWNrZXIsIEcuPC9hdXRob3I+PGF1dGhv

cj5Eb21pbmljemFrLCBBLjwvYXV0aG9yPjxhdXRob3I+R2FsZGVyaXNpLCBNLjwvYXV0aG9yPjxh

dXRob3I+R3JvYmJlZSwgRC4gRS48L2F1dGhvcj48YXV0aG9yPkphYXJzbWEsIFQuPC9hdXRob3I+

PGF1dGhvcj5LaXJjaGhvZiwgUC48L2F1dGhvcj48YXV0aG9yPktqZWxkc2VuLCBTLiBFLjwvYXV0

aG9yPjxhdXRob3I+TGF1cmVudCwgUy48L2F1dGhvcj48YXV0aG9yPk1hbm9saXMsIEEuIEouPC9h

dXRob3I+PGF1dGhvcj5OaWxzc29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+UnVpbG9wZSwgTC4g

TS48L2F1dGhvcj48YXV0aG9yPlNjaG1pZWRlciwgUi4gRS48L2F1dGhvcj48YXV0aG9yPlNpcm5l

cywgUC4gQS48L2F1dGhvcj48YXV0aG9yPlNsZWlnaHQsIFAuPC9hdXRob3I+PGF1dGhvcj5WaWln

aW1hYSwgTS48L2F1dGhvcj48YXV0aG9yPldhZWJlciwgQi48L2F1dGhvcj48YXV0aG9yPlphbm5h

ZCwgRi48L2F1dGhvcj48YXV0aG9yPlJlZG9uLCBKLjwvYXV0aG9yPjxhdXRob3I+RG9taW5pY3ph

aywgQS48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhvcj5OaWxz

c29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+QnVybmllciwgTS48L2F1dGhvcj48YXV0aG9yPlZp

aWdpbWFhLCBNLjwvYXV0aG9yPjxhdXRob3I+QW1icm9zaW9uaSwgRS48L2F1dGhvcj48YXV0aG9y

PkNhdWZpZWxkLCBNLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1dGhvcj48YXV0aG9yPk9s

c2VuLCBNLiBILjwvYXV0aG9yPjxhdXRob3I+U2NobWllZGVyLCBSLiBFLjwvYXV0aG9yPjxhdXRo

b3I+VHNpb3VmaXMsIEMuPC9hdXRob3I+PGF1dGhvcj52YW4gZGUgQm9ybmUsIFAuPC9hdXRob3I+

PGF1dGhvcj5aYW1vcmFubywgSi4gTC48L2F1dGhvcj48YXV0aG9yPkFjaGVuYmFjaCwgUy48L2F1

dGhvcj48YXV0aG9yPkJhdW1nYXJ0bmVyLCBILjwvYXV0aG9yPjxhdXRob3I+QmF4LCBKLiBKLjwv

YXV0aG9yPjxhdXRob3I+QnVlbm8sIEguPC9hdXRob3I+PGF1dGhvcj5EZWFuLCBWLjwvYXV0aG9y

PjxhdXRob3I+RGVhdG9uLCBDLjwvYXV0aG9yPjxhdXRob3I+RXJvbCwgQy48L2F1dGhvcj48YXV0

aG9yPkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPkZlcnJhcmksIFIuPC9hdXRob3I+PGF1dGhv

cj5IYXNkYWksIEQuPC9hdXRob3I+PGF1dGhvcj5Ib2VzLCBBLiBXLjwvYXV0aG9yPjxhdXRob3I+

S2lyY2hob2YsIFAuPC9hdXRob3I+PGF1dGhvcj5LbnV1dGksIEouPC9hdXRob3I+PGF1dGhvcj5L

b2xoLCBQLjwvYXV0aG9yPjxhdXRob3I+TGFuY2VsbG90dGksIFAuPC9hdXRob3I+PGF1dGhvcj5M

aW5oYXJ0LCBBLjwvYXV0aG9yPjxhdXRob3I+Tmlob3lhbm5vcG91bG9zLCBQLjwvYXV0aG9yPjxh

dXRob3I+UGllcG9saSwgTS4gRi48L2F1dGhvcj48YXV0aG9yPlBvbmlrb3dza2ksIFAuPC9hdXRo

b3I+PGF1dGhvcj5TaXJuZXMsIFAuIEEuPC9hdXRob3I+PGF1dGhvcj5UYW1hcmdvLCBKLiBMLjwv

YXV0aG9yPjxhdXRob3I+VGVuZGVyYSwgTS48L2F1dGhvcj48YXV0aG9yPlRvcmJpY2tpLCBBLjwv

YXV0aG9yPjxhdXRob3I+V2lqbnMsIFcuPC9hdXRob3I+PGF1dGhvcj5XaW5kZWNrZXIsIFMuPC9h

dXRob3I+PGF1dGhvcj5DbGVtZW50LCBELiBMLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1

dGhvcj48YXV0aG9yPkdpbGxlYmVydCwgVC4gQy48L2F1dGhvcj48YXV0aG9yPlRlbmRlcmEsIE0u

PC9hdXRob3I+PGF1dGhvcj5Sb3NlaSwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkFtYnJvc2lvbmks

IEUuPC9hdXRob3I+PGF1dGhvcj5BbmtlciwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkJhdWVyc2Fj

aHMsIEouPC9hdXRob3I+PGF1dGhvcj5IaXRpaiwgSi4gQi48L2F1dGhvcj48YXV0aG9yPkNhdWxm

aWVsZCwgTS48L2F1dGhvcj48YXV0aG9yPkRlIEJ1eXplcmUsIE0uPC9hdXRob3I+PGF1dGhvcj5E

ZSBHZWVzdCwgUy48L2F1dGhvcj48YXV0aG9yPkRlcnVtZWF1eCwgRy4gQS48L2F1dGhvcj48YXV0

aG9yPkVyZGluZSwgUy48L2F1dGhvcj48YXV0aG9yPkZhcnNhbmcsIEMuPC9hdXRob3I+PGF1dGhv

cj5GdW5jay1CcmVudGFubywgQy48L2F1dGhvcj48YXV0aG9yPkdlcmMsIFYuPC9hdXRob3I+PGF1

dGhvcj5HZXJtYW5vLCBHLjwvYXV0aG9yPjxhdXRob3I+R2llbGVuLCBTLjwvYXV0aG9yPjxhdXRo

b3I+SGFsbGVyLCBILjwvYXV0aG9yPjxhdXRob3I+SG9lcywgQS4gVy48L2F1dGhvcj48YXV0aG9y

PkpvcmRhbiwgSi48L2F1dGhvcj48YXV0aG9yPkthaGFuLCBULjwvYXV0aG9yPjxhdXRob3I+S29t

YWpkYSwgTS48L2F1dGhvcj48YXV0aG9yPkxvdmljLCBELjwvYXV0aG9yPjxhdXRob3I+TWFocmhv

bGR0LCBILjwvYXV0aG9yPjxhdXRob3I+T2xzZW4sIE0uIEguPC9hdXRob3I+PGF1dGhvcj5Pc3Rl

cmdyZW4sIEouPC9hdXRob3I+PGF1dGhvcj5QYXJhdGksIEcuPC9hdXRob3I+PGF1dGhvcj5QZXJr

LCBKLjwvYXV0aG9yPjxhdXRob3I+UG9sb25pYSwgSi48L2F1dGhvcj48YXV0aG9yPlBvcGVzY3Us

IEIuIEEuPC9hdXRob3I+PGF1dGhvcj5SZWluZXIsIFouPC9hdXRob3I+PGF1dGhvcj5SeWRlbiwg

TC48L2F1dGhvcj48YXV0aG9yPlNpcmVua28sIFkuPC9hdXRob3I+PGF1dGhvcj5TdGFudG9uLCBB

LjwvYXV0aG9yPjxhdXRob3I+U3RydWlqa2VyLUJvdWRpZXIsIEguPC9hdXRob3I+PGF1dGhvcj5U

c2lvdWZpcywgQy48L2F1dGhvcj48YXV0aG9yPnZhbiBkZSBCb3JuZSwgUC48L2F1dGhvcj48YXV0

aG9yPlZsYWNob3BvdWxvcywgQy48L2F1dGhvcj48YXV0aG9yPlZvbHBlLCBNLjwvYXV0aG9yPjxh

dXRob3I+V29vZCwgRC4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5DZW50cm8gZGkgRmlzaW9sb2dpYSBDbGluaWNhIGUgSXBlcnRlbnNpb25lLCBVbml2

ZXJzaXRhIE1pbGFuby1CaWNvY2NhLCBNaWxhbm8sIEl0YWx5LiBnaXVzZXBwZS5tYW5jaWFAdW5p

bWliLml0PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+MjAxMyBFU0gvRVNDIGd1aWRlbGlu

ZXMgZm9yIHRoZSBtYW5hZ2VtZW50IG9mIGFydGVyaWFsIGh5cGVydGVuc2lvbjogdGhlIFRhc2sg

Rm9yY2UgZm9yIHRoZSBNYW5hZ2VtZW50IG9mIEFydGVyaWFsIEh5cGVydGVuc2lvbiBvZiB0aGUg

RXVyb3BlYW4gU29jaWV0eSBvZiBIeXBlcnRlbnNpb24gKEVTSCkgYW5kIG9mIHRoZSBFdXJvcGVh

biBTb2NpZXR5IG9mIENhcmRpb2xvZ3kgKEVTQyk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RXVy

IEhlYXJ0IEo8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1ciBIZWFydCBKPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RXVyIEhlYXJ0IEo8L2Z1bGwtdGl0

bGU+PGFiYnItMT5FdXJvcGVhbiBoZWFydCBqb3VybmFsPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXIgSGVhcnQgSjwvZnVsbC10aXRsZT48YWJici0x

PkV1cm9wZWFuIGhlYXJ0IGpvdXJuYWw8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4y

MTU5LTIxOTwvcGFnZXM+PHZvbHVtZT4zNDwvdm9sdW1lPjxudW1iZXI+Mjg8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAxMzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxpc2JuPjE1MjItOTY0NSAoRWxlY3Ryb25pYykmI3hEOzAxOTUtNjY4WCAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjM3NzE4NDQ8L2FjY2Vzc2lvbi1udW0+PHdvcmst

dHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1k

YXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+

ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (80). Anti-hypertensive choice will vary depending on the presence of co-morbidities such as renal disease, diabetes and left ventricular hypertrophy. ACE inhibitors and angiotensin receptor blockers, because of their advantages beyond solely correcting hypertension, are useful agents to consider in CTD patients PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW5jaWE8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS

ZWNOdW0+NDQxPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig4MCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+NDQxPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NDE8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1hbmNpYSwgRy48L2F1dGhvcj48YXV0aG9y

PkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhv

cj5SZWRvbiwgSi48L2F1dGhvcj48YXV0aG9yPlphbmNoZXR0aSwgQS48L2F1dGhvcj48YXV0aG9y

PkJvaG0sIE0uPC9hdXRob3I+PGF1dGhvcj5DaHJpc3RpYWVucywgVC48L2F1dGhvcj48YXV0aG9y

PkNpZmtvdmEsIFIuPC9hdXRob3I+PGF1dGhvcj5EZSBCYWNrZXIsIEcuPC9hdXRob3I+PGF1dGhv

cj5Eb21pbmljemFrLCBBLjwvYXV0aG9yPjxhdXRob3I+R2FsZGVyaXNpLCBNLjwvYXV0aG9yPjxh

dXRob3I+R3JvYmJlZSwgRC4gRS48L2F1dGhvcj48YXV0aG9yPkphYXJzbWEsIFQuPC9hdXRob3I+

PGF1dGhvcj5LaXJjaGhvZiwgUC48L2F1dGhvcj48YXV0aG9yPktqZWxkc2VuLCBTLiBFLjwvYXV0

aG9yPjxhdXRob3I+TGF1cmVudCwgUy48L2F1dGhvcj48YXV0aG9yPk1hbm9saXMsIEEuIEouPC9h

dXRob3I+PGF1dGhvcj5OaWxzc29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+UnVpbG9wZSwgTC4g

TS48L2F1dGhvcj48YXV0aG9yPlNjaG1pZWRlciwgUi4gRS48L2F1dGhvcj48YXV0aG9yPlNpcm5l

cywgUC4gQS48L2F1dGhvcj48YXV0aG9yPlNsZWlnaHQsIFAuPC9hdXRob3I+PGF1dGhvcj5WaWln

aW1hYSwgTS48L2F1dGhvcj48YXV0aG9yPldhZWJlciwgQi48L2F1dGhvcj48YXV0aG9yPlphbm5h

ZCwgRi48L2F1dGhvcj48YXV0aG9yPlJlZG9uLCBKLjwvYXV0aG9yPjxhdXRob3I+RG9taW5pY3ph

aywgQS48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhvcj5OaWxz

c29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+QnVybmllciwgTS48L2F1dGhvcj48YXV0aG9yPlZp

aWdpbWFhLCBNLjwvYXV0aG9yPjxhdXRob3I+QW1icm9zaW9uaSwgRS48L2F1dGhvcj48YXV0aG9y

PkNhdWZpZWxkLCBNLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1dGhvcj48YXV0aG9yPk9s

c2VuLCBNLiBILjwvYXV0aG9yPjxhdXRob3I+U2NobWllZGVyLCBSLiBFLjwvYXV0aG9yPjxhdXRo

b3I+VHNpb3VmaXMsIEMuPC9hdXRob3I+PGF1dGhvcj52YW4gZGUgQm9ybmUsIFAuPC9hdXRob3I+

PGF1dGhvcj5aYW1vcmFubywgSi4gTC48L2F1dGhvcj48YXV0aG9yPkFjaGVuYmFjaCwgUy48L2F1

dGhvcj48YXV0aG9yPkJhdW1nYXJ0bmVyLCBILjwvYXV0aG9yPjxhdXRob3I+QmF4LCBKLiBKLjwv

YXV0aG9yPjxhdXRob3I+QnVlbm8sIEguPC9hdXRob3I+PGF1dGhvcj5EZWFuLCBWLjwvYXV0aG9y

PjxhdXRob3I+RGVhdG9uLCBDLjwvYXV0aG9yPjxhdXRob3I+RXJvbCwgQy48L2F1dGhvcj48YXV0

aG9yPkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPkZlcnJhcmksIFIuPC9hdXRob3I+PGF1dGhv

cj5IYXNkYWksIEQuPC9hdXRob3I+PGF1dGhvcj5Ib2VzLCBBLiBXLjwvYXV0aG9yPjxhdXRob3I+

S2lyY2hob2YsIFAuPC9hdXRob3I+PGF1dGhvcj5LbnV1dGksIEouPC9hdXRob3I+PGF1dGhvcj5L

b2xoLCBQLjwvYXV0aG9yPjxhdXRob3I+TGFuY2VsbG90dGksIFAuPC9hdXRob3I+PGF1dGhvcj5M

aW5oYXJ0LCBBLjwvYXV0aG9yPjxhdXRob3I+Tmlob3lhbm5vcG91bG9zLCBQLjwvYXV0aG9yPjxh

dXRob3I+UGllcG9saSwgTS4gRi48L2F1dGhvcj48YXV0aG9yPlBvbmlrb3dza2ksIFAuPC9hdXRo

b3I+PGF1dGhvcj5TaXJuZXMsIFAuIEEuPC9hdXRob3I+PGF1dGhvcj5UYW1hcmdvLCBKLiBMLjwv

YXV0aG9yPjxhdXRob3I+VGVuZGVyYSwgTS48L2F1dGhvcj48YXV0aG9yPlRvcmJpY2tpLCBBLjwv

YXV0aG9yPjxhdXRob3I+V2lqbnMsIFcuPC9hdXRob3I+PGF1dGhvcj5XaW5kZWNrZXIsIFMuPC9h

dXRob3I+PGF1dGhvcj5DbGVtZW50LCBELiBMLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1

dGhvcj48YXV0aG9yPkdpbGxlYmVydCwgVC4gQy48L2F1dGhvcj48YXV0aG9yPlRlbmRlcmEsIE0u

PC9hdXRob3I+PGF1dGhvcj5Sb3NlaSwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkFtYnJvc2lvbmks

IEUuPC9hdXRob3I+PGF1dGhvcj5BbmtlciwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkJhdWVyc2Fj

aHMsIEouPC9hdXRob3I+PGF1dGhvcj5IaXRpaiwgSi4gQi48L2F1dGhvcj48YXV0aG9yPkNhdWxm

aWVsZCwgTS48L2F1dGhvcj48YXV0aG9yPkRlIEJ1eXplcmUsIE0uPC9hdXRob3I+PGF1dGhvcj5E

ZSBHZWVzdCwgUy48L2F1dGhvcj48YXV0aG9yPkRlcnVtZWF1eCwgRy4gQS48L2F1dGhvcj48YXV0

aG9yPkVyZGluZSwgUy48L2F1dGhvcj48YXV0aG9yPkZhcnNhbmcsIEMuPC9hdXRob3I+PGF1dGhv

cj5GdW5jay1CcmVudGFubywgQy48L2F1dGhvcj48YXV0aG9yPkdlcmMsIFYuPC9hdXRob3I+PGF1

dGhvcj5HZXJtYW5vLCBHLjwvYXV0aG9yPjxhdXRob3I+R2llbGVuLCBTLjwvYXV0aG9yPjxhdXRo

b3I+SGFsbGVyLCBILjwvYXV0aG9yPjxhdXRob3I+SG9lcywgQS4gVy48L2F1dGhvcj48YXV0aG9y

PkpvcmRhbiwgSi48L2F1dGhvcj48YXV0aG9yPkthaGFuLCBULjwvYXV0aG9yPjxhdXRob3I+S29t

YWpkYSwgTS48L2F1dGhvcj48YXV0aG9yPkxvdmljLCBELjwvYXV0aG9yPjxhdXRob3I+TWFocmhv

bGR0LCBILjwvYXV0aG9yPjxhdXRob3I+T2xzZW4sIE0uIEguPC9hdXRob3I+PGF1dGhvcj5Pc3Rl

cmdyZW4sIEouPC9hdXRob3I+PGF1dGhvcj5QYXJhdGksIEcuPC9hdXRob3I+PGF1dGhvcj5QZXJr

LCBKLjwvYXV0aG9yPjxhdXRob3I+UG9sb25pYSwgSi48L2F1dGhvcj48YXV0aG9yPlBvcGVzY3Us

IEIuIEEuPC9hdXRob3I+PGF1dGhvcj5SZWluZXIsIFouPC9hdXRob3I+PGF1dGhvcj5SeWRlbiwg

TC48L2F1dGhvcj48YXV0aG9yPlNpcmVua28sIFkuPC9hdXRob3I+PGF1dGhvcj5TdGFudG9uLCBB

LjwvYXV0aG9yPjxhdXRob3I+U3RydWlqa2VyLUJvdWRpZXIsIEguPC9hdXRob3I+PGF1dGhvcj5U

c2lvdWZpcywgQy48L2F1dGhvcj48YXV0aG9yPnZhbiBkZSBCb3JuZSwgUC48L2F1dGhvcj48YXV0

aG9yPlZsYWNob3BvdWxvcywgQy48L2F1dGhvcj48YXV0aG9yPlZvbHBlLCBNLjwvYXV0aG9yPjxh

dXRob3I+V29vZCwgRC4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5DZW50cm8gZGkgRmlzaW9sb2dpYSBDbGluaWNhIGUgSXBlcnRlbnNpb25lLCBVbml2

ZXJzaXRhIE1pbGFuby1CaWNvY2NhLCBNaWxhbm8sIEl0YWx5LiBnaXVzZXBwZS5tYW5jaWFAdW5p

bWliLml0PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+MjAxMyBFU0gvRVNDIGd1aWRlbGlu

ZXMgZm9yIHRoZSBtYW5hZ2VtZW50IG9mIGFydGVyaWFsIGh5cGVydGVuc2lvbjogdGhlIFRhc2sg

Rm9yY2UgZm9yIHRoZSBNYW5hZ2VtZW50IG9mIEFydGVyaWFsIEh5cGVydGVuc2lvbiBvZiB0aGUg

RXVyb3BlYW4gU29jaWV0eSBvZiBIeXBlcnRlbnNpb24gKEVTSCkgYW5kIG9mIHRoZSBFdXJvcGVh

biBTb2NpZXR5IG9mIENhcmRpb2xvZ3kgKEVTQyk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RXVy

IEhlYXJ0IEo8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1ciBIZWFydCBKPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RXVyIEhlYXJ0IEo8L2Z1bGwtdGl0

bGU+PGFiYnItMT5FdXJvcGVhbiBoZWFydCBqb3VybmFsPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXIgSGVhcnQgSjwvZnVsbC10aXRsZT48YWJici0x

PkV1cm9wZWFuIGhlYXJ0IGpvdXJuYWw8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4y

MTU5LTIxOTwvcGFnZXM+PHZvbHVtZT4zNDwvdm9sdW1lPjxudW1iZXI+Mjg8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAxMzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxpc2JuPjE1MjItOTY0NSAoRWxlY3Ryb25pYykmI3hEOzAxOTUtNjY4WCAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjM3NzE4NDQ8L2FjY2Vzc2lvbi1udW0+PHdvcmst

dHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1k

YXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+

ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW5jaWE8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS

ZWNOdW0+NDQxPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig4MCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+NDQxPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40NDE8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1hbmNpYSwgRy48L2F1dGhvcj48YXV0aG9y

PkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhv

cj5SZWRvbiwgSi48L2F1dGhvcj48YXV0aG9yPlphbmNoZXR0aSwgQS48L2F1dGhvcj48YXV0aG9y

PkJvaG0sIE0uPC9hdXRob3I+PGF1dGhvcj5DaHJpc3RpYWVucywgVC48L2F1dGhvcj48YXV0aG9y

PkNpZmtvdmEsIFIuPC9hdXRob3I+PGF1dGhvcj5EZSBCYWNrZXIsIEcuPC9hdXRob3I+PGF1dGhv

cj5Eb21pbmljemFrLCBBLjwvYXV0aG9yPjxhdXRob3I+R2FsZGVyaXNpLCBNLjwvYXV0aG9yPjxh

dXRob3I+R3JvYmJlZSwgRC4gRS48L2F1dGhvcj48YXV0aG9yPkphYXJzbWEsIFQuPC9hdXRob3I+

PGF1dGhvcj5LaXJjaGhvZiwgUC48L2F1dGhvcj48YXV0aG9yPktqZWxkc2VuLCBTLiBFLjwvYXV0

aG9yPjxhdXRob3I+TGF1cmVudCwgUy48L2F1dGhvcj48YXV0aG9yPk1hbm9saXMsIEEuIEouPC9h

dXRob3I+PGF1dGhvcj5OaWxzc29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+UnVpbG9wZSwgTC4g

TS48L2F1dGhvcj48YXV0aG9yPlNjaG1pZWRlciwgUi4gRS48L2F1dGhvcj48YXV0aG9yPlNpcm5l

cywgUC4gQS48L2F1dGhvcj48YXV0aG9yPlNsZWlnaHQsIFAuPC9hdXRob3I+PGF1dGhvcj5WaWln

aW1hYSwgTS48L2F1dGhvcj48YXV0aG9yPldhZWJlciwgQi48L2F1dGhvcj48YXV0aG9yPlphbm5h

ZCwgRi48L2F1dGhvcj48YXV0aG9yPlJlZG9uLCBKLjwvYXV0aG9yPjxhdXRob3I+RG9taW5pY3ph

aywgQS48L2F1dGhvcj48YXV0aG9yPk5hcmtpZXdpY3osIEsuPC9hdXRob3I+PGF1dGhvcj5OaWxz

c29uLCBQLiBNLjwvYXV0aG9yPjxhdXRob3I+QnVybmllciwgTS48L2F1dGhvcj48YXV0aG9yPlZp

aWdpbWFhLCBNLjwvYXV0aG9yPjxhdXRob3I+QW1icm9zaW9uaSwgRS48L2F1dGhvcj48YXV0aG9y

PkNhdWZpZWxkLCBNLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1dGhvcj48YXV0aG9yPk9s

c2VuLCBNLiBILjwvYXV0aG9yPjxhdXRob3I+U2NobWllZGVyLCBSLiBFLjwvYXV0aG9yPjxhdXRo

b3I+VHNpb3VmaXMsIEMuPC9hdXRob3I+PGF1dGhvcj52YW4gZGUgQm9ybmUsIFAuPC9hdXRob3I+

PGF1dGhvcj5aYW1vcmFubywgSi4gTC48L2F1dGhvcj48YXV0aG9yPkFjaGVuYmFjaCwgUy48L2F1

dGhvcj48YXV0aG9yPkJhdW1nYXJ0bmVyLCBILjwvYXV0aG9yPjxhdXRob3I+QmF4LCBKLiBKLjwv

YXV0aG9yPjxhdXRob3I+QnVlbm8sIEguPC9hdXRob3I+PGF1dGhvcj5EZWFuLCBWLjwvYXV0aG9y

PjxhdXRob3I+RGVhdG9uLCBDLjwvYXV0aG9yPjxhdXRob3I+RXJvbCwgQy48L2F1dGhvcj48YXV0

aG9yPkZhZ2FyZCwgUi48L2F1dGhvcj48YXV0aG9yPkZlcnJhcmksIFIuPC9hdXRob3I+PGF1dGhv

cj5IYXNkYWksIEQuPC9hdXRob3I+PGF1dGhvcj5Ib2VzLCBBLiBXLjwvYXV0aG9yPjxhdXRob3I+

S2lyY2hob2YsIFAuPC9hdXRob3I+PGF1dGhvcj5LbnV1dGksIEouPC9hdXRob3I+PGF1dGhvcj5L

b2xoLCBQLjwvYXV0aG9yPjxhdXRob3I+TGFuY2VsbG90dGksIFAuPC9hdXRob3I+PGF1dGhvcj5M

aW5oYXJ0LCBBLjwvYXV0aG9yPjxhdXRob3I+Tmlob3lhbm5vcG91bG9zLCBQLjwvYXV0aG9yPjxh

dXRob3I+UGllcG9saSwgTS4gRi48L2F1dGhvcj48YXV0aG9yPlBvbmlrb3dza2ksIFAuPC9hdXRo

b3I+PGF1dGhvcj5TaXJuZXMsIFAuIEEuPC9hdXRob3I+PGF1dGhvcj5UYW1hcmdvLCBKLiBMLjwv

YXV0aG9yPjxhdXRob3I+VGVuZGVyYSwgTS48L2F1dGhvcj48YXV0aG9yPlRvcmJpY2tpLCBBLjwv

YXV0aG9yPjxhdXRob3I+V2lqbnMsIFcuPC9hdXRob3I+PGF1dGhvcj5XaW5kZWNrZXIsIFMuPC9h

dXRob3I+PGF1dGhvcj5DbGVtZW50LCBELiBMLjwvYXV0aG9yPjxhdXRob3I+Q29jYSwgQS48L2F1

dGhvcj48YXV0aG9yPkdpbGxlYmVydCwgVC4gQy48L2F1dGhvcj48YXV0aG9yPlRlbmRlcmEsIE0u

PC9hdXRob3I+PGF1dGhvcj5Sb3NlaSwgRS4gQS48L2F1dGhvcj48YXV0aG9yPkFtYnJvc2lvbmks

IEUuPC9hdXRob3I+PGF1dGhvcj5BbmtlciwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkJhdWVyc2Fj

aHMsIEouPC9hdXRob3I+PGF1dGhvcj5IaXRpaiwgSi4gQi48L2F1dGhvcj48YXV0aG9yPkNhdWxm

aWVsZCwgTS48L2F1dGhvcj48YXV0aG9yPkRlIEJ1eXplcmUsIE0uPC9hdXRob3I+PGF1dGhvcj5E

ZSBHZWVzdCwgUy48L2F1dGhvcj48YXV0aG9yPkRlcnVtZWF1eCwgRy4gQS48L2F1dGhvcj48YXV0

aG9yPkVyZGluZSwgUy48L2F1dGhvcj48YXV0aG9yPkZhcnNhbmcsIEMuPC9hdXRob3I+PGF1dGhv

cj5GdW5jay1CcmVudGFubywgQy48L2F1dGhvcj48YXV0aG9yPkdlcmMsIFYuPC9hdXRob3I+PGF1

dGhvcj5HZXJtYW5vLCBHLjwvYXV0aG9yPjxhdXRob3I+R2llbGVuLCBTLjwvYXV0aG9yPjxhdXRo

b3I+SGFsbGVyLCBILjwvYXV0aG9yPjxhdXRob3I+SG9lcywgQS4gVy48L2F1dGhvcj48YXV0aG9y

PkpvcmRhbiwgSi48L2F1dGhvcj48YXV0aG9yPkthaGFuLCBULjwvYXV0aG9yPjxhdXRob3I+S29t

YWpkYSwgTS48L2F1dGhvcj48YXV0aG9yPkxvdmljLCBELjwvYXV0aG9yPjxhdXRob3I+TWFocmhv

bGR0LCBILjwvYXV0aG9yPjxhdXRob3I+T2xzZW4sIE0uIEguPC9hdXRob3I+PGF1dGhvcj5Pc3Rl

cmdyZW4sIEouPC9hdXRob3I+PGF1dGhvcj5QYXJhdGksIEcuPC9hdXRob3I+PGF1dGhvcj5QZXJr

LCBKLjwvYXV0aG9yPjxhdXRob3I+UG9sb25pYSwgSi48L2F1dGhvcj48YXV0aG9yPlBvcGVzY3Us

IEIuIEEuPC9hdXRob3I+PGF1dGhvcj5SZWluZXIsIFouPC9hdXRob3I+PGF1dGhvcj5SeWRlbiwg

TC48L2F1dGhvcj48YXV0aG9yPlNpcmVua28sIFkuPC9hdXRob3I+PGF1dGhvcj5TdGFudG9uLCBB

LjwvYXV0aG9yPjxhdXRob3I+U3RydWlqa2VyLUJvdWRpZXIsIEguPC9hdXRob3I+PGF1dGhvcj5U

c2lvdWZpcywgQy48L2F1dGhvcj48YXV0aG9yPnZhbiBkZSBCb3JuZSwgUC48L2F1dGhvcj48YXV0

aG9yPlZsYWNob3BvdWxvcywgQy48L2F1dGhvcj48YXV0aG9yPlZvbHBlLCBNLjwvYXV0aG9yPjxh

dXRob3I+V29vZCwgRC4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5DZW50cm8gZGkgRmlzaW9sb2dpYSBDbGluaWNhIGUgSXBlcnRlbnNpb25lLCBVbml2

ZXJzaXRhIE1pbGFuby1CaWNvY2NhLCBNaWxhbm8sIEl0YWx5LiBnaXVzZXBwZS5tYW5jaWFAdW5p

bWliLml0PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+MjAxMyBFU0gvRVNDIGd1aWRlbGlu

ZXMgZm9yIHRoZSBtYW5hZ2VtZW50IG9mIGFydGVyaWFsIGh5cGVydGVuc2lvbjogdGhlIFRhc2sg

Rm9yY2UgZm9yIHRoZSBNYW5hZ2VtZW50IG9mIEFydGVyaWFsIEh5cGVydGVuc2lvbiBvZiB0aGUg

RXVyb3BlYW4gU29jaWV0eSBvZiBIeXBlcnRlbnNpb24gKEVTSCkgYW5kIG9mIHRoZSBFdXJvcGVh

biBTb2NpZXR5IG9mIENhcmRpb2xvZ3kgKEVTQyk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RXVy

IEhlYXJ0IEo8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1ciBIZWFydCBKPC9hbHQtdGl0

bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RXVyIEhlYXJ0IEo8L2Z1bGwtdGl0

bGU+PGFiYnItMT5FdXJvcGVhbiBoZWFydCBqb3VybmFsPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXIgSGVhcnQgSjwvZnVsbC10aXRsZT48YWJici0x

PkV1cm9wZWFuIGhlYXJ0IGpvdXJuYWw8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4y

MTU5LTIxOTwvcGFnZXM+PHZvbHVtZT4zNDwvdm9sdW1lPjxudW1iZXI+Mjg8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAxMzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bDwvZGF0ZT48L3B1Yi1kYXRl

cz48L2RhdGVzPjxpc2JuPjE1MjItOTY0NSAoRWxlY3Ryb25pYykmI3hEOzAxOTUtNjY4WCAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjM3NzE4NDQ8L2FjY2Vzc2lvbi1udW0+PHdvcmst

dHlwZT5QcmFjdGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1k

YXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+

ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (80).Smoking (Level C)We believe that smoking status should be ascertained in all CTD patients. In SLE, smoking may increase disease activity ADDIN EN.CITE <EndNote><Cite><Author>Ghaussy</Author><Year>2003</Year><RecNum>416</RecNum><DisplayText>(81)</DisplayText><record><rec-number>416</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">416</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ghaussy, N. O.</author><author>Sibbitt, W., Jr.</author><author>Bankhurst, A. D.</author><author>Qualls, C. R.</author></authors></contributors><auth-address>Department of Internal Medicine, The University of New Mexico Health Sciences Center, Albuquerque 87131, USA.</auth-address><titles><title>Cigarette smoking and disease activity in systemic lupus erythematosus</title><secondary-title>J Rheumatol</secondary-title><alt-title>J Rheumatol</alt-title></titles><periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></periodical><alt-periodical><full-title>J Rheumatol</full-title><abbr-1>The Journal of rheumatology</abbr-1></alt-periodical><pages>1215-21</pages><volume>30</volume><number>6</number><dates><year>2003</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0315-162X (Print)&#xD;0315-162X (Linking)</isbn><accession-num>12784392</accession-num><work-type>Research Support, U.S. Gov&apos;t, P.H.S.</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(81). It also interferes with the response to anti-malarial medications PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KZXdlbGw8L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxS

ZWNOdW0+NDE5PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig4MiwgODMpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjQxOTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDE5PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5KZXdlbGwsIE0uIEwuPC9hdXRob3I+

PGF1dGhvcj5NY0NhdWxpZmZlLCBELiBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgRGVybWF0b2xvZ3ksIFVuaXZlcnNpdHkgb2Yg

Tm9ydGggQ2Fyb2xpbmEgU2Nob29sIG9mIE1lZGljaW5lLCBDaGFwZWwgSGlsbCwgVVNBLjwvYXV0

aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlBhdGllbnRzIHdpdGggY3V0YW5lb3VzIGx1cHVzIGVy

eXRoZW1hdG9zdXMgd2hvIHNtb2tlIGFyZSBsZXNzIHJlc3BvbnNpdmUgdG8gYW50aW1hbGFyaWFs

IHRyZWF0bWVudDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Kb3VybmFsIG9mIHRoZSBBbWVyaWNh

biBBY2FkZW15IG9mIERlcm1hdG9sb2d5PC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5KIEFt

IEFjYWQgRGVybWF0b2w8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5Kb3VybmFsIG9mIHRoZSBBbWVyaWNhbiBBY2FkZW15IG9mIERlcm1hdG9sb2d5PC9mdWxsLXRp

dGxlPjxhYmJyLTE+SiBBbSBBY2FkIERlcm1hdG9sPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQt

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIHRoZSBBbWVyaWNhbiBBY2FkZW15IG9m

IERlcm1hdG9sb2d5PC9mdWxsLXRpdGxlPjxhYmJyLTE+SiBBbSBBY2FkIERlcm1hdG9sPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+OTgzLTc8L3BhZ2VzPjx2b2x1bWU+NDI8L3ZvbHVt

ZT48bnVtYmVyPjY8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwMDwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkp1bjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAxOTAtOTYyMiAoUHJpbnQp

JiN4RDswMTkwLTk2MjIgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjEwODI3NDAwPC9h

Y2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q2xpbmljYWwgVHJpYWwmI3hEO1Jlc2VhcmNoIFN1cHBv

cnQsIFUuUy4gR292JmFwb3M7dCwgUC5ILlMuPC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+Q2hhc3NldDwv

QXV0aG9yPjxZZWFyPjIwMTU8L1llYXI+PFJlY051bT40MTc8L1JlY051bT48cmVjb3JkPjxyZWMt

bnVtYmVyPjQxNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDE3PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DaGFzc2V0LCBGLjwvYXV0aG9yPjxhdXRob3I+RnJh

bmNlcywgQy48L2F1dGhvcj48YXV0aG9yPkJhcmV0ZSwgUy48L2F1dGhvcj48YXV0aG9yPkFtb3Vy

YSwgWi48L2F1dGhvcj48YXV0aG9yPkFybmF1ZCwgTC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5BUC1IUCwgR3JvdXBlbWVudCBIb3NwaXRhbGllciBQaXRp

ZS1TYWxwZXRyaWVyZSwgRTNNIEluc3RpdHV0ZSwgSW50ZXJuYWwgTWVkaWNpbmUgRGVwYXJ0bWVu

dCwgRnJlbmNoIE5hdGlvbmFsIFJlZmVyZW5jZSBDZW50ZXIgZm9yIFN5c3RlbWljIEx1cHVzIEVy

eXRoZW1hdG9zdXMsIFBhcmlzLCBGcmFuY2U7IERlcGFydG1lbnQgb2YgRGVybWF0b2xvZ3kgYW5k

IEFsbGVyZ29sb2d5IFRlbm9uIEhvc3BpdGFsLUFQSFAsIFBhcmlzLCBGcmFuY2UuJiN4RDtEZXBh

cnRtZW50IG9mIERlcm1hdG9sb2d5IGFuZCBBbGxlcmdvbG9neSBUZW5vbiBIb3NwaXRhbC1BUEhQ

LCBQYXJpcywgRnJhbmNlOyBTb3Jib25uZSBVbml2ZXJzaXRlcywgVVBNQyBVbml2IFBhcmlzIDA2

LCBQYXJpcywgRnJhbmNlLiYjeEQ7QVAtSFAsIEdyb3VwZW1lbnQgSG9zcGl0YWxpZXIgUGl0aWUt

U2FscGV0cmllcmUsIEUzTSBJbnN0aXR1dGUsIEludGVybmFsIE1lZGljaW5lIERlcGFydG1lbnQs

IEZyZW5jaCBOYXRpb25hbCBSZWZlcmVuY2UgQ2VudGVyIGZvciBTeXN0ZW1pYyBMdXB1cyBFcnl0

aGVtYXRvc3VzLCBQYXJpcywgRnJhbmNlOyBTb3Jib25uZSBVbml2ZXJzaXRlcywgVVBNQyBVbml2

IFBhcmlzIDA2LCBQYXJpcywgRnJhbmNlLiYjeEQ7QVAtSFAsIEdyb3VwZW1lbnQgSG9zcGl0YWxp

ZXIgUGl0aWUtU2FscGV0cmllcmUsIEUzTSBJbnN0aXR1dGUsIEludGVybmFsIE1lZGljaW5lIERl

cGFydG1lbnQsIEZyZW5jaCBOYXRpb25hbCBSZWZlcmVuY2UgQ2VudGVyIGZvciBTeXN0ZW1pYyBM

dXB1cyBFcnl0aGVtYXRvc3VzLCBQYXJpcywgRnJhbmNlOyBTb3Jib25uZSBVbml2ZXJzaXRlcywg

VVBNQyBVbml2IFBhcmlzIDA2LCBQYXJpcywgRnJhbmNlOyBJTlNFUk0gVU1SLVMgMTEzNiwgR1JD

IDA4LCBJbnN0aXR1dCBQaWVycmUgTG91aXMgZCZhcG9zO0VwaWRlbWlvbG9naWUgZXQgU2FudGUg

UHVibGlxdWUsIFBhcmlzLCBGcmFuY2UuIEVsZWN0cm9uaWMgYWRkcmVzczogTGF1cmVudC5hcm5h

dWRAcHNsLmFwaHAuZnIuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+SW5mbHVlbmNlIG9m

IHNtb2tpbmcgb24gdGhlIGVmZmljYWN5IG9mIGFudGltYWxhcmlhbHMgaW4gY3V0YW5lb3VzIGx1

cHVzOiBhIG1ldGEtYW5hbHlzaXMgb2YgdGhlIGxpdGVyYXR1cmU8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+Sm91cm5hbCBvZiB0aGUgQW1lcmljYW4gQWNhZGVteSBvZiBEZXJtYXRvbG9neTwvc2Vj

b25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBBbSBBY2FkIERlcm1hdG9sPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiB0aGUgQW1lcmljYW4gQWNh

ZGVteSBvZiBEZXJtYXRvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkogQW0gQWNhZCBEZXJtYXRv

bDwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5h

bCBvZiB0aGUgQW1lcmljYW4gQWNhZGVteSBvZiBEZXJtYXRvbG9neTwvZnVsbC10aXRsZT48YWJi

ci0xPkogQW0gQWNhZCBEZXJtYXRvbDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjYz

NC05PC9wYWdlcz48dm9sdW1lPjcyPC92b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGRhdGVzPjx5

ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4xMDk3LTY3ODcgKEVsZWN0cm9uaWMpJiN4RDswMTkwLTk2MjIgKExpbmtpbmcp

PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1NjQ4ODI0PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+

TWV0YS1BbmFseXNpczwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXBy

b3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1

YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5KZXdlbGw8L0F1dGhvcj48WWVhcj4yMDAwPC9ZZWFyPjxS

ZWNOdW0+NDE5PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig4MiwgODMpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjQxOTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDE5PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5KZXdlbGwsIE0uIEwuPC9hdXRob3I+

PGF1dGhvcj5NY0NhdWxpZmZlLCBELiBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgRGVybWF0b2xvZ3ksIFVuaXZlcnNpdHkgb2Yg

Tm9ydGggQ2Fyb2xpbmEgU2Nob29sIG9mIE1lZGljaW5lLCBDaGFwZWwgSGlsbCwgVVNBLjwvYXV0

aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlBhdGllbnRzIHdpdGggY3V0YW5lb3VzIGx1cHVzIGVy

eXRoZW1hdG9zdXMgd2hvIHNtb2tlIGFyZSBsZXNzIHJlc3BvbnNpdmUgdG8gYW50aW1hbGFyaWFs

IHRyZWF0bWVudDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Kb3VybmFsIG9mIHRoZSBBbWVyaWNh

biBBY2FkZW15IG9mIERlcm1hdG9sb2d5PC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5KIEFt

IEFjYWQgRGVybWF0b2w8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs

ZT5Kb3VybmFsIG9mIHRoZSBBbWVyaWNhbiBBY2FkZW15IG9mIERlcm1hdG9sb2d5PC9mdWxsLXRp

dGxlPjxhYmJyLTE+SiBBbSBBY2FkIERlcm1hdG9sPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQt

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIHRoZSBBbWVyaWNhbiBBY2FkZW15IG9m

IERlcm1hdG9sb2d5PC9mdWxsLXRpdGxlPjxhYmJyLTE+SiBBbSBBY2FkIERlcm1hdG9sPC9hYmJy

LTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+OTgzLTc8L3BhZ2VzPjx2b2x1bWU+NDI8L3ZvbHVt

ZT48bnVtYmVyPjY8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwMDwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkp1bjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAxOTAtOTYyMiAoUHJpbnQp

JiN4RDswMTkwLTk2MjIgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjEwODI3NDAwPC9h

Y2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q2xpbmljYWwgVHJpYWwmI3hEO1Jlc2VhcmNoIFN1cHBv

cnQsIFUuUy4gR292JmFwb3M7dCwgUC5ILlMuPC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1v

dGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1

YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+Q2hhc3NldDwv

QXV0aG9yPjxZZWFyPjIwMTU8L1llYXI+PFJlY051bT40MTc8L1JlY051bT48cmVjb3JkPjxyZWMt

bnVtYmVyPjQxNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDE3PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DaGFzc2V0LCBGLjwvYXV0aG9yPjxhdXRob3I+RnJh

bmNlcywgQy48L2F1dGhvcj48YXV0aG9yPkJhcmV0ZSwgUy48L2F1dGhvcj48YXV0aG9yPkFtb3Vy

YSwgWi48L2F1dGhvcj48YXV0aG9yPkFybmF1ZCwgTC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5BUC1IUCwgR3JvdXBlbWVudCBIb3NwaXRhbGllciBQaXRp

ZS1TYWxwZXRyaWVyZSwgRTNNIEluc3RpdHV0ZSwgSW50ZXJuYWwgTWVkaWNpbmUgRGVwYXJ0bWVu

dCwgRnJlbmNoIE5hdGlvbmFsIFJlZmVyZW5jZSBDZW50ZXIgZm9yIFN5c3RlbWljIEx1cHVzIEVy

eXRoZW1hdG9zdXMsIFBhcmlzLCBGcmFuY2U7IERlcGFydG1lbnQgb2YgRGVybWF0b2xvZ3kgYW5k

IEFsbGVyZ29sb2d5IFRlbm9uIEhvc3BpdGFsLUFQSFAsIFBhcmlzLCBGcmFuY2UuJiN4RDtEZXBh

cnRtZW50IG9mIERlcm1hdG9sb2d5IGFuZCBBbGxlcmdvbG9neSBUZW5vbiBIb3NwaXRhbC1BUEhQ

LCBQYXJpcywgRnJhbmNlOyBTb3Jib25uZSBVbml2ZXJzaXRlcywgVVBNQyBVbml2IFBhcmlzIDA2

LCBQYXJpcywgRnJhbmNlLiYjeEQ7QVAtSFAsIEdyb3VwZW1lbnQgSG9zcGl0YWxpZXIgUGl0aWUt

U2FscGV0cmllcmUsIEUzTSBJbnN0aXR1dGUsIEludGVybmFsIE1lZGljaW5lIERlcGFydG1lbnQs

IEZyZW5jaCBOYXRpb25hbCBSZWZlcmVuY2UgQ2VudGVyIGZvciBTeXN0ZW1pYyBMdXB1cyBFcnl0

aGVtYXRvc3VzLCBQYXJpcywgRnJhbmNlOyBTb3Jib25uZSBVbml2ZXJzaXRlcywgVVBNQyBVbml2

IFBhcmlzIDA2LCBQYXJpcywgRnJhbmNlLiYjeEQ7QVAtSFAsIEdyb3VwZW1lbnQgSG9zcGl0YWxp

ZXIgUGl0aWUtU2FscGV0cmllcmUsIEUzTSBJbnN0aXR1dGUsIEludGVybmFsIE1lZGljaW5lIERl

cGFydG1lbnQsIEZyZW5jaCBOYXRpb25hbCBSZWZlcmVuY2UgQ2VudGVyIGZvciBTeXN0ZW1pYyBM

dXB1cyBFcnl0aGVtYXRvc3VzLCBQYXJpcywgRnJhbmNlOyBTb3Jib25uZSBVbml2ZXJzaXRlcywg

VVBNQyBVbml2IFBhcmlzIDA2LCBQYXJpcywgRnJhbmNlOyBJTlNFUk0gVU1SLVMgMTEzNiwgR1JD

IDA4LCBJbnN0aXR1dCBQaWVycmUgTG91aXMgZCZhcG9zO0VwaWRlbWlvbG9naWUgZXQgU2FudGUg

UHVibGlxdWUsIFBhcmlzLCBGcmFuY2UuIEVsZWN0cm9uaWMgYWRkcmVzczogTGF1cmVudC5hcm5h

dWRAcHNsLmFwaHAuZnIuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+SW5mbHVlbmNlIG9m

IHNtb2tpbmcgb24gdGhlIGVmZmljYWN5IG9mIGFudGltYWxhcmlhbHMgaW4gY3V0YW5lb3VzIGx1

cHVzOiBhIG1ldGEtYW5hbHlzaXMgb2YgdGhlIGxpdGVyYXR1cmU8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+Sm91cm5hbCBvZiB0aGUgQW1lcmljYW4gQWNhZGVteSBvZiBEZXJtYXRvbG9neTwvc2Vj

b25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+SiBBbSBBY2FkIERlcm1hdG9sPC9hbHQtdGl0bGU+PC90

aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5hbCBvZiB0aGUgQW1lcmljYW4gQWNh

ZGVteSBvZiBEZXJtYXRvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkogQW0gQWNhZCBEZXJtYXRv

bDwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Sm91cm5h

bCBvZiB0aGUgQW1lcmljYW4gQWNhZGVteSBvZiBEZXJtYXRvbG9neTwvZnVsbC10aXRsZT48YWJi

ci0xPkogQW0gQWNhZCBEZXJtYXRvbDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjYz

NC05PC9wYWdlcz48dm9sdW1lPjcyPC92b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGRhdGVzPjx5

ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4xMDk3LTY3ODcgKEVsZWN0cm9uaWMpJiN4RDswMTkwLTk2MjIgKExpbmtpbmcp

PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1NjQ4ODI0PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+

TWV0YS1BbmFseXNpczwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXBy

b3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1

YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA (82, 83). In SSc, smokers are prone to more severe Raynaud’s phenomenon and digital ulceration PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJyaXNvbjwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+

PFJlY051bT41MjA8L1JlY051bT48RGlzcGxheVRleHQ+KDg0LCA4NSk8L0Rpc3BsYXlUZXh0Pjxy

ZWNvcmQ+PHJlYy1udW1iZXI+NTIwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9

IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj41MjA8L2tl

eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm

LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkhhcnJpc29uLCBCLiBKLjwvYXV0

aG9yPjxhdXRob3I+U2lsbWFuLCBBLiBKLjwvYXV0aG9yPjxhdXRob3I+SGlkZXIsIFMuIEwuPC9h

dXRob3I+PGF1dGhvcj5IZXJyaWNrLCBBLiBMLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPk5vcnRoIE1hbmNoZXN0ZXIgR2VuZXJhbCBIb3NwaXRhbCBhbmQg

QVJDIEVwaWRlbWlvbG9neSBVbml0LCBNYW5jaGVzdGVyLCBVSy4gQmV2ZXJsZXkuSGFycmlzb25A

bWFpbC5ubWFuaGMtdHIubndlc3QubmhzLnVrPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

Q2lnYXJldHRlIHNtb2tpbmcgYXMgYSBzaWduaWZpY2FudCByaXNrIGZhY3RvciBmb3IgZGlnaXRh

bCB2YXNjdWxhciBkaXNlYXNlIGluIHBhdGllbnRzIHdpdGggc3lzdGVtaWMgc2NsZXJvc2lzPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFydGhyaXRpcyBSaGV1bTwvc2Vjb25kYXJ5LXRpdGxlPjxh

bHQtdGl0bGU+QXJ0aHJpdGlzIFJoZXVtPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+QXJ0aHJpdGlzIFJoZXVtPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlz

IGFuZCByaGV1bWF0aXNtPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5BcnRocml0aXMgUmhldW08L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgYW5k

IHJoZXVtYXRpc208L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zMzEyLTY8L3BhZ2Vz

Pjx2b2x1bWU+NDY8L3ZvbHVtZT48bnVtYmVyPjEyPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDI8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5EZWM8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMDA0LTM1OTEgKFByaW50KSYjeEQ7MDAwNC0zNTkxIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4xMjQ4MzczNzwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5IdWRzb248L0F1dGhvcj48

WWVhcj4yMDExPC9ZZWFyPjxSZWNOdW0+MDwvUmVjTnVtPjxJRFRleHQ+Q2lnYXJldHRlIHNtb2tp

bmcgaW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBzY2xlcm9zaXM8L0lEVGV4dD48cmVjb3JkPjxk

YXRlcz48cHViLWRhdGVzPjxkYXRlPkphbjwvZGF0ZT48L3B1Yi1kYXRlcz48eWVhcj4yMDExPC95

ZWFyPjwvZGF0ZXM+PGtleXdvcmRzPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+Q3Jv

c3MtU2VjdGlvbmFsIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxr

ZXl3b3JkPkdhc3Ryb2ludGVzdGluYWwgRGlzZWFzZXMvY29tcGxpY2F0aW9uczwva2V5d29yZD48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+THVuZyBEaXNlYXNlcy9jb21wbGljYXRp

b25zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8

L2tleXdvcmQ+PGtleXdvcmQ+UmVncmVzc2lvbiBBbmFseXNpczwva2V5d29yZD48a2V5d29yZD5T

Y2xlcm9kZXJtYSwgU3lzdGVtaWMvKmNvbXBsaWNhdGlvbnM8L2tleXdvcmQ+PGtleXdvcmQ+U2V2

ZXJpdHkgb2YgSWxsbmVzcyBJbmRleDwva2V5d29yZD48a2V5d29yZD5TbW9raW5nLyphZHZlcnNl

IGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+U21va2luZyBDZXNzYXRpb248L2tleXdvcmQ+PGtl

eXdvcmQ+VmFzY3VsYXIgRGlzZWFzZXMvY29tcGxpY2F0aW9uczwva2V5d29yZD48L2tleXdvcmRz

Pjxpc2JuPjAwMDQtMzU5MTwvaXNibj48dGl0bGVzPjx0aXRsZT5DaWdhcmV0dGUgc21va2luZyBp

biBwYXRpZW50cyB3aXRoIHN5c3RlbWljIHNjbGVyb3NpczwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRpcyBh

bmQgcmhldW1hdGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwYWdlcz4yMzAtODwvcGFnZXM+PG51

bWJlcj4xPC9udW1iZXI+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkh1ZHNvbiwgTS48

L2F1dGhvcj48YXV0aG9yPkxvLCBFLjwvYXV0aG9yPjxhdXRob3I+THUsIFkuPC9hdXRob3I+PGF1

dGhvcj5IZXJjeiwgRC48L2F1dGhvcj48YXV0aG9yPkJhcm9uLCBNLjwvYXV0aG9yPjxhdXRob3I+

U3RlZWxlLCBSLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48ZWRpdGlvbj4yMDEw

LzEwLzEyPC9lZGl0aW9uPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjxhZGRlZC1kYXRlIGZvcm1h

dD0idXRjIj4xNDU2MTQ0OTQyPC9hZGRlZC1kYXRlPjxub3Rlcz4xNTI5LTAxMzEmI3hEO0h1ZHNv

biwgTWFyaWUmI3hEO0xvLCBFcm5lc3QmI3hEO0x1LCBZaW5nJiN4RDtIZXJjeiwgRGFuaWVsJiN4

RDtCYXJvbiwgTXVycmF5JiN4RDtTdGVlbGUsIFJ1c3NlbGwmI3hEO0NhbmFkaWFuIFNjbGVyb2Rl

cm1hIFJlc2VhcmNoIEdyb3VwJiN4RDtDYW5hZGlhbiBJbnN0aXR1dGVzIG9mIEhlYWx0aCBSZXNl

YXJjaC9DYW5hZGEmI3hEO0pvdXJuYWwgQXJ0aWNsZSYjeEQ7UmVzZWFyY2ggU3VwcG9ydCwgTm9u

LVUuUy4gR292JmFwb3M7dCYjeEQ7VW5pdGVkIFN0YXRlcyYjeEQ7QXJ0aHJpdGlzIFJoZXVtLiAy

MDExIEphbjs2MygxKToyMzAtOC4gZG9pOiAxMC4xMDAyL2FydC4zMDA3MS48L25vdGVzPjxyZWYt

dHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48YXV0aC1hZGRyZXNzPlNN

QkQtSmV3aXNoIEdlbmVyYWwgSG9zcGl0YWwgYW5kIE1jR2lsbCBVbml2ZXJzaXR5LCBNb250cmVh

bCwgUXVlYmVjLCBDYW5hZGEuIG1hcmllLmh1ZHNvbkBtY2dpbGwuY2E8L2F1dGgtYWRkcmVzcz48

cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxy

ZWMtbnVtYmVyPjEyPC9yZWMtbnVtYmVyPjxsYXN0LXVwZGF0ZWQtZGF0ZSBmb3JtYXQ9InV0YyI+

MTQ1NjE0NDk0MjwvbGFzdC11cGRhdGVkLWRhdGU+PGFjY2Vzc2lvbi1udW0+MjA5MzY2MzM8L2Fj

Y2Vzc2lvbi1udW0+PGFic3RyYWN0Pk9CSkVDVElWRTogVG8gZGV0ZXJtaW5lIHRoZSBlZmZlY3Rz

IG9mIGNpZ2FyZXR0ZSBzbW9raW5nIG9uIHZhc2N1bGFyLCBnYXN0cm9pbnRlc3RpbmFsLCBhbmQg

cmVzcGlyYXRvcnkgb3V0Y29tZXMgaW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBzY2xlcm9zaXMg

KFNTYykuIE1FVEhPRFM6IFN1YmplY3RzIHdlcmUgcGF0aWVudHMgZW5yb2xsZWQgaW4gdGhlIENh

bmFkaWFuIFNjbGVyb2Rlcm1hIFJlc2VhcmNoIEdyb3VwIGNvaG9ydC4gU21va2luZyBoaXN0b3J5

IHdhcyBvYnRhaW5lZCBieSBwYXRpZW50IHNlbGYtcmVwb3J0LiBUaGUgZWZmZWN0IG9mIHNtb2tp

bmcgd2FzIGFzc2Vzc2VkIHVzaW5nIG11bHRpcGxlIHJlZ3Jlc3Npb24gYW5hbHlzaXMgb2YgZWFj

aCBTU2MgY2xpbmljYWwgb3V0Y29tZSBvZiBpbnRlcmVzdCAodmFzY3VsYXIsIGdhc3Ryb2ludGVz

dGluYWwsIGFuZCByZXNwaXJhdG9yeSkuIFNtb2tpbmcgd2FzIG1vZGVsZWQgYm90aCBhcyBjYXRl

Z29yaWNhbCB2YXJpYWJsZXMgKGN1cnJlbnQsIHBhc3QsIGFuZCBuZXZlcikgYW5kIHVzaW5nIHRo

ZSBDb21wcmVoZW5zaXZlIFNtb2tpbmcgSW5kZXggKENTSSksIHdoaWNoIGludGVncmF0ZXMgc21v

a2luZyBpbnRlbnNpdHksIGR1cmF0aW9uIG9mIHNtb2tpbmcsIGFuZCB0aW1lIHNpbmNlIGNlc3Nh

dGlvbiBpbnRvIGEgc2luZ2xlIGNvdmFyaWF0ZSBvZiBzbW9raW5nIGVmZmVjdC4gQWxsIHJlZ3Jl

c3Npb24gbW9kZWxzIHdlcmUgYWRqdXN0ZWQgZm9yIGFnZSwgc2V4LCBkaXNlYXNlIGR1cmF0aW9u

LCBhbmQgbGltaXRlZCBvciBkaWZmdXNlIHNraW4gaW52b2x2ZW1lbnQuIFJFU1VMVFM6IFRoaXMg

c3R1ZHkgaW5jbHVkZWQgNjA2IHBhdGllbnRzIHdpdGggU1NjLCBvZiB3aG9tIDg3JSB3ZXJlIHdv

bWVuIGFuZCA5MCUgd2VyZSB3aGl0ZSwgYW5kIHRoZSBtZWFuIGFnZSB3YXMgNTUgeWVhcnMsIG1l

YW4gZGlzZWFzZSBkdXJhdGlvbiB3YXMgMTEgeWVhcnMsIGFuZCAzNiUgaGFkIGRpZmZ1c2UgZGlz

ZWFzZS4gT2YgdGhlc2UgcGF0aWVudHMsIDE2JSB3ZXJlIGN1cnJlbnQgc21va2VycywgNDIlIHdl

cmUgcGFzdCBzbW9rZXJzLCBhbmQgNDIlIHdlcmUgbmV2ZXIgc21va2Vycy4gVGhlIHJlZ3Jlc3Np

b24gYW5hbHlzZXMgc2hvd2VkIHRoYXQgc21va2luZyBoYWQgYSBzaWduaWZpY2FudCBuZWdhdGl2

ZSBlZmZlY3Qgb24gYWxtb3N0IGFsbCB2YXNjdWxhciwgZ2FzdHJvaW50ZXN0aW5hbCwgYW5kIHJl

c3BpcmF0b3J5IG91dGNvbWVzLiBUaGUgZWZmZWN0cyBvZiBzbW9raW5nIHdlcmUgaW4gc29tZSBj

YXNlcyBsb25nLWxhc3RpbmcgKGUuZy4sIHBlcnNpc3RlbnQgcmVzcGlyYXRvcnkgYWJub3JtYWxp

dGllcyksIGFuZCBzbW9raW5nIGNlc3NhdGlvbiBhcHBlYXJlZCBiZW5lZmljaWFsIHdpdGggcmVz

cGVjdCB0byBzb21lIG91dGNvbWVzIChlLmcuLCByZWR1Y2VkIHNldmVyaXR5IG9mIFJheW5hdWQm

YXBvcztzIHBoZW5vbWVub24pLiBDT05DTFVTSU9OOiBQaHlzaWNpYW5zIGNhcmluZyBmb3IgcGF0

aWVudHMgd2l0aCBTU2Mgc2hvdWxkIHByaW9yaXRpemUgc21va2luZyBjZXNzYXRpb24gYXMgYSBy

ZWNvbW1lbmRhdGlvbiB0byBwYXRpZW50cywgYW5kIHJlc291cmNlcyBkaXJlY3RlZCB0byBzdXBw

b3J0aW5nIHNtb2tpbmcgY2Vzc2F0aW9uIGluIHBhdGllbnRzIHdpdGggU1NjIHNob3VsZCBiZSBt

b3JlIHJlYWRpbHkgYXZhaWxhYmxlLjwvYWJzdHJhY3Q+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjEwMDIvYXJ0LjMwMDcxPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48dm9sdW1lPjYzPC92

b2x1bWU+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJyaXNvbjwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+

PFJlY051bT41MjA8L1JlY051bT48RGlzcGxheVRleHQ+KDg0LCA4NSk8L0Rpc3BsYXlUZXh0Pjxy

ZWNvcmQ+PHJlYy1udW1iZXI+NTIwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9

IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj41MjA8L2tl

eT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVm

LXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkhhcnJpc29uLCBCLiBKLjwvYXV0

aG9yPjxhdXRob3I+U2lsbWFuLCBBLiBKLjwvYXV0aG9yPjxhdXRob3I+SGlkZXIsIFMuIEwuPC9h

dXRob3I+PGF1dGhvcj5IZXJyaWNrLCBBLiBMLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPk5vcnRoIE1hbmNoZXN0ZXIgR2VuZXJhbCBIb3NwaXRhbCBhbmQg

QVJDIEVwaWRlbWlvbG9neSBVbml0LCBNYW5jaGVzdGVyLCBVSy4gQmV2ZXJsZXkuSGFycmlzb25A

bWFpbC5ubWFuaGMtdHIubndlc3QubmhzLnVrPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+

Q2lnYXJldHRlIHNtb2tpbmcgYXMgYSBzaWduaWZpY2FudCByaXNrIGZhY3RvciBmb3IgZGlnaXRh

bCB2YXNjdWxhciBkaXNlYXNlIGluIHBhdGllbnRzIHdpdGggc3lzdGVtaWMgc2NsZXJvc2lzPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFydGhyaXRpcyBSaGV1bTwvc2Vjb25kYXJ5LXRpdGxlPjxh

bHQtdGl0bGU+QXJ0aHJpdGlzIFJoZXVtPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+QXJ0aHJpdGlzIFJoZXVtPC9mdWxsLXRpdGxlPjxhYmJyLTE+QXJ0aHJpdGlz

IGFuZCByaGV1bWF0aXNtPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5BcnRocml0aXMgUmhldW08L2Z1bGwtdGl0bGU+PGFiYnItMT5BcnRocml0aXMgYW5k

IHJoZXVtYXRpc208L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zMzEyLTY8L3BhZ2Vz

Pjx2b2x1bWU+NDY8L3ZvbHVtZT48bnVtYmVyPjEyPC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDI8

L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5EZWM8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4wMDA0LTM1OTEgKFByaW50KSYjeEQ7MDAwNC0zNTkxIChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4xMjQ4MzczNzwvYWNjZXNzaW9uLW51bT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRh

YmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5n

PC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5IdWRzb248L0F1dGhvcj48

WWVhcj4yMDExPC9ZZWFyPjxSZWNOdW0+MDwvUmVjTnVtPjxJRFRleHQ+Q2lnYXJldHRlIHNtb2tp

bmcgaW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBzY2xlcm9zaXM8L0lEVGV4dD48cmVjb3JkPjxk

YXRlcz48cHViLWRhdGVzPjxkYXRlPkphbjwvZGF0ZT48L3B1Yi1kYXRlcz48eWVhcj4yMDExPC95

ZWFyPjwvZGF0ZXM+PGtleXdvcmRzPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+Q3Jv

c3MtU2VjdGlvbmFsIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxr

ZXl3b3JkPkdhc3Ryb2ludGVzdGluYWwgRGlzZWFzZXMvY29tcGxpY2F0aW9uczwva2V5d29yZD48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+THVuZyBEaXNlYXNlcy9jb21wbGljYXRp

b25zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8

L2tleXdvcmQ+PGtleXdvcmQ+UmVncmVzc2lvbiBBbmFseXNpczwva2V5d29yZD48a2V5d29yZD5T

Y2xlcm9kZXJtYSwgU3lzdGVtaWMvKmNvbXBsaWNhdGlvbnM8L2tleXdvcmQ+PGtleXdvcmQ+U2V2

ZXJpdHkgb2YgSWxsbmVzcyBJbmRleDwva2V5d29yZD48a2V5d29yZD5TbW9raW5nLyphZHZlcnNl

IGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+U21va2luZyBDZXNzYXRpb248L2tleXdvcmQ+PGtl

eXdvcmQ+VmFzY3VsYXIgRGlzZWFzZXMvY29tcGxpY2F0aW9uczwva2V5d29yZD48L2tleXdvcmRz

Pjxpc2JuPjAwMDQtMzU5MTwvaXNibj48dGl0bGVzPjx0aXRsZT5DaWdhcmV0dGUgc21va2luZyBp

biBwYXRpZW50cyB3aXRoIHN5c3RlbWljIHNjbGVyb3NpczwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5BcnRocml0aXMgUmhldW08L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFydGhyaXRpcyBh

bmQgcmhldW1hdGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwYWdlcz4yMzAtODwvcGFnZXM+PG51

bWJlcj4xPC9udW1iZXI+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkh1ZHNvbiwgTS48

L2F1dGhvcj48YXV0aG9yPkxvLCBFLjwvYXV0aG9yPjxhdXRob3I+THUsIFkuPC9hdXRob3I+PGF1

dGhvcj5IZXJjeiwgRC48L2F1dGhvcj48YXV0aG9yPkJhcm9uLCBNLjwvYXV0aG9yPjxhdXRob3I+

U3RlZWxlLCBSLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48ZWRpdGlvbj4yMDEw

LzEwLzEyPC9lZGl0aW9uPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjxhZGRlZC1kYXRlIGZvcm1h

dD0idXRjIj4xNDU2MTQ0OTQyPC9hZGRlZC1kYXRlPjxub3Rlcz4xNTI5LTAxMzEmI3hEO0h1ZHNv

biwgTWFyaWUmI3hEO0xvLCBFcm5lc3QmI3hEO0x1LCBZaW5nJiN4RDtIZXJjeiwgRGFuaWVsJiN4

RDtCYXJvbiwgTXVycmF5JiN4RDtTdGVlbGUsIFJ1c3NlbGwmI3hEO0NhbmFkaWFuIFNjbGVyb2Rl

cm1hIFJlc2VhcmNoIEdyb3VwJiN4RDtDYW5hZGlhbiBJbnN0aXR1dGVzIG9mIEhlYWx0aCBSZXNl

YXJjaC9DYW5hZGEmI3hEO0pvdXJuYWwgQXJ0aWNsZSYjeEQ7UmVzZWFyY2ggU3VwcG9ydCwgTm9u

LVUuUy4gR292JmFwb3M7dCYjeEQ7VW5pdGVkIFN0YXRlcyYjeEQ7QXJ0aHJpdGlzIFJoZXVtLiAy

MDExIEphbjs2MygxKToyMzAtOC4gZG9pOiAxMC4xMDAyL2FydC4zMDA3MS48L25vdGVzPjxyZWYt

dHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48YXV0aC1hZGRyZXNzPlNN

QkQtSmV3aXNoIEdlbmVyYWwgSG9zcGl0YWwgYW5kIE1jR2lsbCBVbml2ZXJzaXR5LCBNb250cmVh

bCwgUXVlYmVjLCBDYW5hZGEuIG1hcmllLmh1ZHNvbkBtY2dpbGwuY2E8L2F1dGgtYWRkcmVzcz48

cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxy

ZWMtbnVtYmVyPjEyPC9yZWMtbnVtYmVyPjxsYXN0LXVwZGF0ZWQtZGF0ZSBmb3JtYXQ9InV0YyI+

MTQ1NjE0NDk0MjwvbGFzdC11cGRhdGVkLWRhdGU+PGFjY2Vzc2lvbi1udW0+MjA5MzY2MzM8L2Fj

Y2Vzc2lvbi1udW0+PGFic3RyYWN0Pk9CSkVDVElWRTogVG8gZGV0ZXJtaW5lIHRoZSBlZmZlY3Rz

IG9mIGNpZ2FyZXR0ZSBzbW9raW5nIG9uIHZhc2N1bGFyLCBnYXN0cm9pbnRlc3RpbmFsLCBhbmQg

cmVzcGlyYXRvcnkgb3V0Y29tZXMgaW4gcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBzY2xlcm9zaXMg

KFNTYykuIE1FVEhPRFM6IFN1YmplY3RzIHdlcmUgcGF0aWVudHMgZW5yb2xsZWQgaW4gdGhlIENh

bmFkaWFuIFNjbGVyb2Rlcm1hIFJlc2VhcmNoIEdyb3VwIGNvaG9ydC4gU21va2luZyBoaXN0b3J5

IHdhcyBvYnRhaW5lZCBieSBwYXRpZW50IHNlbGYtcmVwb3J0LiBUaGUgZWZmZWN0IG9mIHNtb2tp

bmcgd2FzIGFzc2Vzc2VkIHVzaW5nIG11bHRpcGxlIHJlZ3Jlc3Npb24gYW5hbHlzaXMgb2YgZWFj

aCBTU2MgY2xpbmljYWwgb3V0Y29tZSBvZiBpbnRlcmVzdCAodmFzY3VsYXIsIGdhc3Ryb2ludGVz

dGluYWwsIGFuZCByZXNwaXJhdG9yeSkuIFNtb2tpbmcgd2FzIG1vZGVsZWQgYm90aCBhcyBjYXRl

Z29yaWNhbCB2YXJpYWJsZXMgKGN1cnJlbnQsIHBhc3QsIGFuZCBuZXZlcikgYW5kIHVzaW5nIHRo

ZSBDb21wcmVoZW5zaXZlIFNtb2tpbmcgSW5kZXggKENTSSksIHdoaWNoIGludGVncmF0ZXMgc21v

a2luZyBpbnRlbnNpdHksIGR1cmF0aW9uIG9mIHNtb2tpbmcsIGFuZCB0aW1lIHNpbmNlIGNlc3Nh

dGlvbiBpbnRvIGEgc2luZ2xlIGNvdmFyaWF0ZSBvZiBzbW9raW5nIGVmZmVjdC4gQWxsIHJlZ3Jl

c3Npb24gbW9kZWxzIHdlcmUgYWRqdXN0ZWQgZm9yIGFnZSwgc2V4LCBkaXNlYXNlIGR1cmF0aW9u

LCBhbmQgbGltaXRlZCBvciBkaWZmdXNlIHNraW4gaW52b2x2ZW1lbnQuIFJFU1VMVFM6IFRoaXMg

c3R1ZHkgaW5jbHVkZWQgNjA2IHBhdGllbnRzIHdpdGggU1NjLCBvZiB3aG9tIDg3JSB3ZXJlIHdv

bWVuIGFuZCA5MCUgd2VyZSB3aGl0ZSwgYW5kIHRoZSBtZWFuIGFnZSB3YXMgNTUgeWVhcnMsIG1l

YW4gZGlzZWFzZSBkdXJhdGlvbiB3YXMgMTEgeWVhcnMsIGFuZCAzNiUgaGFkIGRpZmZ1c2UgZGlz

ZWFzZS4gT2YgdGhlc2UgcGF0aWVudHMsIDE2JSB3ZXJlIGN1cnJlbnQgc21va2VycywgNDIlIHdl

cmUgcGFzdCBzbW9rZXJzLCBhbmQgNDIlIHdlcmUgbmV2ZXIgc21va2Vycy4gVGhlIHJlZ3Jlc3Np

b24gYW5hbHlzZXMgc2hvd2VkIHRoYXQgc21va2luZyBoYWQgYSBzaWduaWZpY2FudCBuZWdhdGl2

ZSBlZmZlY3Qgb24gYWxtb3N0IGFsbCB2YXNjdWxhciwgZ2FzdHJvaW50ZXN0aW5hbCwgYW5kIHJl

c3BpcmF0b3J5IG91dGNvbWVzLiBUaGUgZWZmZWN0cyBvZiBzbW9raW5nIHdlcmUgaW4gc29tZSBj

YXNlcyBsb25nLWxhc3RpbmcgKGUuZy4sIHBlcnNpc3RlbnQgcmVzcGlyYXRvcnkgYWJub3JtYWxp

dGllcyksIGFuZCBzbW9raW5nIGNlc3NhdGlvbiBhcHBlYXJlZCBiZW5lZmljaWFsIHdpdGggcmVz

cGVjdCB0byBzb21lIG91dGNvbWVzIChlLmcuLCByZWR1Y2VkIHNldmVyaXR5IG9mIFJheW5hdWQm

YXBvcztzIHBoZW5vbWVub24pLiBDT05DTFVTSU9OOiBQaHlzaWNpYW5zIGNhcmluZyBmb3IgcGF0

aWVudHMgd2l0aCBTU2Mgc2hvdWxkIHByaW9yaXRpemUgc21va2luZyBjZXNzYXRpb24gYXMgYSBy

ZWNvbW1lbmRhdGlvbiB0byBwYXRpZW50cywgYW5kIHJlc291cmNlcyBkaXJlY3RlZCB0byBzdXBw

b3J0aW5nIHNtb2tpbmcgY2Vzc2F0aW9uIGluIHBhdGllbnRzIHdpdGggU1NjIHNob3VsZCBiZSBt

b3JlIHJlYWRpbHkgYXZhaWxhYmxlLjwvYWJzdHJhY3Q+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjEwMDIvYXJ0LjMwMDcxPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48dm9sdW1lPjYzPC92

b2x1bWU+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA (84, 85).In general, it is important to establish patients’ willingness to stop smoking and methods available to assist them. We hope that reminding patients repeatedly of the risks associated with smoking will improve cessation rates. Pharmacological treatments and nicotine replacement therapy may be offered PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QZXJrPC9BdXRob3I+PFllYXI+MjAxMjwvWWVhcj48UmVj

TnVtPjQyMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oODYpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjQyMDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDIwPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5QZXJrLCBKLjwvYXV0aG9yPjxhdXRob3I+RGUg

QmFja2VyLCBHLjwvYXV0aG9yPjxhdXRob3I+R29obGtlLCBILjwvYXV0aG9yPjxhdXRob3I+R3Jh

aGFtLCBJLjwvYXV0aG9yPjxhdXRob3I+UmVpbmVyLCBaLjwvYXV0aG9yPjxhdXRob3I+VmVyc2No

dXJlbiwgVy4gTS48L2F1dGhvcj48YXV0aG9yPkFsYnVzLCBDLjwvYXV0aG9yPjxhdXRob3I+QmVu

bGlhbiwgUC48L2F1dGhvcj48YXV0aG9yPkJveXNlbiwgRy48L2F1dGhvcj48YXV0aG9yPkNpZmtv

dmEsIFIuPC9hdXRob3I+PGF1dGhvcj5EZWF0b24sIEMuPC9hdXRob3I+PGF1dGhvcj5FYnJhaGlt

LCBTLjwvYXV0aG9yPjxhdXRob3I+RmlzaGVyLCBNLjwvYXV0aG9yPjxhdXRob3I+R2VybWFubywg

Ry48L2F1dGhvcj48YXV0aG9yPkhvYmJzLCBSLjwvYXV0aG9yPjxhdXRob3I+SG9lcywgQS48L2F1

dGhvcj48YXV0aG9yPkthcmFkZW5peiwgUy48L2F1dGhvcj48YXV0aG9yPk1lenphbmksIEEuPC9h

dXRob3I+PGF1dGhvcj5QcmVzY290dCwgRS48L2F1dGhvcj48YXV0aG9yPlJ5ZGVuLCBMLjwvYXV0

aG9yPjxhdXRob3I+U2NoZXJlciwgTS48L2F1dGhvcj48YXV0aG9yPlN5dmFubmUsIE0uPC9hdXRo

b3I+PGF1dGhvcj5PcCBSZWltZXIsIFcuIEouPC9hdXRob3I+PGF1dGhvcj5WcmludHMsIEMuPC9h

dXRob3I+PGF1dGhvcj5Xb29kLCBELjwvYXV0aG9yPjxhdXRob3I+WmFtb3Jhbm8sIEouIEwuPC9h

dXRob3I+PGF1dGhvcj5aYW5uYWQsIEYuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3Jz

PjxhdXRoLWFkZHJlc3M+U2Nob29sIG9mIEhlYWx0aCBhbmQgQ2FyaW5nIFNjaWVuY2VzLCBMaW5u

YWV1cyBVbml2ZXJzaXR5LCBLYWxtYXIsIFN3ZWRlbi4gam9lcC5wZXJrQGxudS5zZTwvYXV0aC1h

ZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkV1cm9wZWFuIGd1aWRlbGluZXMgb24gY2FyZGlvdmFzY3Vs

YXIgZGlzZWFzZSBwcmV2ZW50aW9uIGluIGNsaW5pY2FsIHByYWN0aWNlICh2ZXJzaW9uIDIwMTIp

IDogdGhlIGZpZnRoIGpvaW50IHRhc2sgZm9yY2Ugb2YgdGhlIEV1cm9wZWFuIHNvY2lldHkgb2Yg

Y2FyZGlvbG9neSBhbmQgb3RoZXIgc29jaWV0aWVzIG9uIGNhcmRpb3Zhc2N1bGFyIGRpc2Vhc2Ug

cHJldmVudGlvbiBpbiBjbGluaWNhbCBwcmFjdGljZSAoY29uc3RpdHV0ZWQgYnkgcmVwcmVzZW50

YXRpdmVzIG9mIG5pbmUgc29jaWV0aWVzIGFuZCBieSBpbnZpdGVkIGV4cGVydHMpPC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPkludGVybmF0aW9uYWwgam91cm5hbCBvZiBiZWhhdmlvcmFsIG1lZGlj

aW5lPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5JbnQgSiBCZWhhdiBNZWQ8L2FsdC10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5JbnRlcm5hdGlvbmFsIGpvdXJuYWwg

b2YgYmVoYXZpb3JhbCBtZWRpY2luZTwvZnVsbC10aXRsZT48YWJici0xPkludCBKIEJlaGF2IE1l

ZDwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SW50ZXJu

YXRpb25hbCBqb3VybmFsIG9mIGJlaGF2aW9yYWwgbWVkaWNpbmU8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5JbnQgSiBCZWhhdiBNZWQ8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz40MDMtODg8

L3BhZ2VzPjx2b2x1bWU+MTk8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZGF0ZXM+PHllYXI+

MjAxMjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjE1MzItNzU1OCAoRWxlY3Ryb25pYykmI3hEOzEwNzAtNTUwMyAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MjMwOTM0NzM8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5QcmFj

dGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5n

dWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QZXJrPC9BdXRob3I+PFllYXI+MjAxMjwvWWVhcj48UmVj

TnVtPjQyMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oODYpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjQyMDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDIwPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5QZXJrLCBKLjwvYXV0aG9yPjxhdXRob3I+RGUg

QmFja2VyLCBHLjwvYXV0aG9yPjxhdXRob3I+R29obGtlLCBILjwvYXV0aG9yPjxhdXRob3I+R3Jh

aGFtLCBJLjwvYXV0aG9yPjxhdXRob3I+UmVpbmVyLCBaLjwvYXV0aG9yPjxhdXRob3I+VmVyc2No

dXJlbiwgVy4gTS48L2F1dGhvcj48YXV0aG9yPkFsYnVzLCBDLjwvYXV0aG9yPjxhdXRob3I+QmVu

bGlhbiwgUC48L2F1dGhvcj48YXV0aG9yPkJveXNlbiwgRy48L2F1dGhvcj48YXV0aG9yPkNpZmtv

dmEsIFIuPC9hdXRob3I+PGF1dGhvcj5EZWF0b24sIEMuPC9hdXRob3I+PGF1dGhvcj5FYnJhaGlt

LCBTLjwvYXV0aG9yPjxhdXRob3I+RmlzaGVyLCBNLjwvYXV0aG9yPjxhdXRob3I+R2VybWFubywg

Ry48L2F1dGhvcj48YXV0aG9yPkhvYmJzLCBSLjwvYXV0aG9yPjxhdXRob3I+SG9lcywgQS48L2F1

dGhvcj48YXV0aG9yPkthcmFkZW5peiwgUy48L2F1dGhvcj48YXV0aG9yPk1lenphbmksIEEuPC9h

dXRob3I+PGF1dGhvcj5QcmVzY290dCwgRS48L2F1dGhvcj48YXV0aG9yPlJ5ZGVuLCBMLjwvYXV0

aG9yPjxhdXRob3I+U2NoZXJlciwgTS48L2F1dGhvcj48YXV0aG9yPlN5dmFubmUsIE0uPC9hdXRo

b3I+PGF1dGhvcj5PcCBSZWltZXIsIFcuIEouPC9hdXRob3I+PGF1dGhvcj5WcmludHMsIEMuPC9h

dXRob3I+PGF1dGhvcj5Xb29kLCBELjwvYXV0aG9yPjxhdXRob3I+WmFtb3Jhbm8sIEouIEwuPC9h

dXRob3I+PGF1dGhvcj5aYW5uYWQsIEYuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3Jz

PjxhdXRoLWFkZHJlc3M+U2Nob29sIG9mIEhlYWx0aCBhbmQgQ2FyaW5nIFNjaWVuY2VzLCBMaW5u

YWV1cyBVbml2ZXJzaXR5LCBLYWxtYXIsIFN3ZWRlbi4gam9lcC5wZXJrQGxudS5zZTwvYXV0aC1h

ZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkV1cm9wZWFuIGd1aWRlbGluZXMgb24gY2FyZGlvdmFzY3Vs

YXIgZGlzZWFzZSBwcmV2ZW50aW9uIGluIGNsaW5pY2FsIHByYWN0aWNlICh2ZXJzaW9uIDIwMTIp

IDogdGhlIGZpZnRoIGpvaW50IHRhc2sgZm9yY2Ugb2YgdGhlIEV1cm9wZWFuIHNvY2lldHkgb2Yg

Y2FyZGlvbG9neSBhbmQgb3RoZXIgc29jaWV0aWVzIG9uIGNhcmRpb3Zhc2N1bGFyIGRpc2Vhc2Ug

cHJldmVudGlvbiBpbiBjbGluaWNhbCBwcmFjdGljZSAoY29uc3RpdHV0ZWQgYnkgcmVwcmVzZW50

YXRpdmVzIG9mIG5pbmUgc29jaWV0aWVzIGFuZCBieSBpbnZpdGVkIGV4cGVydHMpPC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPkludGVybmF0aW9uYWwgam91cm5hbCBvZiBiZWhhdmlvcmFsIG1lZGlj

aW5lPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5JbnQgSiBCZWhhdiBNZWQ8L2FsdC10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5JbnRlcm5hdGlvbmFsIGpvdXJuYWwg

b2YgYmVoYXZpb3JhbCBtZWRpY2luZTwvZnVsbC10aXRsZT48YWJici0xPkludCBKIEJlaGF2IE1l

ZDwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SW50ZXJu

YXRpb25hbCBqb3VybmFsIG9mIGJlaGF2aW9yYWwgbWVkaWNpbmU8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5JbnQgSiBCZWhhdiBNZWQ8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz40MDMtODg8

L3BhZ2VzPjx2b2x1bWU+MTk8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZGF0ZXM+PHllYXI+

MjAxMjwveWVhcj48cHViLWRhdGVzPjxkYXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVz

Pjxpc2JuPjE1MzItNzU1OCAoRWxlY3Ryb25pYykmI3hEOzEwNzAtNTUwMyAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MjMwOTM0NzM8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5QcmFj

dGljZSBHdWlkZWxpbmU8L3dvcmstdHlwZT48dXJscz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5n

dWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (86). In addition to drugs, referral to smoking cessation clinics to provide and support behavioural interventions improves the likelihood of success. Dyslipidaemia (Level C)An abnormal lipid profile is prevalent in SLE and has also been reported in some studies in pSS PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Mb2RkZTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+PFJl

Y051bT40MjE8L1JlY051bT48RGlzcGxheVRleHQ+KDg3LCA4OCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDIxPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40MjE8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkxvZGRlLCBCLiBNLjwvYXV0aG9yPjxh

dXRob3I+U2Fua2FyLCBWLjwvYXV0aG9yPjxhdXRob3I+S29rLCBNLiBSLjwvYXV0aG9yPjxhdXRo

b3I+TGVha2FuLCBSLiBBLjwvYXV0aG9yPjxhdXRob3I+VGFrLCBQLiBQLjwvYXV0aG9yPjxhdXRo

b3I+UGlsbGVtZXIsIFMuIFIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRo

LWFkZHJlc3M+R2VuZSBUaGVyYXB5IGFuZCBUaGVyYXBldXRpY3MgQnJhbmNoL05hdGlvbmFsIElu

c3RpdHV0ZSBvZiBEZW50YWwgYW5kIENyYW5pb2ZhY2lhbCBSZXNlYXJjaCwgTmF0aW9uYWwgSW5z

dGl0dXRlcyBvZiBIZWFsdGgsIDEwIENlbnRlciBEcml2ZSwgUm9vbSAxTjExNCwgTVNDIDExOTAs

IEJldGhlc2RhLCBNRCAyMDg5Mi0xMTkwLCBVU0EuIGJsb2RkZUBtYWlsLm5paC5nb3Y8L2F1dGgt

YWRkcmVzcz48dGl0bGVzPjx0aXRsZT5TZXJ1bSBsaXBpZCBsZXZlbHMgaW4gU2pvZ3JlbiZhcG9z

O3Mgc3luZHJvbWU8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+UmhldW1hdG9sb2d5IChPeGZvcmQs

IEVuZ2xhbmQpPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9y

ZCk8L2FsdC10aXRsZT48L3RpdGxlcz48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UmhldW1h

dG9sb2d5IChPeGZvcmQpPC9mdWxsLXRpdGxlPjxhYmJyLTE+UmhldW1hdG9sb2d5PC9hYmJyLTE+

PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NDgxLTQ8L3BhZ2VzPjx2b2x1bWU+NDU8L3ZvbHVtZT48

bnVtYmVyPjQ8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNjwveWVhcj48cHViLWRhdGVzPjxkYXRl

PkFwcjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NjItMDMyNCAoUHJpbnQpJiN4

RDsxNDYyLTAzMjQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE2MzAzODIxPC9hY2Nl

c3Npb24tbnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTm9uLVUuUy4gR292JmFwb3M7

dDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwv

cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3Jk

PjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkdlcmxpPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48UmVj

TnVtPjQyMjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NDIyPC9yZWMtbnVtYmVyPjxmb3Jl

aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBm

ZTlkZDByejVkIj40MjI8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h

bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkdl

cmxpLCBSLjwvYXV0aG9yPjxhdXRob3I+QmFydG9sb25pIEJvY2NpLCBFLjwvYXV0aG9yPjxhdXRo

b3I+VmF1ZG8sIEcuPC9hdXRob3I+PGF1dGhvcj5NYXJjaGVzaSwgUy48L2F1dGhvcj48YXV0aG9y

PlZpdGFsaSwgQy48L2F1dGhvcj48YXV0aG9yPlNob2VuZmVsZCwgWS48L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+VHJhZGl0aW9uYWwgY2FyZGlvdmFzY3Vs

YXIgcmlzayBmYWN0b3JzIGluIHByaW1hcnkgU2pvZ3JlbiZhcG9zO3Mgc3luZHJvbWUtLXJvbGUg

b2YgZHlzbGlwaWRhZW1pYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5SaGV1bWF0b2xvZ3kgKE94

Zm9yZCwgRW5nbGFuZCk8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPlJoZXVtYXRvbG9neSAo

T3hmb3JkKTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5S

aGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2Z1bGwtdGl0bGU+PGFiYnItMT5SaGV1bWF0b2xvZ3k8L2Fi

YnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNTgwLTE7IGF1dGhvciByZXBseSAxNTgxLTI8

L3BhZ2VzPjx2b2x1bWU+NDU8L3ZvbHVtZT48bnVtYmVyPjEyPC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5EZWM8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4xNDYyLTAzMjQgKFByaW50KSYjeEQ7MTQ2Mi0wMzI0IChMaW5raW5nKTwvaXNibj48

YWNjZXNzaW9uLW51bT4xNzA0MzA0MzwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPkNvbW1lbnQm

I3hEO0xldHRlcjwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3Zp

ZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdl

PjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Mb2RkZTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+PFJl

Y051bT40MjE8L1JlY051bT48RGlzcGxheVRleHQ+KDg3LCA4OCk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+NDIxPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj40MjE8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkxvZGRlLCBCLiBNLjwvYXV0aG9yPjxh

dXRob3I+U2Fua2FyLCBWLjwvYXV0aG9yPjxhdXRob3I+S29rLCBNLiBSLjwvYXV0aG9yPjxhdXRo

b3I+TGVha2FuLCBSLiBBLjwvYXV0aG9yPjxhdXRob3I+VGFrLCBQLiBQLjwvYXV0aG9yPjxhdXRo

b3I+UGlsbGVtZXIsIFMuIFIuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRo

LWFkZHJlc3M+R2VuZSBUaGVyYXB5IGFuZCBUaGVyYXBldXRpY3MgQnJhbmNoL05hdGlvbmFsIElu

c3RpdHV0ZSBvZiBEZW50YWwgYW5kIENyYW5pb2ZhY2lhbCBSZXNlYXJjaCwgTmF0aW9uYWwgSW5z

dGl0dXRlcyBvZiBIZWFsdGgsIDEwIENlbnRlciBEcml2ZSwgUm9vbSAxTjExNCwgTVNDIDExOTAs

IEJldGhlc2RhLCBNRCAyMDg5Mi0xMTkwLCBVU0EuIGJsb2RkZUBtYWlsLm5paC5nb3Y8L2F1dGgt

YWRkcmVzcz48dGl0bGVzPjx0aXRsZT5TZXJ1bSBsaXBpZCBsZXZlbHMgaW4gU2pvZ3JlbiZhcG9z

O3Mgc3luZHJvbWU8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+UmhldW1hdG9sb2d5IChPeGZvcmQs

IEVuZ2xhbmQpPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5SaGV1bWF0b2xvZ3kgKE94Zm9y

ZCk8L2FsdC10aXRsZT48L3RpdGxlcz48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UmhldW1h

dG9sb2d5IChPeGZvcmQpPC9mdWxsLXRpdGxlPjxhYmJyLTE+UmhldW1hdG9sb2d5PC9hYmJyLTE+

PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NDgxLTQ8L3BhZ2VzPjx2b2x1bWU+NDU8L3ZvbHVtZT48

bnVtYmVyPjQ8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNjwveWVhcj48cHViLWRhdGVzPjxkYXRl

PkFwcjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NjItMDMyNCAoUHJpbnQpJiN4

RDsxNDYyLTAzMjQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE2MzAzODIxPC9hY2Nl

c3Npb24tbnVtPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTm9uLVUuUy4gR292JmFwb3M7

dDwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPk5MTTwv

cmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3Jk

PjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkdlcmxpPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48UmVj

TnVtPjQyMjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NDIyPC9yZWMtbnVtYmVyPjxmb3Jl

aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBm

ZTlkZDByejVkIj40MjI8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h

bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkdl

cmxpLCBSLjwvYXV0aG9yPjxhdXRob3I+QmFydG9sb25pIEJvY2NpLCBFLjwvYXV0aG9yPjxhdXRo

b3I+VmF1ZG8sIEcuPC9hdXRob3I+PGF1dGhvcj5NYXJjaGVzaSwgUy48L2F1dGhvcj48YXV0aG9y

PlZpdGFsaSwgQy48L2F1dGhvcj48YXV0aG9yPlNob2VuZmVsZCwgWS48L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+VHJhZGl0aW9uYWwgY2FyZGlvdmFzY3Vs

YXIgcmlzayBmYWN0b3JzIGluIHByaW1hcnkgU2pvZ3JlbiZhcG9zO3Mgc3luZHJvbWUtLXJvbGUg

b2YgZHlzbGlwaWRhZW1pYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5SaGV1bWF0b2xvZ3kgKE94

Zm9yZCwgRW5nbGFuZCk8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPlJoZXVtYXRvbG9neSAo

T3hmb3JkKTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5S

aGV1bWF0b2xvZ3kgKE94Zm9yZCk8L2Z1bGwtdGl0bGU+PGFiYnItMT5SaGV1bWF0b2xvZ3k8L2Fi

YnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNTgwLTE7IGF1dGhvciByZXBseSAxNTgxLTI8

L3BhZ2VzPjx2b2x1bWU+NDU8L3ZvbHVtZT48bnVtYmVyPjEyPC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5EZWM8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4xNDYyLTAzMjQgKFByaW50KSYjeEQ7MTQ2Mi0wMzI0IChMaW5raW5nKTwvaXNibj48

YWNjZXNzaW9uLW51bT4xNzA0MzA0MzwvYWNjZXNzaW9uLW51bT48d29yay10eXBlPkNvbW1lbnQm

I3hEO0xldHRlcjwvd29yay10eXBlPjx1cmxzPjwvdXJscz48cmVtb3RlLWRhdGFiYXNlLXByb3Zp

ZGVyPk5MTTwvcmVtb3RlLWRhdGFiYXNlLXByb3ZpZGVyPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdl

PjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA (87, 88). A meta-analysis of 3 trials in SLE found that despite significant reductions in cholesterol with statin therapy, measures of subclinical atherosclerosis did not improve ADDIN EN.CITE <EndNote><Cite><Author>Ye</Author><Year>2013</Year><RecNum>526</RecNum><DisplayText>(89)</DisplayText><record><rec-number>526</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">526</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ye, Y.</author><author>Zhao, X.</author><author>Xie, H.</author><author>Tian, Z.</author><author>Zhang, S.</author></authors></contributors><titles><title>Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials</title><secondary-title>Int J Cardiol</secondary-title><alt-title>Int J Cardiol</alt-title></titles><periodical><full-title>Int J Cardiol</full-title><abbr-1>International journal of cardiology</abbr-1></periodical><alt-periodical><full-title>Int J Cardiol</full-title><abbr-1>International journal of cardiology</abbr-1></alt-periodical><pages>301-3</pages><volume>167</volume><number>1</number><dates><year>2013</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>1874-1754 (Electronic)&#xD;0167-5273 (Linking)</isbn><accession-num>23084817</accession-num><work-type>Letter&#xD;Meta-Analysis&#xD;Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(89). Therefore, whilst ‘all’ patients with SLE should not automatically be prescribed a statin, we believe that statins still have a key role in CTD patients to enable patients to achieve their ideal target LDL. We recommend that CTD patients have a baseline and annual lipid profile measured. If dyslipidaemia is discovered, treatment should be initiated and the lipid profile repeated to ensure normalisation. Therapeutic lifestyle changes, including reduction in dietary saturated fat content, weight loss and moderate physical activity should be employed and may be sufficient to enable the patient to achieve an ideal LDL in those with moderate LDL elevations, i.e. LDL of 2.6 to 3.4mmol/L. This step is particularly relevant in SLE as steroid dose modification and the introduction of an antimalarial (where appropriate) may both add to lipid lowering in such patients. When the LDL cholesterol is > 3.4 mmol/L, unless the patient is on high dose glucocorticoids, it is unlikely that lifestyle modification alone will be sufficient to achieve an ideal LDL; such patients most likely will require statin therapy. The Adult Treatment Panel III guidelines recommend an LDL target of 2.6mmol/L for diabetic patients ADDIN EN.CITE <EndNote><Cite><Author>Stone</Author><Year>2005</Year><RecNum>435</RecNum><DisplayText>(90)</DisplayText><record><rec-number>435</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">435</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stone, N. J.</author><author>Bilek, S.</author><author>Rosenbaum, S.</author></authors></contributors><auth-address>Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. n-stone@northwestern.edu</auth-address><titles><title>Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options</title><secondary-title>Am J Cardiol</secondary-title><alt-title>Am J Cardiol</alt-title></titles><periodical><full-title>Am J Cardiol</full-title><abbr-1>The American journal of cardiology</abbr-1></periodical><alt-periodical><full-title>Am J Cardiol</full-title><abbr-1>The American journal of cardiology</abbr-1></alt-periodical><pages>53E-59E</pages><volume>96</volume><number>4A</number><dates><year>2005</year><pub-dates><date>Aug 22</date></pub-dates></dates><isbn>0002-9149 (Print)&#xD;0002-9149 (Linking)</isbn><accession-num>16098845</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(90). Given the high CV risk nature of SLE, we recommend using these diabetic treatment targets. If LDL is >2.6mmol/L despite lifestyle changes, lipid lowering therapy should be commenced and titrated according to response ADDIN EN.CITE <EndNote><Cite><Author>Wajed</Author><Year>2004</Year><RecNum>415</RecNum><DisplayText>(77)</DisplayText><record><rec-number>415</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">415</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wajed, J.</author><author>Ahmad, Y.</author><author>Durrington, P. N.</author><author>Bruce, I. N.</author></authors></contributors><auth-address>The University of Manchester, Rheumatism Research Centre, Central Manchester and Manchester Children&apos;s University Hospitals NHS Trust, Oxford Road, Manchester M13 9WL, UK.</auth-address><titles><title>Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management</title><secondary-title>Rheumatology (Oxford, England)</secondary-title><alt-title>Rheumatology (Oxford)</alt-title></titles><alt-periodical><full-title>Rheumatology (Oxford)</full-title><abbr-1>Rheumatology</abbr-1></alt-periodical><pages>7-12</pages><volume>43</volume><number>1</number><dates><year>2004</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1462-0324 (Print)&#xD;1462-0324 (Linking)</isbn><accession-num>12867578</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(77). Currently, we recommend following lipid target guidelines as for the general population in patients with other CTDs. Obesity and the metabolic syndrome (MetS) (Level C)We recommend that weight, height and calculation of body mass index (BMI) should be measured at baseline. Measurement of waist circumference gives additional information about CV risk. A BMI of <25Kg/m2 and a waist circumference of < 40 inches for males and <35 inches for females are ideal targets in Caucasian patients. If patients are overweight or have a high waist circumference, advice regarding a healthy diet low in saturated fat and the importance of regular exercise should be given. MetS in SLE can be present without central obesity. Therefore it is important to consider this diagnosis in patients whose waist circumference is normal but have clustering of other factors PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJrZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS

ZWNOdW0+MzQ3PC9SZWNOdW0+PERpc3BsYXlUZXh0PigzMSwgMzIpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjM0NzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+MzQ3PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5QYXJrZXIsIEIuPC9hdXRob3I+PGF1

dGhvcj5Vcm93aXR6LCBNLiBCLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhv

cj48YXV0aG9yPkx1bnQsIE0uPC9hdXRob3I+PGF1dGhvcj5Eb25uLCBSLjwvYXV0aG9yPjxhdXRo

b3I+QmFlLCBTLiBDLjwvYXV0aG9yPjxhdXRob3I+U2FuY2hlei1HdWVycmVybywgSi48L2F1dGhv

cj48YXV0aG9yPlJvbWVyby1EaWF6LCBKLjwvYXV0aG9yPjxhdXRob3I+R29yZG9uLCBDLjwvYXV0

aG9yPjxhdXRob3I+V2FsbGFjZSwgRC4gSi48L2F1dGhvcj48YXV0aG9yPkNsYXJrZSwgQS4gRS48

L2F1dGhvcj48YXV0aG9yPkJlcm5hdHNreSwgUy48L2F1dGhvcj48YXV0aG9yPkdpbnpsZXIsIEUu

IE0uPC9hdXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC4gQS48L2F1dGhvcj48YXV0aG9yPlJhaG1h

biwgQS48L2F1dGhvcj48YXV0aG9yPk1lcnJpbGwsIEouIFQuPC9hdXRob3I+PGF1dGhvcj5BbGFy

Y29uLCBHLiBTLjwvYXV0aG9yPjxhdXRob3I+RmVzc2xlciwgQi4gSi48L2F1dGhvcj48YXV0aG9y

PkZvcnRpbiwgUC4gUi48L2F1dGhvcj48YXV0aG9yPkhhbmx5LCBKLiBHLjwvYXV0aG9yPjxhdXRo

b3I+UGV0cmksIE0uPC9hdXRob3I+PGF1dGhvcj5TdGVpbnNzb24sIEsuPC9hdXRob3I+PGF1dGhv

cj5Eb29sZXksIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5NYW56aSwgUy48L2F1dGhvcj48YXV0aG9y

PktoYW1hc2h0YSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPlJhbXNleS1Hb2xkbWFuLCBSLjwvYXV0

aG9yPjxhdXRob3I+Wm9tYSwgQS4gQS48L2F1dGhvcj48YXV0aG9yPlN0dXJmZWx0LCBHLiBLLjwv

YXV0aG9yPjxhdXRob3I+Tml2ZWQsIE8uPC9hdXRob3I+PGF1dGhvcj5BcmFub3csIEMuPC9hdXRo

b3I+PGF1dGhvcj5NYWNrYXksIE0uPC9hdXRob3I+PGF1dGhvcj5SYW1vcy1DYXNhbHMsIE0uPC9h

dXRob3I+PGF1dGhvcj52YW4gVm9sbGVuaG92ZW4sIFIuIEYuPC9hdXRob3I+PGF1dGhvcj5LYWx1

bmlhbiwgSy4gQy48L2F1dGhvcj48YXV0aG9yPlJ1aXotSXJhc3RvcnphLCBHLjwvYXV0aG9yPjxh

dXRob3I+TGltLCBTLiBTLjwvYXV0aG9yPjxhdXRob3I+S2FtZW4sIEQuIEwuPC9hdXRob3I+PGF1

dGhvcj5QZXNjaGtlbiwgQy4gQS48L2F1dGhvcj48YXV0aG9yPkluYW5jLCBNLjwvYXV0aG9yPjxh

dXRob3I+QnJ1Y2UsIEkuIE4uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRs

ZXM+PHRpdGxlPkltcGFjdCBvZiBlYXJseSBkaXNlYXNlIGZhY3RvcnMgb24gbWV0YWJvbGljIHN5

bmRyb21lIGluIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM6IGRhdGEgZnJvbSBhbiBpbnRl

cm5hdGlvbmFsIGluY2VwdGlvbiBjb2hvcnQ8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFJo

ZXVtIERpczwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRp

YyBkaXNlYXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTUzMC02PC9wYWdlcz48dm9s

dW1lPjc0PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTU8L3llYXI+

PC9kYXRlcz48aXNibj4xNDY4LTIwNjAgKEVsZWN0cm9uaWMpJiN4RDswMDAzLTQ5NjcgKExpbmtp

bmcpPC9pc2JuPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTiBJIEggLCBFeHRyYW11cmFs

JiN4RDtSZXNlYXJjaCBTdXBwb3J0LCBOb24tVSBTIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJs

cz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+UGFya2VyPC9BdXRob3I+PFll

YXI+MjAxMDwvWWVhcj48UmVjTnVtPjM0NjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MzQ2

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iMGV6NXNlOWVi

OXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDY8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVm

LXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48

YXV0aG9ycz48YXV0aG9yPlBhcmtlciwgQi48L2F1dGhvcj48YXV0aG9yPkJydWNlLCBJLiBOLjwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkFSQyBFcGlkZW1p

b2xvZ3kgVW5pdCwgTWFuY2hlc3RlciBBY2FkZW1pYyBIZWFsdGggU2NpZW5jZXMgQ2VudHJlLCBU

aGUgVW5pdmVyc2l0eSBvZiBNYW5jaGVzdGVyIFN0b3Bmb3JkIEJ1aWxkaW5nLCBPeGZvcmQgUm9h

ZCwgTWFuY2hlc3RlciBNMTMgOVBULCBVSy48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5U

aGUgbWV0YWJvbGljIHN5bmRyb21lIGluIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM8L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+UmhldW0gRGlzIENsaW4gTm9ydGggQW08L3NlY29uZGFyeS10

aXRsZT48YWx0LXRpdGxlPlJoZXVtIERpcyBDbGluIE5vcnRoIEFtPC9hbHQtdGl0bGU+PC90aXRs

ZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UmhldW0gRGlzIENsaW4gTm9ydGggQW08L2Z1bGwt

dGl0bGU+PGFiYnItMT5SaGV1bWF0aWMgZGlzZWFzZXMgY2xpbmljcyBvZiBOb3J0aCBBbWVyaWNh

PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5SaGV1bSBE

aXMgQ2xpbiBOb3J0aCBBbTwvZnVsbC10aXRsZT48YWJici0xPlJoZXVtYXRpYyBkaXNlYXNlcyBj

bGluaWNzIG9mIE5vcnRoIEFtZXJpY2E8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz44

MS05NywgdmlpaTwvcGFnZXM+PHZvbHVtZT4zNjwvdm9sdW1lPjxudW1iZXI+MTwvbnVtYmVyPjxk

YXRlcz48eWVhcj4yMDEwPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RmViPC9kYXRlPjwvcHViLWRh

dGVzPjwvZGF0ZXM+PGlzYm4+MTU1OC0zMTYzIChFbGVjdHJvbmljKSYjeEQ7MDg4OS04NTdYIChM

aW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMDIwMjU5MjwvYWNjZXNzaW9uLW51bT48dXJs

cz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJrZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS

ZWNOdW0+MzQ3PC9SZWNOdW0+PERpc3BsYXlUZXh0PigzMSwgMzIpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjM0NzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+MzQ3PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5QYXJrZXIsIEIuPC9hdXRob3I+PGF1

dGhvcj5Vcm93aXR6LCBNLiBCLjwvYXV0aG9yPjxhdXRob3I+R2xhZG1hbiwgRC4gRC48L2F1dGhv

cj48YXV0aG9yPkx1bnQsIE0uPC9hdXRob3I+PGF1dGhvcj5Eb25uLCBSLjwvYXV0aG9yPjxhdXRo

b3I+QmFlLCBTLiBDLjwvYXV0aG9yPjxhdXRob3I+U2FuY2hlei1HdWVycmVybywgSi48L2F1dGhv

cj48YXV0aG9yPlJvbWVyby1EaWF6LCBKLjwvYXV0aG9yPjxhdXRob3I+R29yZG9uLCBDLjwvYXV0

aG9yPjxhdXRob3I+V2FsbGFjZSwgRC4gSi48L2F1dGhvcj48YXV0aG9yPkNsYXJrZSwgQS4gRS48

L2F1dGhvcj48YXV0aG9yPkJlcm5hdHNreSwgUy48L2F1dGhvcj48YXV0aG9yPkdpbnpsZXIsIEUu

IE0uPC9hdXRob3I+PGF1dGhvcj5Jc2VuYmVyZywgRC4gQS48L2F1dGhvcj48YXV0aG9yPlJhaG1h

biwgQS48L2F1dGhvcj48YXV0aG9yPk1lcnJpbGwsIEouIFQuPC9hdXRob3I+PGF1dGhvcj5BbGFy

Y29uLCBHLiBTLjwvYXV0aG9yPjxhdXRob3I+RmVzc2xlciwgQi4gSi48L2F1dGhvcj48YXV0aG9y

PkZvcnRpbiwgUC4gUi48L2F1dGhvcj48YXV0aG9yPkhhbmx5LCBKLiBHLjwvYXV0aG9yPjxhdXRo

b3I+UGV0cmksIE0uPC9hdXRob3I+PGF1dGhvcj5TdGVpbnNzb24sIEsuPC9hdXRob3I+PGF1dGhv

cj5Eb29sZXksIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5NYW56aSwgUy48L2F1dGhvcj48YXV0aG9y

PktoYW1hc2h0YSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPlJhbXNleS1Hb2xkbWFuLCBSLjwvYXV0

aG9yPjxhdXRob3I+Wm9tYSwgQS4gQS48L2F1dGhvcj48YXV0aG9yPlN0dXJmZWx0LCBHLiBLLjwv

YXV0aG9yPjxhdXRob3I+Tml2ZWQsIE8uPC9hdXRob3I+PGF1dGhvcj5BcmFub3csIEMuPC9hdXRo

b3I+PGF1dGhvcj5NYWNrYXksIE0uPC9hdXRob3I+PGF1dGhvcj5SYW1vcy1DYXNhbHMsIE0uPC9h

dXRob3I+PGF1dGhvcj52YW4gVm9sbGVuaG92ZW4sIFIuIEYuPC9hdXRob3I+PGF1dGhvcj5LYWx1

bmlhbiwgSy4gQy48L2F1dGhvcj48YXV0aG9yPlJ1aXotSXJhc3RvcnphLCBHLjwvYXV0aG9yPjxh

dXRob3I+TGltLCBTLiBTLjwvYXV0aG9yPjxhdXRob3I+S2FtZW4sIEQuIEwuPC9hdXRob3I+PGF1

dGhvcj5QZXNjaGtlbiwgQy4gQS48L2F1dGhvcj48YXV0aG9yPkluYW5jLCBNLjwvYXV0aG9yPjxh

dXRob3I+QnJ1Y2UsIEkuIE4uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRs

ZXM+PHRpdGxlPkltcGFjdCBvZiBlYXJseSBkaXNlYXNlIGZhY3RvcnMgb24gbWV0YWJvbGljIHN5

bmRyb21lIGluIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM6IGRhdGEgZnJvbSBhbiBpbnRl

cm5hdGlvbmFsIGluY2VwdGlvbiBjb2hvcnQ8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFJo

ZXVtIERpczwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkFubiBSaGV1bSBEaXM8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2YgdGhlIHJoZXVtYXRp

YyBkaXNlYXNlczwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTUzMC02PC9wYWdlcz48dm9s

dW1lPjc0PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTU8L3llYXI+

PC9kYXRlcz48aXNibj4xNDY4LTIwNjAgKEVsZWN0cm9uaWMpJiN4RDswMDAzLTQ5NjcgKExpbmtp

bmcpPC9pc2JuPjx3b3JrLXR5cGU+UmVzZWFyY2ggU3VwcG9ydCwgTiBJIEggLCBFeHRyYW11cmFs

JiN4RDtSZXNlYXJjaCBTdXBwb3J0LCBOb24tVSBTIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJs

cz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+UGFya2VyPC9BdXRob3I+PFll

YXI+MjAxMDwvWWVhcj48UmVjTnVtPjM0NjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MzQ2

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iMGV6NXNlOWVi

OXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDY8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVm

LXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48

YXV0aG9ycz48YXV0aG9yPlBhcmtlciwgQi48L2F1dGhvcj48YXV0aG9yPkJydWNlLCBJLiBOLjwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkFSQyBFcGlkZW1p

b2xvZ3kgVW5pdCwgTWFuY2hlc3RlciBBY2FkZW1pYyBIZWFsdGggU2NpZW5jZXMgQ2VudHJlLCBU

aGUgVW5pdmVyc2l0eSBvZiBNYW5jaGVzdGVyIFN0b3Bmb3JkIEJ1aWxkaW5nLCBPeGZvcmQgUm9h

ZCwgTWFuY2hlc3RlciBNMTMgOVBULCBVSy48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5U

aGUgbWV0YWJvbGljIHN5bmRyb21lIGluIHN5c3RlbWljIGx1cHVzIGVyeXRoZW1hdG9zdXM8L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+UmhldW0gRGlzIENsaW4gTm9ydGggQW08L3NlY29uZGFyeS10

aXRsZT48YWx0LXRpdGxlPlJoZXVtIERpcyBDbGluIE5vcnRoIEFtPC9hbHQtdGl0bGU+PC90aXRs

ZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+UmhldW0gRGlzIENsaW4gTm9ydGggQW08L2Z1bGwt

dGl0bGU+PGFiYnItMT5SaGV1bWF0aWMgZGlzZWFzZXMgY2xpbmljcyBvZiBOb3J0aCBBbWVyaWNh

PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5SaGV1bSBE

aXMgQ2xpbiBOb3J0aCBBbTwvZnVsbC10aXRsZT48YWJici0xPlJoZXVtYXRpYyBkaXNlYXNlcyBj

bGluaWNzIG9mIE5vcnRoIEFtZXJpY2E8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz44

MS05NywgdmlpaTwvcGFnZXM+PHZvbHVtZT4zNjwvdm9sdW1lPjxudW1iZXI+MTwvbnVtYmVyPjxk

YXRlcz48eWVhcj4yMDEwPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+RmViPC9kYXRlPjwvcHViLWRh

dGVzPjwvZGF0ZXM+PGlzYm4+MTU1OC0zMTYzIChFbGVjdHJvbmljKSYjeEQ7MDg4OS04NTdYIChM

aW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMDIwMjU5MjwvYWNjZXNzaW9uLW51bT48dXJs

cz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE.DATA (31, 32). There is evidence that the risk of MetS is reduced in patients taking hydroxychloroquine PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJrZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS

ZWNOdW0+MzQ3PC9SZWNOdW0+PERpc3BsYXlUZXh0PigzMik8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MzQ3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDc8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBhcmtlciwgQi48L2F1dGhvcj48YXV0aG9y

PlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PGF1dGhvcj5HbGFkbWFuLCBELiBELjwvYXV0aG9yPjxh

dXRob3I+THVudCwgTS48L2F1dGhvcj48YXV0aG9yPkRvbm4sIFIuPC9hdXRob3I+PGF1dGhvcj5C

YWUsIFMuIEMuPC9hdXRob3I+PGF1dGhvcj5TYW5jaGV6LUd1ZXJyZXJvLCBKLjwvYXV0aG9yPjxh

dXRob3I+Um9tZXJvLURpYXosIEouPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+

PGF1dGhvcj5XYWxsYWNlLCBELiBKLjwvYXV0aG9yPjxhdXRob3I+Q2xhcmtlLCBBLiBFLjwvYXV0

aG9yPjxhdXRob3I+QmVybmF0c2t5LCBTLjwvYXV0aG9yPjxhdXRob3I+R2luemxlciwgRS4gTS48

L2F1dGhvcj48YXV0aG9yPklzZW5iZXJnLCBELiBBLjwvYXV0aG9yPjxhdXRob3I+UmFobWFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+TWVycmlsbCwgSi4gVC48L2F1dGhvcj48YXV0aG9yPkFsYXJjb24s

IEcuIFMuPC9hdXRob3I+PGF1dGhvcj5GZXNzbGVyLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+Rm9y

dGluLCBQLiBSLjwvYXV0aG9yPjxhdXRob3I+SGFubHksIEouIEcuPC9hdXRob3I+PGF1dGhvcj5Q

ZXRyaSwgTS48L2F1dGhvcj48YXV0aG9yPlN0ZWluc3NvbiwgSy48L2F1dGhvcj48YXV0aG9yPkRv

b2xleSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPk1hbnppLCBTLjwvYXV0aG9yPjxhdXRob3I+S2hh

bWFzaHRhLCBNLiBBLjwvYXV0aG9yPjxhdXRob3I+UmFtc2V5LUdvbGRtYW4sIFIuPC9hdXRob3I+

PGF1dGhvcj5ab21hLCBBLiBBLjwvYXV0aG9yPjxhdXRob3I+U3R1cmZlbHQsIEcuIEsuPC9hdXRo

b3I+PGF1dGhvcj5OaXZlZCwgTy48L2F1dGhvcj48YXV0aG9yPkFyYW5vdywgQy48L2F1dGhvcj48

YXV0aG9yPk1hY2theSwgTS48L2F1dGhvcj48YXV0aG9yPlJhbW9zLUNhc2FscywgTS48L2F1dGhv

cj48YXV0aG9yPnZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9yPkthbHVuaWFu

LCBLLiBDLjwvYXV0aG9yPjxhdXRob3I+UnVpei1JcmFzdG9yemEsIEcuPC9hdXRob3I+PGF1dGhv

cj5MaW0sIFMuIFMuPC9hdXRob3I+PGF1dGhvcj5LYW1lbiwgRC4gTC48L2F1dGhvcj48YXV0aG9y

PlBlc2Noa2VuLCBDLiBBLjwvYXV0aG9yPjxhdXRob3I+SW5hbmMsIE0uPC9hdXRob3I+PGF1dGhv

cj5CcnVjZSwgSS4gTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48

dGl0bGU+SW1wYWN0IG9mIGVhcmx5IGRpc2Vhc2UgZmFjdG9ycyBvbiBtZXRhYm9saWMgc3luZHJv

bWUgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czogZGF0YSBmcm9tIGFuIGludGVybmF0

aW9uYWwgaW5jZXB0aW9uIGNvaG9ydDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm4gUmhldW0g

RGlzPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5u

IFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRp

c2Vhc2VzPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTMwLTY8L3BhZ2VzPjx2b2x1bWU+

NzQ8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxNTwveWVhcj48L2Rh

dGVzPjxpc2JuPjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8

L2lzYm4+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOIEkgSCAsIEV4dHJhbXVyYWwmI3hE

O1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VIFMgR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwv

dXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXJrZXI8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFyPjxS

ZWNOdW0+MzQ3PC9SZWNOdW0+PERpc3BsYXlUZXh0PigzMik8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MzQ3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zNDc8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBhcmtlciwgQi48L2F1dGhvcj48YXV0aG9y

PlVyb3dpdHosIE0uIEIuPC9hdXRob3I+PGF1dGhvcj5HbGFkbWFuLCBELiBELjwvYXV0aG9yPjxh

dXRob3I+THVudCwgTS48L2F1dGhvcj48YXV0aG9yPkRvbm4sIFIuPC9hdXRob3I+PGF1dGhvcj5C

YWUsIFMuIEMuPC9hdXRob3I+PGF1dGhvcj5TYW5jaGV6LUd1ZXJyZXJvLCBKLjwvYXV0aG9yPjxh

dXRob3I+Um9tZXJvLURpYXosIEouPC9hdXRob3I+PGF1dGhvcj5Hb3Jkb24sIEMuPC9hdXRob3I+

PGF1dGhvcj5XYWxsYWNlLCBELiBKLjwvYXV0aG9yPjxhdXRob3I+Q2xhcmtlLCBBLiBFLjwvYXV0

aG9yPjxhdXRob3I+QmVybmF0c2t5LCBTLjwvYXV0aG9yPjxhdXRob3I+R2luemxlciwgRS4gTS48

L2F1dGhvcj48YXV0aG9yPklzZW5iZXJnLCBELiBBLjwvYXV0aG9yPjxhdXRob3I+UmFobWFuLCBB

LjwvYXV0aG9yPjxhdXRob3I+TWVycmlsbCwgSi4gVC48L2F1dGhvcj48YXV0aG9yPkFsYXJjb24s

IEcuIFMuPC9hdXRob3I+PGF1dGhvcj5GZXNzbGVyLCBCLiBKLjwvYXV0aG9yPjxhdXRob3I+Rm9y

dGluLCBQLiBSLjwvYXV0aG9yPjxhdXRob3I+SGFubHksIEouIEcuPC9hdXRob3I+PGF1dGhvcj5Q

ZXRyaSwgTS48L2F1dGhvcj48YXV0aG9yPlN0ZWluc3NvbiwgSy48L2F1dGhvcj48YXV0aG9yPkRv

b2xleSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPk1hbnppLCBTLjwvYXV0aG9yPjxhdXRob3I+S2hh

bWFzaHRhLCBNLiBBLjwvYXV0aG9yPjxhdXRob3I+UmFtc2V5LUdvbGRtYW4sIFIuPC9hdXRob3I+

PGF1dGhvcj5ab21hLCBBLiBBLjwvYXV0aG9yPjxhdXRob3I+U3R1cmZlbHQsIEcuIEsuPC9hdXRo

b3I+PGF1dGhvcj5OaXZlZCwgTy48L2F1dGhvcj48YXV0aG9yPkFyYW5vdywgQy48L2F1dGhvcj48

YXV0aG9yPk1hY2theSwgTS48L2F1dGhvcj48YXV0aG9yPlJhbW9zLUNhc2FscywgTS48L2F1dGhv

cj48YXV0aG9yPnZhbiBWb2xsZW5ob3ZlbiwgUi4gRi48L2F1dGhvcj48YXV0aG9yPkthbHVuaWFu

LCBLLiBDLjwvYXV0aG9yPjxhdXRob3I+UnVpei1JcmFzdG9yemEsIEcuPC9hdXRob3I+PGF1dGhv

cj5MaW0sIFMuIFMuPC9hdXRob3I+PGF1dGhvcj5LYW1lbiwgRC4gTC48L2F1dGhvcj48YXV0aG9y

PlBlc2Noa2VuLCBDLiBBLjwvYXV0aG9yPjxhdXRob3I+SW5hbmMsIE0uPC9hdXRob3I+PGF1dGhv

cj5CcnVjZSwgSS4gTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48

dGl0bGU+SW1wYWN0IG9mIGVhcmx5IGRpc2Vhc2UgZmFjdG9ycyBvbiBtZXRhYm9saWMgc3luZHJv

bWUgaW4gc3lzdGVtaWMgbHVwdXMgZXJ5dGhlbWF0b3N1czogZGF0YSBmcm9tIGFuIGludGVybmF0

aW9uYWwgaW5jZXB0aW9uIGNvaG9ydDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm4gUmhldW0g

RGlzPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5u

IFJoZXVtIERpczwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiB0aGUgcmhldW1hdGljIGRp

c2Vhc2VzPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4xNTMwLTY8L3BhZ2VzPjx2b2x1bWU+

NzQ8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAxNTwveWVhcj48L2Rh

dGVzPjxpc2JuPjE0NjgtMjA2MCAoRWxlY3Ryb25pYykmI3hEOzAwMDMtNDk2NyAoTGlua2luZyk8

L2lzYm4+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOIEkgSCAsIEV4dHJhbXVyYWwmI3hE

O1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VIFMgR292JmFwb3M7dDwvd29yay10eXBlPjx1cmxzPjwv

dXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (32).Diabetes Mellitus (DM) (Level C)DM is more prevalent in CTD than the general population ADDIN EN.CITE <EndNote><Cite><Author>Bruce</Author><Year>2003</Year><RecNum>448</RecNum><DisplayText>(30)</DisplayText><record><rec-number>448</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">448</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bruce, I. N.</author><author>Urowitz, M. B.</author><author>Gladman, D. D.</author><author>Ibanez, D.</author><author>Steiner, G.</author></authors></contributors><auth-address>University of Toronto Lupus Clinic, and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.</auth-address><titles><title>Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study</title><secondary-title>Arthritis Rheum</secondary-title><alt-title>Arthritis Rheum</alt-title></titles><periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></periodical><alt-periodical><full-title>Arthritis Rheum</full-title><abbr-1>Arthritis and rheumatism</abbr-1></alt-periodical><pages>3159-67</pages><volume>48</volume><number>11</number><dates><year>2003</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0004-3591 (Print)&#xD;0004-3591 (Linking)</isbn><accession-num>14613278</accession-num><work-type>Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(30). Patients should therefore have a baseline and annual fasting glucose (and/or HbA1C) measured. A fasting glucose >7.0mmol/L and/or a random glucose > 11.1mmol/L confirms a diagnosis of DM. Such patients should be managed in conjunction with their primary care physician and /or a diabetologist. A glucose tolerance test should be considered in patients with a fasting glucose of >6.1mmol/L. Hydroxychloroquine can help to improve glycaemic control ADDIN EN.CITE <EndNote><Cite><Author>Gerstein</Author><Year>2002</Year><RecNum>433</RecNum><DisplayText>(91)</DisplayText><record><rec-number>433</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">433</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gerstein, H. C.</author><author>Thorpe, K. E.</author><author>Taylor, D. W.</author><author>Haynes, R. B.</author></authors></contributors><auth-address>Department of Medicine, McMaster University, Room 3V38, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5. gerstein@mcmaster.ca</auth-address><titles><title>The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial</title><secondary-title>Diabetes research and clinical practice</secondary-title><alt-title>Diabetes Res Clin Pract</alt-title></titles><periodical><full-title>Diabetes research and clinical practice</full-title><abbr-1>Diabetes Res Clin Pract</abbr-1></periodical><alt-periodical><full-title>Diabetes research and clinical practice</full-title><abbr-1>Diabetes Res Clin Pract</abbr-1></alt-periodical><pages>209-19</pages><volume>55</volume><number>3</number><dates><year>2002</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0168-8227 (Print)&#xD;0168-8227 (Linking)</isbn><accession-num>11850097</accession-num><work-type>Clinical Trial&#xD;Comparative Study&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(91). In established DM, the addition of an anti-malarial can potentially induce hypoglycaemia and the patient should be informed that their insulin or oral hypoglycaemic agent dosing may need some adjustment. Exercise prescription (Level C)Physicians should discuss the benefits of exercise with their CTD patients. Three to 5 hours of moderate intensity aerobic activity per week is recommended in healthy individuals. There is evidence of improvements in disease activity and vascular function with regular exercise in patients with CTD ADDIN EN.CITE <EndNote><Cite><Author>Barnes</Author><Year>2012</Year><RecNum>432</RecNum><DisplayText>(92)</DisplayText><record><rec-number>432</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">432</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barnes, J. N.</author><author>Tanaka, H.</author></authors></contributors><auth-address>Department of Anesthesiology, Mayo Clinic, Rochester, MN. barnes.jill@mayo.edu.</auth-address><titles><title>Cardiovascular benefits of habitual exercise in systemic lupus erythematosus: a review</title><secondary-title>The Physician and sportsmedicine</secondary-title><alt-title>Phys Sportsmed</alt-title></titles><periodical><full-title>The Physician and sportsmedicine</full-title><abbr-1>Phys Sportsmed</abbr-1></periodical><alt-periodical><full-title>The Physician and sportsmedicine</full-title><abbr-1>Phys Sportsmed</abbr-1></alt-periodical><pages>43-8</pages><volume>40</volume><number>3</number><dates><year>2012</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0091-3847 (Print)&#xD;0091-3847 (Linking)</isbn><accession-num>23528620</accession-num><work-type>Review</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(92). However, exercise recommendations should be individualized, as factors such as fatigue, CVD and musculoskeletal manifestations of the disease will alter patient’s ability to participate in regular physical activity.Disease-related risk factor modification (Level C)Early control of disease activity is very important. At each clinic visit, patients should have a renal function assessment and urine quantified for proteinuria. Chronic kidney disease is a CVD-risk equivalent so early diagnosis and management is imperative. All patients with a CTD should also be screened for the presence of co-existing antiphospholipid antibodies, i.e. antibodies to lupus anticoagulant, anti-cardiolipin antibodies and where available, β2-microglobulin, at time of diagnosis. The opportunity to rationalize corticosteroid dose and use should be taken at every clinical assessment to minimise negative CV effects. Use of hydroxychloroquine is recommended in all SLE patients unless there is a contraindication, as it is proposed to have cardio protective properties PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYWdkZXI8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NDEzPC9SZWNOdW0+PERpc3BsYXlUZXh0PigzOCwgNDMpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjQxMzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDEzPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5NYWdkZXIsIEwuIFMuPC9hdXRob3I+

PGF1dGhvcj5QZXRyaSwgTS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5EZXBhcnRtZW50IG9mIEVwaWRlbWlvbG9neSBhbmQgUHVibGljIEhlYWx0aCwgVW5p

dmVyc2l0eSBvZiBNYXJ5bGFuZCwgQmFsdGltb3JlLCBNRCAyMTIwMS0xNTk2LCBVU0EuIGxtYWdk

ZXJAZXBpLnVtYXJ5bGFuZC5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5JbmNpZGVu

Y2Ugb2YgYW5kIHJpc2sgZmFjdG9ycyBmb3IgYWR2ZXJzZSBjYXJkaW92YXNjdWxhciBldmVudHMg

YW1vbmcgcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzPC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPkFtIEogRXBpZGVtaW9sPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRs

ZT5BbSBKIEVwaWRlbWlvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkFtIEogRXBpZGVtaW9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW1lcmljYW4gam91cm5hbCBv

ZiBlcGlkZW1pb2xvZ3k8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkFtIEogRXBpZGVtaW9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW1lcmljYW4gam91cm5h

bCBvZiBlcGlkZW1pb2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz43MDgtMTk8

L3BhZ2VzPjx2b2x1bWU+MTc2PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMTI8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3QgMTU8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4xNDc2LTYyNTYgKEVsZWN0cm9uaWMpJiN4RDswMDAyLTkyNjIgKExpbmtpbmcp

PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzMDI0MTM3PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+

UmVzZWFyY2ggU3VwcG9ydCwgTi5JLkguLCBFeHRyYW11cmFsPC93b3JrLXR5cGU+PHVybHM+PC91

cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlk

ZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+

TmlrcG91cjwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+PFJlY051bT40Mjg8L1JlY051bT48cmVj

b3JkPjxyZWMtbnVtYmVyPjQyODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDI4PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtwb3VyLCBNLjwvYXV0aG9yPjxh

dXRob3I+VXJvd2l0eiwgTS4gQi48L2F1dGhvcj48YXV0aG9yPkliYW5leiwgRC48L2F1dGhvcj48

YXV0aG9yPkhhcnZleSwgUC4gSi48L2F1dGhvcj48YXV0aG9yPkdsYWRtYW4sIEQuIEQuPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+VW5pdmVyc2l0eSBvZiBU

b3JvbnRvIEx1cHVzIENsaW5pYyBhbmQgdGhlIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMg

aW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLCAzOTkg

QmF0aHVyc3QgU3RyZWV0LCBUb3JvbnRvLCBPTiwgTTVUIDJTOCwgQ2FuYWRhLjwvYXV0aC1hZGRy

ZXNzPjx0aXRsZXM+PHRpdGxlPkltcG9ydGFuY2Ugb2YgY3VtdWxhdGl2ZSBleHBvc3VyZSB0byBl

bGV2YXRlZCBjaG9sZXN0ZXJvbCBhbmQgYmxvb2QgcHJlc3N1cmUgaW4gZGV2ZWxvcG1lbnQgb2Yg

YXRoZXJvc2NsZXJvdGljIGNvcm9uYXJ5IGFydGVyeSBkaXNlYXNlIGluIHN5c3RlbWljIGx1cHVz

IGVyeXRoZW1hdG9zdXM6IGEgcHJvc3BlY3RpdmUgcHJvb2Ytb2YtY29uY2VwdCBjb2hvcnQgc3R1

ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QXJ0aHJpdGlzIFJlcyBUaGVyPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L2FsdC10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L2Z1bGwtdGl0bGU+PGFi

YnItMT5BcnRocml0aXMgcmVzZWFyY2ggJmFtcDsgdGhlcmFweTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlzIFJlcyBUaGVyPC9mdWxsLXRp

dGxlPjxhYmJyLTE+QXJ0aHJpdGlzIHJlc2VhcmNoICZhbXA7IHRoZXJhcHk8L2FiYnItMT48L2Fs

dC1wZXJpb2RpY2FsPjxwYWdlcz5SMTU2PC9wYWdlcz48dm9sdW1lPjEzPC92b2x1bWU+PG51bWJl

cj41PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PC9kYXRlcz48aXNibj4xNDc4LTYz

NjIgKEVsZWN0cm9uaWMpJiN4RDsxNDc4LTYzNTQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24t

bnVtPjIxOTU1NjUyPC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q29tcGFyYXRpdmUgU3R1ZHkm

I3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJs

cz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYWdkZXI8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NDEzPC9SZWNOdW0+PERpc3BsYXlUZXh0PigzOCwgNDMpPC9EaXNwbGF5VGV4dD48cmVj

b3JkPjxyZWMtbnVtYmVyPjQxMzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDEzPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5NYWdkZXIsIEwuIFMuPC9hdXRob3I+

PGF1dGhvcj5QZXRyaSwgTS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5EZXBhcnRtZW50IG9mIEVwaWRlbWlvbG9neSBhbmQgUHVibGljIEhlYWx0aCwgVW5p

dmVyc2l0eSBvZiBNYXJ5bGFuZCwgQmFsdGltb3JlLCBNRCAyMTIwMS0xNTk2LCBVU0EuIGxtYWdk

ZXJAZXBpLnVtYXJ5bGFuZC5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5JbmNpZGVu

Y2Ugb2YgYW5kIHJpc2sgZmFjdG9ycyBmb3IgYWR2ZXJzZSBjYXJkaW92YXNjdWxhciBldmVudHMg

YW1vbmcgcGF0aWVudHMgd2l0aCBzeXN0ZW1pYyBsdXB1cyBlcnl0aGVtYXRvc3VzPC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPkFtIEogRXBpZGVtaW9sPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRs

ZT5BbSBKIEVwaWRlbWlvbDwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkFtIEogRXBpZGVtaW9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW1lcmljYW4gam91cm5hbCBv

ZiBlcGlkZW1pb2xvZ3k8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkFtIEogRXBpZGVtaW9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW1lcmljYW4gam91cm5h

bCBvZiBlcGlkZW1pb2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz43MDgtMTk8

L3BhZ2VzPjx2b2x1bWU+MTc2PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMTI8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3QgMTU8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4xNDc2LTYyNTYgKEVsZWN0cm9uaWMpJiN4RDswMDAyLTkyNjIgKExpbmtpbmcp

PC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzMDI0MTM3PC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+

UmVzZWFyY2ggU3VwcG9ydCwgTi5JLkguLCBFeHRyYW11cmFsPC93b3JrLXR5cGU+PHVybHM+PC91

cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlk

ZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+

TmlrcG91cjwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+PFJlY051bT40Mjg8L1JlY051bT48cmVj

b3JkPjxyZWMtbnVtYmVyPjQyODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJF

TiIgZGItaWQ9IjBlejVzZTllYjl0MmFwZXJ0OTR2NTVkZWZwZmU5ZGQwcno1ZCI+NDI4PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5OaWtwb3VyLCBNLjwvYXV0aG9yPjxh

dXRob3I+VXJvd2l0eiwgTS4gQi48L2F1dGhvcj48YXV0aG9yPkliYW5leiwgRC48L2F1dGhvcj48

YXV0aG9yPkhhcnZleSwgUC4gSi48L2F1dGhvcj48YXV0aG9yPkdsYWRtYW4sIEQuIEQuPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+VW5pdmVyc2l0eSBvZiBU

b3JvbnRvIEx1cHVzIENsaW5pYyBhbmQgdGhlIENlbnRyZSBmb3IgUHJvZ25vc2lzIFN0dWRpZXMg

aW4gdGhlIFJoZXVtYXRpYyBEaXNlYXNlcywgVG9yb250byBXZXN0ZXJuIEhvc3BpdGFsLCAzOTkg

QmF0aHVyc3QgU3RyZWV0LCBUb3JvbnRvLCBPTiwgTTVUIDJTOCwgQ2FuYWRhLjwvYXV0aC1hZGRy

ZXNzPjx0aXRsZXM+PHRpdGxlPkltcG9ydGFuY2Ugb2YgY3VtdWxhdGl2ZSBleHBvc3VyZSB0byBl

bGV2YXRlZCBjaG9sZXN0ZXJvbCBhbmQgYmxvb2QgcHJlc3N1cmUgaW4gZGV2ZWxvcG1lbnQgb2Yg

YXRoZXJvc2NsZXJvdGljIGNvcm9uYXJ5IGFydGVyeSBkaXNlYXNlIGluIHN5c3RlbWljIGx1cHVz

IGVyeXRoZW1hdG9zdXM6IGEgcHJvc3BlY3RpdmUgcHJvb2Ytb2YtY29uY2VwdCBjb2hvcnQgc3R1

ZHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QXJ0aHJpdGlzIFJlcyBUaGVyPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L2FsdC10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcnRocml0aXMgUmVzIFRoZXI8L2Z1bGwtdGl0bGU+PGFi

YnItMT5BcnRocml0aXMgcmVzZWFyY2ggJmFtcDsgdGhlcmFweTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QXJ0aHJpdGlzIFJlcyBUaGVyPC9mdWxsLXRp

dGxlPjxhYmJyLTE+QXJ0aHJpdGlzIHJlc2VhcmNoICZhbXA7IHRoZXJhcHk8L2FiYnItMT48L2Fs

dC1wZXJpb2RpY2FsPjxwYWdlcz5SMTU2PC9wYWdlcz48dm9sdW1lPjEzPC92b2x1bWU+PG51bWJl

cj41PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PC9kYXRlcz48aXNibj4xNDc4LTYz

NjIgKEVsZWN0cm9uaWMpJiN4RDsxNDc4LTYzNTQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24t

bnVtPjIxOTU1NjUyPC9hY2Nlc3Npb24tbnVtPjx3b3JrLXR5cGU+Q29tcGFyYXRpdmUgU3R1ZHkm

I3hEO1Jlc2VhcmNoIFN1cHBvcnQsIE5vbi1VLlMuIEdvdiZhcG9zO3Q8L3dvcmstdHlwZT48dXJs

cz48L3VybHM+PHJlbW90ZS1kYXRhYmFzZS1wcm92aWRlcj5OTE08L3JlbW90ZS1kYXRhYmFzZS1w

cm92aWRlcj48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE.DATA (38, 43). Patient Involvement (Level C)Patient education is a vital part of CV risk management in CTD, as their involvement is more likely to result in success. Evidence in the lupus literature shows limited awareness amongst patients of their CV risk factors and of their increased CV risk PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XZWluc3RlaW48L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFy

PjxSZWNOdW0+MzgwPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig5Myk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzgwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zODA8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPldlaW5zdGVpbiwgUC4gSy48L2F1dGhv

cj48YXV0aG9yPkFtaXJraG9zcmF2aSwgQS48L2F1dGhvcj48YXV0aG9yPkFuZ2Vsb3BvdWxvcywg

VC4gSi48L2F1dGhvcj48YXV0aG9yPkJ1c2h5LCBBLjwvYXV0aG9yPjxhdXRob3I+Q292ZWxsaSwg

TS4gTS48L2F1dGhvcj48YXV0aG9yPkRlbm5pcywgSy4gRS48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5QYXRyaWNpYSBLLiBXZWluc3RlaW4sIFBoRCwgQVJO

UCwgTlAtQywgQ05FIEFkanVuY3QgRmFjdWx0eSwgQ29sbGVnZSBvZiBOdXJzaW5nLCBVbml2ZXJz

aXR5IG9mIENlbnRyYWwgRmxvcmlkYSwgT3JsYW5kby4gQWxpIEFtaXJraG9zcmF2aSwgUGhEIFBy

aW5jaXBhbCBTY2llbnRpc3QsIEZsb3JpZGEgSG9zcGl0YWwgQ2VudGVyIGZvciBUaHJvbWJvc2lz

IFJlc2VhcmNoLCBPcmxhbmRvLiBUaGVvZG9yZSBKLiBBbmdlbG9wb3Vsb3MsIFBoRCwgTVBIIFBy

b2Zlc3NvciwgQ29sbGVnZSBvZiBIZWFsdGggYW5kIFB1YmxpYyBBZmZhaXJzLCBVbml2ZXJzaXR5

IG9mIENlbnRyYWwgRmxvcmlkYSwgT3JsYW5kby4gQW5nZWxpbmUgQnVzaHksIFBoRCwgUk4sIEZB

QU4sIFBIQ05TLUJDIEJlcnQgRmlzaCBFbWluZW50IFNjaG9sYXIgRW5kb3dlZCBDaGFpciwgUHJv

ZmVzc29yLCBhbmQgQ29vcmRpbmF0b3IsIENvbGxlZ2Ugb2YgTnVyc2luZywgVW5pdmVyc2l0eSBv

ZiBDZW50cmFsIEZsb3JpZGEsIERheXRvbmEuIE1hdXJlZW4gTS4gQ292ZWxsaSwgUGhELCBSTiBB

c3NvY2lhdGUgUHJvZmVzc29yLCBDb2xsZWdlIG9mIE51cnNpbmcsIFVuaXZlcnNpdHkgb2YgQ2Vu

dHJhbCBGbG9yaWRhLCBPcmxhbmRvLiBLYXJlbiBFLiBEZW5uaXMsIFBoRCwgUk4sIEZBQU4gUHJv

ZmVzc29yLCBDb2xsZWdlIG9mIE51cnNpbmcsIFVuaXZlcnNpdHkgb2YgQ2VudHJhbCBGbG9yaWRh

LCBPcmxhbmRvLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJlZHVjaW5nIGNhcmRpb3Zh

c2N1bGFyIHJpc2sgaW4gd29tZW4gd2l0aCBsdXB1czogcGVyY2VwdGlvbiBvZiByaXNrIGFuZCBw

cmVkaWN0b3JzIG9mIHJpc2stcmVkdWNpbmcgYmVoYXZpb3JzPC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPlRoZSBKb3VybmFsIG9mIGNhcmRpb3Zhc2N1bGFyIG51cnNpbmc8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPkogQ2FyZGlvdmFzYyBOdXJzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2FyZGlvdmFzY3VsYXIgbnVyc2luZzwv

ZnVsbC10aXRsZT48YWJici0xPkogQ2FyZGlvdmFzYyBOdXJzPC9hYmJyLTE+PC9wZXJpb2RpY2Fs

PjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5UaGUgSm91cm5hbCBvZiBjYXJkaW92YXNjdWxh

ciBudXJzaW5nPC9mdWxsLXRpdGxlPjxhYmJyLTE+SiBDYXJkaW92YXNjIE51cnM8L2FiYnItMT48

L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xMzAtOTwvcGFnZXM+PHZvbHVtZT4yOTwvdm9sdW1lPjxu

dW1iZXI+MjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

TWFyLUFwcjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTAtNTA0OSAoRWxlY3Ry

b25pYykmI3hEOzA4ODktNDY1NSAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjMzNjQ1

NzQ8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBH

b3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlk

ZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+

PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XZWluc3RlaW48L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFy

PjxSZWNOdW0+MzgwPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig5Myk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MzgwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iMGV6NXNlOWViOXQyYXBlcnQ5NHY1NWRlZnBmZTlkZDByejVkIj4zODA8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPldlaW5zdGVpbiwgUC4gSy48L2F1dGhv

cj48YXV0aG9yPkFtaXJraG9zcmF2aSwgQS48L2F1dGhvcj48YXV0aG9yPkFuZ2Vsb3BvdWxvcywg

VC4gSi48L2F1dGhvcj48YXV0aG9yPkJ1c2h5LCBBLjwvYXV0aG9yPjxhdXRob3I+Q292ZWxsaSwg

TS4gTS48L2F1dGhvcj48YXV0aG9yPkRlbm5pcywgSy4gRS48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5QYXRyaWNpYSBLLiBXZWluc3RlaW4sIFBoRCwgQVJO

UCwgTlAtQywgQ05FIEFkanVuY3QgRmFjdWx0eSwgQ29sbGVnZSBvZiBOdXJzaW5nLCBVbml2ZXJz

aXR5IG9mIENlbnRyYWwgRmxvcmlkYSwgT3JsYW5kby4gQWxpIEFtaXJraG9zcmF2aSwgUGhEIFBy

aW5jaXBhbCBTY2llbnRpc3QsIEZsb3JpZGEgSG9zcGl0YWwgQ2VudGVyIGZvciBUaHJvbWJvc2lz

IFJlc2VhcmNoLCBPcmxhbmRvLiBUaGVvZG9yZSBKLiBBbmdlbG9wb3Vsb3MsIFBoRCwgTVBIIFBy

b2Zlc3NvciwgQ29sbGVnZSBvZiBIZWFsdGggYW5kIFB1YmxpYyBBZmZhaXJzLCBVbml2ZXJzaXR5

IG9mIENlbnRyYWwgRmxvcmlkYSwgT3JsYW5kby4gQW5nZWxpbmUgQnVzaHksIFBoRCwgUk4sIEZB

QU4sIFBIQ05TLUJDIEJlcnQgRmlzaCBFbWluZW50IFNjaG9sYXIgRW5kb3dlZCBDaGFpciwgUHJv

ZmVzc29yLCBhbmQgQ29vcmRpbmF0b3IsIENvbGxlZ2Ugb2YgTnVyc2luZywgVW5pdmVyc2l0eSBv

ZiBDZW50cmFsIEZsb3JpZGEsIERheXRvbmEuIE1hdXJlZW4gTS4gQ292ZWxsaSwgUGhELCBSTiBB

c3NvY2lhdGUgUHJvZmVzc29yLCBDb2xsZWdlIG9mIE51cnNpbmcsIFVuaXZlcnNpdHkgb2YgQ2Vu

dHJhbCBGbG9yaWRhLCBPcmxhbmRvLiBLYXJlbiBFLiBEZW5uaXMsIFBoRCwgUk4sIEZBQU4gUHJv

ZmVzc29yLCBDb2xsZWdlIG9mIE51cnNpbmcsIFVuaXZlcnNpdHkgb2YgQ2VudHJhbCBGbG9yaWRh

LCBPcmxhbmRvLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJlZHVjaW5nIGNhcmRpb3Zh

c2N1bGFyIHJpc2sgaW4gd29tZW4gd2l0aCBsdXB1czogcGVyY2VwdGlvbiBvZiByaXNrIGFuZCBw

cmVkaWN0b3JzIG9mIHJpc2stcmVkdWNpbmcgYmVoYXZpb3JzPC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPlRoZSBKb3VybmFsIG9mIGNhcmRpb3Zhc2N1bGFyIG51cnNpbmc8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPkogQ2FyZGlvdmFzYyBOdXJzPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2FyZGlvdmFzY3VsYXIgbnVyc2luZzwv

ZnVsbC10aXRsZT48YWJici0xPkogQ2FyZGlvdmFzYyBOdXJzPC9hYmJyLTE+PC9wZXJpb2RpY2Fs

PjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5UaGUgSm91cm5hbCBvZiBjYXJkaW92YXNjdWxh

ciBudXJzaW5nPC9mdWxsLXRpdGxlPjxhYmJyLTE+SiBDYXJkaW92YXNjIE51cnM8L2FiYnItMT48

L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xMzAtOTwvcGFnZXM+PHZvbHVtZT4yOTwvdm9sdW1lPjxu

dW1iZXI+MjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

TWFyLUFwcjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTAtNTA0OSAoRWxlY3Ry

b25pYykmI3hEOzA4ODktNDY1NSAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjMzNjQ1

NzQ8L2FjY2Vzc2lvbi1udW0+PHdvcmstdHlwZT5SZXNlYXJjaCBTdXBwb3J0LCBOb24tVS5TLiBH

b3YmYXBvczt0PC93b3JrLXR5cGU+PHVybHM+PC91cmxzPjxyZW1vdGUtZGF0YWJhc2UtcHJvdmlk

ZXI+TkxNPC9yZW1vdGUtZGF0YWJhc2UtcHJvdmlkZXI+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+

PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA (93). Future considerations (Level C)Dedicated CV screening clinics for CTD may be the way forward, with evidence of their benefit in other inflammatory rheumatic conditions already available ADDIN EN.CITE <EndNote><Cite><Author>Rollefstad</Author><Year>2013</Year><RecNum>425</RecNum><DisplayText>(94)</DisplayText><record><rec-number>425</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">425</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rollefstad, S.</author><author>Kvien, T. K.</author><author>Holme, I.</author><author>Eirheim, A. S.</author><author>Pedersen, T. R.</author><author>Semb, A. G.</author></authors></contributors><titles><title>Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic</title><secondary-title>Ann Rheum Dis</secondary-title></titles><periodical><full-title>Ann Rheum Dis</full-title><abbr-1>Annals of the rheumatic diseases</abbr-1></periodical><pages>1968-74</pages><volume>72</volume><number>12</number><dates><year>2013</year></dates><isbn>1468-2060 (Electronic)&#xD;0003-4967 (Linking)</isbn><work-type>Research Support, Non-U S Gov&apos;t</work-type><urls></urls></record></Cite></EndNote>(94). Another consideration for the future is the use of screening tools such as carotid ultrasound to assess cIMT and presence of plaque as these markers have been shown to be independent predictors of CVEs ADDIN EN.CITE <EndNote><Cite><Author>Kao</Author><Year>2013</Year><RecNum>423</RecNum><DisplayText>(28)</DisplayText><record><rec-number>423</rec-number><foreign-keys><key app="EN" db-id="0ez5se9eb9t2apert94v55defpfe9dd0rz5d">423</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kao, A. H.</author><author>Lertratanakul, A.</author><author>Elliott, J. R.</author><author>Sattar, A.</author><author>Santelices, L.</author><author>Shaw, P.</author><author>Birru, M.</author><author>Avram, Z.</author><author>Thompson, T.</author><author>Sutton-Tyrrell, K.</author><author>Ramsey-Goldman, R.</author><author>Manzi, S.</author></authors></contributors><auth-address>Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania. Electronic address: akao@.</auth-address><titles><title>Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus</title><secondary-title>Am J Cardiol</secondary-title><alt-title>Am J Cardiol</alt-title></titles><periodical><full-title>Am J Cardiol</full-title><abbr-1>The American journal of cardiology</abbr-1></periodical><alt-periodical><full-title>Am J Cardiol</full-title><abbr-1>The American journal of cardiology</abbr-1></alt-periodical><pages>1025-32</pages><volume>112</volume><number>7</number><dates><year>2013</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>1879-1913 (Electronic)&#xD;0002-9149 (Linking)</isbn><accession-num>23827400</accession-num><work-type>Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t</work-type><urls></urls><remote-database-provider>NLM</remote-database-provider><language>eng</language></record></Cite></EndNote>(28). Summary (Level A)Information on the risk of ACVD and risk factors for the development of CVD in patients with CTDs other than SLE is sparse. This is, in part, because the study of cause-specific mortality and morbidity requires large cohorts of patients followed over long periods of time with robust identification of the outcomes of interest. Assembling such cohorts is a challenge in rare CTDs and often requires multi-centre collaboration. There is an increasing body of evidence that TRFs, disease specific factors and treatment all contribute to the excess risk of CVD in patients with SLE. It is probable that a similar pattern will emerge in non-SLE CTDs although the relative contribution of these factors is likely to differ. The minimisation of CV risk in the individual patient with CTD will require attention to optimise TRFs and control of disease activity whilst minimising exposure to steroids.Practice points (Level C)CTD patients should have a CV risk assessment, ideally at baseline and annually thereafterTRFs and disease related factors, including medications, must be considered when assessing CV risk If TRFs are identified they should be managed at least as stringently as recommended in guidelines for the general population As a validated composite CV risk assessment model for CTD is not currently available, we recommend a target-based approach to the assessment and management of CV risk for these patientsResearch agenda (Level C)Further research is necessary to expand on what is known with respect to CV risk in CTDs other than SLE.Whether CV outcomes in SLE and other CTDs improve with the use of more stringent targets than is recommended in the general population needs to be determined.When disease activity is controlled and TRF have been addressed, research will be important to investigate whether CV risk in CTD is then level with that in the general population or whether other non-modifiable risk factors are involved.Conflict of interest statement (Level C)Miriam O’Sullivan, Ian Bruce and Deborah Symmons have no conflicts of interestReferences: * most important ADDIN EN.REFLIST 1.Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59(12):1690-7. Epub 2008/11/28.2.Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. The American journal of medicine 1976;60(2):221-5.*3.Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr., Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145(5):408-15.4.Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC. Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum 2012;41(6):830-9.5.Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54(8):2550-7.*6.Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014;66(4):608-16.7.Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppanen O. Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000-2008. Lupus 2014;23(13):1430-4.8.Lerang K, Gilboe IM, Steinar Thelle D, Gran JT. Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study. Lupus 2014;23(14):1546-52.9.Rees F, Doherty M, Grainge MJ, Lanyon P, Davenport G, Zhang W. Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012. Rheumatology (Oxford, England) 2016.10.Yee CS, Su L, Toescu V, Hickman R, Situnayake D, Bowman S, et al. Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years. Rheumatology (Oxford) 2015;54(5):836-43.11.Wang Z, Wang Y, Zhu R, Tian X, Xu D, Wang Q, et al. Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore) 2015;94(17):e794. Epub 2015/05/02.12.Souza DC, Santo AH, Sato EI. Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis. J Rheumatol 2012;39(3):496-503.13.Thomas G, Mancini J, Jourde-Chiche N, Sarlon G, Amoura Z, Harle JR, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis & rheumatology (Hoboken, NJ) 2014;66(9):2503-11.14.Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum 2009;61(10):1396-402.15.Abstracts of the10th International Congress on SLE. April 18-21, 2013. Buenos Aires, Argentina. Lupus 2013;22 Suppl 1:1-196.16.Lin CY, Shih CC, Yeh CC, Chou WH, Chen TL, Liao CC. Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies. Int J Cardiol 2014;176(3):847-51.17.Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, et al. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol 2014;41(4):680-7.18.Maksimowicz-McKinnon K, Selzer F, Manzi S, Kip KE, Mulukutla SR, Marroquin OC, et al. Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv 2008;1(3):201-8.19.Lai CH, Lai WW, Chiou MJ, Lin WC, Yang YJ, Li CY, et al. Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study. Ann Rheum Dis 2015.20.Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42(2):338-46.21.Urowitz MB, Gladman D, Ibanez D, Bae SC, Sanchez-Guerrero J, Gordon C, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010;62(6):881-7.22.Shah MA, Shah AM, Krishnan E. Poor outcomes after acute myocardial infarction in systemic lupus erythematosus. J Rheumatol 2009;36(3):570-5. Epub 2009/02/12.23.Holmqvist M, Simard JF, Asplund K, Arkema EV. Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies. RMD open 2015;1(1):e000168.*24.Burgos PI, Vila LM, Reveille JD, Alarcon GS. Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX). Lupus 2009;18(14):1303-8.25.Hassan AA, Habib HM, Eissa AA. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study. International journal of rheumatic diseases 2013;16(3):319-24.26.Chuang YW, Yu MC, Lin CL, Yu TM, Shu KH, Kao CH. Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) 2015;94(46):e2121.27.Wu GC, Liu HR, Leng RX, Li XP, Li XM, Pan HF, et al. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis. Autoimmunity reviews 2016;15(1):22-37.28.Kao AH, Lertratanakul A, Elliott JR, Sattar A, Santelices L, Shaw P, et al. Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus. Am J Cardiol 2013;112(7):1025-32.29.Tselios K, Sheane BJ, Gladman DD, Urowitz MB. Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review. J Rheumatol 2016;43(1):54-65.*30.Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum 2003;48(11):3159-67.31.Parker B, Bruce IN. The metabolic syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am 2010;36(1):81-97, viii.32.Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, et al. Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis 2015;74(8):1530-6.33.Tselios K, Koumaras C, Urowitz MB, Gladman DD. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal. Semin Arthritis Rheum 2014;43(4):521-5.34.Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44(10):2331-7.35.Urowitz MB, Ibanez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007;34(1):70-5.36.Ballocca F, D'Ascenzo F, Moretti C, Omede P, Cerrato E, Barbero U, et al. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. European journal of preventive cardiology 2015;22(11):1435-41.37.Gustafsson JT, Simard JF, Gunnarsson I, Elvin K, Lundberg IE, Hansson LO, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther 2012;14(2):R46.38.Magder LS, Petri M. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 2012;176(8):708-19.*39.Rojas-Villarraga A, Toro CE, Espinosa G, Rodriguez-Velosa Y, Duarte-Rey C, Mantilla RD, et al. Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmunity reviews 2010;9(4):229-32.40.Franco JS, Molano-Gonzalez N, Rodriguez-Jimenez M, Acosta-Ampudia Y, Mantilla RD, Amaya-Amaya J, et al. The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians. PLoS One 2014;9(10):e110242.41.Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62(11):1071-7. Epub 2003/10/30.42.Yang L, Tao J, Tang X, Wang Y, He X, Xu G, et al. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients. Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26(1):95-101.43.Nikpour M, Urowitz MB, Ibanez D, Harvey PJ, Gladman DD. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Res Ther 2011;13(5):R156.44.Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Archives of cardiovascular diseases 2010;103(1):46-52.45.Cannarile F, Valentini V, Mirabelli G, Alunno A, Terenzi R, Luccioli F, et al. Cardiovascular disease in systemic sclerosis. Annals of translational medicine 2015;3(1):8.46.Rubio-Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 2014;44(2):208-19.47.Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69(10):1809-15.48.Dave AJ, Fiorentino D, Lingala B, Krishnan E, Chung L. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014;66(2):323-7.49.Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Van Doornum S. Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 2012;71(12):1980-3.*50.Man A, Zhu Y, Zhang Y, Dubreuil M, Rho YH, Peloquin C, et al. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 2013;72(7):1188-93.51.Chu SY, Chen YJ, Liu CJ, Tseng WC, Lin MW, Hwang CY, et al. Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. The American journal of medicine 2013;126(11):982-8.52.Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, et al. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 2011;63(7):2078-90.53.Gupta R, Wayangankar SA, Targoff IN, Hennebry TA. Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 2011;148(3):261-70.54.Limaye V, Hakendorf P, Woodman RJ, Blumbergs P, Roberts-Thomson P. Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Intern Med J 2012;42(2):191-8.55.Ungprasert P, Suksaranjit P, Spanuchart I, Leeaphorn N, Permpalung N. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 2014;44(1):63-7.*56.Lin YN, Lin CL, Chang KC, Kao CH. Increased subsequent risk of acute coronary syndrome for patients with dermatomyositis/polymyositis: a nationwide population-based retrospective cohort study. Scandinavian journal of rheumatology 2015;44(1):42-7.57.Lai YT, Dai YS, Yen MF, Chen LS, Chen HH, Cooper RG, et al. Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population-based longitudinal follow-up study. The British journal of dermatology 2013;168(5):1054-9.58.Tisseverasinghe A, Bernatsky S, Pineau CA. Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol 2009;36(9):1943-6.59.de Moraes MT, de Souza FH, de Barros TB, Shinjo SK. Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. Arthritis Care Res (Hoboken) 2013;65(5):793-9.60.Limaye VS, Lester S, Blumbergs P, Roberts-Thomson PJ. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. International journal of rheumatic diseases 2010;13(2):132-7.61.Wang H, Cai Y, Cai L, Hu Y, Chen X, Deng J. Altered lipid levels in untreated patients with early polymyositis. PLoS One 2014;9(2):e89827. Epub 2014/03/04.62.Diederichsen LP, Diederichsen AC, Simonsen JA, Junker P, Sondergaard K, Lundberg IE, et al. Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study. Arthritis Care Res (Hoboken) 2015;67(6):848-54.63.Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, et al. Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol 2014;171(3):326-30.*64.Hajas A, Szodoray P, Nakken B, Gaal J, Zold E, Laczik R, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol 2013;40(7):1134-42.65.Soltesz P, Bereczki D, Szodoray P, Magyar MT, Der H, Csipo I, et al. Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease. Arthritis Res Ther 2010;12(3):R78.66.Bodolay E, Seres I, Szodoray P, Csipo I, Jakab Z, Vegh J, et al. Evaluation of paraoxonase activity in patients with mixed connective tissue disease. J Rheumatol 2008;35(2):237-43.67.Brito-Zeron P, Kostov B, Solans R, Fraile G, Suarez-Cuervo C, Casanovas A, et al. Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis 2014.68.Chiang CH, Liu CJ, Chen PJ, Leu HB, Hsu CY, Huang PH, et al. Primary Sjogren's Syndrome and the Risk of Acute Myocardial Infarction: A Nationwide Study. Acta Cardiologica Sinica 2013;29(2):124-31.*69.Chiang C-H, Liu C-J, Chen P-J, Huang C-C, Hsu C-Y, Chan W-L, et al. Primary Sjogren's syndrome and risk of ischemic stroke: a nationwide study. Clin Rheumatol 2014;33(7):931-7.70.Bartoloni E, Baldini C, Schillaci G, Quartuccio L, Priori R, Carubbi F, et al. Cardiovascular disease risk burden in primary Sjogren's syndrome: results of a population-based multicentre cohort study. Journal of Internal Medicine 2015;278(2):185-92.71.Juarez M, Toms TE, de Pablo P, Mitchell S, Bowman S, Nightingale P, et al. Cardiovascular risk factors in women with primary Sjogren's syndrome: United Kingdom primary Sjogren's syndrome registry results. Arthritis Care Res (Hoboken) 2014;66(5):757-64.72.Mankad R. Atherosclerotic vascular disease in the autoimmune rheumatologic patient. Current atherosclerosis reports 2015;17(4):497.73.Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010;69(7):1269-74.74.Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation 2011;123(11):1243-62.75.O'Neill SG, Pego-Reigosa JM, Hingorani AD, Bessant R, Isenberg DA, Rahman A. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford, England) 2009;48(5):573-5.76.Urowitz MB, Ibanez D, Gladman DD. Adjusted Framingham Risk Factor Scoring for Systemic Lupus Erythematosus. Arthritis Rheum 2011;63(10):S884-S5.77.Wajed J, Ahmad Y, Durrington PN, Bruce IN. Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management. Rheumatology (Oxford, England) 2004;43(1):7-12.*78.Bichile T, Petri M. Prevention and management of co-morbidities in SLE. Presse medicale (Paris, France : 1983) 2014;43(6 Pt 2):e187-95.79.Bruce IN. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford, England) 2005;44(12):1492-502.80.Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34(28):2159-219.81.Ghaussy NO, Sibbitt W, Jr., Bankhurst AD, Qualls CR. Cigarette smoking and disease activity in systemic lupus erythematosus. J Rheumatol 2003;30(6):1215-21.82.Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. Journal of the American Academy of Dermatology 2000;42(6):983-7.83.Chasset F, Frances C, Barete S, Amoura Z, Arnaud L. Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. Journal of the American Academy of Dermatology 2015;72(4):634-9.84.Harrison BJ, Silman AJ, Hider SL, Herrick AL. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum 2002;46(12):3312-6.85.Hudson M, Lo E, Lu Y, Hercz D, Baron M, Steele R. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum 2011;63(1):230-8. Epub 2010/10/12.86.Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). International journal of behavioral medicine 2012;19(4):403-88.87.Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Serum lipid levels in Sjogren's syndrome. Rheumatology (Oxford, England) 2006;45(4):481-4.88.Gerli R, Bartoloni Bocci E, Vaudo G, Marchesi S, Vitali C, Shoenfeld Y. Traditional cardiovascular risk factors in primary Sjogren's syndrome--role of dyslipidaemia. Rheumatology (Oxford, England) 2006;45(12):1580-1; author reply 1-2.89.Ye Y, Zhao X, Xie H, Tian Z, Zhang S. Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials. Int J Cardiol 2013;167(1):301-3.90.Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol 2005;96(4A):53E-9E.91.Gerstein HC, Thorpe KE, Taylor DW, Haynes RB. The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial. Diabetes research and clinical practice 2002;55(3):209-19.92.Barnes JN, Tanaka H. Cardiovascular benefits of habitual exercise in systemic lupus erythematosus: a review. The Physician and sportsmedicine 2012;40(3):43-8.93.Weinstein PK, Amirkhosravi A, Angelopoulos TJ, Bushy A, Covelli MM, Dennis KE. Reducing cardiovascular risk in women with lupus: perception of risk and predictors of risk-reducing behaviors. The Journal of cardiovascular nursing 2014;29(2):130-9.94.Rollefstad S, Kvien TK, Holme I, Eirheim AS, Pedersen TR, Semb AG. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic. Ann Rheum Dis 2013;72(12):1968-74. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download